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ABSTRACT OF THESIS: 
The optimal timing of valve replacement surgery in chronic severe 
aortic regurgitation (AR) has remained a major clinical problem' in 
the management of these patients. Although the onset of symptoms 
is the generally accepted indication for aortic valve replacement 
(AVR), the unpredictable development of pre-symptomatic left 
ventricular (LV) dysfunction as a result of prolonged volume 
overload has resulted in numerous reports attempting to formulate a 
risk profile for these patients. Although aortic root and LV 
cineangiography have been the »gold standard" for defining the 
severity of AR and its effect on LV performance, serial follow-up 
by these means is impractical. More recently numerous non-invasive 
measures of LV size (echocardiogram) and function both at rest and 
on exercise (echocardiogram and equilibrium radionuclide 
angiocardiography., ERNA) have been serially utilised~ In these 
endeavours, the thinking has been clouded by a tendency to equate 
these two measures and failing to appreciate that apparent pre-
operative LV dysfunction (particularly on exercise) may be rapidly 
reversible by AVR and the consequent changes in LV loading 
conditions. 
This study was a prospective, sequential evaluation of left 
ventricular function using both non-invasive and invasive 
techniques in symptomatic and asymptomatic patients with isolated 
chronic, severe (4+) AR at cardia~~atheterisation. The aims of 
the study were to (I) Identify differences in the clinical, 
echocardiographic, resting and exercise haemodynamic and 
I 
radionuclide measures of left ventricular function in symptomatic 
and asymptomatic patients with chronic severe A.R. with particular 
iii 
reference to the incidence of presymptomatic development of left 
ventricular dysfunction. (II) Critically evaluate the role of 
exercise stress (both isotonic and isometric) in the assessment of 
patients with chronic severe A.R. (III) Evaluate the influence of 
time (sequential studies) on the haemodynamic burden in 
asymptomatic patients. (IV) Study the impact of successful aortic 
valve replacement on the reversibility of abnormal pre-operative LV 
function in an attempt to predict which patients would b~nefit from 
this therapeutic intervention and whether operation for symptoms 
alone is the correct clinical practice. 
Thirty two (32) symptomatic patients and twenty eight (28) 










dimensions and systolic function, 
with simultaneous haemodynamic 
catheterisation including coronary monitoring, 
angiography. Two forms of exercise were used, namely graded, 
symptom-limited supine and erect bicycle exercise and isometric 
handgrip. Twenty two (22) of the symptomatic group underwent AVR 
and 19 patients were re-evaluated 6 months postoperatively. Twenty 
six patients (23 asymptomatic and 3 unoperated symptomatic 
patients) were sequentially evaluated at 6 months after the initial 
assessment, with 9 patients re-assessed at 12 months. 
At the initial assessment, the clinical evaluation (including the 
degree of LV hypertrophy on the electrocardiogram and the cardio-
thoracic ratio) and echocardiographic LV dimensions and systolic 
function did not help .in the differentiation of symptomatic from 
iv 
asymptomatic patients. The exerQisa study confirmed that a drop in 
LV ejection fraction (LVEF} on exercise is common, occurring in 81% 
of the symptomatic group and approximately 50% of the asymptomatic 
patients. Contrary to earlier reports, posture was not found to be 
important in the stratification of patients on the basis of LVEF 
response to exercise. Upright exercise more closely resembles 
normal daily activity and is recommended as the posture of choice 
in the exercise evaluaton of patients with chronic severe AR. 
Resting LVEF did not appear predictiv~ of this exercise response 
which occurred early during graded supine bicycle exercise. Low 
level exercise is thus adequate to stratify patients based on LV 
functional reserve, accepting the fact that a normal exercise 
capacity has been shown to be an independent prognostic factor. 
Exercise LVEF correlated poorly with other measured variables 
(haemodynamic and radionuclide). This finding is not surprising 
given the known limitations of this dimensionless measure of LV 
function. 
Despite some of the theoretical advantages, it would appear that, 
isometric handgrip exercise is not a satisfactory alternative to 
dynamic exercise. 
A decrease in LV dilatatjon following AVR is confirmed but occurred 
later (between 2 weeks and 6 months)than in many earlier reports. 
However, patients with marked pre-operative LV dilatation ran a 
major risk of persistent postoperative LV enlargement. The 
prognostic value of a pre-operative end-systolic dimension (DES) of 
> 55mm was not substantiated but the sample size was small. In 
~ 




(LVH) is a slow process following aortic valve 
Although the sequential assessment showed a gradation to 
abnormality in some of the haemodynamic measures and a 
increase in the number of patients with an abnormal LV 
reserve, it is important to note that some patients 




The most important findings were in the postoperative evaluation 
and serve to confirm our present practice at this institution of 
only recommending AVR in symptomatic patients with chronic severe 
aortic regurgitation. 
These included a marked improvement in symptomatic status, a 
normalisation or near-normalisation of LV mass, diastolic filling 
patterns and resting and exercise LVEF in approximately 75% of 
cases. These favourable changes could not be predicted from the 
level of pre-operative exercise LVEF and serve to confirm that an 
abnormal LV functional reserve is not of any prognostic 
significance. 
Despite normalisation of the echocardiographic dimensions and 
resting. LVEF, pulmonary capillary wedge pressure (PCWP) at rest 
remained abnormal in one third of the patients and was markedly 
elevated on exercise in the majority of the group 
observations cannot be adequately explained 
hypertrophy or abnormal diastolic filling and 










In conclusion, it would appear reasonable to delay aortic valve 
replacement in chronic severe aortic regurgitation until the 
development of 
expensive and 
symptoms, negating the need for 
time-consuming follow-up. This is 
sophisticated, 
particularly 
relevant in our society where resources are limited and patients 
often present late in the n~tural history of this disease. 
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CHAPTER 1 
HISTORICAL REVIEW 
Although Sir Dominic Corrigan (Corrigan 1832) publ.ished the classic 
monograph on aortic regurgitation in 1832 entitled "On Permanent 
Patency of the Mouth of the Aorta ~r Inadequacy of. the Aortic 
Valves", earlier reports on the pathology and clinical 
manifestations date back to the early seventeenth century. These 
have been eloquently cited by Crawford Adams (Adams 1969). 
In 1615 Helkiah Crooke (Crooke 1615) described the pathologic 
findings of aortic regurgitation associated with dilatation of the 
heart: "In the dilatation of the'heart they (aortic cups) are all 
extended, the forked valves making certain gaping fissures between 
their forkes, by which the matters are let in". 
Raymond de ViEmssens in 1695 described the clinical manifestations 
of aortic insufficiency published in his book Novum Vasorum 
Corporis Humani Systema(Vieussens 1705) and in 1715 (Vieussens 
1715) described the pulse of aortic insuficiency as It . . . . . . very 
full, very fast, hard and unequal and so strong the arteries on 
both sides struck the fingers like a tense cord vibrating 
violently". William Cowper (Cowper 1703 - 1712) in 1705 described 
the pathophysiologic basis of symptoms due to volume and pressure 
overload of the left ventricle in his paper, "Of' Ossifications or 
Petrifactions in the Coats of Arteries, Particularly in the Valves 
of the Great Artery." 
"The explication of the symptoms in both these cases is obvious 
enough; for though the person in the first instance did not.die of 
2 
the same disease as the other, yet the symptoms in his illness 
plainly showed what must follow from the disorders of these valves, 
as they are rendered more or less useless; for as their office is 
to prevent the return of the blood into the heart, in its diastole, 
I 
by exactly shutting up the passage of the aorta, like the valves in 
water engines, so if by an accident they are hindered from doing 
their duty, as they were by the petrifications mentioned, the 
consequences must be, not only a regurgitation of blood into the 
heart. In the latter instance, these valves were wholly useless, 
and the circulation became more difficult, as appeared by the 
refrigeration of the extreme parts. In both cases, the left 
ventricle of the heart was dilated proportionately to the bad 
constitution of these valves, which plainly shows these valves give 
such assistance to the heart, as it cannot be without, and that it 
gradually suffers according to their indisposition"~ 
The haemodynamic characteristics were further amplified in 1761 by 
John Baptist Morgagni (Morgagni 1761) in his "Letter the Twenty-
third, Article 9":-
..... . ..... , so that, as some portion of it returned into the left 
ventricle of the heart, when this ventricle ought.to receive the 
blood that was coming in from the ~ungs, it would necessarily 
happen, that the returning portion, as well as the portion which 
had not been extruded just before, must occupy some part of that 
space, which, from the design of nature, was entirely due to the 
blood that was coming in from the lungs. Which circumstance, 
finally, could not 'but overload both the lungs and the heart, and 
compel the latter to throw out, every now and then, with a great 
impetus, the blood that stagnated in it". 
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Further knowledge of the signs of aortic insufficiency were 
described in 1827 by Thomas Hodgkin in a paper read before the 
Hunterian Society and later published in the Medical Gazette(l871) 
and described in Wilks' historical note on Valvular Disease of the 
Heart. He refers to the great enlargement of the heart that 
ensues, and of the "bruit de scie" heard during life owing to the 
blood being subjected to two motions, the one progressive, the 
other retrograde. He describes the case of a friend Dr Cos, a 
travelling physician to Sir R K Porter who was an active sportsman 
despite severe aortic regurgitation. He exhibited the heart to the 
Society, which was much enlarged, and one valve was elongated and 
hung down towards the ventricle (Specimen now in Guy's Hospital 
Museum, No. 1427). In the 1829 Lumleyan Lectures before the Royal 
College of Physicians, John Elliotson described a bellows-murmur 
due to aortic regurgitation. This lecture was published in 1830. 
James Hope took exception to Corrigan's initial claim and 
emphasised that aortic regurgitation was first described in his 
treatise on Diseases of the Heart published in December 1831. 
However, he corrected this impression in the 1842 first American 
edition of Diseases of the Heart(Hope 1842) and gave credit to John 
Elliotson. In his treatise he describes the quality and location 
of the murmur, points out that it is of very frequent occurrence, 
though commonly supposed to be rare and that the reason for this 
was that it was invariably mistaken for a murmur from the mitral 
valve. 
In Corrigan's classic monograph, "On Permanent Patency of the Mouth 
of the Aorta or Inadequacy of the Aortic Valves" published in 1832 
in the Edinburgh Medical and Surgical Journal, he makes three 
pertinent and interesting observations:-
Figure 1.1 CORRIGAN'S ORIGINAL PUBLICATION 
ON PERMANENT PATENCY OF THE MOUTH OF THE 
AORTA, OR INADEQUACY OF THE AORTIC VALVES* 
By 
D. ]. CORRIGAN, M.D. 
One of the 11hysir.ians to the Charitable Infirmary, .[eMJis Street, Dublin; Lecturer on t/&e 
Theory and Practice of Medicine; Consulting Physician to 
St. Patrick's College, Maynooth 
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(i) Firstly, he appreciated the varied pathological conditions 
which may affect the valve , " .... morbid affection of the 
valves and aorta permitting this regurgitation are - that 
the valves may be absorbed in patches, - reticulated and 
present holes; may be ruptured, - flapping back into the 
ventricle; - may be tightened or curled in against the sides 
of the aorta; - or without any proper organic lesion may be 
rendered inadequate to their function by dilatation of the 
mouth of the aorta, - and the blood then, as in the other 
instances, regurgitates freely into the ventricle." 
(ii) Secondly, he recognised that symptoms are non-specific but 
appreciated the diagnostic importance of the physical signs 
and gives a detailed description of the pathophysiologic 
mechanisms behind these signs-" .... what is deficient in 
general symptoms from their obscurity is, however, amply 
supplied by the certainty of the physical and stethoscopic 
signs, which may be referred to the three following 
indications:-
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(a) Visible pulsation of the arteries of the head, and 
superior extremities. 
(b) "Bruit de soufflet" in the ascending aorta, in the 
carotids, and subclavians. 
(c) "Bruit de soufflet" and "fremissemont" or a peculiar 
rushing thrill felt by the finger, in the carotids and 
subclavians. In conjunction with these may be reckoned 
the pulse, which is invariable full." 
(iii) Thirdly, he astutely appreciated and reported the fact that 
chronic severe aortic regurgitation is characterised by a 
protracted clinical course - "Although the cure of 
Inadequacy of the Aortic Valves is probably out of the reach 
of medicine, a correct knowledge of the nature of the 
\ 
affection is not the less necessary. The, patient is 
relieved from harassing treatment, that, however applicable 
in other cases of heart disease, is not alone useless, but 
positively injurious in this. In other affections of the 
heart there is constant danger of sudden death from 
pulmonary apoplexy or haemorrhage, which may be induced even 
by ordinary exertion, and such danger keeps the patients in 
a state of perpetual terror. In this disease, on the 
contrary, assurance may be given against any sudden 
termination; and the patient may be permitted not only to 
attend to his business or profession, but may be assured, 
that in leading a life of business and tolerable activity, 
he is adopting the very best means to prolong his life. 
Under treatment such as recommended, it is astonishing what 





is the dilemma of the practising 
Now that treatment for aortic 
regurgitation is available the deci~ion as to when to 
intervene is difficult and forms the basis of the thesis. 
Although the presence of a double murmur heard by pressure 
of the stethoscope was first described by Bouilland, its 
importance was emphasised by his pupil Paul Louis De Roziez 
in his paper on "The Double Intermittent Murmur over the 
Femoral Arteries as a sign of Aortic Insufficiency" 
published in 1861. 
"DuRoziez's sign". 
This murmur later became known as 
In this report he makes a number of 
important points, viz:-
(i) The double intermittent murmur described by many 
authors was never given as a constant sign in this 
lesion. 
(ii) Most commonly it is not present and it is necessary 
to produce it by compression the finger, 
compressing the artery about two centimeters above 
the stethoscope, produces the first murmur; two 
centimeters below, the second murmur. 
In subsequent years clinical observation has made it increasingly 
evident that, while DuRoziez's sign usually can be elicited in 
patients with the intracardiac signs of aortic regurgitation, these 
phenomena are not mutually dependent - one may be present without 
the other. The diagnostic significance of DuRoziez's sign 
consequently 
investigation. 
has occasioned considerable discussion and 
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A few years later Traube (Traube 1872) described a double tone 
(Doppeltone) which could be heard in rare cases by applying the 
stethoscope lightly over the femoral artery, so that the diameter 
of the vessel was not modified by the compression. The fundamental 
work of DuRoziez and Traube made many points clear concerning the 
causation of these murmurs and sounds despite the confusion 
introduced by later workers. The first arterial murmur was 
explained ·as caused by the eddies which are formed by the pulse 
wave under the narrow arterial section where the stethoscope is 
applied. The second murmur was explained as caused by a backward 
wave coming from the periphery and the centripetal nature of the 
wave was admitted by all later authors. 
The presystolic murmur which sometimes accompanies aortic 
regurgitation, later to be known as the Austin Flint murmur, was 
first observed in 1859 by Dr A Flint in examining a patient with 
well-marked signs of aortic regurgitation in whom a presystolic 
murmur was audible at the apex. At autopsy however, the mitral 
valve was found to be normal. This classic desription was 
published in 1862 in the American Journal of the Medical 
Sciences(Flint 1862). Flint heartily disapproved of associating 
any physical sign with the name of the original describer and wrote 
(Landis 1912): "So long as signs are determined from fancied 
analogies, and named from these or after the person who describes·. 
them, there cannot but be obscurity and confusion." 
From the time of these early descriptions, the medical treatment of 
aortic regurgitation of severe degree had been unsatisfactory. 
Although it was appreciated that the asymptom~tic state may be 
present for many years, the onset of symptoms heralded a rapid 
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downhill course (Langley 1921, Reader 1947 and Webster 1953). In 
general however, the prognosis was better in the rheumatic group 
than the syphilitic group. Signs of poor prognosis included severe 
praecordial pain, severe congestive heart failure, cardiomegaly, 
low diastolic pressure, prolongation of the PR interval and active 
endocarditis. 
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Once surgery became possible for the management of severe aortic 
regurgitation, with Hufnagel in the 1950s (Hufnagel 19~4) and 
later Starr(Starr 1963) in 1960 using a ball valve prosthesis and 
Ross (Ross 1966)and Barratt-Bayes (Barratt-Bayes 1965) inserting 
the first 
important 
homografts a few years later, 
to know about the natural 
it became particularly 
clinical course of this 
condition, so as to more optimally select patients for valve 
replacement surgery. In 1956 Segal, Proctor Harvey and Hufnagel 
(Segal 1956) reported their experience with a selected population 
of 100 cases of severe aortic regurgitation referred to the 
Georgetown University Medical Centre for cardiac evaluation and 
suitability for insertion of the Hufnagel aortic plastic valve. 
Although many interesting and unusual clinical features became 
evident from this study, they were able to particularly emphasise 
the natural history of chronic rheumatic aortic regurgitation. The, 
following profile history typified the average patient with aortic 
regurgitation: acute rheumatic fever at the age of 13 years with 
recurrent attacks in subsequent years; haemodynamically significant 
aortic regurgitation by age 20 years; a ten year "asymptomatic" 
period, followed by the final phase of 6.4 years from the onset of 
symptoms to the time of evaluation. Usually the symptoms were 
slowly progressive in nature, first manifested by mild dyspnoea on 
effort or a sensation of increased cardiac thrust. They emphasised 
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the frequency of classic angina (almost 50% of cases), occurring in 
the majority a few years .after the onset of dyspnoea on effort. 
The average age of those with and without angina was the same. 
\ 
The symptom was usually effort induced but rest angina did occur 
fairly commonly- autopsies in a number of these cases\ showed 'no 
evidence of coronary artery disease or ostial narrowing~ They 
proposed three pathophysiological mechanisms namely:-
( i ) Marked lowering of diastolic pressure with resultant 
decrease in coronary blood flow, 
(ii) The "sucking" action of the regurgitant stream on the 
coronary arteries (Bernouilli's. principle), 
(iii) Relative coronary insufficiency related to the large left 
ventricular mass. 
They were able to show that the following clinical and radiographic 
factors indicated a poor prognosis:-
( i) Recent occurrence· of bacterial endocardi ti,s with subsequent 
increasing signs of aortic regurgitation 
(ii) Co-existence of angina and congestive heart failur~ 
(iii) Syphilitic aetiology 
(iv) Marked cardiomegaly 
(v) Increasing age (over 40 years) 
(vi) Increasing duration of symptoms. 
In addition, approximately 5% of these patients with severe, fairly 
well compensated, aortic regurgitation died suddenly and 
unexpectedly. Ventricular premature beats were common in this 
group and the presumed mechanism of death was ventricular 
fibrillation. Neither this group nor patients who died soon after 
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their episode of heart failure were included in this evaluation. 
In subsequent studies to refine patient selection for surgery:-
(1) Spagnuolo et al (Spagnuolo 1971), in evaluating the medical 
course of 174 patients with rheumatic aortic regurgitation 
prospectively followed for a median of 10 years, were able to 
show by lif.e table analysis that the development of the triad 
of moderate or marked left ventricular enlargement on chest X-
ray, left ventricular hypertrophy with or without 
repolarisation change on electrocardiogram and an abnormal 
blood pressure (systolic BP > 140, diastolic BP <40) were the 
criteria predictive of death, congestive heart failure and 
angina. By one year, a third of patients in the "high risk" 
group had reached one of his end-points, increasing 
progressively until by 6 years only 13% of patients had not 
died or had an episode of congestive heart failure or angina. 
This study included most of the patients at risk, and took 
into account year-by-year changes in clinical status. The 
deterioration was particularly rapid within the first 3 years 
from the fulfillment of the "high risk'' criteria. 
(2) Goldschlager et al (Goldschlager 1973), in a combined 
prospective and retrospective analysis of clinical and 
haemodynamic data in 150 patients with aortic regurgitation of 
varying aetiologies, confirmed the protracted clinical course 
of chronic aortic regurgitation. They also highlighted the 
still unresolved dilemma of the late appearance of clinical 
disability at a stage when irreversible myocardial damage may 
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have occurred. However, with a ten year prosthetic valve 
attrition rate of 25-50%, as well as numerous non-fatal 
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complications, they cautioned that both early operation and 
prolonged procrastination appeared to be equally 
unsatisfactory approaches to patients with chronic severe 
aortic regurgitation. In reporting the rest and exercise 
haemodynamic profiles in their patients, in accordance with 
the earlier work of Lewis (Lewis 1970), they found them normal 
in &o% of cases at rest and in one-third of all cases after 4 
minutes of supine bicycle exercise. The earliest abnormality 
was an elevation of left ventricular end-diastolic pressure 
(measured by pulmonary capillary wedge pressure) occurring 
initially as an isolated abnormality during exercise. This 
they presumed to be 1 due to decreased compliance of the 
hypertrophied left ventricle. Ross et al (Ross 1971) showed 
that chronic volume overload in dogs resulted in a dilated 
left ventricle with a steep pressure - volume relationship and 
therefore a less compliant chamber. Additional factors are 
the inevitable intramyocardial fibrosis associated with severe 
left ventricular hypertrophy and the altered ventricular 
geometry and ultrastructure (Meesner 1968, Fanburg, 1970). 
Clinical disability developed when there was a more~ronounced 
haemodynamic abnormality, namely a combination of elevated 
filling pressure and reduced flow (cardiac output) at rest. 
(3) Rapaport (1~75) at a Symposium on the Effect of Surgical 
Treatment on the Natural History of Acquired Heart Disease, 
presented the survival statistics for patients seen at the 
University of California Medical Centre in San Fransisco. He 
stated that moderate or severe aortic regurgitation had a 
relatively good prognosis with a 10 year survival rate of 
about 50%. He also reported that serious cardiovascular 
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symptoms occurred relatively late in the course of the 
disease, out once cardiac decompensation supervened, the 
patients condition usually deteriorated rapidly. Most 
patients died within 2 years of the onset of congestive heart 
failure and within approximately 5 years of the onset of 
angina. These results were in agreement with other reports 
(Masse!! 1966, Dexter 1969). 
(4) Smith et al (Smith 1976) from Green Lane Hospital, Auckland, 
New Zealand, investigated the indications for surgical 
intervention in the treatment of severe rheumatic aortic 
regurgitation. In evaluating 180 patients between 1957 
through 1967, using 39 clinical and haemodynamic parameters in 
. 
an attempt to define those associated with increased pre-
operative death, higher operation mortality and morbidity and 
poor long term survival, only 3 proved to be reliable 
indicators for operative intervention. These included:-
(i) Cardia-thoracic ratio greater than 0.60 
(ii) A history of heart failure, and 
(iii) Extreme left ventricular hypertrophy on electro-
cardiogram. 
No factor predisposed to surgical complications and although 
surgery could be safely postponed until these above criteria 
were met, premature ventricular contractions and independent 
evidence of myocardial disease were further factors that were 
considered to influence the timing of operative intervention. 
In contrast to other studies (Bland 1957, De Georges 1966) 
citing the onset of angina as a poor prognostic feature, this 
series revealed that the presence of pre-operative angina 
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alone did not affect early or late survival results (all 
patients with angina who died pre-operatively had other 
unfavourable features). They postulated that, although the 
simpler clinical observations used in their study allowed a 
surprisingly accurate prediction of outcome, serial non-
invasive measurements of myocardial function might improve the 
assessment of optimal timing of surgery. It is the evolution 
of these measures that I will review in Chapter II. 
TIMING 
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Over the past 25 years, valve replacment surgery has emerged as the 
most important advance for the management of patients with valvular 
I 
heart disease(Rahimtoola 1983). The first diseased aortic and 
mitral valves were replaced with ball-valve prostheses in 1960 by 
Harken (Harken 1960) and Starr et al (Herr 1968, Starr 1971), 
followed by homograft devices a few years later for aortic valve 
replacement by Ross (Ross 1967) and Barratt-Boyea (Barratt-Boyea 
196.7) . 
This therapeutic option has both evolved and changed over the past 
2 decades with superior results attributed to:-
(a) Improved operative techniques (McGoon 1967, Maloney 1974, 
Bigelow 1975, Chapin 1975, Baird 1975, Buckberg 1977, Kirklin 
1979). 
(b) Better prosthetic devices - although innumerable devices have 
been evaluated, the majority have not stood the test of. time 
and the perfect valve substitute still has to be developed. 
(c) Better peri- and post-operative management(Oldfield 1985). 
(d) Possibly earlier surgery i.e. in the 1960's class III and IV 
NYHA patients formed the majority of the cohort, whereas more 
recently predominantly Class II with a smaller proportion of 
Class I and III patients have undergone aortic valve 
replacement (Pluth 1974, Carey 1974, Starr 1974, Bonchek 
1975, Kouchoukos 1976). 
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Although symptomatic relief and subsequent improved quality of life 
are the main indications for valve replacement, when severe 
symptoms are used as the only indicator, long term postoperative 
results have been considered to be disappointing (Herr 1968, Beall 
1969, Duvoisin 1969, Aston 1971, Rotman 1971, Shean 1971, Hirshfeld 
1974, Isom 1974, Badenhorst 1975, Roberts 1976, Rubin 1977, Bonow 
1982). 
The following figure(Fig. 2.1) shows the survival after aortic 
valve replacement for consecutive symptomatic patients with aortic 
regurgitation at the National Institutes of Health from 1963 to 
1971 and from 1972 to 1978. Numbers in parentheses indicate the 
number undergoing operation during each period:-
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(Figure 1, Am J Cardiel 50;326,1982) 
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In the years 1963 to 1971, during which period 88 patients 
underwent aortic valve replacement for severe symptomatic aortic 
regurgitation at the National Institutes of Health, the survival 
at 1 year was 60% with a 4 year survival of 50%. Although in the 
years 1972 to 1978 operative mortality (6%) and early (2 year) 
postoperative survival improved (85%), probably reflecting improved 
operative techniques (Pupello 1976, Adams 1978, Richardson 1979, 
Kirklin 1979), perioperative care (Pupello 1976, Copeland 1977, 
Rubin ~977, Cohn 1981) and valve design, the 4 year survival of 63% 
was only slightly better than the earlier period. Similar 
experiences were reported from many other centres (Copeland 1977, 
O'Toole 1978, Schwartz 1979, Clark 1980, Henry 1980, Cohn 1981, 
Greves 1981). Seventy eight percent of late postoperative deaths 
were due to congestive heart failure. It was postulated that 
prolonged volume overload of the left ventricle led to irreversible 
LV dysfunction and it was considered important to define pre-
operative markers ~hat would predict a high risk of dying from 
congestive heart failure secondary to left ventricular dysfunction 
during long term follow-up. 
Another important consideration therefore, is the role of the valve 
replacement in the preservation of left ventricular function. 
Successful valve replacement has been shown to preserve left 
ventricular function and prolong life in patients with severe 
aortic regurgitation by preventing the late development of heart 
failure(Bonchek 1975, Kouchoukos 1976). As early as 1974, Starr 
(Starr 1974) and Carey et al (Carey 1974) proposed the role of 
early valve replacement in asymptomatic or minimally symptomatic 
patients, using the rationale of reduced operative mortality, 
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improved device design, clarification of long term results against 
the background of the known prognostic significance of pre-
operative measures of left ventricular function and the recognition 
of congestive heart failure in causing late morbidity and mortality 
(Barnhorst 1975, . Bonchek 1975, Bonow 1982). In cont~ast to this 
view however, clinicians are faced with:-
(i) the unpredictable postoperative functional result after 
aortic valve replacement. 
(ii) the major problem of valve related morbidity and 




(iv) the excellent prognosis with conservativ~, non-operative 
management in patients with severe aortic regurgitatjon and 
normal left ventricular function 1!id~ .infra). ~ 
A number of important factors therefore need consideration prior to 
the recommendation of early valve replacement for the preservation 
of left ventricular function, namely:-
1.0 Prosthetic heart valves and their problems. 
2.0 The natural history of asymptomatic severe aortic 
regurgitation and normal left ventricular function. 
3.0 The development of pre-symptomatic left ventricular 
dysfunction. 
4.0 The non-invasive evaluation of left ventric~lar function in 
symptomatic patients with severe aortic regurgitation 
echocardiographic and radionuclide markers of poor 
postoperative survival. 
5.0 The non-invasive evaluation of left ventricular function in 
asymptomatic severe aortic regurgitation. 
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6.0 Postoperative assessment. 
7.0 Problems associated with published data. 
These aspects are addressed in more detail in this chapter. 
II.l.O PROSTHETIC HEART VALVES AND THEIR PROBLEMS: 
An appreciation of the operative, perioperative and postoperative 
morbidity and mortality associated with prosthetic heart valves is 
fundamental to the management of patients with chronic aortic 
regurgitation. Although reports in the literature may serve as 
guidelines, the experience in one's own institution(Cardiac Clinic, 
Groote Schuur Hospital) should be the ultimate guide in the timing 
. 
of operative intervention, . always remembering that valve 
replacement is a palliative procedure, leaving the patient device-
dependent (Rahimtoola 1980). Over the past five years(l981 to 
1985) the· operative mortality for aortic valve replacement(elective 
and emergency) at our hospital has ranged from 1.5% to 5.4% with a 
mean of 3.2%(unpublished data). 
II.l.l Operative Mortality: 
The published data on the operative mortality rate for aortic valve 
replacement in the late 1970's from leading centres in the United 
States of America and elsewhere varies considerably, with quoted 
operative mortalities of between 3% and 12% (Karp 1974, Barnhorst 
1975, Lee 1975, Bjork 1976, Daenen 1976, Barratt-Boyea 1977, 
Blackstone 1977, Copeland-1977, Ionescu 1977, Thompson 1977, Starr 
1977, Cohn 1981). An estimate of 5-7% is reasonable. Factors 
contributing to a high operative mortality include he~rt failure, 
reduced left ventricular function, poor effort tolerance (New York 
Heart Association Class III or IV) and associated coronary artery 
disease. 
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Nevertheless the major cause of death is the low output 
state due to pre-existing or perioperative myocardial damage. 
This factor assumes critical importance in patients with severe 
aortic regurgitation where left ventricular mass ~ay be two to 
three times normal (Pantely 1978). However, with better techniques 
of myocardial protection, namely the use of cold cardioplegia with 
potassium ion arrest and topical cooling, there has been a 
significant reduction 
operative mortality, 
evaluated (Adams 1978, 
in perioperative myocardial damage and 
with the long-term benefit still to be 
Conti 1978, Kirklin 1979, Richardson 1979). 
Currently, a reasonable estimate of perioperative myocardial damage 
is 5%. 
II.l.2 Influence of Valve Replacement on Left Ventricular Functon: 
It is important to consider the intra-operative, perioperative and 
late postoperative periods, and although methods of myocardial 
protection have been refined, no adequately defined method of 
assessing postoperative myocardial damage has been reported. 
Electrocardiographic Q wave criteria, which usually underestimates 
myocardial damage (Klausner 1977, Righetti 1977, Ellis 1979), · 
reveal a 10-12% peri-operative myocardial infarction rate in 
patients undergoing aortic valve replacement, predominantly in 
patients with associated coronary artery disease. However, 
myocardial infarction also occurs in patients -without coronary 
artery disease, reported at approximately 5% (Murphy 1977, Oldfield 
1985), and is presumably related to left ventricular hypertrophy 
and an inadequate supply of cardioplegia to the hypertrophied 
myocardium. Severe myocardial damage can also occur in the absence 
of pathological Q waves - in such cases myocardial infarction is 
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presumably non-transmural but may be extensive. In addition, 
varying degrees of reperfusion damage may contribute to the overall 
injury sustained by the left ventricle during surgery. 
The late 
largely 
results are not accurately defined and at present are 
unknown, although Turina et al (Turina 1984) have shown a 
substantial improvement in late postoperative survival of patients 
with chronic aortic regurgitation during the past decade as a 
result of a reduction in the frequency of death caused by post-
operative heart failure; this improvement is attributed to earlier 
operation. However, if patients remain free of complications and 
left ventricular dysfunction is not too far advanced, improved left 
ventricular function is the rule following aortic valve replacement 
(Gault 1970, Doces 1974, Dodge 1974, Bristow 1975, Morton 1976). 
This is in contrast to patients undergoing mitral valve replacement 
(Doces 1975). This hypothesis must be viewed with the background 
knowledge that there exists a major problem in evaluating the 
effects of valve replacement on ventricular function, namely, the 
difficulty in separating the effects of removal of abnormal loading 
conditions from those of primary myocardial dysfunction (Rahimtoola 
1977). 
11.1.3 Long Term Record of Prosthetic Devices: 
Actuarial 
meaningful 
techniques (Cutler 1958) probably allow the most 
analysis of long term results, and require adequate 
of follow-up and numbers of patients with at 




assessment of longterm 
complication rates, including durability, thrombogenicity and 
haemodynamic efficiency. 
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At present the intermediate and longterm results are only known for 
some of the mechanical prostheses (LeFrak 1979, Teply 1981, McGoori 
1984), and although the initial results with bioprostheses appeared 
encouraging with estimated survival times of 12-15 years and the 
advantage of patients in sinus rhythm not requiring anticoagulation 
(Hannah 1975, Angell 1977, Ionescu 1977, Stinson 1977), it is 
important to appreciate that an incidence of thromboembolism of up 
to 2% has been reported in the literature (Stinson 1977, Cohn 
1979). In addition, premature failure due to valve degeneration 
occurring less than 4 years after valve replacement is well 
recognised particularly in young patients. This is of particular 
importance in the South African context where many of our patients 
coming to valve replacement are <35 years old(Rose 1978, Thandroyen 
1980, Curcio 1981). The status of patients 10 years after aortic 
valve replacement, derived from numerous publications, with some 
extrapolation of data and appreciating that improved device design 
and operative techniques may lower the incidence of some 
complications, can be summarised in the Table 2.1 '(Bjork 1979). 




Perioperative myocardial infarction 
Reoperation 
Thromboembolism 
Major hemorrhage with anticoagulants 











(Table III, J Thorac Cardiovasc Surg 79;164,1980) 
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Two recent 10-20 year follow-up studies have been published and 
deserve more detailed review. The first is a 20 year follow-up 
study on patients operated on from 1960 to 1980 bf Teply and Starr 
et al (Teply 1981) using the Starr-Edwards caged-ball 'valve 
prosthesis. . The 10 and 15 year survival for isolated aortic and 
mitral valve replacement was similar; 56% at 10 years and 44% at 15 
years, with a lower survival rate for patients undergoing multiple 
valve replacement. By multivariate analysis, the year of operation 
was the most important determinant of late survival with a 5 year 
survival of patients undergoing aortic valve replacement in the 
current period (1973 to 1980) 73%, compared to 67% during the years 
1960 to 1972. The study of Starr is an actuarial analysis and is 
prone to the errors of such analyses. Data from remote periods 
with more complete follow-up and larger numbers may not be strictly 
comparable to more recently acquired data. The 5 and 10 year 
survival with the Bjork-Shiley tilting-disc prosthesis (Bjork 1979, 
Karp 1981) 
(Oyer 1979, 
and the 5 year survival with the porcine heterograft 
Oyer 1980, Cohn 1981), are similar to survival data 
with the Starr-Edwards caged-ball prosthesis. 
The second study by McGoon et al (McGoon 1984) from the Mayo 
Clinic, evaluated the 10 to 19 year follow-up in 336 patients with 
severe symptomatic valvular regurgitation in whom a Starr-Edwards 
caged-ball prosthetic valve was implanted between 1962 and 1971. 
Early mortality was 10% for patients with aortic regurgitation and 
advanced functional disability. The causes were evenly 
distributed between inability to wean from·cardiopulmonary bypass, 
embolic events, infections, haemorrhage and aortic dissection. 
Late mortality by actuarial survival curves was highest in the 
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first year (16%), remaining high for the first 3 years at which 
point actuarial survival was 69%. Death during this period 
probably represented a combination of a technically imperfect 
operative result and advanced irreversible myocardial dysfunction. 
The mortality declined until the 6th year postoperatively and then 
stabilised at the same rate as that of an age- and sex- matched 
general population. At 15 years, survival was 40%, which is 
comparable to other longterm studies (Macmanus 1978, Teply 1981). 
Despite the lack of controlled trials, the survival curve of 
operated patients shows a definite improvement over •urvival rates 
of comparable patients without surgery (Spagnuolo 1971, Munoz 1975, 
McGoon 1981) . The mode of late death was sudden in 27% of cases, 
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followed by emoblic events in 16%, myocardial infarction in 15%, 
unknown in 12%, congestive heart failure in 10% and infection or 
prosthetic valve complications in 6% each. Although rhythm 
disturbances in patients with severe aortic regurgitation have not 
been thoroughly investigated until now, a high incidence of 
frequent and complex ventricular arrhythmias have been recorded 
during ambulatory monitoring (Hochreiter 1982, von Olshausen 1983). 
A recently reported study by von Olshausen et al (von Olshausen 
1984) indicated that repetitive ventricular arrhythmias (Lown grade 
4A and B) were infrequent in patients with normal left ventricular 
ejection fraction before and late after aortic valve replacement. 
In contrast, in patients with impaired left ventricular ejection 
fraction, complex ventricular premature beats are common pre-' 
operatively, but the postoperative improvement in left ventricular 
function was usually accompanied by a significant reduction in the 
grade of the ventricular premature contractions. In addition, 
24 
although the frequency of postoperative sudden death varies 
considerably in different studies from between 6% to more than 50% 
(Hirschfeld 1974, Copeland 1977, Samuels 1979, Turina 1984), its 
recognition as a factor in late causation of death following valve 
replacement for severe aortic regurgitation emphasises the need to 
detect and treat arrhythmias and eliminate arrhythmogenic factors 
in the management of the postoperative patient (McGoon 1984, Turina 
1984) . 
In addition, although the durability of the Starr-Edwards valve is 
high and symptomatic status is improved in approximately 80% of 
patients by at least one functional class (with 40% asymptomatic), 
thromboembolism remains a major problem with almost half (44%) of 
patients having sustained a systemic embolic event by 15 years of 
follow-up. Seventeen percent of patients sustained multiple events 
with cerebral events (80%) being the most frequent. 
II.2.0 THE NATURAL HISTORY OF SEVERE ASYMPTOMATIC AORTIC 
REGURGITATION AND NORMAL LEFT VENTRICULAR FUNCTION: 
It is suggested that symptomatic patients with severe aortic 
regurgitation and impaired left ventricular systolic function are 
at risk of irreversible myocardial dysfunction and death from 
congestive heart failure following successful aortic valve 
replacement (Cunha 1980, Forman 1980, Henry 1980, Greves 1981). 
However, within the subgroup with pre-operative left ventricular 
dysfunction, those with less marked symptoms (Cunha 1980, Greves 
1981), preserved exercise capacity (Bonow 1980), and shorter 
duration of pre-operative left ventricular dysfunction (Bonow 1984) 
have a better prognosis and greater likelihood of improvement. 
\ 
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Nevertheless, because of the fear of irreversible left ventricular 
dysfunction, some authors have recommended aortic valve replacement 
in all patients wtih severe aortic regurgitation, even if 
asymptomatic with preserved left ventricular systolic function 
(Kirklin 1973, Isom 1974, Smith 1976). This controversial 
recommendation is not universally accepted and was proposed prior 
to the detailed description of the natural history of asymptomatic 
patients with severe aortic regurgitation and normal left 
ventricular function by Bonow et al (Bonow 1983) in which they 
emphasised this subset's excellent prognosis with conservative non-
operative management. Their study consisted of a serial evaluation 
of 77 patients with asymptomatic severe aortic regurgitation and 
normal resting left ventricular systolic function measured non-
invasively by echocardiogram (fractional shortening >29%) and 
radionuclide ventriculography (ejection fraction> 45%). These 
patients were followed from 6 to 114 months (mean 49 months) with 
no deaths. Twelve patients required aortic valve replacement. In 
eleven of these, the indication for surgery was the onset of 
symptoms, with the development of left ventricular dysfunction 
occurring 6 12 months before or coincident with the onset of 
symptoms in 5 of the 11 patients. One patient was operated on for 
progressive left ventricular dysfunction without the development of 
symptoms when ejection fraction dropped from 61% to 45% and end-
systolic diameter increased from 5lmm to 58mm over a 36 month 
follow-up period. All 12 patients had preserved effort tolerance 
and were able to complete the first stage of the National 
Institutes of Health protocol(Bonow 1980) without limiting 
symptoms. 
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The following life table (Fig. 2.2) depicts the course of the 77 
patients, with the onset of symptoms or the onset of left 
ventricular dysfunction used as end points. At 7 years, 75 ~ 7% of 
the patients remained asymptomatic with normal left ventricular 
function:-
Figure 2.2 LIFE TABLE ANALYSIS IN ASYMPTOMATIC AORTIC 
REGURGITATION 
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(Figure 1, Circulation 88;511,1983) 
11.2.1 Influence of Initial Left Ventricular Dimensions and 
Systolic Function on Clinical Course: 
Using a Cox univariate life table analysis(Cox 1972) several 
echocardiographic parameters were identified which predicted the 
subsequent development of symptoms or left ventricular dysfunction. 
These are summarised in Table 2.2. Rest ejection fraction(EF) 
determined by equilibrium radionuclide angiocardiography (ERNA) was 
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not a significant predictor but peak exercise ejection fraction and 
the magnitude of change in ejection fraction from rest to 
of 
peak 
the exercise (functional reserve) were both predictive 
subsequent clinical course. 
Table 2.2 VARIABLES ON INITAL STUDY ASSOCIATED WITH SUBSEQUENT 
SYMPTOMS OF LEFT VENTRICULAR DYSFUNCTION 
Variable p value 
Echocardiographic data 
LV fractional shortening 
LV end-~ystolic dimension 
LV end-diastolic dimension 
Radionuclide angiographic data 
LV EF at rest 
LV EF during exercise 















end-systolic dimension (DES) of 
significantly greater likelihood 
ventricular dysfunction. Only 
> 50mm (21 
of developing 
31% of such 
patients were asymptomatic at 4.5 years of follow-up. In contrast, 
no patient with an initial end-systolic dimension of < 40mm 
developed symptoms during this follow-up period. 
The following figure (2.3) shows the influence of the initial left 
ventricular end-systolic dimension on the subsequent clinical 
course. 
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Figure 2.3: INFLUENCE OF INITIAL LEFT VENTRICULAR END-SYSTOLIC 
DIMENSION ON SUBSEQUENT CLINICAL COURSE. 
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(Figure 4, Circulation 68;512,1983) 
Similarly end-diastolic diameter (DED) at the time of initial 
evaluation was predictive. Fifty three of seventy seven patients 
had an initial LVDED > 70mm and developed symptoms during the 
follow-up period. This is shown in figure 2.4. 
Similar but less significant trends were observed when patients 
were stratified on the basis of either peak exercise ejection 
fraction or functional reserve (change in ejection fraction on 
exercise) and are summarised in figure 2.5. No patients who 
increased their ejection fraction on exercise required surgery 
compared to those with a drop in ejection fraction (irrespective of 
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Thus the ejection fraction response to exercise ·was significantly 
associated with subsequent clinical course when this variable was 
analysed as a continuous function by the Cox model. 
11.2.2 Relationship of Ejection Fraction Response to Exercise and 
Resting Echocardiographic Dimensions: 
With increasing echocardiographic systolic and diastolic dimensions 
at rest, there was a progressive increase in the number of patients 
who had a fall in ejection,fraction on exercise:-
DES < 40mm - 35% patients had a drop in EF on exercise 
DES 41-49mm - 62% patients had a drop in EF on exercise. 
DES > 50mm - 90% patients had a drop in EF on exercise. 
DED < 60mm·- 29% patients had a drop in EF on exercise. 
DED 61-69mm- 54% patients had a drop in.EF on exercise. 
DED > 70mm - 82% patients had a drop in EF on exercise; 
The correlation coefficients between functional reserve and resting 
s~stolic and diastolic dimensions were significant (p < 0.01) and 
it is thus uncertain whether ejection fraction response to exercise 
provides added prognostic information. Statistically this could not 
be pr?ven by a stepwise Cox regression, but small sample size and 
limited end points,precluded a firm conclusion. 
II.2.3 Change in Left Ventricular Dimensions and Function: 
Despite a statistically non-significant change in end-diastolic 
diameter in both the stable and operated groups at initial and late 
(6-8 months postoperatively) evaluation, an increase of > 5mm was 
observed in 11 patients. 
End-systolic dimension did increase significantly in both groups 
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with time, with 5 out of 12 patients whose dimensions increased by 
> 5mm developing symptoms or left ventricular dysfunction. 
Fractional shortening, in contrast, only decreased significantly in 
the group undergoing aortic valve replacement. 
Although radionuclide ejection fraction at rest decreased 
significantly in both groups, with 8 of 12 patients with a drop in 
ejection fraction to < 50% developing symptoms, functional reserve 
showed great variability between early and late studies and did not 
change significantly in either group. 
II.2.4 Results of Aortic Valve Replacement: _ 
' These were extremely encouraging with no operative or peri-
operative deaths. Most patients were re-evaluated 6-8 months 
postoperatively, with end-diastolic diameter returning to normal (< 
55mm) in 75% of cases - 10 of the 12 patients undergoing valve 
replacement had a pre-operative end-diastolic diameter of > 70mm. 
This is important prognostically since previous studies indicate 
that patients with persistent left ventricular dilatation (> 70mm) 
postoperatively, are at increased risk of death from congestive 
heart failure (Gaasch 1978, Bonow 1980, Clark 1980, Henry 1980). 
There was an associated improvement in systolic pump function with 
rest ejection fraction normalising in all patients (> 45%), peak 
exercise ejection fraction increasing from 36 ~ 7% to 56 + 15% and 
a concomitant improvement in functional reserve. 
II.3.0 THE PRE-SYMPTOMATIC 
DYSFUNCTION: 
DEVELOPMENT OF LEFT 
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VENTRICULAR 
Despite these apparently reassuring conclusions, there remains the 
clinical problem of a group of patients who develop 
ventricular dysfunction prior to the onset of symptoms. It is not 
known (i) how frequently this occurs, (ii) whether this can be 
predicted in individual patients (iii) whether left ventricular 
dysfunction can be stabilised, improved or preserved by valve 
replacement and (iv) whether patient survival will be better with 
or without aortic valve replacement. 
Among the studies claiming benefit with earlier surgery are the 
following. None are perfect:-
(i) Spagnuolo et al (Spagnuolo 1971) identified a "high risk" 
triad in young patients with rheumatic aortic regurgitation 
with an eighty seven percent risk of angina, heart failure 
or death within 6 years. It was not clearly stated whether 
the development of angina or heart failure resulted in a 
poor postoperative outcome. 
(ii) Smith et al (Smith 1976), using data based on the incidence 
of death before aortic valve replacement, did not report a 
favourable influence of aortic valve replacement in any 
subgroup of patients studied, and 
(iii) Braun et al (Braun 1973), reported that the prognosis after 
aortic valve replacement was related to a pre-operative 
cardia-thoracic ratio of greater than 0.56. The problem 
with this study was that only operated patients were 
compared, the majority had aortic stenosis and thus it 
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compared aortic stenosis with mixed aortic valve disease. 
In addition, it has been assumed that the asymptomatic patient with 
severe aortic regurgitation will only become symptomatic with the 
onset of left ventricular dysfunction, thus making it "too late'' if 
symptoms are used as the only indication for surgery. However, it 
is important to appreciate that the onset of symptoms is not 
necessarily always associated with the onset of left ventricular 
systolic dysfunction (Greves et al 1980), and thus symptoms cannot 
be automatically attributed to impaired resting left ventricular 
systolic function. Furthermore, Schwarz and Clark (Schwarz 1979, 
.Clark 1980) have shown that in symptomatic patients with impaired 
systolic function, aortic valve replacement can be perfo~med with a 
low operative mortality; a 3 year survival of 60-70% with 
functional class improved or maintained i~ late survivors; there 
was an associated significant but usually incomplete regression of 
left ventricular dilatation and hypertrophy with normalisation of 
the left ventricular end-diastolic pressure (16 + 3mmHg to 10 + 
2mmHg) and an improvement in systolic function in 50% of cases. 
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accepted that this recommendation is not based on firm data. 
Improved medical management e.g. chronic 
(Greenberg 1980, Greenberg 1980, McKay 1983, 
vasodilator therapy 
Shen 1984) has be~n 
suggested and is being evaluated but has not, as yet, been accepted 
as a therapeutic option. The development of "perfect" prosthetic 
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devices that are haemodynamically sound, do not suffer mechanical 
failure or degeneration, are free of thromboembolic complications 
without the need for long term anticoagulants and do not damage the 
blood cells, may similarly change clinical practice. Twenty five 
years after implantation of the first prosthetic valves, advances 
and improvements in valve design have been minor. 
11.4.0 THE NON-INVASIVE EVALUATION OF LEFT VENTRICULAR FUNCTION IN 
SYMPTOMATIC PATIENTS WITH SEVERE AORTIC REGURGITATION: 
ECHOCARDIOGRAPHIC AND RADIONUCLIDE MARKERS OF POOR POST-
OPERATIVE SURVIVAL: 
Aortic root and left ventricular cineangiography have been the 
''gold standard" for defining the severity of aortic regurgitation 
and its effect on left ventricular performance - however, serial 
follow-up by these means is impractical. More recently non-
invasive measures of left ventricular size (echocardiography) and 
function (echocardiography and equilibrium radionuclide 
angiocardiography) have been serially utilised in an attempt to 
optimise the timing of surgery by formulating pre-operative markers 
of left ventricular dysfunction and poor postoperative survival. 
In these endeavours, the thinking has been clouded by a tendency to 
equate the ,two and failing to appreciate that apparent pre-
operative left ventricular dysfunction may be rapidly reversible by 
aortic valve replacement and the consequent cha~ges in LV loading 
conditions. 
II.4.1 Impaired Systolic Function at Rest 
The normal response to chronic volume overload is chamber 
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dilatation with compensatory hypertrophy, associated with a normal 
extent of systolic wall shortening per unit of circumference and 
thus preserved ejection fraction (Ross 1972, Ross 1981). As in 
other forms of mechanical overload, if preload reserve is fully 
utilised and afterload is excessive for the degree of hypertrophy, 
the ejection fraction may be reduced i.e. ~ifterload mismatch'' can 
result in reduced left ventricular performance without necessarily 
being accompanied by reduced contractility (Ross 1976). The 
ventricle will resume normal shortening and ejection as soon as the 
excess load is removed by aortic valve replacement. Usually 
compensatory mechanisms lead to an appropriate extent of 
hypertrophy to match the increased load, and in doing so wall 
stress is normalised. Impaired resting pre-operative ejection 
fraction, measured either non-invasively using echocardiographic 
fractional shortening (Cunha 1980, Henry 1980) or angiographically 
by left ventricular ejection fraction (Cohn 1974, Fish! 1977, 
Forman 1980, Greves 1981) often represents depressed myocardial 
contractility and thus may predict which symptomatic patients are 
at risk of death from congestive heart failure after technically 
successful aortic valve replacement. At the National Institutes of 
Health between 1972 and 1978 patients with a suboptimal fractional 
shortening 'of less than 29% had a 3 year survival of 62% compared 
to 91% in patients with normal fractional shortening (Henry 1980). 
In those patients with severely depressed systolic function 
(fractional shortening< 25%), 3 year survival was only 42%. These 
results are graphically displayed in figure 2.6. 
Comparable data are reported by Cunha (Cunha 1980), using a 
fractional shortening of< 30% (4 year survival 77% versus 96%). 
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In a study from our own institution (Forman 1980), the effect of 
pre-operative left ventricular ejection fraction and other 
Figure 2.6 SURVIVAL AFTER OPERATION FOR AORTIC REGURGITATION FROM 
1972 TO 1978 
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(Figure 2, Am J Cardiol 50;326,1982) 
variables on postoperative survival was examined in 279 patients 
after isolated aortic valve replacement between August 1972 and 
February 1978. During the initial period Lillehei-Kaster 
prostheses were used but discontinued because of unsatisfactory 
results (Forman 1977). Subsequently the Starr-Edwards model 2400 
prosthesis or the Bjork-Shiley prosthesis were used for patients 
with large and small aortic roots respectively. Later the 
glutaraldehyde preserved procine heterograft was used. In 
contrast to patients with aortic stenosis or mixed aortic valve 
disease, patients with aortic regurgitation and a pre-operative 
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left ventricular ejection fraction (LVEF) of <50% had. a 
significantly worse 3 year survival rate (64 + 10%) than those 
patients with a LVEF >50% (91 ± 8% (p < 0.02). In addition a 
2 
reduced cardiac index < 2.5 litres/minute per M also significantly 
predicted a reduced 3 year survival compared to patients with a 
normal cardiac index (p < 0.02). The operative mortality of 3.5% 
was not affected by any pre-operative variable studied. Nine of 
the twenty-two late deaths occurred in the group with pure aortic 
regurgitation, 56% due to congestive heart failure, and one patient 
each due to embolism, mybcardial infarction, infective endocarditis 
and sudden death. The recommendation was to monitor LVEF non-
invasively in patients with aortic regurgitation and to advise 
valve replacement before ejection fraction became severely 
depressed. 
II.4.2 Echocardiographic End-Systolic Diameter (DES): 
Henry (1980), using an end-systolic diameter greater than 55mm was 
able to identify a high risk group of patients undergoing aortic 
valve replacement with a 3.5 year survival of 40%. In contrast, 
those with a DES < 55mm had a 3.5 year survival of 80%. These 
results are summarised in figure 2.7. It is important to note that 
56% of deaths (5 out of 9) occurred in the immediate postoperative 
period. 
This study is compatible with the data from Cunha (1980) and the 
angiographic study of Borow (1980) and in agreement with the report 
from Grossman (1977) characterising the contractile state of the 
left ventricle by end-systolic volume and thus subgrouping patients 
according to their left ventricular function. 
I 
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In contrast, Turina and Krayenbuehl (1979) reported that 
postoperative results could not be predicted from the M-mode 
echocardiogram, including an DES greater than 55mm. 
Figure 2.7 SURVIVAL AFTER OPERATION FOR AORTIC REGURGITATION FROM 
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(Figure 3, Am J Cardiol 50;327,1982) 
11.4.3 Echocardiographic End-Diastolic Diameter (DED): 
This dimensional_measure is less sensitive than the pre-operative 
DES, but does identify a small subgroup of patients with severe 
ventricular dilatation (DED > 80mm) who are at increased risk 
postoperatively of persistent left ventricular dilatation and 
subsequent development of congestive heart failure (Gaasch 1978, 
Clark 1980, Henry 1980, Stone 1984). Survival analysis has not 
been calculated in this subset of patients because of the small 
numbers of patients in all reported series. It would appear that 
I 
this dimension is a marker of very severe le£t ventricular 
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dilatation and of little practical clinical value. 
II.4.4 Radius to Wall Thickness Ratio (Wall Stress): 
The prognostic implications of the end-diastolic diameter can be 
refined by evaluating the degree of associated compensatory left 
ventricular hypertrophy. This results in a normalisation of wall 
stress (Gould,l974, Grossman 1975, Gaasch 1979, Kumpuris 1982). 
The ratio of end-diastolic radius to posterior wall thickness thus 
serves as a measure of appropriate left ventricular muscle mass .for 
a given chamber volume (volume to mass ratio). 
In a number of studies (Gault 1970, Gaasch 1978, Osbakken 1981, 
Kumpuris 1982) this pre-operative ratio was a strong predictor of 
subsequent postoperative regression of left ventricular hypertrophy 
and a reduction in left ventricular dimension. An increased pre-
operative ratio of > 4; reflected inadequate hypertrophy with 
increased wall stress and was associated with persistent 
postoperative dilatation and congestive heart failure. Because few 
patients in the reported series have a_ very high pre-operative 
ratio (similar to a DED > 80mm), this index appears to be very 
insensitive in identifying the majority of pa£ients at risk. 
In addition, in contrast to the above studies, Cunha (1980) found 
no predictive value in this ratio. Thus, although conceptually 
dilatation, hypertrophy and attractive, the integration of 
contractile. function expressed as wall stress, has not been 
demonstrated to be a pre-operative predictor of long term outcome 
in the majority of patients with severe aortic regurgitation. 
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!!.4.5 Exercise Equilibrium Radionuclide Angiocardiography (ERNA): 
This form of investigation has been utilised in an attempt to 
refine the prognostic implications of resting left ventricular 
systolic function by detecting early, reversible myocardial 
dysfunction. Although Borer (1978) has shown that the majority of 
patients with symptomatic aortic regurgitation have an abnormal 
ejection fraction response to maximum supine exercise despite 
normal resting values, no level is clearly associated with either 
impaired postoperative survival or irreversibility of left 
ventricular dysfunction (Borer 1979, Bonow 1980). There is growing 
evidence to suggest that exercise - induced left ventricular 
dysfunction is reversible postoperatively. In a consecutive study 
of 43 patients with symptomatic aortic regurgitation undergoing 
valve replacement between 1976 and 1980 and re-evaluation 6 months 
postoperatively, 93% of patients had a postoperative peak exercise 
ejection fraction greater than their pre-operative value, and 40% 
of those with a subnormal pre-operative exercise ejection fraction 
normalised postoperatively. Neither the postoperative ejection 
fraction nor the change in ejection fraction from the pre-operative 
to the postoperative value could be predicted by the pre-operative 
exercise ejection fraction. These results are summarised 1n figure 
2.8. 
A more detailed discussion on the exercise evaluation of patients 
with severe aortic regurgitation will follow. 
II.4.6 Exercise Capacity: 
This parameter is used both as a measure of cardiac reserve and as 
a quantitative measure of functional class, being less subjective 
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than the New York Heart Association classification (NYHA 1979). In 
the series reported by Bonow (Bonow 1980), exercise capacity did 
not co.rrelate with echocardiographic dimensions or systolic 
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(Figure 4, Am J Cardiol 50;329,1982) 
function measured non-invasively. Many patients had an excellent 
exercise tolerance despite severe left ventricular dysfunction, 
thus confirming the observation that patients with severe aortic 
regurgitation and left ventricular dysfunction may indeed be 
asymptomatic (Lewis 1970, ;Goldschlager 1973, Karaian 1980). In 
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summary:-
(i) Exercise capacity appears to be an independent measure of 
cardiac reserve not reflected in the usual indices of left 
ventricular systolic function (Benge 1980, Franciosca l981, 
Litchfield 1982) and in the above series, only one patient 
who completed stage 1 of the National Institutes of Health 
protocol died 61 months postoperatively compared to an 
operative mortality of 11% ~nd a 3 year mortality rate of 32% 
in the group with poor exercise tolerance. This dissociation 
between exercise capacity and measured LV function is well 
recognised in LV dysfunction due to other causes and 
explained by compensatory tachycardia and utilisation of 
preload reserve (Benge 1980). 
The following' table (2.3) summarises the National Institutes of 
Health exercise protocol. 
Table 2.3 NIH EXERCISE PROTOCOL 
Stage I Stage IT 
Time Speed Speed 
(min) (mph) Grade (mph) Grade 
0 2.2 0% 1.9 10% 
2.5 2.2 2.5% 2.3 12% 
5 .o 2.2 5.0% 2.7 14% 
7.5 2.2 7.5% 3.1 16% 
10.0 2.2 10.0% 3.5 18% 
12.5 2.2 12.5% 3.9 20% 
15 .o 2.2 15.0% 4.7 20% 
17.5 2.2 17.5% 5.5 20% 
20.0 2.2 20.0% 6.3 20% 
22.5 End of End of 7.1 20% 
Stage I Stage I 
(Table 1, Circulation 62;1282,1980) 
( ii) The combined analysis of exercise capacity and left 
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ventricular systolic function further refines the prognostic 
subgroups, with those patients _who have preserved- exercise 
tolerance despite impaired systolic function at rest having 
an_ excellent long term prognosis compared to the group with 
poor effort tolerance and impaired resting systolic function. 
This is summarised in figure 2.10 with the numbers in italics 
indicating the patients at risk at each time interval. 
The following graph (figure 2.9) displays the fP9Stoperative 
survival based on pre-operative exercise capacity. 
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This work by Bonow (1980) is substantiated by the work of Cunha 
(1980) and Greves (1981) who showed improved late postoperative 
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survival in those patients with left ventricular dysfunction and 
New York Heart Association functional class one and two (compared 
to class 3 and class 4). 
Figure 2.10 SURVIVAL AFTER OPERATION FROM 1972 TO 1978 IN 32 
PATIENTS WITH SUBNORMAL PRE-OPERATIVE FS, SUBGROUPED 
ON THE BASIS OF PRE-OPERATIVE EXERCISE CAPACITY 
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(Figure 6, Am J Cardiol 50;330, 1982) 
(iii) It also proves helpful in predicting the reversal of left 
ventricular dysfunction, with those patients who have a 
preserved exercise capacity demonstrating a greater 
postoperative reduction in left ventricular end-diastolic 
dimension and a significantly higher postoperative resting 
and peak exercise ejection fraction (Bonow 1980). This 
change in LV ejection fraction from pre-operative to 6 
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months postoperative in symptomatic patients operated on 
between 1976 and 1981 subgrouped on pre-operative exercise 
capacity is summarised in the figure overleaf. 
Thus, in symptomatic patients with impaired pre-operative resting 
left ventricular systolic function, preserved exercise capacity 
rather than the ejection fraction is predictive of normalisation of 
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postoperative left ventricular systolic function. 
II.4.7 Postoperative Echocardiographic End-Diastolic Dimension(DED): 
In contrast to pre-operative end-diastolic diameter, its 
postoperative measurement has considerable prognostic value, with 
persistent postoperative dilatation of greater than 70mm 
identifying a significant number of patients at risk of subsequent 
death from congestive heart failure (Gaasch 1978, Clark 1980, Henry 
1980). These reports are consistent with an earlier report of 
cardiac dimensions on chest X-ray which showed that failure of 
cardia-thoracic ratio to decrease following aortic valve 
replacement was associated with a subsequent poor prognosis 
\ 
~Hirshfeld 1974). The reduction in end-diastolic dimension occurs 
early, i.e. between 2 weeks and 2 months postoperatively (Venco 
1976, Gaasch 1978, Schuler 1979, Henry 1980), with little further 
change at late follow-up evaluation (Gaasch 1978, Schuler 1979, 
Henry 1980). The reduction in dimension may be predicted by the 
pre-operative end-systolic dimension and fractional shortening 
(Clark 1980, Henry 1980, Kumpuris 1982, Stone 1984). These 
echocardiographic studies have been substantiated by both contrast 
angiography (Borow 1980) and radionuclidetventriculography (Boucher 
1981). 
In conclusion, the results of surgery including postoperative 
survival, reversal of left ventricular dilatation and hypertrophy, 
or the development of congestive heart failure following valve 
replacement for symptomatic aortic regurgitation can be predicted 
from non-invasive pre-operative evaluation of LV size, systolic 
function, wall stress and preserved exercise capacity . These 
.. 
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markers are more sensitive than hae~odynamic variables in 
identifying patients at risk (Henry 1980), and although systolic 
dysfunction at rest is a sensitive predictor of ultimate outcome, 
it is not specific, with improvement and ev~n normalisation of left 
ventricular systolic function frequently occurring despite severe 
pre-operative depression of systolic function (Kennedy 1977, Gaasch 
1978, Borer 1979, Herreman 1979, Schuler 1979, Schwartz 1979, Bonow 
1980, Clark 1980, Ross 1981). 
II.5.0 THE NON-INVASIVE EVALUATION OF LEFT VENTRICULAR FUNCTION IN 
ASYMPTOMATIC AORTIC REGURGITATION: 
II.5.1 Echocardiographic Systolic Size and Function at Rest: 
Against this background, serial non-invasive echocardiographic 
assessments of left ventricular systolic size and function appeared 
to be potentially useful in helping to optimise the timing of 
surgery in asymptomatic patients with left ventricular dysfunction. 
Two studies are particularly relevant in this regard (Henry 1980, 
McDonald 1980). A total of 50 asymptomatic patients with severe 
aortic regurgitation (37 patients from the National Institute of 
Health and 13 patients from the Univesity of Melbourne) underwent 
serial M-mode echocardiographic follow-up. Twenty six percent 
(26%) of these patients had an end-systolic dimension greater than 
55mm, and 36% had a fractional shortening of less than 29% i.e. a 
significant abnormality of left ventricular systolic dimension 
associated with evidence of systolic dysfunction. 
Life table analysis, using the onset of symptoms as the end-point, 
showed· that two-thirds of asymptomatic patients with this 
abnormality required aortic valve replacement during a 3 year 
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follow up period because of the development of symptoms .. Thus, the 
time between the demonstration of left ventricular systolic 
dysfunction and the onset of symptoms is short. 
It thus appears reasonable to consider aortic valve replacement in 
this subset of asymptomatic patients before the onset of symptoms -
this conclusion has been substantiated by observations that 
asymptomatic patients with 
improved late postoperative 
left ventricular dysfunction have 
survival compared to the severely 
symptoma~ic group (Cunha 1980, Greves 1981). 
II.5.2 Limitations in the Use of M-mode Echocardiography: 
However, decisions should not be based on a single 
echocardiographic measurement. Although it is an excellent 
technique for the measurement of left ventricular dimensions and 
fractional shortening in patients with left ventricles of normal 
dimension, its limitations in severe left ventricular dilatation 
need to be appreciated. When the left ventricle is dilated and if 
contractile function is impaired:-
(i) the ventricular geometry changes from an ellipsoid to a more 
spherical shape (Gould 1974, Linhart 1975, Johnson 1976, 
Fischl 1977, Abdulla 1980). 
(ii) abnormal apex to base shortening occurs (Gould 1976, Hecht 
1981, Osbakken 1981), 
(iii) Regional contraction abnormalities may develop, thereby 
limiting M-mode echocardiography in the assessment of left 
ventricular dimensions and global systolic function. When 
compared to angiographic indices (Johnson 1976, Bhatt 1978, 
O'Rourke 1980), the echocardiogram consistently 
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underestimates dimensions and overestimates contractile 
function. The degree of LV dysfunction may thus be more 
severe than the echocardiogram sugge.sts. 
Despite the above concerns, this view is not universally 
held. Vandenbossche and others (1984) recently correlated 
M-mode echocardiographic measurements of left ventricular 
size and function in patients with chronic severe aortic 




method using gated blood pool 
They used a corrected cube 




dimensional control. This approach provided a practical and 
convenient way of improving the M-mode evaluation of left. 
ventricular shape and functi9n. 
Other limitations include the following:-
(i) Minor changes in patient position or transducer angulation 
may cause errors in left ventricular dimension measurement 
of up to 20%, although calculation of fractional shortening 
is less variable (Linhart 1975, Popp 1975). 
(ii) Postoperative assessment of overall left ventricular 
function is subject to considerable error due to paradoxical 
septal motion which occurs in ± 90% of cases (Burggraf 1975, 
Righetti 1977). Recent work. has suggested that such 
abnormal motion of the interventricular septum appears to be 
a motion artifact caused by exaggerated systolic 
anteromedial translation of the entire heart within the 
chest, as viewed from a fixed external frame of reference 
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(Kerber 1982, Waggoner 1982, Force 1983). Force et al 
(1984), using quantitative two-¢imensional echocardiographic 
analysis of regional wall motion in patients with 
perioperative myocardial infarction following coronary 
artery bypass surgery, demonstrated that floating-axis 
analysis, by' correcting the abnormal motion of the septum 
and normalising the apparently enhanced motion of the 
lateral wall of the left ventricle, was more accurate and 
clinically relevant in the evaluation of these patients. 
(iii) Dimensional and ejection phase measurements are only as good 
as the echocardiogram from which they are measured - the 
requirement is a high-class left ventricular echocardiogram. 
In addition, there are conflicting reports on the reproducibility 
of serial evaluation, with McDonald (1980) reporting limited 
reproducibility in individual patients, but Clark (1980) 
maintaining that both dimensions and fractional shortening are 
reproducible and valuable in documenting deterioration. 
II.5.3 Radionuclide Ejection Fraction at Rest: 
This index of left ventricular systolic function is independent of 
left ventricular geometry and thus useful in those patients in whom 
serial echocardiographic studies are technically inadequate or 
poorly reproducible. 
Normal values, correlation with contrast angiography, 
reproducibility and intra- and inter-observer variation have been 
investigated in our own laboratory (see Appendix II) and in others 
(Bacharach 1979, Okada 1980, Machac 1984) and found to be 
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satisfactory. 
II.5.4 Radionuclide Ejection Fraction Response to Exercise: 
The rationale behind this form 6f assessment is the fact that 
because resting left ventricular systolic function is such a 
sensitive predictor of long term prognosis, stress induced 
dysfunction may represent early, reversible myocardial dysfunction 
and thus help in the selection of asymptomatic patients for valve 
replacement surgery before the onset of irreversible dysfunction 
methods of (Bolen 1976, Ross 1976, Borer 1978). A number of 
stressing the left ventricle have been proposed, including 
angiotensin infusion (Bolen 1976), incremental atrial pacing (Firth 
1982), isometric handgrip exercise (Fisher 1973, Gumbiner 1983, 
Gordon dePuey 1984) and supine and erect bicycle exercise (Borer 
1978, Poliner 1980, Dehmer 1981, Lewis 1982, Peter 1982, Huxley 
1983). Using supine bicycle exercise, Borer (1978) reported a drop 
in exercise ejection fraction in two-thirds of asymptomatic 
patients with severe aortic regurgitation. Thus, abnormal exercise 
reserve, i.e. a drop in ejection fraction on exercise, appears 
early in the natural history of the disease, predating symptoms or 
resting left ventricular systolic dysfunction. However, the 
exercise response in patients with aortic regurgitation is 
variable. There is a reduction in regurgitant fraction with 






volume, end-systolic volume and ejection fraction 
Dehmer 1981) due to the fact that volume changes are 
influenced by the complex interaction of changes in 
preload and afterload (Karliner 1974, Ranklin 1975, 
Boucher 1981, Ross 1981). In turn these variable 
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responses depend on the severity and type of exercise (Epstein 
1967, Thadani 1978). Although a decrease in functional reserve may 
thus represent the unmasking of early, reversible· myocardial 
dysfunction in some patients, in others it may merely reflect 
altered loading conditions in a · severely volume-overloaded 
ventricle (Ross 1976). It would therefore appear that a decrease 
in functional reserve is too sensitive a marker, as it occurs very 
early in the natural history of asymptomatic severe aortic 
regurgitation (Henry 1979), usually preceding systolic dimensional 
changes of greater than 50mm at a time when fractional shortening 
or ejection fraction are normal at rest. Should symptoms develop in 
this subset, long term prognosis is excellent (Henry 1980). In 
addition, no absolute level of pre-operative exercise ejection 
fraction has been demonstrated to be associated with irreversible 
postoperative dysfunction or impaired postoperative survival. 
Defects in many of the above quoted studies include:-
(i) the presence of aortic regurgitation was not proven by 
aortic angiography in all patients evaluated, 
(ii) the severity of the aortic regurgitation was not documented 
by cine aortography in all patients, 
(iii) as not all patients had invasive studies, some may have had 
clinically undetected coronary artery disease and thus some. 
of the responses to exercise may have been due to exercise -
induced ischaemia rather than simply the response of volume 
overload due to chronic severe aortic regurgitation. 
II.5.5 Frequency 
Surgery: 
of Follow-Up Evaluation and Guidelines for 
Current recommendations are that the frequency of f~llow-up. 
53 
evaluation should probably be based on the echocardiographic 
measurement of end-systolic diameter, with full awareness of the 
limitations of this investigation and an appreciation that the end-
systolic dimension rarely increases by more than 6mm per year 
(Henry 1980). The following .is thus a reasonable set of 
recommendations based on current knowledge, with the proviso that 
the cornerstone of individualised 
management:-
decision-making remains 
(i) ASYMPTOMATIC SEVERE AORTIC REGURGITATION WITH A DES <50mm: 
. ( i i) 
Annual echocardiogram and a biennial radionuclide 
ventriculogram. Some 20% of patients in this subgroup will 
develop symptoms or left ventricular systolic dysfunction 
and require surgery within a 39 month follow-up period • 
ASYMPTOMATIC SEVERE AORTIC REGURGITATION WITH A DES 50-55mm: 
Six monthly echocardiogram and an annual radionuclide 
ventriculogram. Approximately 50% of patients in this 
subset will develop symptoms and require aortic valve 
replacement within a 2 year follow-up period. Only 20% will 
develop an end-systolic dim~nsion of greater than 55mm, and 
postoperative congestive heart failure is distinctly 
uncommon, only occurring in 3% of patients. 
(iii) ASYMPTOMATIC SEVERE AORTIC REGURGITATION WITH A DES >55mm: 
The majority (80%) of this subgroup will develop symptoms 
and require valve replacement surgery within a 39 month 
follow-up period, at which stage they would constitute a 
"high risk" group of symptomatic aortic regurgitation with 
impaired left ventricular function. Thus, in this group of 
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patients, a confirmed echocardiographic DES of > 55mm 
repeated within a few weeks, together with a radionuclide 
ventriculogram and formal cardiac catheterisation. is 
recommended. Unless data from the latter two investigations 
are in major conflict with the echocardiogram, patients in 
this category 
particularly 
should undergo aortic valve 
if they have an associated 
fractional shortening to less than 29%. 
(iv) SYMPTOMATIC SEVERE AORTIC REGURGITATION: 
replacement, 
reduction in 
These patienta should undergo aortic valve replacement 
irrespective of their dimensions or systolic function. 
II.6.0 POSTOPERATIVE ASSESSMENT: 
The review of postoperative evaluation of patients will be 
discussed under the following headings:-
(i) the effects of aortic valve replacement on survival. 
(ii) rest and exercise radionuclide ventriculography. 
(iii) echocardiographic evaluation of left ventricular volume, 
mass and function following aortic valve replacement. 
(iv) postoperative rest and exercise haemodynamic assessment. 
II.6.1 The Effects of Aortic Valve Replacement on Survival: 
Patient survival after aortic valve replacement depends primarily 
on patient factors and not necessarily on the types of prosthetic 
valve used; this despite considerable variation in the haemodynamic 
characteristics of the various prosthetic and bioprosthetic valves. 
Even an imperfect prosthesis serves to remove the severe volume 
load on the left ventricle and provided an adequately sized 
prosthesis is inserted, minimal obstruction to left ventricular 
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outflow is produced. The probability of long-term survival and the 
haemodynamic performance of the various aortic valve prostheses is 
illustrated in the following tables:-
Table 2.4 PROBABILITY 
PROSTHESES 


















(Table 1, Chest 85 : 391, 1984) 
Table 2.5 HAEMODYNAMIC PERFORMANCE OF 
PROSTHESES 
Prosthesis PSG 
Starr-Edwards 9a-23mm 30 
Bjork-Shiley 19mm 16 
2lmm 24 
St Jude lSmm 16 
2lmm 6 
Hancock(modified orifice)2lmm 10 
Carpentier-Edwards 21-23mm 13 
Ionescu-Shiley 19mm 8 
2lmm 8 
Abbreviations: PSG = peak systolic gradient 
EOA = effective orifice area 












(Table 2, Chest 85 391, 1984) 
It is noted that the long term survival is not significantly 
different in the large series with the currently used devices 
(Bjork 1979, Craver 1981, Teply 1981, Ionescu 1982, Pelletier 
1982). 
Prospective studies evaluating long term survival of medical and 
surgical management of patients with severe aortic regurgitation 
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are not considered ethical and thus a retrospective analysis 
appears to be the only approach. Munoz (1975) failed to document a 
significant difference in 5 year survival between surgically and 
medically treated patients. Schwarz (1982), in evaluating the 
follow-up data of all patients with isolated chronic aortic valve 
disease who were recommended surgery between October 1975 and April 
1980 (252 operated and 47 unoperated patients), showed that surgery 
did not influence survival in patients with aortic regurgitation 
and normal left ventricular function. Those with left ventricular 
dysfunction tended to live longer following surgery. Although this 
supports the practice of delaying aortic valve replacement, it does 
not allow negative conclusions regarding the effectiveness of valve 
replacement in aortic regurgitation as· survival was the only 
criterion tested. In contrast, the Mayo Clinic experience of the 
medical and surgical long term follow-up (10-21 years) of 295 
patients with Class III and IV chronic aortic regurgitation (McGoon 
1981) showed that the 10 year survival was 4% in the medical 
treated group versus 45% in the surgically treated group. The 
survival in this group decreased to 38% by 19 years which equalled 
that of the control age and sex matched general population. Thus 
there was a significant improvement in survival in the operated 
group at 10 years with a minimal attrition rate thereafter. They 
speculated that earlier surgery might decrease the high early 
mortality. 
II.6.2 Equilibrium Radionuclide Angiocardiography at Rest and 
during Exercise: 
Ejection phase indices are presently widely used to assess pre- and 
postoperative ventricular function in patients with valvular heart 
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disease. Equilibrium radionuclide angiocardiography (ERNA) permits 
this to be done, not only non-invasively, but also during exercise, 
which may uncover dysfunction not evident during evaluation at 
rest. In the evaluation of 16 symptomatic -patients who underwent 
aortic valve replacement between 1976 and 1977 and who were re-
evaluated 6-9 months postoperatively, Borer (1979) found that 
although 63% of the patients had a normal resting ejection fraction 
pre-operatively, none had a normal functional reserve, with a mean 
ejection fraction at peak supine bicycle exercise of 37 + 4%. 
Postoperatively resting ejection fraction normalised in a total of 
14 of 16 patients. In contrast, only 4 had a normal peak exercise 
ejection fraction, i.e. aortic valve replacement can improve but 
does not usually normalise postoperative left ventricular systolic 
function during exercise; if exercise ejection fraction normalises, 
it does so in patients with a normal resting pre-operative ejection 
fraction. However, if pre-operative exercise ejection fraction was 
< 35%, it did not normalise irrespective of the pre-operative 
resting value. 
This study is in agreement with a small clinical and haemodynamic 
study following aortic valve replacement which reported that 
despite clinical and haemodynamic improvement at rest, cardiac 
output response to exercise remained subnormal(Bristow 1964). The 
small but significant improvement in resting ejection fraction 
after operation is in contrast to reports by other investigators 
that abnormalities in left ventricular function noted before 
operation most often persist to some degree after operation 
(Kennedy 1977, Bonow 1978, Rahimtoola 1978). This discrepancy 
appears to be related to earlier surgery, i.e. less impaired 
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functional class and preserved left ventricular systolic function. 
Other findings' from this study include (Borer 1979):-
(i) pre- and postoperative left ventricular function at rest or 
on exercise could not be accurately predicted from the pre-
operative symptomatic status, 
(ii) in addition, cardia-thoracic ratio on chest radiograph and 
the degree of left ventricular hypertrophy as estimated from 
the Romhilt-Estes electrocardiograph score (Romhilt 1968), 
were poor predictors of postoperative rest and exercise 
systolic function. 
These findings suggested that irreversible myocardial dysfunction 
has often occurred by the time patients developed symptoms 
(Hirshfeld 1974, Bonow 1978), and only become apparent when the 
heart was stressed. Pre-operative irreversible myocardial, damage 
secondary to chronic volume overload has been proven 
ultrastructurally with the demonstration of fibre degeneration, 
replacement fibrosis and altered myocardial architecture with fibre 
slippage due to excessive left ventricular distention (Ross 1971, 
Maron 1975). 
II.6.3 Postoperative Echocardiographic Evaluation: 
To determine whether volume overload myocardial hypertrophy 
secondary to chronic aortic regurgitation was reversible, the time 
course of change in left ventricular volume, mass and systolic 
performance was examined by Gaasch (1978). Pre-operative, early 
postoperative (7-10 days) and serial late postoperative 
echocardiograms were performed at 3, 6, 9, 12 and 24 months and are 
~ 
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summarised in figure 2.12 below. Due to the postoperative problem 
of paradoxical septal motion, Gaasch calculated the fractional 
increase in wall thickness from end-diastole to end-systole and 
used this measure as an index of left ventricular systolic 
function. 
The left ventricular end-diastolic dimension decreased 
significantly early postoperatively, with a tendency for continued 
reduction in DED for the first 9 months postoperat~vely. The total 
decrease in volume ranged from 50% to 60%, with 75% of the overall 
decrease occurring in the first 7 to 10 days and predominantly 
determined by the degree of pre-operative regurgitation. 
The lack of early change in muscle cross-sectional area (as a 
measure of left ventricular mass) despite a substantial reduction 
in left ventricular volume occurred as a result of a significant 
increase in posterior wall thickness. There was a progressive 
decrease in cross-sectional area (± 23%) until 9 mo~ths, which 
corresponded to a 40% decrease in left ventricular mass or an 
absolute reduction of 100 grams of left ventricular muscle 
(Modified Troy method, 1972). This index was developed by Sasayama 
et al and was initially utilised in studies of the response of the 
left ventricle to chronic pressure overload. (Sasayama 1976). 
These changes in left ventricular volume and mass are similar to 
other experimental (Papadimitriou 1974) and clinical studies 
(Burggraf 1975, Schuler 1976, Kennedy 1977). The change in left 
ventricular mass depends on the accurate determination of wall 
thickness and assumes that left ventricular myocardial hypertrophy 
occurs in a uniform manner and is accurately represented by free 
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wall thickness - this has been previously validated in patients 
with acquired valvular heart disease (Rackley 1964, Kennedy 1967). 
Figure 2.12 SERIAL PRE-OPERATIVE AND POSTOPERATIVE ECHOCARDIO-
GRAPHIC DATA 
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(Figure 2, Circulation 58: 830, 1978) 
The fractional shortening was not calculated postoperatively 
because of paradoxical septal motion. Pre-operative values were in 
the normal range and postoperatively the fractional increase in 
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wall thickness was used as a measure of left ventricular systolic 
function. Although there was a tendency to increase in the late 
postoperative studies, the changes were not statistically 
significant. This observation was also made by Schuler (1976) but 
other workers using both echocardiographic fractional shortening 
and angiographic ejection fraction have found little change 




correlation between fractional shortening and fractional 
in wall thickness, its wide range of normal (52+ 30%), 
afterload dependency (Quinones 1978), limit its 
applicability in man. 
The relation between muscle mass and ventricular volume, expressed 
tends to as the ratio of internal radius to wall thickness (R/Th), 
remain within the normal range in patients with 
compensated left ventricular volume overload. Once this 
chronic, 
ratio 
increases, it implies that LV dilatation has increased without 
adequate compensatory hypertrophy taking place. 
Although easily measured directly from the echocardiogram and 
linearly related to the volume to mass ratio over a wide range of 
ventricular dimensions, certain qualifications are necessary before 
its prognostic significance in aortic regurgitation can be 
evaluated, viz. (i) acute aortic regurgitation must be excluded, 
(ii) .radius to wall thickness ratio must be "normalised" for' left 
ventricular systolic pressure so as to provide an index of peak 
systolic stress (radius to wall thickness ratio at end-diastole is 
nearly equal to this ratio at the time of peak systolic stress) 
(Grant 1965). 
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In 19 patients evaluated by Gaasch (1978), 4 had persistent 
postoperative left ventricular dilatation in the abscence of aortic 
regurgitation - the single pre-operative echocardiographic 
parameter that identified this group was a radius to wall thickness 
ratio of greater than 4. They thus concluded that left ventricular 
hypertrophy is not only a critical compensatory mechanism 
normalising wall stress, but insufficient muscle mass relative to 
chamber size implies a poor prognosis. 
II.6.4 Postoperative Haemodynamic Assessment: 
The response of the normal left ventricle to supine exercise 
consists of a small increase in stroke volume (Chapman 1960, Wang 
1960) and a, slight fall or rise of less than 3mmHg in left 
ventricular end-diastolic pressure (Braunwald 1963, Ross 1966). It 
it well established both experimentally (Sarnoff 1954) and 
clinically (Braunwald 1964, Ross 1964) that the failing left. 
ventricle responds to a change in end-diastolic pressure or volume 
by an abnormally small alteration in stroke volume. These changes 
would not be apparent from changes in cardiac output and 0 
2 
consumption alone, whicn may be adequate to meet the stress of 
exercise. 
In explaining an abnormal rise in end-diastolic pressure (EDP) on 
exercise, several pertinent experimental and clinical observations 
need to be considered:-
(i) alterations in sympathetic tone and changes in heart rate, 
short of marked tachycardia, do not result in acute changes 
in the distensibility of the left ventricle (Mitchell 1960, 
Braunwald 1960, Sonnenblick 1963). 
(ii) 
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mean intrapleural pressure may decrease slightly during the 
hyperventilation that accompanies exercise (Donald 1955) and 
this effect would tend to lower the left ventricular EDP 
with reference to an external zero reference point. 
Therefore, 
reflects 
an increase in left ventricular EDP during 
an increase in end-diastolic volume, but during 
exercise 
chronic 
volume overload, increased wall stiffness may magnify this pressure 
elevation (Braunwald 1963, Kennedy 1977). Grossman et al (Grossman 
1974) however, in a combined echocardiographic and angiographic 
study evaluating late diastolic wall stiffness in patients with 
pressure and volume overload, found increased diastolic wall 
stiffness associated with pressure overload, but elevated stiffness 
in volume overload, when corrected for left ventricular dilatation, 
was similar to controls. They concluded that changes in EDP· are 
secondary to alteration in end-diastolic volume and not to changes 
in the diastolic properties of the ventricular myocardium. 
In patients with aortic regurgitation, regurgitant flow is 
~ promptly stopped by valve replacement. The prosthetic aortic va~ve 
thus functions as a competent but slightly stenotic valve under 
conditions of rest and moderate exercise, and the residual 
obstruction should be well within the capacity of the normal left 
ventricular myocardium. However, it could constitute a significant 
load in patients with left ventricular dysfunction (Beck 1966). 
Contrary to the high incidence of abnormal cardiac function 
reported by Linhart (1967), numerous investigators have reported a 
20% incidence of abnormal rest and exercise haemodynamics 
approximately nine months after aortic valve replacement (Bristow 
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1964, Beck 1966, Lewis 1966, Ross 1966, Bjork 1967). In a study by 
1 Hultgren et al (1969), eleven of nineteen patients with symptomatic 
class II to IV aortic regurgitation were re-evaluated a mean of 
8.5 months after aortic valve replacement with a Starr-Edwards 
ball-valve prosthesis. Ten of the eleven cases were asymptomatic. 
The mean pulmonary capillary wedge pressure (PCWP) at rest pre-
operatively was 15mmHg and dropped to 7mmHg postoperatively. Mean 
exercise PCWP dropped from 2lmmHg to lOmmHg with only one patient 
having an exercise PCWP > 15mmHg. Although resting cardiac index 
2 
rose from a 
2 
3.26L/min/m 
mean of 2.68L/min/m pre-operatively to a mean of 
(4.67 VS 
postoperatively, exercise cardiac index was similar 
4.95). They thus demonstrated excellent haemodynamic 
improvement with normalisation of exercise PCWP in ten of eleven 
patients. 
II.7.0 PROBLEMS ASSOCIATED WITH THE PUBLISHED DATA: 
In evaluating the role of aortic valve replacement in asymptomatic 
severe aortic regurgitation, one must weigh up the results of 
operative versus 
regurgitation from 
non-operative therapy for 





reasonably firm conclusion as to whether valve replacement therapy 
is indicated. Unfortunately, problems associated with the published 
data preclude such a comparison. These have been eloquently 
summarised by Rahimtoola (1983) and include:-
(i) Patients with mixed aortic valve disease or aortic stenosis 
are frequently not separated from those patients with 
isolated aortic regurgitation. 
(ii) Criteria for the assessment of the severity of the lesion 
65 
are often not stated. 
(iii) In some studies quantitative left ventricular functional 
data is not quoted although it may have been obtained. 
(iv) The number of patients excluded in the analysis of results 
needs to be carefully scrutinised as the statistics on 
operative mortality, peri-operative myocardial infarction 
rate, anticoagulant haemorrhage and prosthetic 




excluded from the analysis. Hospital mortality must be 
included to get a realistic idea of overall survival. 
(v) Life table analysis is not always performed. 
(vi) If life table analysis is performed, standard error (or 
confidence limits) should be presented because the precision 
of the estimated mean is directly affected by the sample 
size used to determine the mean. In some cases, so-called 
event-free curves include some complications. 
(vii) The accurate evaluation of prosthetic failure or valve 
related complications can be extremely difficult. Patients 
with prosthetic valve malfunction may be asymptomatic and 
the non-invasive detection of mechanical prosthesis failure 
is unreliable. Thus some patients may have a degree of 
asymptomatic regurgitation or stenosis postoperatively which 
may influence left ventricular function. In addition, not 
all symptoms or bleeding complications are volunteered and 




EXERCISE EVALUATION IN SEVERE AORTIC REGURGITATION 
III.O.O INTRODUCTION 
Rushmer et al (1959) noted that deficiencies in our basic 
understanding of accepted haemodynamic theories are o£ten corrected 
with the introduction of new or improved techniques. This 
observation, made more than 2 decades ago in an article about the 
ventricular response to exercise in animal preparations, remains 
applicable. In 1977, Borer et al, demonstrated exercise-induced 
abnormalities of left ventricular function not apparent at rest in 
patients with coronary artery disease. In symptomatic patients 
with severe chronic aortic regurgitation it is well known that 
various measures of left ventricular function including ejection 
fraction, end-diastolic pressure and cardiac output may be normal 
at rest, but that dysfunction almost invariably develops during 
exercise (Lewis 1970). Similarly, even asymptomatic patients may 
develop functional abnormalities when the heart is subjected to 
stress (Bolen 1976). 
Thus it appeared that the sequential use of non-invasive ERNA for 
the assessment of left ventricular function during exercise might 
prove valuable in the follow-up of these patients before the 
development of symptoms or the occurrerrce of left ventricular 
dysfunction at rest. 
Exercise evaluation will be discussed under the following 
headings:-
III.l.O Pathophysiologic Principles. 
III.2.0 Effects of Posture. 
III.3.0 Type of Exercise. 
III.4.0 Rest and Exercise Haemodynamics. 
III.5.0 Radionuclide Left Ventricular Ejection Fraction. 
III.l.O PATHOPHYSIOLOGIC PRINCIPLES 
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The haemodynamic burden of alterations in preload! afterload and 
aortic impedance may alter the ventricular contraction pattern seen 
on an angiogram without necessarily representing a change in 




Preload is the extent of stress on the muscle or filling of the 
ventricle at end-diastole which is measured clinically by end-
diastolic volume or end-diastolic pressure. By the Starling 
principal, the greater the preload, the greater the shortening or 
ejection, given a constant afterload and contractile state (Little 
1982). 
Afterload is a more complicated concept, representing the tension· 
against which the muscle contracts or ejects and is measured 
clinically as the peak systolic wall stress. Variables such as 
systolic pressure and ventricular size affect afterload. 
Aortic regurgitation represents an increase in both preload and 
afterload with the net effect on the contraction of the ventricle 
depending on the relative contribution of each factor. 
Furthermore, compensatory hypertrop~y alters contractility and may 
affect the extent of ventricular emptying seen on the angiogram. 
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Just as the chronic haemodynamic burden of severe aortic 
regurgitation may alter ventricular contraction, so does its 
removal by aortic valve replacement. With the removal of the 
regurgitant volume following valve replacement, there is usually an 
immediate decrease in end-diastolic volume with lit.tle or no change 
in end-systolic volume and thus a resultant decrease in ejection 
fraction. This reduction is primarily due to a change in loading 
conditions and not to a decrease in contractility. With time end-
systolic volume continues to decrease and the ejection fraction 
improves in most patients. 
111.2.0 THE EFFECTS OF POSTURE 
Posture has important physiologic effects on the cardiovascular 
system both at rest and during exercise (Crawford 1979). Recent 
studies have reported significant differences in the haemodynamic 
and functional responses to exercise with alterations in posture in 
normal persons (Poliner 1980, Manyari 1983) and in patients with 
coronary artery disease (Thadani 1977, Freeman 1981). These 
effects of posture on exercise response should be especially 
relevant in patients with aortic regurgitation because of the 
altered loading conditions and the dynamic nature of the leak in 
individual patients. 
Shen et al (1985) utilising equilibrium radionuclide angiocardio-
graphy demonstrated that posture was important in determining left 
ventricular response to exercise in patients with moderate to 
severe aortic regurgitation. Its effects on haemodynamics 
included a higher resting heart rate and a lower left ventricular 
stroke volume in the upright posture. The former may be the result 
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of increased sympathetic and reduced vagal tone (Gauer 1965), the 
latter because of the decreased left ventricular preload. During 
exercise, stroke volume remained unchanged in the supine position 
and slightly increased in the upright position. 
In contrast to normal subjects where left ventricular ejection 
fraction was similar at rest in both postures, ejection fraction 
was significantly lower in the upright position in patients with 
aortic regurgitation and this may be a function of reduced preload 
without a compensatory increase in contractility (Poliner 1980, 
Manyari 1983). During exercise left ventricular ejection fraction 
decreased in the supine position and was unchanged in the upright 
posture. It was proposed that the results obtained in one body 
position should not be compared to those in another in the 
individual patient and since exercise-induced left ventricular 
dysfunction occurs more frequently in the supine posture, this may 
be the preferred position for assessment of left ventricular 
functional capacity in asymptomatic patients with aortic 
r 
regurgitation. Several other studies have been reported and will 
be discussed. 
III.3.0 EXERCISE TYPE 
Left ventricular functional reserv~ can be assessed non-invasively 
by equilibrium radionuclide angiography used in conjunction with a 
number of provocations, including dynamic bicycle exercise, 
isometric handgr~p exercise, and cold pressor stress testing. 
III.3.1 Isotonic Bicycle Exercise 
Although isotonic bicycle exercise is the most commonly employed 
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means of stress, some workers believe that isometric handgrip 
exercise is a more ''physiologic approach" to the evaluation oi left 
ventricular functional reserve. 
Dynamic exercise increases myocardial oxygen demand primarily by a 
sympathetic mediated increase in heart rate and contractility 
without a significant increase in left ventricular diastolic 
pressure. 
III.3.2 Isometric Hangrip Exercise 
During handgrip exercise, there is little increase in heart rate 
but a significant increase in systemic pressure, most likely caused 
by impedance to the increased forearm blood flow by sustained 
muscle contraction (Savin 1980). In normal subjects, despite this 
increase in afterload, there is no increase in left ventricular 
end-diastolic pressure but in patients with aortic ·regurgitation, 
left ventricular end-diastolic pressure increases and stroke work 
decreases (Helfant 1971, Kivowitz 1971, Osbakken 1981). 
In patients with chronic .aortic regurgitation, left ventricular 
dysfunction results from a progressive increase in both preload and 
' afterload. Once preload has been exhausted, it has been postulated 
that a further increase in afterload results in a deterioration in 
left ventricular function (Ricci 1982). Handgrip exercise which 
represents an afterload stress, has been used as a simple 
provocative non-invasive test to assess the severity of impairment 
of left ventricular functional reserve. In addition, its effects 
disappear within a few seconds of release and it has been 
\ 
postulated that it is a better provocative test in patients with 
aortic regurgitation than dynamic bicycle exercise because of its 
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potential ability to evoke a greater increase in left ventricular 
end-diastolic pressure. 
However, a number of disadvantages of this manoeuvre preclude its 
general use and these include:-
(a) Poor patient co-operation with relatively submaximal handgrip 
resulting in minimal stress to the circulation. This can be 
offset by taking a rise in systolic blood pressure of 15-
20mmHg as a measure of the adequacy of the stress, similar to 
the increase in heart rate during isotonic exercise (Ellestad 
1969)' 
(b) An arrhythmogenic effect (Athins 1971) and 
(c) The performance of the Valsalva manoeuvre during the test. 
This can be avoided by simple patient instruction and careful 
observation by the attending physician during the sustained 
three minute contraction (Gorlin 1957). 
III.4.0 REST AND EXERCISE HAEMODYNAMICS 
It is well known that impairment of cardiac function often does not 
result in distinct haemodynamic abnormalities at rest. It 
frequently is necessary to determine the circulatory response 
during exercise before any functional limitation can be 
demonstrated. In addition, alterations in posture significantly 
alter the haemodynamic profile, with the resting values for end-
diastolic 
index, 
pressure, pulmonary capillary wedge 





significantly lower in the erect position and heart rate being 
higher (Wang 1960, Bevegard 1963, Tuckman 1966). 
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The increased venous return and consequent increased cardiac output 
is the major mechanism by which the elevated metabolic requirements 
of the exercising muscle are satisfied during exercise. Cardiac 
output increases as a linear function of oxygen consumption 
(Bevegard 1963) and can rise up to four fold in man (Saltin 1968), 
with heart rate being the predominant mechanism under physiologic 
conditions. Since the classic work of Starling (1920), stroke 
volume has been asigned a pre-eminent role in mediating an increase 
in cardiac output during exercise, particularly during near maximal 
exercise (Horowitz 1972). At low or moderate levels of supine 
exercise the heart rate increases to augment the cardiac output, 
whereas at maximal exercise, there is also an increase in end-
diastolic volume and stroke volume. Furthermore, in the supine 
position, with the leg lifting necessary to perform exercise 
studies, there is a slight increase in end-diastolic volume above 
the control measurements with the legs in the supine position. 
Therefore, further changes in end-diastolic volume during supine 
exercise may not be apparent. On the other hand, blood pooling 
reduces the end-diastolic volume at rest in the upright position. 
During upright exercise, the end-diastolic volume increases but may 
remain lower than the end-diastolic volume at peak supine exercise. 
Numerous studies in the supine position have confirmed that in the 
absence of severe pulmonary hypertension or obstruction at the 
level of the pulmonary veins or left atrium, the mean pulmonary 
capillary wedge pressure corresponds approximately to the left 
atrial pressure, which itself is approximately equal to the 
diastolic pressure in the left ventricle (Luchsenger 1962, Thadani 
1977). During exercise there is an increase in pulmonary capillary 
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wedge pressure during both po~tures but in normal subjects exercise 
pulmonary capillary wedge pressure does not exceed 15mmHg. 
Lewis and co-workers (1970) using a one-legged bicycle ergometer, 
reported that the classic clinical criteria for judging the 
severity of aortic regurgitation were of little value in predicting 
the exercise haemodynamics in 23 patients with Class II or III 
chronic aortic regurgitation. Although resting cardiac index was 
normal in most patients, it rose insufficiently with exercise in 11 
cases. Paradoxically, they found that the 12 patients with an 
appropriate cardiac index response had elevated left ventricular 
end-diastolic pressures, while those with a low cardiac index 
usually had normal pressures. No obvious explanation was offered. 
In an attempt to better understand the ejection fraction response 
during exercise in aortic regurgitation, Boucher et al (1983), in a 
study of 28 asymptomatic or minimally symptomatic patients with 
catheter proven severe aortic regurgitation, used supine symptom-
( 
limited bicycle exercise and stratified patients on the basis of 
their pulmonary capillary wedge pressure response to exercise. 
This objective measure was then used to compare the clinical, 
respiratory gas exchange and haemodynamic data in the two groups. 
An exercise pulmonary capillary wedge pressure of 15mmHg was used 
to divide patients into normal and abnormal left ventricular 
function (Ross 1966, Braunwald 1969, Rahimtoola 1975). Aithough 
75% of patients had normal resting pulmonary capillary wedge 
pressures, only 40% were normal at peak exercise. Using stepwise 
multiple regression analysis, the best predictor of the exercise 
pulmonary capillary wedge pressure was the oxygen uptake at peak 
' 
exercise. This measure reflects 
cardiovascular system in terms of 
deliver oxygen to the working muscles 
74 
the integrity of the 
its ability to adequately 
(Wasserman 1975, Astrand 
1976). Its primary determinants are central cardiac output, the 
ability to shift regional cardiac output to the working muscles and 
peripheral oxygen extraction. Mechanisms for reduced uptake 
include relatively reduced forward cardiac output, reflex 
vasoconstriction or the inability to vasodilate - this may 
translate in patients with poor cardiac compensation as an 
increased pulmonary capillary wedge pressure (Vatner. 1976). 
Failure to shift regional cardiac output to working muscles may 
occur independently of a reduction in central cardiac output, and 
may explain the better correlation of peak oxygen uptake with 
pulmonary capillary wedge pressure, rather than ejection fraction. 
The exercise level achieved is an alternative method of 
approximating peak oxygen uptake. 
When peak oxygen uptake was excluded, other variables also 
correlated, including absolute rest and exercise ejection fraction 
and age, but not change in ejection fraction on exercise. Numerous 
reasons could explain the inability of change in ejection fraction 
on exercise to correlate with filling pressures, namely, 
interpatient variability in the degree of change in exercise 
preload, afterload and contractile stimulation, altered loading 
conditions due to a decrease in regurgitant volume (Levinson 1970) 
, and other independent causes of wedge pressure elevation, e.g. 
diastolic stiffness (Eichorn 1982) or exercise induced mitral 
regurgitation. 
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Age was the only clinical variable that correlated with the 
exercise pulmonary capillary wedge pressure by multiple regre~sion 
analysis. This was similar to other reports (Schuler 1982, 
Gerstenblith 1976) where a~e-related abnormalities in cardiac 
contraction, ventricular relaxation and peripheral resistance 
occurred in some patients, and thus impaired the ability of older 
patients to tolerate severe aortic regurgitation. Although this 
objective 
defined a 
measure of exercise pulmonary capillary 
subset of patients with asymptomatic 
wedge pressure 
severe aortic 
regurgitation and left ventricular dysfunction, its prognostic 
value in terms of the development of severe symptoms, irreversible 
left ventricular dysfunction or death are presently unknown. 
III.5.0 RADIONUCLIDE LEFT VENTRICULAR EJECTION FRACTION 
Ejection fraction, the ratio of stroke volume to end-diastolic 
volume, is a simple, meaningful, unitless, non-invasive measure of 
cardiac function, but does not measure contractility (Krayenbuehl 
1968). It is significantly influenced by altered loading 
conditions and other factors including age, sex, resting heart 
rate, ejection fraction at rest, level and type of exercise (Borer 
1979, Port 1980, Jones 1981). In addition, left ventricular 
performance during exercise may be modified by training (Rerych 
1980, Bar-Shlomo 1982). Exercise (dynamic and isometric) 
equilibrium radionuclide angiography (ERNA) was first proposed by 
Borer and co-workers (1978, 1979) as a method of unmasking systolic 
ventricular dysfunction not evident at rest. The equilibrium 
technique is the most widely used method (Berger 1981). The normal 
reported response is a 5% or greater increase in ejection 
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fraction from rest to peak exercise although subjects with a 
resting ejection fraction of greater than 70% may not increase 
their ejection fraction with exercise (Thadani 1978, Osbakken 
1983) . 
Borer and co-workers found that all 21 symptomatic and 16 of 22 
asymptomatic patients with severe aortic regurgitation had an 
abnormal supine exercise left ventricular ejection fraction 
increase of less than 5%. The presence of an abnormal exercise 
ejection fraction response was unrelated to symptoms, degree of 
left ventricular hypertrophy on ECG or increased cardia-thoracic 
ratio on chest X-ray. The authors suggested that the unmasking of 
exercise induced left ventricular dysfunction might indicate that 
surgery was necessary, but because of the large number of 
asymptomatic patients in this category it may be overly sensitive. 
In addition, motivation and individual differences in the way 
patients change heart rate, preload, afterload and sympathetic 
status may all affect ejection fraction in different ways 
(Wasserman 1975, Astrand 1976, Port 1980). Posture during exercise 
(supine versus erect) may also affect the ejection fraction (Marx 
1982, Manyari 1982). Numerous factors influence the ejection 
fraction response to exercise and preclude its use in establishing 
a simple criterion to answer questions such as "what is the optimal 
time to perform aortic valve replacement in patients with 
asymptomatic severe aortic regurgitation?" 
In an attempt to better understand the left ventricular ejection 
fraction response in patients with severe aortic regurgitation, 
Boucher et al (1982) correlated left ventricular ejection fraction 
and left ventricular end-diastolic pressure during supine exercise 
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in 28 symptomatic or minimaily symptomatic patients. Only 40% (8 
patients) had a normal exercise pulmonary capillary wedge pressure 
response and these patients had a higher rest (64% + 8%) and 
exercise (63% ± 1%) ejection fraction compared to the 12 pat~ents 
with higher filling pressures (rest 49% ± 13%; exercise 4% + 18%, 
p <0.01). Although the difference in mean ejection fraction 
between the two groups was significant, overlap did occur. The 
best correlate with exercise pulmonary capillary wedge pressure was 
peak oxygen uptake, and although rest and exercise ejection 
fraction values also demonstrated a correlation, the change in 
ejection fraction with exercise and the cardio-thoracic ratio did 
not correlate. They concluded that in asymptomatic patients with 
aortic regurgitation the ejection fraction did not reflect left 
ventricular reserve and.the spectrum of haemodynamic findings was 
.large and varied. 
These apparently paradoxical observations may be partly explained 
by a number of limitations of this measure in assessing left 
ventricular performance in aortic regurgitation. The haemodynamic 
burden of volume overload in aortic regurgitation is complex (Ross 
1974, Ricci 1980). In addition, the regurgitant volume decreases 
with exercise because of reduced diastolic filling time and an 
exercise induced decrease in peripheral vascular resistance 
(Levinson 1970). Thus the forward stroke volume actually increases 
despite a fall in total stroke volume and end-diastolic volume. 
Because the ejection fraction reflects total stroke volume and does 
not separate regurgitant from forward stroke volume, it is possfble 
\ 
to have a drop in ejection fraction with an increase in forward 
stroke volume during exercise. 
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For these reasons, the exercise response of ejection fraction in 
patients with chronic aortic regurgitation is likely to be 
different from that in normal patients, and it may be inappropriate 
to compare the ejection fraction during exercise in chronic aortic 
regurgitation with the expected response of the normal left 
ventricle. 
As previously discussed, the position of the patient during bicycle 
exercise is also an important factor. Several studies have used 
upright exercise, with Iskandrian and associates (1981) and Lewis 
(1982) reporting a 5% or more increase in ·ejection fraction 
during exercise in the majority of asymptomatic patients and also 
symptomatic patients. However, the sample size of symptomatic 
patients was small. Marx and ~a-workers (1982) used both supine 
and upright exercise in a small study of 12 patients with aortic 
regurgitation. The ejection fraction was similar at rest, but the 
change in ejection fraction was higher for upright than supine 
exercise. Only two of the 12 patients studied had a fall in 
ejection fraction of 5% or greater during upright exercise, 
compared with 8 of 12 patients during supine exercise. Therefore, 
ejection fraction response in one position during exercise should 
not be applied to another. 
Other parameters utilising radionuclide ventriculography have also 
been studied, including left ventricular ejection rate (Johnson 
1982), volume changes during supine exercise (Dehmer 1981), and the 
end-systolic pressure-to-volume relationship as an assessment of 
myocardial contractility (Schuler 1982). This ratio has been 
proposed as an alternative to exercise evaluation. 
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Bonow and co-workers (1980) studied 45 asymptomatic patients with 
aortic regurgitation by echocardiography, 
treadmill testing (see Table 2.3). 
exercise ERNA and 
Twenty seven patients (Group A) ·did not complete 22.5min of the 
National Institute of Health exercise treadmill protocol without 
developing symptoms, whereas 18 patients (Group B) did. Groups A 
and B did not differ with respect to rest and exercise ejection 
fraction, end-systolic dimension or fractional shortening, yet the 
survival rate amongst 32 patients undergo{ng aortic valve 
replacement was 100% in Group B, but 53% in Group A. These findings 
challenge the prognostic significance after aortic valve 
of the considered markers of left ventricular replacement 
dysfunction, with exercise duration alone appearing to have 
predictive value. 
Ultimately the best method of determining which pre-operative 
parameter identifies the patient with severe aortic regurgitation 
at risk of irreversible left ventricular dysfunction, is to analyse 
patients after aortic valve replacement. Previous studies, 
including one from our institution (Forman 1980), have shown that a 
normal resting pre-operative left ventricular ejection fraction is 
associated with an excellent prognosis. Similarly another study 
shows that these patients have normal ejection fraction late after 
valve replacement (Merci 1981). Only patients with a reduced pre-
operative ejection fraction at rest have an increased postoperative 
morbidity and mortality, and even in this group, the majority 
normalise their resting ejection fraction (Clark 1980). In 
contrast in a radionuclide and cine-angiographic study of 16 
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symptomatic patients with aortic regurgitation before and six 
months postoperatively, Borer et al (1979) reported that resting 
left ventricular ejection fraction normalised postoperatively (46 ± 
3 to 57 ± 4%) but that although exercise ejection fraction improved 
(37 ± 4 to 53± 4%), it did not normalise following aortic valve 
replacement. 
Thus in conclusion, although exercise equilibrium radionuclide 
~ngiography appears to provide an assessment of left ventricular 
function, its role in aiding the timing of aortic valve replacement 








A discussion of the development and regression of left ventricular 
hypertrophy is pertinent as hypertrophy is an important factor in 
the structural adaptation of heart muscle, and regression of 
ventricular hypertrophy is vital to the structural and functional 
normalisation of heart muscle following surgical correction of 
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accepted limits of ·normal for 




adult weight (average 




heart is a consequence of an increase in the size of its 
constituent cells. However, although hypertrophy is mainly due to 
enlargement of individual muscle cells, this is an 
oversimplification, as an increase in the number of various 
connective tissue proteins in the interstitial space also occurs 
(Ferrans 1984). The connective tissue component may have important 
but as yet not clearly defined effects on systolic and perhaps more 
importantly diastolic function. 
Evidence supports the concept that normal cardiac growth and 
hypertrophy develop in response to increased haemodynamic loading 
and abnormal systolic and diastolic stresses at the myocardial 
82 
fibre level and the pattern of hypertrophy reflects the nature of 
the inciting stress (Linzbach 1960, Grant 1965, Grossman 1975). It 
is not understood how the heart translates signals generated by 
haemodynamic activity (a physical phenomenon) into biochemical· and 
ultrastructural changes (Zak 1984). 
Chronic volume overload is initially matched by adequate 
hypertrophy in the appropriate pattern, but in some instances, when 
the process fails to keep pace with the haemodynamic burden, 
systolic wall stress rises, possibly converting physiologic to 
pathologic hypertrophy and eventually left ventricular pump failure 
ensues. 
The development and regression of hypertrophy in the normal and 
failing heart will be reviewed under the following headings:-
IV.l.O Biochemical, physiological and ultrastructural aspects of 
cardiac hypertrophy. 
IV.2.0 Pathophysiologic mechanism. 
IV.3.0 Detection. 
IV.4.0 Clinical implications. 
-
IV.5.0 Regr~ssion - clinical importance and longterm prognostic 
implications. 
IV.l.O BIOCHEMICAL, PHYSIOLOGICAL AND ULTRASTRUCTURAL ASPECTS: 
Shortly after birth the myocardial muscle fibre loses mitotic 
activity and myocardial cell enlargement is the principal process 
by which the heart hypertrophies. Muscle mass increases with 
workload (Zak 1973, Wikman-Coffelt 1976) and the heart 
physiologically responds to an increased workload by increasing the 
number of sarcomeres. Although the mechanism of sarcomere genesis 
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has not been fully elucidated, two micro-anatomical locations for 
new sarcomere production have been suggested, namely the 
intercalated discs (Adomian 1974) and the Z bands (Legato 1970). 
Pressure alone (Schreiber 1978), or simply stretch of muscle fibres 
(Vandenburgh 1979) appears to activate the genetic apparatus of the 
myocardial cell with resultant enhanced nucleic acid (Fanburg i968, 
Markin 1968), and protein, including myosin, synthesis (Schreiber 
1966; Zak 1976). It is suggested, but as yet not generally 
accepted, that new genetic expression in the form of new myosin 
isoenzymes (Schwartz 1978, Flink 1979) occurs. Haemodynamic 
overload is followed within a very short space of time by increased 
protein synthesis with the preferential synthesis and accumulation 
of mitochondrial proteins during the early phases of myocardial 
hypertrophy (Albin 1973, Zak 1976). Although mitochondria increase 
both in size and number with the progression of hypertrophy 
(Schreiber 1973), the normal inciting stimulus of mitochondrial 
neogenesis is not established at this time (Gevers 1972). 
Following these early microsomal and mitochondrial adjustments in 
response· to wall stress, there is an increase in myosin 
biosynthesis. 
(Everett 1977, 
Protein degradation, however, remains constant 
Laurent 1978). These structural and biochemical 
changes that occur early in the genesis of cardiac hypertrophy may 
not be the same for physiological and pathological hyper~rophy, and 
the asynchronous synthesis of certain cardiac proteins (e.g. · a 
disproportionate synthesis of mitochondrial to myofibrillar 
proteins) may result in normal or supernormal velocity of muscle 
shortening in physiological hypertrophy and a depressed velocity of 
shortening in pathological hypertrophy (Wikman-Coffelt 1979). 
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With time, myocardial hypertrophy progresses and further structural 
and biochemical alterations occur:-
(i) enhanced myofibrillar accumulation results in a decrease in 
the relative volume occupied by the mitochondria in the 
cardiac fibre (Wollenberger 1966). 
(ii) an increase in muscle mass and enlargement of individual 
muscle fibres (Geha 1966). The resultant decrease in the 
cell surface-to-cell volume ratio, may limit efficient 
exchange of metabolites and tissue gases and serve as a 
stimulus for collagen synthesis. The maximum fibre size 
attained with myocardial hypertrophy is restricted partially 
by the ability of component organelles to increase in number. 
The distance between capillaries also increases until the 
slower growth of the capillary bed "catches up" (Tomanek 
1982). It is unclear whether a completely normal 
relationship of cell size to capillary density is ever 
regained. 
The ability of mitochondria to increase in number proportionate to 
demands may determine whether the contractile units work at a 
decreased, normal, or increased shortening velocity, which in turn 
is partially regulated by the type of myosin isoenzyme present. 
There is a direct relationship between the rate of calcium-
activated myosin ATPase activity and the maximum velocity of muscle 
shortening (Barany 1967). Animal studies have demonstrated that 
accompanying myocardial, hypertrophy, new isoenzymes of myosin 
occur, principally determined by the degree of haemodynamic stress 
(Wikman-Coffelt 1975). In the case of physiological hypertrophy 
these new isoenzymes demonstrate an increased rate of ATP 
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hydrolysis (Flink 1977) and, in the case of pathological 
hypertrophy, a decreased rate of ATP hydrolysis (Schwartz 1978). 
The decrease in myosin ATPase activity in failing, haemodynamically 
stressed, hypertrophied hearts is associated with alterations in 
the sulfhydryl groups of myosin involved in the active site (Thomas 
1977) and may be seen as a compensatory mechanism because the 
decreased shortening velocity leads to less heat production and a 
more efficient contraction. It is important to note however, that 
in man changes between the isoenzymes (Vl and V3) are considered 
not to be an important adaptive mechanism (Mercadier 1983) and the 
relevance of these changes to clinical events are as yet unclear. 
When the stimulus to hypertrophy is particularly prolonged and 
intense, excessive cell growth is elicited with disproportionate 
biosynthesis of organelles and contractile proteins, thereby 
leading to the evolution of pathological hypertrophy. This form of 
hypertrophy is characterised by a reduced myosin ATPase activity 
(Wikman-Coffelt 1975, 1976), and depressed contractile function 
(Meerson 1969). 
In summary, all inducers of hypertrophy appear to initiate the 
process by a common mechanical-biochemical coupling mechanism; the 
work overload causes an increased pressure on the myocardial cells 
with stretch of muscle fibres and this, perhaps mediated by 
noradrenaline release, causes an augmentation of RNA transcription 
and protein synthesis. Then, depending on the severity of the 
2 
workload, secondary factors such as increased tissue pCO could 
determine whether the heart adjusts to the new work demand by 
developing the characteristics of either physiological or 
pathological hypertrophy (Wikman-Coffelt 1979). 
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Histologically normal left ventricular muscle cells range up to 
15~m in diameter. When hypertrophy occurs, the diameter of many 
cells exceed 20~m and cells with a diameter of 50~m may be seen, 
resulting in marked variation in the diameter of adjacent 
myocardial cells. The reason for such variation in cell size, 
presumably all subject to the same haemodynamic stress, 
certain. 
is not 
While >ultrastructural changes in the early and stable phases of 
hypertrophy reveal variations in the appearance of hypertrophied 
cardiac muscle cells depending on the cause and the stage of the 
hypertrophy, the size of the contractile elements are similar to 
normal cardiac muscle cells (Richter 1963); In the late stage of 
hypertrophy a variety of de~enerative changes and interstitial 
fibrosis dominate the morphologic picture. The effects of these 
degenerative changes on measured systolic function are difficult to 
separate from the effects of hypertrophy alone. With removal of 
the haemodynamic load regression of hypertrophy may occur but 
restoration of normal architecture and function is unlikely if 
these degenerative changes are extensive. 
The degenerative chan~es include (a) loss of contractile elements 
particularly the thick myosin filaments and specialised 
intercellular contacts; (bl alterations in other cytoplasmic 
organelles; and (c) interstitial fibrosis. The stimuli that 
produce hypertrophy of myocardial cells also stimulate the 
formation of collagen. Occasionally the rate of collagen synthesis 
is excessive and it is postulated that this may impair left 
ventricular mechanical function, particularly diastolic function. 
At a biochemical level, the increase of collagen can be measured by 
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an increase in hydroxyproline, the level of which remains unaltered 
when the inciting stimulus is removed (Cutiletta 1975). This is 
presumably because collagen deposition in the interstitial space 
makes it inaccessible to normal breakdown. This permanent increase 
in the content of left ventricular connective tissue may have 
important long term consequences, such as alterations in diastolic 
function of the left ventricle (Brutsaert 1985). 
IV.2.0 PATHOPHYSIOLOGIC MECHANISM 
Normal ventricular growth involves an increase in the number of 
myocardial cells (HYPERPLASIA) throughout foetal life and up to 6 
months of age (Perloff 1982). The stimulus is predominantly 
haemodynamic with a possible hormonal or biochemical link 
(norepinephrine Laks 1976). Thereafter cardiac growth is 
associated with progressive cell enlargement (HYPERTROPHY), 
resulting in a 20 times increase in mass (Zak 1973, Perloff 1982). 
Thus, substantial increases in ventricular dimension an~ wall 
thickness result from the addition of new contractile proteins in 
series and in parallel within a virtually constant population of 
cardiac muscle cells (Zak 1973, Wikman-Coffelt 1979). Normal 
growth is therefore a form of "physiologic" volume overload 
hypertrophy (Wikman-Coffelt 1979). 
-' 
In patients with aortic regurgitation, Grant et al (1965) observed 
that the eccentric hypertrophy that develops strongly resembles the 
pattern of normal growth; in contrast, pressure overload or 
concentric hypertrophy involves a disproportionate increase in wall 
thickness at a normal or reduced chamber dimension. 





and the pattern of hypertrophy, wall stress (the magnitude of 
forces acting at the myocardial cell level) needs to be calculated. 
A modification of the Law of LaPlace (Grossman 1975) is used, which 
states that the wall stress or tension per unit cross sectional 
area (WS) is proportional to the pressure (P) and radius (R) of the 
chamber and inversely proportional to its wall thickness (h) 
(Gaasch 1979):-
P.R 
ws = /h 
The following table 4.1 demonstrates the proposed ~ypothesis of 
Grossman (1980), invoking the relationship between inciting 
stimulus and pattern of hypertrophy. 
Table 4.1 PATHOGENESIS OF HYPERTROPHY: 
(Table 1, JAm Coll Cardiel 3: 1310, 1984) 
When the primary stimulus to hypertrophy is pressure overload, 
increased left ventricular systolic pressure and wall stress result 
in the parallel addition of new myofibrils, with resultant increase 
in wall thickness and concentric hypertrophy. The wall thickening 
tends to normalise wall stress. In contrast, when volume overload 
is the inciting stimulus, increased diastolic pressure and wall 
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stress leads to the series addition of new sarcomeres, fibre 
elongation and chamber enlargement. This progressive 'ch~mber 
enlargement results in elevated systolic wall stress by the LaPlace 
relationship with the subsequent development of eccentric 
hypertrophy to normalise the systolic stress; i.e. myocardial 
hypertrophy occurs in concert with chamber dilatation and thereby 
serves to normalise the force per unit cross sectional area of the 
myocardium. 
which the 
This resembles the normal myocardial growth pattern in 
R 
radius-to-wall thickness ratio ( /Th) remains constant 
(Gaasch 1979) and may account for the fact that patients with 
chronic volume overload may remain asymptomatic for many years 
despite severe volume overload and significant cardiac enlargement. 
IV.3.0 DETECTION: 
The electrocardiogram is commonly used for the detection of left 
• ventricular hypertrophy. It has a specificity of 95%, however, its 
sensitivity is less than 60%. The Romhilt-Estes point score 
(Romhilt 1969) is better than the Sokolow-Lyon voltage criteria 
(Sokolow 1949r and the praecordial leads better than the limb leads 
(Reichek 1981). Carroll (1982) reported a strong correlation 
between left ventricular voltage on the electrocardiogram and 
muscle cross-sectional area on the echocardiogram in data from 59 
studies before and after aortic valve replacement in patients with 
chronic aortic regurgitation (r = 0.81). 
~ 
At present M-mode echocardiography is widely used for the detection 
of left ventricular hypertrophy, correlating well with autopsy left 
ventricular mass (Devereux 1980) and having a sensitivity , and 
specificity in excess of 90%. There are a number of measurement 
methods which all assume that the ventricle is ellipsoidal at end-
I 
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diastole. Left ventricular mass is . then calculated using a 
3 
specific gravity of ventricular muscle of 1.05 G/cm (McFarland 
1978, Reichek 1981). However, there are limitations in using this 
technique to measure wall thickness and the calculation of left 
ventricular mass, namely:-
( i ) difficulties in defining the endocardium - the Penn 
convention method which excludes endocardial echoes 
(compared to the standard convention method) provides a more 
accurate estimate of left ventricular mass. 
( ii) the problem of abnormal echoes (e.g. chordal structures and 
left ventricular bands)(Keren 1984). 
(iii) significant interobserver variation and difficulty in 
reproducibility (Felner 1980, Pietro 1981). 
(iv) abnormal left ventricular geometry. 
Two dimensional echocardiography is probably the method which is 
most widely available and most accurate at present and has been 
shown to correlate well in clinico-pathologic studies(Salcedo 1979, 
Helak 1981). 
IV.4.0 CLINICAL IMPLICATIONS: 
Although normal cardiac growth ("physiologic'' volume overload) and 
volume overload hypertrophy in experimental animals is associated 
with normal contractile function (Turina 1969, Newman 1978), there 
appear to be a number of differences in patients with clinical 
volume overload:-
(i) The degree of hypertrophy is proportional to the duration 
and haemodynamic severity of the volume overload (Panidis 
1984), the myocardium does not possess an unlimited ability 
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to increase its mass in response to haemodynamic stress. At 
present the limiting factor is not known, but may be 
capillary density and cell size (Tomanek 1982). The 
inability of hypertrophy to keep pace with the haemodynamic 
burden may lead to increased wall stress and an unfavourable 
outcome (Field 1973, Gaasch 1978, Benjamin 1981). 
(ii) When severe left ventricular hypertrophy develops, some 
patients exhibit depressed systolic function and do not 
recover normal function after corrective surgery. There 
appears to be a pathologic continuum from normal to severely 
depressed contractile 
I 
function in patients with volume 
overload due to chronic aortic regurgitation. Gaasch and 
co-workers (1978) postulated that this might be due to 
inadequate hypertrophy, with an inability to sustain the 
addition of new myofibrils in parallel to balance the series 
addition of new sarcomeres, resulting in a high wall stress 
with decreased fibre shortening and eventual ventricular 
failure. In addition, failure to improve ventricular 
performance postoperatively could reflect persistence of 
h 
high wall stress (low /R) secondary to:-
-inability to resorb new sarcomeres laid down in' series 
(Jarmakani 1971). 
-continued inability to increase fibre thickness by parallel 
addition of new myofibrils. 
However, exactly when compensatory (adaptive) hypertrophy becomes 
"pathologic", irreversible myocardial damage and impaired 
contractility is presently unknown. 
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IV.5.0 REGRESSION AND ITS SIGNIFICANCE: 
Although experimental and clinical data reveal regression of 
ventricular hypertrophy after correction of· haemodynamic overload 
(Gault 1970, Cutiletta 1975, Carey 1970), contractility often 
remains depressed (Gault 1970), with connective tissue not 
appearing to regress as readily as myocardial mass (Cutiletta 
1975). The extent of reversibility of contractility chang~s appear 
to depend on the inciting stimulus, duration of wall stress and the 
age, health and species concerned. 
Many studies (Gaasch 1978~ Schuler 1979, Carroll 1981, Carroll 
1982), using echocardiographic or angiographic techniques, have 
shown regression of left ventricular hypertrophy and improvement in 
indices of myocardial contractility in most (but not all) patients 
6 to 15 months after aortic valve replacement. 
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Some reports (Boucher 1981, Toussaint 1981) show that even if 
performance is initially.depressed postoperatively, 
with time. 
it may improve 
Most of these studies are limited by the small number of patients 
in each study and the serial assessment by means of M-mode 
echocardiography with its inherent difficulties (Teicholz 1976, 
Ditchey 1981, Pietro 1981). 
Experimentally Papadimitriou (1974) showed that regression of left 
ventricular mass after correction of volume overload was associated 
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with normalisation of myofibre ultrastructural morphology; however, 
the role of histopathologic myocardial changes in the regression of 
hypertrophy and the recovery of cardiac function after removal of 
volume overload in man has not been clearly defined (Jarmakani 
1971, Dodge 1974) with contradictory reports in the more recent 
literature (Maron 1975, Maron 1975, Schwarz 1978). It is generally 
accepted that in advanced left ventricular hypertrophy interstitial 
fibrosis develops, probably as a result of focal cell destruction 
(Wigle 1957, Linzbach 1960, Reichenbach 1967), but this fibrosis 
has not been shown to be a primary determinant of impaired left 
ventricular function. (Maron 1975, Schwarz 1978). 
In patients, regression of left ventricular mass is usually PARTIAL 
(Kennedy 1977, Bodem 1978, Carroll 1981) with the final estimates 
of mass remaining somewhat greater than normal. Varied explanations 
include irreversible fibrosis (Reichenbach 1967, Maron 1975) and 
relative prosthesis "stenosis" with the substitution of pressure 
overload for volume overload (Schuler 1979). Most importantly, 
regression may be a slow process which occurs late and thus may not 
be detected 6-9 months postoperatively when patients are usually 
re-evaluated. 
It is not known whether the clinical and functional outcome is 
influenced by the extent of the regression. Much of the reported 
data on postoperative left ventricular function has not been 
serially obtained, and for this reason the time course of such 
changes has not been fully evaluated. 
Carroll et al (1981) speculate that persistent left ventricular 
hypertrophy after aortic valve replacement may be associated with 
' 
persistent dysfunction, while gradual regression parallels 
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functional imp~ovement. In contrast, Henry et al (1980) and 
Schuler (1979) found no pre- or postoperative echocardiographic or 
haemodynamic variables that could predict irreversibility of 
hypertrophy, persistence of left ventricular dysfunction or 
ultimate prognosis. 
Thus, regression of left ventricular hypertrophy does not 
necessarily assure normalisation of left ventricular function, and 
failure to regress does not mean that function is abnormal (Perloff 
1982). Further studies are required to determine the degree and 
type of left ventricular hypertrophy that constitutes a 
"pathologic" irreversible state and to highlight the consequences 
of the regression of hypertrophy. 
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CHAPTER V 
DIASTOLIC FUNCTION IN SEVERE AORTIC REGURGITATION 
V.O.O. INTRODUCTION 
Most investigations concerning ventricular function in valvular 
heart disease have examined systolic performance of the ventricle. 
However, the diastolic properties of the heart (its ability to 
relax) are also important, possibly independent factors that may 
precede or accompany the development of impaired systolic function 
(Bristow 1970, Hammermerster 1974, Eichhorn 1982, Brutsaert 1985). 
Several catheterisation studies have shown that the careful 
measurement of left ventricular volumes during diastole permits one 
to calculate the rate ~f diastolic filling. Patients with 
disorders of left ventricular compliance have a lower diastolic 
filling rate than normal. 
The non-invasive evaluation of left ventricular diastolic 
performance by gated equilibrium radionuclide angiography (ERNA) 
has been suggested as a reliable method of uncovering diastolic 
dysfunction in patients with coronary artery disease and systemic 
hypertension 
(Bonow 1981, 
independent of left ventricular systolic function 
Reduto 1981, Mancini 1983, Inouye 1984). Few reports 
deal with the relaxation process in volume overload hypertrophy 
(Haurath 1980, Osbakken 1984, Lavine 1985). 
V.l.O. LEFT VENTRICULAR RELAXATION 
Left ventricular relaxation is a complex, energy dependent process 
(Langer 1968, Katz 1973) with the sarcoplasmic reticulum playing a 
central role by its abilit~ to sequestrate calcium ions. The 
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lowering of the calcium concentration in the vicinity of the 
myofibrillar proteins is thought to result in · actin-myosin 
dissociation by inhibition of myofibrillar ATPase activity (Langer· 
1974). 
V.2.0 PASSIVE ELASTIC PROPERTIES 
The passive elastic properties of the left ventricular chamber are 
expressed as the ratio of the change in pressure to the change in 
volume. This ratio reflects left ventricular chamber stiffness, 
and its reciprocal, the left ventricular chamber compliance. The 
relationship is curvi-linear such that the left ventricle is 
relatively compliant at low volume but becomes progressively less 
so with increased volume. Therefore a comparison of stiffness in 
different ventricles can only be meaningful if pressure and volume 
are specified. Additionally, relative changes in pressure and 
volume are influenced by extrinsic factors, which include atrial 
systole, heart rate, the pericardium, arterial pressure and 
ventricular interaction (Grossman 1976, Ross 1979, Grossman 1980, 
Janicki 1980). This is in contradistinction to myocardial 
stiffness or compliance which is a function of the stress and 
strain within the wall of the ventricle (Mirsky 1973, Gibson 1974). 
Chronic alterations in preload as occur in aortic regurgitation 
have been reported to result in major changes in left ventricular 
chamber stiffness (Dodge 1962, Gault 1970, Gaasch 1972, Grossman 
1974). In a study by Grossman (1974), left ventricular diastolic 
chamber stiffness correlated well with wall thickness in a diverse 
group of· cardiac disorders, emphasising the importance of wall 
thickness as a determinant of ventricular stiffness. However, in 
chronic volume overload, diastolic pressure has been reported to 
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frequently be normal despite an increase in diastolic volume (Dodge 
1962); although it might be interpreted as indicating decreased 
ventricular stiffness (increased compliance), the slope of the 
pressure volume curve is usually normal or increased, suggesting 
normal or increased stiffness. The clinical significance of this 
alteration in ventricular stiffness is uncertain - it possibly 
limits dilatation and encourages anterograde flow of blood in the 
aorta during diastole by offering increased resistance to 
regurgitant flow. 
V.3.0 VISCOUS AND INERTIAL PROPERTIES 
The viscous and inertial properties of the left ventricle are of 
theoretical significance· in the clinical setting and will not be 
/ 
discussed any further. 
V.4.0 EFFECTS OF EXERCISE AND POSTURE 
During exercise end-diastolic volume increases in most persons and 
end-systolic volume decreases, with a resultant increase in stroke 
volume and an increase in ejection fraction (Poliner 1980). With 
increased heart rate, the duration of diastole shortens and the 
proportion of the cardiac cycle available for filling is decreased, 
with most of the cycle devoted to systolic ejection. It follows 
that filling becomes more rapid to accommodate the increase in end-
diastolic volume. Body position also alters ventricular volume 
(Poliner 1980, Reduto 1981), with the heart doing more volumetric 
work at a lower heart rate in the supine position, while . in the 
upright posture at comparible workloads, delivery of cardiac output 
is more rate related. 
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V.5.0 EARLY DIASTOLIC FILLING 
Early diastolic filling, in contrast to late filling caused by 
atrial systole, is responsible for significant filling of the 
ventricle before diastolic pressure reaches a minimum (Fioretti 
1980). Although there are few ventricular models capable of 
describing the complex dynamics and interactions between pressure 
and volume during this part of the cardiac cycle, it is reasonable 
to conclude that early ventricular filling is dependent on the 
pressure gradient across the mitral valve and the resistance of the 
ventricular wall to distention. 
V.6.0 SYSTOLIC-DIASTOLIC INTER-RELATIONSHIPS. 
The importance of diastolic relaxation and filling to adequate 
systolic function has not always been well appreciated. To these 
"mechanical" or "primary" factors, more subtle influences can be 
added namely the impact of neurohumoral factors (Sonnenblick 1963, 
Fouad 1983), which appear to improve left ventricular contraction 
and enhance relaxation rate and filling (Fouad 1984). It has been 
shown that the velocity of lengthening is directly related to the 
extent of_ preceding shortening, and when using , equilibrium 
radionuclide angiocardiography this means the relationship between 
peak filling rate or the velocity of lengthening and- ejection 
fraction or the extent of shortening (Bonow 1981, Polak 1982, 
Bahler 1983). Consequently, for proper comparisons between 
patient groups and during interventions within a group, the peak 
velocity of filling must be related to the concurrent extent 6f 
systolic shortening. 
V.7.0 NON-INVASIVE RADIONUCLIDE VARIABLES OF DIASTOLIC FUNCTION 
Radionuclide derived peak filling rate (PFR), expressed as end-
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diastolic volumes per second, correlates best with haemodynamic 
variables that reflect active rather than passive diastolic 
function (Gaasch 1976, Rankin 1980). It is defined as the late 
positive peak of the first derivative of the volume curve. It 
correlates with left ventricular end-diastolic pressure which 
depends on both cardiac and non-cardiac factors (Braunwald 1963). 
In addition, it shows a strong correlation with the systolic 
haemodynamic variable ejection fraction, demonstrating the integral 
coupling of cardiac contractility to myocardial relaxation. Average 
diastolic filling rate (ADFR), which averages filling from end-
systole to the end of the R-R interval, has more recently been used 
in accessing rapid ventricular filling in both physiologic and 
pathologic hypertrophy (Smith 1985). 
In a recent gated blood scintigraphic study (Lavine 1985), the 
abnormal pattern of resting diastolic filling of the left ventricle 
in patients with moderate to severe chronic symptomatic and 
asymptomatic aortic regurgitation is reported. Peak filling rate 
(PFR) was lower in the aortic regurgitation group than in normal 
subjects (2.24 ± 0.70 versus 3.09 ± 0.71 EDV/Sec, p < 0.001). 
Similarly, average diastolic filling rate (ADFR) was lower in the 
aortic regurgitation group (1.31 ± 0.40 versus 1.63 ± 0.29 EDV/Sec, 
p < 0.01). They also showed that diastolic filling patterns were 
not significantly different in asymptomatic and .symptomatic groups 
and did not differentiate patients with congestive ~eart failure or 
more severe aortic regurgitation from those with less severe 
disease. 
Time to peak filling rate (TPFR) is the time from end-systole 
(derived from the volume curve) to the occurrence of peak filling 
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(derived from the first derivative of the volume curve). Although 
not reported to be independently useful, in combination with a 
reduced peak filling rate it increases the sensitivity for the 
detection of coronary artery disease (Bonow 1981, Kemper 1981). 
When calculated during exercise, it must be normalised for the 
heart rate(R-R interval). 
V.8.0 LIMITATIONS 
Despite the recent interest in the use of equilibrium radionuclide 
angiocardiography to assess diastolic function in a varied number 
of cardiac conditions, there are important limitations in the 
technique: 
(i) The timing of events during the cardiac cycle is not accurate 
because mitral valve opening and mitral valve closure are not 
accurately delineated and thus time to peak filling rate 
contains both isovolumic relaxation as well as early 
diastolic filling. As a result, interpretation of the 
anomalies in this interval are difficult (Grossman 1980). 
(ii) Fundamental differences exist in the rest and exercise 
measurement of peak filling rate - at rest the contribution 
of atrial systole can easily be identified and excluded, but 
at peak exercise with a much shorter R-R interval, atrial 
systole may be a major determinant of the measured peak 
filling rate. 
(iii) The forward-backward reformat technique more accurately 
characterises the correlation of filling rates and later 
diastolic curve events, but this elegant technique requires 
considerable computer memory space and is thus not applicable 
to exercise studies where evaluation needs to be made at 





This study was a prospective, sequential evaluation of left 
ventricular function using both non-invasive and invasive 
techniques in symptomatic and asymptomatic patients with isolated 
chronic, severe (4+) AR at cardiac catheterisation. 
The aims of the study were to: 
(I) Identify differences in the clinical, echocardiographic, 
resting and exercise haemodynamic and radionuclide measures 
of left ventricular function in symptomatic and asymptomatic 
patients with chronic severe AR with particular 'reference to 
the incidence of presymptomatic d~velopment of left 
ventricular dysfunction. 
(II) Critically evaluate the role of exercise stress (both 
isotonic and isometric) in the assessment of patients with 
chronic severe AR. 
(III) Evaluate the influence of time (sequential studies) on the 
haemodynamic burden in asymptomatic patients. 
(IV) Study the impact of successful aortic valve replacement on 
the reversibility of abnormal pre-operative LV function in 
an attempt to predict which patients would benefit from this 
therapeutic intervention and whether operation for symptoms 
alone is the correct clinical practice. 
Vi.l.O STUDY DESIGN: 
This was a prospective analysis of 60 patients with chronic severe 
aortic regurgitation seen at the Cardiac Clinic, Groote Schuur 
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Hospital, Cape. Patients of both sexes between the ages of 13 and 
65 years were included. Thirty two(32) symptomatic patients were 
identified following consultation in the Cardiac Clinic and 
referred for cardiac catheterisation prior to aortic valve 
replacement. Twenty eight(28) asymptomatic patients with severe 
aortic regurgitation who were being seen regularly in our 
Outpatients Department were also evaluated. 
The details of the study design are summarised in Figure 6.1. It 
should be noted that only 22 symptomatic patients underwent aortic 
valve replacement, the other 10 patients declining surgery. Three 
patients died postoperatively at 17 days, 2 months and 6 months 
respectively, resulting in the re-evaluation of 19 patients at 6 
months following valve replacement surgery. Twenty three (23) 
asymptomatic patients and three of the symptomatic group who 
declined operation (total n = 26) underwent sequential assessment 
at 6 months .following the initial evaluation. Only 9 patients (8 
asymptomatic and 1 symptomatic) agreed to follow up study at 12 
months. The design and performance of this study was approved by 
the Ethics and Research Committee of the University of Cape Town 
Medical School on the 13th April 1983. Informed consent was 
obtained by the author according to the Declaration of Helsinki. 
All aspects of the assessment, namely clinical evaluation, rest and 
exercise equilibrium radionuclide angiocardiography and cardiac 
catheterisation were performed personally by the author. 
Echocardiography was performed by experienced echocardiographers. 
VI.l.l Clinical Assessment. 
All patients were evaluated on admission to hospital. 
history was obtained wjth particular reference to:-
A detailed 
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(i) Dyspnoea on effort classified according to the New York 
Heart Association criteria (1973). 




The presence or absence of palpitations. 
Symptoms of orthopnoea, nocturnal dyspnoea or 
swelling. 
(v) A history of acute rheumatic fever in the past. 
ankle 
In the symptomatic patients every effort was made to accurately 
establish the exact time of onset of symptoms. 
Physical examination included characterisation of the peripheral 
pulse, the presence of peripheral signs of aortic regurgitation 
including Corrigan's sign in the neck, pistol-shot femoral pulses 
and Duroziezs' sign. The blood pressure was measured with a 
standard sphygmomanometer, taking phase IV Korotkow sound 
(muffling) as the diastolic pressure. In addition, the presence or 
absence of signs of congestive heart failure were noted, namely an 
elevated jugular venous pressure, pedal and/or sacral oedema and 
hepatomegaly. Finally, localisation and characterisation of the 
cardiac apex and a number of auscultatory phenomena, namely the 
intensity of the lst heart sound, the presence of a middiastolic 
rumble at the apex and the intensity and length of the basal early 
diastolic murmur were recorded. 
A 12-lead electrocardiogram was recorded in every patient, and note 
taken of the rhythm, P-R interval and the degree of left 
ventricular hypertrophy as judged by the Romhilt-Estes voltage 
criteria (Romhilt-Estes 1968) - the largest R or S wave in the limb 
leads equal to or greater than 20mm, the largest S wave in Vl or V2 
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equal to or greater than 30mm, the largest R wave in V5 or V6 equal 
to or greater than 30mm. The Sokolow-Lyon index (Sokolow-Lyon 
1949) namely the sum of the S wave in Vl plus the larger of the R 
wave in V5 or V6 greater than or equal to 45mm in the absence of 
ST-T wave abnormalities or greater than or equal to 35mm in the 
presence of ST-T wave changes was also used. 







































A standard chest radiograph (posterior-anterior and lateral at 6ft) 
also formed part of the evaluation. The cardiothoracic ratio was 
calculated from the frontal posterior-anterior film by dividing the 
maximal frontal width of the heart, excluding the apical fat pad, 
by the internal width of the che~t at the level of the dome of the 
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right hemidiaphragm (Chikof 1977). The lung fields were assessed 
as being normal, or demonstrating upper lobe blood diversion or 
interstitial pulmonary oedema. 
This clinical assessment was repeated at six monthly intervals in 
the asymptomatic patients and at six months postoperatively in the 
symptomatic patients who underwent successful aortic valve 
replacement. 
VI.1.2 Echocardiography. 
Echocardiography was performed on all patients during their 
hospital admission. This was repeated at six monthly intervals in 
the asymptomatic .group and performed at 10 days and six months 
postoperatively in those symptomatic patients who underwent 
successful aortic valve replacement. 
M-mode echocardiograms were obtained using an Aloka SSD-800 phased 
' array ultrasonoscope equipped with a 2.3-megaHertz focused 
transducer interfaced with a Honeywell LS6B high resolution CRS 
Visicorder. All recordings were made at lOOmm/sec paper speed with 
a simultaneously recorded e1ectrocardiogram. Patients were 
examined in the supine position with slight cranial tilt with the 
transducer applied along the left sternal border at that interspace 
from which the mitral echogram could be visualised with the 
transducer held perpendicular to the chest wall with only slight 
medial and no superior or inferior angulation. From this position 
the transducer was gradually tilted inferolaterally until the 
echoes of the mitral valve were replaced by those of the chordae 
tendineae with clear visualisation of the endocardium of the left 
side of the interventricular septum and of the posterior wall (Popp 
1975). 
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Left ventricular dimensions at end-diastole (DED) were measured at 
the R wave of the electrocardiogram and the end-systolic dimension 
(DES) was measured as the smallest vertical dimension between the 
left septal ecpo and the posterior wall endocardium. In addition, 
these dimensions were normalised for body surface area. 
Posterior wall thickness (Th) was measured at end-diastole from the 
leading edge of the epicardial echo to the leading edge of the 
endocardial echo, with the gain adjustment set to minimise the 
width of these signals. 
septal thickness. 
A similar technique was used to measure 
The fractional shortening (FS), expressed as the percentage change 
in left ventricular dimension from end-diastole to end-systole was 
calculated as:-
FS = (DED - DES/DED) x 100 
(MacDonald 1972, Fortuin 1972). 
Because of the limitations involved in estimating left ventricular· 
volume measurements by echocardiography (Linhart 




The cross sectional area (CSA) of the ventricular wall in a 
transverse plane was used as an index of myocardial mass. This 
_method, first developed by Sasayama et al (1976), has been used in 
the serial follow up of changes in left ventricular mass in both 
clinical and experimental studies (Gaasch 1978, Schuler 1979). 
It is a useful index·since it incorporates directly two measurable 
determinants of mass, i.e. wall thickness and the minor diameter of 
the left ventricle. However, it is assumed that the mean wall 
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thickriess of the whole ventricle can be approximated by the 
posterior wall thickness (PWTh) in the absence of asymmetric septal 
hypertrophy or coronary heart disease. 
CSA = 





1T ( EDD) 
2 
The relative wall thickness of the left ventricle (radius to 
thickness ratio) as a measure of appropriate left ventricular 
·hypertrophy was determined as:-
R/Th = DEDI 
2.Th 
This index is linearly related to the end-diastolic volume to mass 
ratio within a broad range of dimensions and mass. The product of 
systolic blood pressure, as measured by the cuff technique, and the 
end-diastolic radius to thickness ratio was used as an index of 
peak systolic wall stress (Grossman 1975, Gaasch 1979). The 
rationale for the use of end-diastolic geometry is based on the 
observation that LV dimension and thickness at the time of peak 
systolic stress (in the normal ventricle) is almost equal to LV 
dimension and wall thickness at end-diastole (Grossman 1975). 
VI.1.3 Rest and Exercise Equilibrium Radionuclide Angiocardio-
graphy. 
0 
Supine and semi-erect (45 ) bicycle exercise and isometric handgrip 
exercise was performed in all patients. After obtaining informed 
consent, patients were transferred to the Cardiac Catheterisation 
Laboratory. All patients were studied in the non-sedated, 
postabsorptive state (Brown 1983). 
Under local anaesthesia with 5ml of ~ 1% Lignocaine solution, a 
balloon tipped triple-lumen Swan-Ganz catheter (93A~131-7F, 
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American Edwards Laboratory, Santa Anna CA) was introduced into the 
right subclavian vein using a modified, Seldinger technique and the 
supraclavicular approach. It was advanced to the right atrium, 
right ventricle and main pulmonary artery to one of the branches of 
the right pulmonary artery supplying the right lower lobe under 
direct fluoroscopic screening. The position of the catheter was 
considered acceptable when satisfactory pulmonary capillary wedge 
pressure measurements were obtained after balloon inflation. 
Patients were then transferred to our exercise laboratory for 
further evaluation. 
Each patient was familiarised with the exercise apparatus prior to 
the commencement of the exercise study. This evaluation was 
repeated at six monthly intervals in the asymptomatic group and six 
months postoperatively in the patients who underwent successful 
aortic valve replacement. 
Exercise was performed on an Engineering Dynamic Corporation Model 
No. 8430 Hi-Low Cardiac Stress Testing System consisting of an 
imaging table with an integral multiple position bicycle ergometer 
and a mobile ergometer control unit. 
Pulmonary artery and pulmonary capillary wedge pressures were 
measured using an Altech Physiological Transducer Model No. MSlO-E 
and an Elema Schonander Mingograf EM1600.161 Multipurpose Polygraf 
Biomedical Recording System. 
A Siemens L.E.M. Scintillation Camera with a high resolution 
2 
collimator interfaced to an A Medical Data System dedicated 
minicomputer was used to acquire radionuclide data. 
Arterial pressure was recorded with a standard Baumanometer Model 
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300 Sphygmomanometer and cardiac output was measured with an 
Edwards Laboratories 9520A Cardiac Output Computer. Handgrip 
isometric exercise was performed using a Meredith Registered Design 
861405 Handgrip Dynamometer. 
VI.1.3.1 Exercise Protocol 
Patients were first studied in the supine position with the bicycle 
ergometer so positioned that the legs_ were elevated above the 
chest. In addition, a three minute period of isometric handgrip 
exercise at 33% of maximal grip-strength was performed in the 
supine position. Exercise consisted of compressing a callibrated 
dynamometer with the dominant hand. Maximal handgrip strength was 
determined as the greater of two consecutive brief maximal efforts, 
and following two minutes of rest, the patient performed three 
minutes of handgrip isometric exercise at 33% of his or . her 
determined maximum. The level of tension was regularly checked and 
the patient instructed to make minor correction as indicated. In 
addition, patient~ were encouraged to breathe normally. 
Graded, three minute levels of exercise were commenced at an 
external workload of 150 kilopond-metres (k.p.m.) per minute and 
increased by l50k.p.m. per level in males and by a lOOk.p.m. per 
level in females until limited by shortness of breath or leg 
fatigue or both. Pedal speed was held constant at 50 to 60 
revolutions per minute. Data were acquired during the last two 
minutes of each three minute period. 
A rest period of 15 minutes was interspaced between supine and 
0 
semi-erect hicycle exercise, which was then performed with a 45 
0 
cranial tilt of the imaging table. The 45 semi-sitting position 
was used as it provides ~aximum patient comfort during bicycle 
110 
exercise without the excessive leg fatigue commonly experienced in 
the supine position. In addition, it enables near-optimal camera 
head positioning and also simulates upright physiologic conditions. 
Over a two minute period patients were gradedly taken up to their 
maximal supine external workload. The order of exercise was not 
randomised. Patients were verbally encouraged to exercise until 
peak tolerance and instructed to gently hold but not grip the hand 
supports to avoid isometric contraction. 
VI.1.3.2 Haemodynamic Data Acquisition 
Baseline heart rate, blood pressure, cardiac output, pulmonary 
artery and pulmonary capillary wedge pressures were recorded. 
Heart rate was obtained from the simultaneously recorded electro~ 
cardiogram during pressure measurements. 
Arterial pressure was recorded in duplicate by the cuff technique 
using a standard Baumonometer Model 300 Sphygmomanometer and taking 
the phase 4 Korotkow sound (muffling) as the diastolic pressure. 
Mean arterial pressure waa calculated as the diastolic pressure 
plus one third of the pulse pressure. 
The thermodilution technique (Ganz 1971, Forrester 1972) was used 
to measure cardiac output at rest and during each level of bicycle 
exercise. Multiple syringes were prefilled with exactly 5ml of a 
sterile 5% solution of dextrose in water, and then capped so that 
sterility was maintained. The syringes were then placed in an ice 
0 
bath at 0 C and allowed to equilibrate for a minimum of 20 minutes. 
The syringe's barrel was submerged in the bath so that its contents 
were below the bath's level. Additionally, a syringe filled with a 
5% solution of dextrose in water was placed in the icebath with the 
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plunger removed in order to accommodate a temperature sensing probe 
from the Edwards Laboratories 9520A Cardiac Output Computer. The 
sensing probe was placed inside the barrel so that at least two 
thirds of its length was submerged in the indicator. When ready 
for use, the syringes with injectate were removed from the bath, 
care being taken to ensure minimal handling of the barrel, 
connected to the catheter, and injected without hesitation. A 
minimum of three determinations were made at each level of exercise 
and the mean value taken. Cardiac index was derived by dividing 
the cardiac output by the body surface area. 
Phasic and mean pulmonary artery and pulmonary capillary wedge 
\ 
pressures were measured from a zero level in the fourth right 
intercostal space in the mid-axillary line over at least two 
respiratory cycles. Recordings were made on an Elema-Shonander 
Mingograph EM1600.161 Multipurpose Polygraf Biomedical Recording 
System at a paper speed of 25mm/sec. These recordings were made at 
rest, during isometric and at each level of supine and semi-erect 
exercise. 
Stroke volume index, stroke work index and systemic vascular 
resistance were derived from the above values using the following 
formulae:-
Stroke Volume Index = Cardiac Index in ml/min. divided by heart 
2 
rate and expressed as ml/b/M . 
Stroke Work Index = Cardiac Index in L/min. multiplied by 13.6 
multiplied by the difference between the mean arterial pressure 
and the pulmonary capillary wedge pressure divided by the .heart 
rate. 
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Pulmonary capillary wedge pressure was considered to be equivalent 
to left ventricular end-diastolic pressure. !Mitral valve disease 
was excluded at echocardiography and cardiac catheterisation in 
all patients). 
Systemic Vascular Resistance = mean arterial pressure in mmHg 
divided by the cardiac output in L/min. 
The following are the predicted maximum heart rates in the various 
age categories (from the proceedings of the National Workshop on 
Exercise in 1969):-
Age Qy_ Decade Maximal Heart Rate 
20 - 29 190 
30 - 39 182 
40 - 49 179 
50 - 59 171 
60 - 69 164 
VI.1.3.3 Radionuclide Data Acquisition 
Equilibrium radionuc~ide angiocardiography(ERNA) was perforiiled 
after in vitro labelling of red blood cells with 30 millicuries 
(1110 megabequerels) of Technetium-99m Sodium Pertechnetate using 
the Brookhaven National Laboratory (BNL) Red Blood Cell technique 
(see Appendix I for details), Electrocardiographic gating was 
performed using the praecordial lead giving the largest R-wave 
deflection. 
Rest and Exercise Equilibrium Radionuclide Angiocardiographs were 
performed using a Siemens Low Energy Mobile (L.E.M) Scintillation 
2 
Camera with a high resolution collimator interfaced to an A 
Medical Data System dedicated single terminal minicomputer. 
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Data acquisition was performed at rest and during the last two 
minutes of each three minute bicycle exercise level in 64 x 64 byte 
mode at 24 frames per R-R interval. Images were acquired in an 
0 
approximately 45 Left Anterior Oblique (LAO) view which provided 
best septal separation. This provided ± 200,000 counts per frame. 
Patient data was stored on removable 2.5mB discs for subsequent 
' 
analysis. 
Visually interpretable information is produced within 30 seconds of 
the onset of data acquisition, and statistically reliable results 
are available within one to two minutes (Bacharach 1977, Borer 
1978). Because blood radioactivity is proportional to blood 
volume, quantitation of radioactive emissions collected from the 
left ventricle after background correctionr permits direct 
determination of relative left ventricle volume; the collection of 
such information over many successive intervals permits 
determination of average ejection fraction (EF) with a high degree 
of precision (Green 1978). 
VI.l.3.4 Radionuclide Data Analysis 
The left anterior oblique images at rest and at each exercise level 
were analysed to determine ejection fraction and average and peak 
diastolic filling rate. Visual analysis was performed by two 
experienced observers viewing the studies in endless-loop 'cine 
2 
display format using the M.D.S.A 
2 
Multiterminal System and 
commercially available software (A MUGE Programme with automatic 
edge detection and background correction). 
All image data was temporarily and spatially filtered using 9 point 
filters. To generate a volume curve, the edges (regions of 
interest) of the left ventricle for each image in the study were 
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detected using the filtered data and the M.D.S. MUGE Programme 
which detects the edges by means of second derivative and threshold 
values. 
A background region is automatically generated by the computer 
inferolateral to the systolic image of the left ventricle. This 
region is verified by the operator, or a manually drawn region may 
be substituted if the computer-generated background region impinges 
excessively on the screen. 
Subsequently, a background corrected time-activity curve is 
generated from the computer defined region of interest and this is 
used for the calculation of the left ventricular ejection fraction. 
This is calculated as background corrected end-diastolic counts 
minus end-systolic counts divided by end-diastolic counts. Peak and 
average emptying and filling rates are calculated from the first 
derivative of this time-activity curve. 
A histogram of the number of beats versus the beat length (the R-R 
histogram) is automatically generated during acquisition and this 
wa~ viewed to determine the stability of the electrocardiogram. 
This sequence was repeated for each level of study and as 
previously noted, this exercise protocol was repeated at six 
monthly intervals in the asymptomatic group and six months 
postoperatively in those patients who underwent successful aortic 
valve replacement. 
The normal values and the correlation co-efficients ( R) 
representing the validation, reproducibility and inter- and intra-
observer varia~ility of the rest radionuclide ejection fraction in 
our laboratory are in Appendix II. 
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VI.1.4 Cardiac Catheterisation. 
Cardiac catheterisation was performed within 24 to 48 hours of the 
exercise evaluation in all patients. The purpose of the procedure 
was to confirm the severity of aortic regurgitation and exclude 
other valvular and coronary artery disease. All patients were 
studied in the post absorptive state, using Clonazepam lmg, one 
hour prior to the procedure, for sedation. 
Under local anaesthesia with lOml of a 2% Lignocaine solution, via 
a modified Seldinger approach to the right groin, a number 7 
Cournand Catheter (Size 7 French 125cm USCI Cournand Cardiovascular 
Catheter No. 007456) was introduced to the right femoral vein and 
advanced via the right atrium, right ventricle, and pulmonary 
artery to the wedge position. Critically damped pressure 
recordings were obtained through this fluid-filled catheter using a 
Statham P23Id Pressure Transducer and recorded on an Electronics 
for Medicine VR12 Recorder System. 
A No. 8 Pigtail Catheter (Size 8 French llOcm USCI/Positrol II 
tight radius Pigtailed Cardiovascular Catheter No. 007818) was 
introduced to the right femoral artery and passed retrogradely up 
the aorta and through the aortic valve into the left ventricle. 
Critically damped pressures were recorded using an identical 
recording system. 
Cardiac output was measured by the indicator dye technique of 
Hamilton et al (1948) using 5mg of Indocyanine Green. Forward 
stroke volume was derived by dividing the cardiac output by the 
heart rate at the time of measurement. 
0 
Left ventriculography was performed in a single-plane 30 right 
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anterior oblique projection with the pigtail catheter positioned 2-
3om above the aortic valve to avoid ventricular irritability. Sixty 
millilitres(60) of Jopamiron 300 (Iopamidol) was injected over 
three seconds using an Angiomat 3000 (Sybron Medical Products 
Division) Power Injector. The left ventricular angiograms were 
exposed on 35mm film at 60 frames per second using a Phillips nine 
inch image intensifier system. Subsequently left ventricular 
volumes were calculated using the area length method of Dodge et al 
(Dodge 1968) after adjustment for radiologic enlargement and 
distortion, the coefficient being determined by means of a grid 
positioned at the mid-thoracic level. Left ventricular volumes 
were quantitated from a well opacified sinus beat, not preceeded by 
an extrasystole. Angiographic stroke volume was calculated as the 
. 
difference between the end-diastolic and end-systolic volumes and 
the left ventricular ejection fraction derived as the ratio of 
stroke volume to end-diastolic volume. Angiographic cardiac index 
was derived by multiplying angiographic stroke volume index by 
heart rate at the time of the study. 
0 
Cine aortography was performed after left ventriculography in a 60 
left anterior oblique projection. · Catheter placement was as 
described above and 60ml Jopamiron 300 was injected over 3 seconds 
and the studies recorded on 35mm cine film at 60 frames per second. 
The angiographic severity of the aortic regurgitation was agreed 
upon by two independent observers according to the following 
grading system (Grossman 1980):-
1+ = faint opacification of part of (but not the entire) left 
ventricle, which clears with each systole; 
2+ = left ventricular opacification to a degree less than that in 
the aorta, but which does not clear with each beat; 
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3+ = left ventricular opacification equal to that of the aorta; 
4+ = complete and dense left ventricular opacification in one 
beat with an eventual density of contrast greater than that 





left and right coronary angiography was subsequently 
in all patients using 8/4 left and right Judkins 
(Size 8 French lOOcm USCI/Positrol II Judkins Type 4cm 
Right Coronary Taper Tipped Cardiovascular Catheters). 
The coronary angiograms were routinely obtained in various angles 
of right and left anterior oblique projection. Eight to ten 
millilitres of Jopamiron 370 were injected over 2-3 seconds and the 
studies recorded on 35mm cine film at 50 frames per second. 
Quantitative evaluation of cine aortography in the assessment of 
aortic regurgitation was then performed in a group of these 
patients using a Size 7 French Carolina Medical Electronics Square 
Wave Electromagnetic Flowmeter (Model FM501). Zero flow reference 
was determined extravascularly by inserting the catheter into 50ml 
of the patients blood withdrawn prior to this part of the study. 
The electromagnetic flowmeter probe was then inserted and 
retrogradely passed up a Size 8 French 59cm USC! Mullins 
Transseptal Catheter Introducer Sheaths (No. 008552) and positioned 
2-3cm above the aortic valve. In this way the probe was centred 
in the lumen of the ascending aorta. The area beneath the flow 
curve, above and below zero reference, were planimetered and the 
percentage regurgitation was calculated from the formula:-
Percentage regurgitation = area of negative flow divided by area of 
forward flow. 
This part of the study was designed to assess the accuracy of 
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qualitative angiographic grading, by comparing it to the 
quantitative angiographic technique (Sandler 1963, Hunt 1973) and 
the above electromagnetic flowmeter technique (Mennel 1972). 
VI.2.0 DATA ANALYSIS: 
Patients were divided into symptomatic and asymptomatic groups. 
Further division was based on the LV ejection fraction response to 
exercise. 
Analysis of variance (Winer 1971) was performed to analyse serial 
changes in echocardiographic, haemodynamic and radionuclide data. 
Paired t test was used to compare pre-operative and postoperative 
measurements and the unpaired t test was used to compare different 
patient groups. A p ¥alue <0.05 was considered significant. 





Sixty (60) patients were entered into this prospective evaluation 
of left ventricular function in severe aortic regurgitation. 
Thirty two (32) of these patients were symptomatic and admitted to 
the Cardiac Clinic beds for assessment prior to aortic valve 
replacement - these patients constitute Group 1. 
asymptomatic patients with clinically severe 
regurgitation were admitted for comparison 
assessment and constitute Group 2. 
VII.1.0 CLINICAL CHARACTERISTICS 
Twenty eight (28) 
chronic aortic 
and sequential 
At the time of first assessment the clinical characteristics of the 








In the symptomatic group -
14 to 66 years (mean 32 years) 







- 14 patients (44%) gave a history consistent with a previous 
episode of acute rheumatic fever. 
- 4 patients (12.5%) had a documented episode of infective 
'' 
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endocarditis in the past. 
- 2 patients (both older; 63 years and 66 years) were considered to 
have syphilitic aortic valve disease on the basis of positive 
serology. 
- in twelve patients (38%) the aetiology is unknown. 
In ~he asymptomatic group -
-14 patients (50%) gave a history of a previous episode of acute 
rheumatic fever. 
-two patients (ages 38 and 44 years) had serology positive for 
syphilis. 
- one patient had a bicuspid aortic valve. 
- in eleven patients (39%) the aetiology is unknown. 
VII.1.4 Symptoms 
VII.1.4.1 SOB: 
All 32 symptomatic patients gave a history of dyspnoea on effort:-
Although 











the majority of patients had dyspnoea on moderate 
exercise, 10 patients had a previous episode of congestive heart 
failure prior to referral which had responded promptly to routine 
therapy for congestive heart failure(CHF). At the time of 
evaluation 7 of this group were Class IIB limited, 2 were Class III 
limited and 1 patient was only short of breath on extreme effort. 
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VII.1.4.2 Duration: 
The duration of symptoms ranged from 1 to 130 months with a mean 
duration of 16 ± 4 months. In the subgroup of patients who had 
presented with an episode of CHF, the mean duration of SOB was 14 + 
17.5 months with a range of 1 to 60 months. 
VII.1.4.3 Atypical Chest Pain: 
Eighteen patients in group 1 (56%) gave a history of atypical, 
sharp left praecordial chest pain of short duration which was self-
limiting and usually occurred at night. Eight asymptomatic 
patients (29%) volunteered transient short-lived atypical left' 
praecordial chest pain. 
VII.1.4.4 Palpitations: 
Fifteen patients (47%) in the symptomatic group had experienced 
occasional, short-lived, rapid, regular palpitations which were 
almost exclusively effort related and not associated with any other 
symptoms. 
VII.1.4.5 Medication 
At the time of initial evaluation nineteen patients (59%) in 
the symptomatic group were receiving treatment for heart failure. 
Medication included digoxin and diuretics (furosemide or amiloride 
5mg +hydrochlorothiazide 50mg). Medication was discontinued at 
least 48 hours prior to exercise and invasive evaluation. 
VII.1.5 Physical Findings: 
All patients, both symptomatic and asymptomatic, had the clinicar 
features of severe aortic regurgitation, namely a wide pulse 
pressure, a positive Du Roziez's sign, a soft or inaudible first 
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heart sound and a basal early diastolic murmur. In addition, most 
patients had an Austin-Flint mid-diastolic rumble at the apex. The 
mean pulse pressure was similar in the two groups (Group 1 115 + 
34mmHg; Group 2 121 ± 23mmHg). 
VII.1.6 Electrocardiogram 
All patients were in sinus rhythm. The PR interval ranged from 
0.16 - 0.40 sec (mean 0.20 ± 0.05sec). All but two. symptomatic 
patients had left ventricular hypertrophy with repolarisation 
change as assessed by the S~kolow-Lyon index. Similarly, all but 
two asymptomatic patients had left ventricular hypertrophy with 
repolarisation change. 
VII.1.7 Chest Radiograph 
Every patient had a standard postero-anterior and lateral chest 
radiograph. The cardia-thoracic ratio was similar,· 0.47 to 0.69 
(mean 0.59 ± 0.05) in the symptomatic group and 0.44 to 0.69 (mean 
0.55 + 0.06) in the asymptomatic patients. The lung fields were 
assessed as being normal in all patients at the time of initial 
evaluation. 
Table 7.1 overleaf summarises the clinical details in the two 
groups of patients. 
The subsequent stepwise evaluation of these two groups of patients 
is summarised in Figure 6.l(see page 104) and will be discussed as 
follows:-
1. INITIAL ASSESSMENT. 
2. POSTOPERATIVE EVALUATION. 
3. SEQUENTIAL STUDIES. 
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Table 7 .1: CLINICAL PROFILE 
Symptomatic !l =- 32 Asymptomatic !l = 28 
Age (years) 32 (14 - 66) 24 (16 - 44) 
Sex - Male 17 24 
Female 15 4 
Aetiology: 
RH. Fever 14 14 
Inf. Endocarditis 4 0 
Syphilis(positive serology)2 2 
Bicuspid AV 0 1 
Unknown 12 11 
NYHA Class: 





Duration (Months) 16 + 4 (1-130) 
Atypical Chest Pain 18 8 
Palpitations 15 0 
Pulse Pressure (mmHg) 115 + 34 121 + 23 
CTR o. 59 + 0.05 o. 55 + 0.06 
VII.2.0 INITIAL ASSESSMENT 
The initial non-invasive and invasive evaluation of the two groups 
of patients included:-
(a) M-mode echocardiography. 
(b) Isometric and isotonic symptom-limited bicycle exercise in 
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both the supine and semi-erect positions. 
(c) Cardiac catheterisation. 
VII.2.1 M-MODE ECHOCARDIOGRAPHY: 
The echocardiographic measurements of LV dimensions and wall 
thickness and the derived measures of LV volume, mass, systolic 
function and systolic wall stress in the two groups of patients are 
summarised in tables 7.2 and 7.3. Technically satisfactory 
recording enabling accurate measurements were available in 28 of 




Appendix III tabulates the range of echocardiographic ,measurements 
in patients with compensated, borderline and decompensated chronic 
aortic regurgitation as compared to normal values(Gaasch 1983). 
VII.2.l.l SYMPTOMATIC GROUP (n = 28): 
LV Dimensions: 
The LV DED in this group of patients ranged from 5.0 to 9.7cm with 
a mean of 6.9 ± l.lcm. All but two patients had echocardiographic 
evidence of LV enlargement and 5 patients (18%) had marked LV 
dilatation (LV DED > 8.0cm). Indexing these measu~es for body 
surface area, 17 patients (61%) fell into the decompensated range 
2 
of >4.0cm/m . The LV DES ranged from 2.6- 7.7cm (mean 4.7 ± 1.1) 
and 7 patients (28%) had a LV DES > 5.5cm. Similarly, when 
corrected for body surface area, 17 patients (61%) were in the 
2 
decompensated range of >2.6cm/m . 
( . 
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Table 7 . 2 : ECHOCARDIOGRAPHIC MEASURES IN THE SYMPTOMATIC PATIENTS 
(n = 28): 
PT. DED DEDI DES _DES I FS PWT R/Th SWS CSA ESV PSP PSP/ESV 
M.A. 7.2 3.8 4.8 2.5 33 1.1 2.5 589 29 67 180 3.8 
F.A. 7.6 5.1 4.9 3.3 35 1.5 2.5 456 43 70 180 2.6 
R.A. 7.6 4.5 5.5 3.3 28 1.0 3.8 608 27 88 160 1.8 
M.B. 9.7 4.9 7.7 3.9 21 1.1 4.4 1004 37 173 230 1.3 
B.B. 8.3 5.3 5 .o . 3. 2 40 1.2 3.5 588 36 73 170 3.8 
R.C. 8.4 4.2 5.5 2.8 34 1.0 4.2 651 30 88 155 1.8 
D.D. 5.3 4.0 3.4 2.6 36 1.2 2.2 331 25 34 150 4.5 
MdV 7 .o 4.7 4.4 3 .o 37 1.6 2.2 306 43 57 140 2.5 
E.G. 7.7 5.1 5.0 3.3 35 1.1 3.5 560 30 73 160 2.2 
K.G. 6.0 3.1 4.0 2 .o 33 1.6 1.9 300 38 47 160 3.4 
M.H. 8.6 4.0 6.0 2.8 30 1.5 2.9 401 48 105 140 1.3 
B.H. 6.7 3.9 5 .o 2.9 25 1.2 3.2 475 33 73 150 2.1 
E.J. 6.5 3.9 4.3 2.6 34 1.2 2.7 542 29 54 200 3.7 
J.L. 8.6 5.3 6.7 4.1 22 1.3 3.3 430 41 131 130 1.0 
N.L. 7.4 4.7 5.6 3.5 24 1.0 3.7 592 26 92 160 1.8 
R.L. 5 .o 2.7 2.6 1.4 48 1.3 2.9 269 26 20 140 7.1 
·M .. L. 6.8 4 .o 5.8 3.4 15 0.8 4.3 595 19 98 140 1.4 
S.M. 6.2 4.1 3.7 2.4 40 1.0 3.1 465 23 40 150 3.8 
H.M. 6.0 3.8 3.7 2.3 38 1.3 2.3 439 30 40 190 4.8 
H.M. 7.2 4.6 5.2 3.3 28 1.2 3 .o 450 32 79 150 1.9 
M.N. 7.1 4.3 4.6 2.8 35 1.3 2.8 443 35 62 160 2.6 
E.N. 6.0 3.9 4.1 2.7 32 1.1 2.7 382 26 49 140 2.4 
J.N. 6.2 4.3 4.2 2.9 32 0.9 3.4 482 20 52 140 2.7 
N.P. 6.6 4.4 4.7 3.1 29 1.5 2.2 330 38 64 150 2.3 
P.P. 5.7 3.4 3.2 1.9 44 0.8 3.6 499 16 30 140 4.7 
M.vB 6.2 3.2 4.6 2.4 25 1.0 3.1 465 23 62 150 2.4 
E.vH 6.7 4.0 4.4 2.7 34 1.0 3.9 663 28 57 170 4.8 
M.vw 5.9 3.8 3.5 2.3 41 1.2 2.5 435 27 46 175 3.8 
MEAN 6.9 4.2 4.7 2.8 32 1.2 3 .o 489 31 68 160 3 .o 
±_S.D.1.1 0. 7 1.1 0.6 7 o. 2 1.7 22 8 32 22 1.4 
DED = Dimension at end-diastole 
DEDI = Dimension at end-diastolic indexed 
DES = Dimension at end-systole 
DES! = Dimension at end-systole indexed 
FS = Fractional Shortening 
PWT = Posterior wall thickness 
R/Th = Radius-to-wall thickness ratio sws = Systolic wall stress 
CSA = Cross-sectional area 
ESV = End-systolic volume 
PSP = Peak systolic pressure 
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Table 7.3: ECHOCARDIOGRAPHIC MEASURES IN THE ASYMPTOMATIC PATIENTS 













































































































































































































































































































































































MEAN 6.8 4.2 4.5 2.8 34 1.2 3.0 470 29 60 154 2.7 
±S.D.0.9 0.6 0.6 0.4 4 0.2 0.6 137 7 18 21 0.8 
LV Mass and the R/Th Ratio: 
The LV mass as reflected by the cross sectional area ranged from 16 
2 1 2 
to 48cm (mea~ 31 ± Scm ) with only 3 patients (11%) having values 
2 
in the normal range (16 + 4cm ). 
The R/Th ratio, used as an index of the volume to mass ratio, 
ranged from 1.9 to 4.4 (mean 3.0 ± 1.7) with only 3 patients (11%) 
having values > 4 reflecting increased peak systolic stress. Peak 
systolic stress, the product of the R/Th ratio and peak systolic 
pressure, ranged from 269 to 1004 (mean 489 ± 22), with 4 patients 
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(14%) having values > 600mmHg. 
LV Systolic Performance: 
The mean fractional shortening was 33% (range 15 to 48%) with the 
majority (68%) of patients in the compensated and only 14% in the 
decompensated range of < 25%. Eighteen percent(l8%) of this group 
had values in the borderline range. The peak_ systolic pressure to 
end systolic volume ratio (PSP/ESV) ranged from 1.0 to 7.1 with a 
mean of 3.0 + 1.4. 
VII.2.1.2 ASYMPTOMATIC GROUP (n: 28): 
LV Dimensions: 
The LV DED in this group ranged from 5.0 to 8.5cm (mean 6.8 ± 0.9). 
Only one patient did not have echocardiographic evidence of LV 
dilatation. Only 2 patients (7%) had an LV DED > 8.0cm. When 'this 
dimension was normalised for body surface area, 71% (20 patients) 
were in the decompensated range. 
The LV DES ranged from 3.0 to 5.7cm (mean 4.5 ± 0.6), with only 2 
patients (7%) having a value > 5.5cm. 
the intermediate range of 5.0 to 5.4cm. 
2 
Five patients (18%) were in 
The mean of this measure 
indexed was 2.8 ± 0.4cm/M , which is in the decompensated range 
2 2 
(>2.6cm/M ), with 18 patients (64%) having values> 2.6cm/M. 
LV Mass and R/Th Ratio: 
The cross sectional area as a measure of LV mass ranged from 16 to 
2 2 
47cm (mean 29 ± 7cm ) with 3 patients (11%) having normal values. 
The R/Th ratio ranged from 2.2 to 4.0 (mean 3.0 ± 0.6) with 2 
patients (7%) having evidence of increased peak systolic wall 
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stress (value > 4) and also reflected in the product of R/Th and 
peak systolic pressure being > 600mmHg. 
LV Systolic Performance: 
The mean fractional shortening was 34 ± 4% in thi~ group with a 
-
range of 25 to 40%. No patients were decompensated as reflected by 
this measure. The mean PSP/ESV as a measure of contractility was 
2.7 + 0.8 with a range of 1.7 to 5.7. 
VII.2.1.3 SUMMARY 
1. The mean values were similar for all echocardiographic measures 
I 
in both the symptomatic and asymptomatic patients, 
2. Although the degree of LV dilatation was the same in the two 
groups (6.9 ± 1.1cm versus 6.8 + 0.9cm), the incidence of 
marked LV dilatation (DED > 8.0cm) was higher in the 
symptomatic group (16% versus 7S). 
3. An end systolic diameter of > 5.5cm was 3.5 times more common 
in the symptomatic group (25% versus 7%) and included 4 of the 
5 symptomatic patients with a DED > 8.0cm. 
4. Fractional shortening as a measure of LV systolic performance 
was similar in the two groups although 6/28 (21%) symptomatic 
patients compared to only 1/28 (4%) had a depressed FS ~ 25. 
5. A peak systolic wall stress in the decompensated range '(> 
600mmHg) occurred infrequently in both groups (3 symptomatic 
and 2 asymptomatic patients). 
6. Virtually identical numbers of patients in each group (11/28 
symptomatic and 10/28 asymptomatic) had significant LV 
2 
hypertrophy as assessed by an echocardiographic CSA > 30.0cm ), 
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VII.2.2 EXERCISE EVALUATION: 
All 28 asymptomatic patients and 31 of the 32 symptomatic group 
participated in this part of the study. 
The results will be reported in the following way:-
VII.2.2.1 Supine Rest and Exercise Haemodynamic and ERNA responses 
in Symptomatic and Asymptomatic Aortic Regurgitation 
(SUPINE- EXERCISE). 
VII.2.2.2 Erect Rest and Exercise Haemodynamic and ERNA responses 
in Symptomatic and Asymptomatic Chronic Aortic 
Regurgitation (ERECT EXERCISE) 
VII.2.2.3 Comparison of the Effects of Isometric and Supine 
Bicycle Exercise on Left Ventricular Performance in 
Symptomatic and Asymptomatic Aortic Regurgitation 
(ISOMETRIC EXERCISE). 
VII.2.2.4 Graded Equivalent Workload (EWL) Supine Exercise 
responses in Symptomatic and Asymptomatic Patients (EWL 
SUPINE EXERCISE). 
VII.2.2.0 NORMAL VALUES 
Five normal healthy volunteers performed supine bicycle exercise to 
exhaustion and serve as controls for this study. In addition to 
~esting and peak exercise values, mean values are also given for 




Table 7. 4: NORMAL RESTING AND PEAK EXERCISE RADIONUCLIDE DATA: 
EF PFR ADFR WORK 
R P.Ex R P.Ex R P.Ex k-pm/min 
1 63 77 3.41 5.49 1.43 2.10 1050 
2 67 69 3.50 4.76 1.26 2.49 600 
3 64 86 2.51 7.33 0.84 3.92 1050 
4 61 84 2.70 8.34 1.60 3.96 1050 
5 60 81 2. 70 6.85 1.07 3.39 750 
Mean 63 79 2.96 6.55 1.24 3.17 900 
±_SD 3 7 0.46 1.43 o. 30 0.84 212 
LEVEL 1 65±_6 3.97±_0.29 1. 70±_0. 36 
LEVEL 2 67±_6 4.22±_0.67 1.99+0.21 
LEVEL 3 73±_5 4.56±_0.74 2.38±_0.41 . 
VII.2.2.1 SUPINE EXERCISE 
Supine exercise will be discussed under the following subheadings:-
VII.2.2.1A Measurements at rest for the two groups. 
VII.2.2.1B Summary of supine rest data. 
VII.2.2.1C Peak exercise results for the two groups. 
VII.2.2.1D Differences within the symptomatic group defined by 
exercise LVEF response. 
VII.2.2.1E Differences within the asymptomatic group defined by 
LV functional reserve. 
VII.2.2.1F Summary of supine exercise data. 
VII.2.2.1A MEASUREMENTS AT REST FOR THE TWO GROUPS: 
------; 
Symptomatic Group (n=31) 
The mean heart rate at rest was normal (82 ±.. 12/min) but 5 patients 
had a resting tachycardia. All patients had a widened pulse 
pressure and the mean SBP was elevated at 157 ±.. 18mmHg. The group 
2 
mean resting cardiac index was normal (3.2 ±.. 0.7 L/min/M ) but 5 
2 
L/min/M ). patients (16%) had a depressed index (range 1.8 to 2.4 
The mean resting PCWP was elevated at 17 ±.. 8mmHg with a wide range 
of 5 to 43mmHg. One third (11 .patients) had normal resting 
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measurements (mean 11 ± 3mmHg). The mean LVEF was in the normal 
range at 57 ± 12% but ranged from 33 to 78%. Nine patients (29%) 
had a reduced resting LVEF (mean 41 ± 6%). Three of the five 
patients with a reduced cardiac index were in this subset, 
including the 2 patients with markedly reduced values of 1.8 and 
2 
1.9 L/min/M respectively. All but two also had an elevated 
resting PCWP (mean 25 ± 12mmHg). 
The mean PFR was significantly reduced at 2.13 + 0.72 EDV/sec 
(normal controls 2.96 ± 0.40 EDV/sec), although the ADFR of 1.14 + 
0.34 EDV/sec was only marginally lower than normal controls (1.24 + 
0.30 EDV/sec). However, both these measures of diastolic filling 
were similar to those of the asymptomatic group (vide infra). 
Asymptomatic Group in ~ ~ 
The mean values for the haemodynamic measurements at rest are 
similar to those of the symptomatic group (see table 7.5), with SBP 
being the only significantly different variable (137 ± 15 versus 
157 + 18mmHg, p <0.01). However, none had a reduced resting 
cardiac index and a slightly higher percentage (43 versus 35%) had 
a normal resting PCWP. 
The LVEF at rest was higher than in the symptomatic group (62 ± 8 
versus 57 + 12%, p = NS) with a range of 40 to 73%. Only 2 
patients (7% compared to 29% in the symptomatic group) had a 
reduced LVEF of <50%. However, both these patients had normal 
2 
cardiac indexes (3.9 and 4.1 L/min/M ) and PCW pressures (13 and 
15mmHg). 
The PFR was marginally higher than in the symptomatic patients 
(2.22 + 0.73 versus 2.13 ± 0.72 EDV/sec, p = NS), but still 
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significantly lower than in the normal controls (2.96 + 0.46 
EDV/sec, p <0.01). The ADFR was marginally higher than in the 
group with symptoms (1.19 ± 0.39 versus 1.14 + 0.34 EDV/sec, p = 
NS) and only slightly lower than controls (1.24 ± 0.30 EDV/sec, p 
' 
= NS). 
Table 7.5: SUPINE HAEMODYNAMIC AND ERNA MEASUREMENTS AT REST 
SYMPTOMATIC (n = 31) 






















































































41 23 62 
43 20 42 
29 16 33 
47 15 76 
19 43 34 
40 16 74 
. 25 12 40 
50 5 72 
38 11 57 
50 16 57 
46 9 60 
37 15 63 
44 12 63 
50 8 67 
38 10 49 
39 18 67 
31 15 51 
- 56 
















2. 24 l. 08 
l. 62 1. 06 
4.07 1.87 
1.54 0.91 










ASYMPTOMATIC (n = 28) 





















































































45 13 65 
41 16 63 
43 12 62 
39 21 64 
42 19 71 
34 16 55 
43 24 54 
38 20 61 
49 18 62 
43 13 59 
51 21 71 
49 17 62 
39 13 72 
55 15 58 
39 15 40 
49 11 65 
39 15 69 
61 18 72 
40 18 60 
33 30 66 
34 15 61 
44 20'53 
47 18 50 
57 14 66 
53 16 65 
45 11 63 
44 16 63 





























MEAN82 157 3.2 
±S.D12 18 0.3 
40 17 57 2.13 1.14 MEAN 80 137 3.4 
9 8 11 0.72 0.34 ±S.D.16 15 0.6 
44 17 62 2.22 1.19 






* Group 1A 
= Heart Rate 
= Systolic blood pressure 
= Cardiac index 
= Stroke volume index 
* Group 2A 
EF = LV ejection fraction 
PFR = Peak filling rate 
ADFR = Average diastolic filling rate 
= Pulmonary capillary wedge pressure 
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VII.2.2.IB SUMMARY OF SUPINE REST DATA: 
1. Resting haemodynamics were similar in the two groups but in the 
symptomatic patients:-
SBP was higher (157 + 18 versus 137 ± 15mmHg, p < 0.01) 
- 16% of this group had a reduced resting cardiac index versus 
no asymptomatic patients. 
- 67% had an elevated PCWP versus 57% of the asymptomatic group 
2. The mean resting LVEF was marginally lower in the symptomatic 
group (57 ± 11 versus 62 ± 8%, p = NS) but 29% had a reduced 
LVEF (<50%) compared to only 7% of the asymptomati6 patients. 
3. Resting peak and average diastolic filling rates were similar 
in the two groups with a significantly reduced PFR (p < 0.01) 
but an only marginally reduced_ ADFR (p = NS). 
VII.2.2.1C PEAK EXERCISE RESULTS FOR THE TWO GROUPS: 
Symptomatic Group 1n ~ ~ 
Work capacity ranged from 150 to 900 kilo-pond meters/minute (k-
pm/min) with a mean external workload of 423 ± 158 k-pm/min or 
approximately 3 levels_ (9 minutes) of exercise. The limiting 
symptom in the vast majority (27/31) of patients was shortness of 
breath, with 8 of this group also complaining of leg fatigue. In 
only 4 patients(l3%) was leg fatigue alone the limiting symptom. 
No patients complained of chest pain. One patient had a self-
limiting run of ventricular tachycardia at peak exercise, otherwise 
no ectopy was noted on exercise. 
Cardiac index increased by a mean of 119% from 3.2 ± 0.7 to 7.0 + 
2 
2.0 L/min/M . Despite this reasonable effort tolerance and 
significant increase in cardiac index, PCWP increased markedly 
6 patients complained of shortness of breath. In only 4 (14%) was 
the limiting symptom shortness of breath alone. None reported 
chest pain and one had a self-l1.m1.t1"ng f run o ventricular 
tachycardia(20 beats) at peak exercise. 
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from 17 + 8 to 30 ± llmmHg with a range of 15 to 55mmHg, and was 
abnormal in all but 3 patients (90%). Those 3 patients with a 
normal exercise PCWP had low resting values of 5,8 and 9mmHg 
respectively. 
The majority (81%) had a signifcant fall in LVEF at peak exercise, 
with the remaining 6 patients having an equivocal response (no 
change) and no patient displaying a normal functional reserve. 
\ . 
This abnormal LVEF response was also seen in the 3 patients whose 
PCWP did not rise on exercise. The mean LVEF fell significantly 
from a resting value of 57± 12.to 47 ± 14%, p <0.01). This value 
was appreciably lower than the exercise LVEF in the asymptomatic 
group, p <O.Ol. Both PFR and ADFR increased significantly at peak 
exercise from 2.13 ± 0.72 to 3.25 ± 1.43 EDV/sec (53%) and 1.14 + 
0.34 to 1.58 ± 0.75 EDV/sec (39%). These peak exercise values are 
approximately only half of normal controls at similar heart rates 
(PFR 6.55 ± 1.43 EDV/sec; ADFR 3.17 + 0.84 EDV/sec). 
Asymptomatic Group in ~ ~ 
The mean maximal workload completed during supine bicycle exercise 
was significantly higher in this group (698 + 186 versus 423 + 158 
k-pm/min, p <0.01), with a range of 350 to 1050 k-pm/min. This 
represents approximately 4.5 levels of exercise or an exercise 
duration of 13.5 minutes, i.e. 1.5 times that of the symptomatic 
patients. In sharp contrast to the symptomatic group, exercise in 
these patients was limited by leg fatigue (24/28 or 86%), and only 
~ patients complained of shortness of breath. In only 4 (14%) was 
the limiting symptom shortness of breath alone. None reported 
chest pain and one had a self-limiting run of ventricular 
tachycardia(20 beats) at peak exercise. 
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Heart rate and systolic blood pressure predictably increased 
significantly from,80 ±. 16/min and 157 + 15mmHg at rest to 173 + 
20/min and 235 ± 29mmHg at peak exercise. Peak heart rate, but not 
SBP, was significantly higher than in the symptomatic patients (p 
<0.01). Cardiac index also increased markedly by an increment of 
2 
185% from 3.4 ±. 0.6 to 9.7 + 3.1 L/min/M at peak exercise, being 
significantly higher than in the symptomatic group (p <0.01). 
Table 7. 6: SUPINE HAEMODYNAMIC AND ERNA MEASUREMENTS AT PEAK EXERCISE 
SYMPTOMATIC (n = 31) ASYMPTOMATIC (n = 28) 
PT HR SBP CI SVI W EF PFR ADFR PT HR SBP CI SVI w EF PFR ADFR 
MA 170 230 6.2 36 38 52 - *SA 200 220. 9.0 45 12 65 3.84 2.31 
EA 165 300 7.2 44 40 52 3.85 1.36 LA 190 240 11.4 60 15 56 5.65 3.00 
RA 180 260 8.5 48 18 50 3.14 1.41 SA 190 230 14.3 75 15 55 5.64 2.77 
MB 130 270 5.7 44 50 36 0. 48 O.l2*MB 165 230 10.5 64 30 62 4.04 2.40 
BB 180 290 7.8 43 28 49 2.08 l.09*SC 180 200 10.3 57 13 82 5.19 2.57 
RC 110 180 3.6 33 23 31 1.31 0.47*AC 130 210 8.3 64 14 60 5.19 2.51 
DD 164 230 10.1 61 28 64 3.93 2.00 GD 190 230 8.9 47 25 43 3.32 1.34 
MdVl40 220 6.6 47 55 52 3.82 1.91 DD 180 290 13.0 72 28 52 5.92 2.31 
EG 142 220 4.8 34 28 28 2.35 0.89 HH 165 250 9.5 58 17 57 4.07 2.52 
KG 130 220 4.8 36 33 49 3.56 1.77*PJ 172 200 9.6 56 31 43 4.99 2.32 
MH 160 280 7. 3 46 - 27 2.26 1.23*JJ 190 220"11.7 62 25 70 3.99 2 .o·7 
BH 122 220 - 38 2.07 o. 96 KK 170 250 9.6 56 20 57 5.93 2.62 
EJ 170 270 7.1 42 40 45 3.44 1'. 44*GM 160 230 8.4 53 15 68 5.48 2.44 
JL 130 165 7.2 55 38 37 3.63 1. 44 PM 150 230 9.3 62 20 52 3.07 1. 29 
*NL 170 180 5.3 31 18 29 1. 32 0.71*FN 170 210 7.3 43 25 46 4.05 1. 48 
*RL 120 200 8.4 70 16 78 4.34 2.13*NO 140 210 10.1 72 10 63 3.44 1.90 
ML 160 240 4.5 28 38 24 2.58 1.12 MP 200 230 9.3 47 28 59 4.04 1.83 
*SM 150 200 6.3 42 30 77 *JP 160 280 10.4 65 17 71 4.07 2.12 
HM 148 190 4.1 28 30 28 IR 195 300 7.6 39 38 43 4.02 2.11 
NM 170 190 9.9 58 15 67 6.27 3.46 SR 140 220 7 .o 50 30 50 3.68 1. 62 
HM 175 260 6.2 36 20 36 3.06 ws 190 240 5.9 31 18 52 4.64 2.20 
MN 180 250 8.1 45 33 36 1.99 1.04 TS 185 210 7.4 40 38 33 2.71 0.75 
EN 150 170 7.9 53 15 53 5.56 2.56 FT 190 220 9.8 5). 35 36 3.38 1.94 
*JN 180 170 7.3 40 48 67 2.58 VdS165 280 13.4 89 17 56 4.53 2.69 
PN 144 210 10.2 71 17 51 3.02 1.33 LV 180 300 12.6 70 35 41 3.52 l. 92 
GN 170 210 11.6 68 15 58 6.01 2.94*CV 168 210 ll. 3 67 15 67 5.37 2.62 
*NP 150 160 8.4 56 37 46 4.07 1.62*DV 140 220 8.9 64 15 61 4.15 l. 90 
pp 130 210 6.2 48 33 52 2.79 l.4l*AW 198 210 6.9 35 15 83 6.33 3.36 
*MvBl20 210 4.0 33 35 49 2.88 1. 63 
EvH140 230 - 38 1.54 
HW 160 280 8.9 56 22 58 4.48 2.44 
MEAN152 223 7. 0 46 30 47 3.25 1.58MEAN173 235 9.7 57 22 57 4.44 2.18 
+SD 21 39 2 .o 12 11 14 l. 43 0.75+SD 20 29 3.1 13 8 12 2.11 0.56 
* Group lA * Group 2A 
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Despite near-normal exercise capacity (698 ± 186 versus 900 + 212 
k-pm/min in normal controls) and an appropriate increase in cardiac 
index, PCWP increased from 17 + 4 to 22 ± 8mmHg (range 12 to 
38mmHg), and was abnormal in the majority (64%) of cases. 
Interestingly, of the 10 patients who had a normal exercise PCWP of 
<15mmHg (mean 14 ± 2mmHg), 4 patients had an abnormal resting value 
and decreased their PCWP on exercise. Importantly, 80% of this 
subset of patients with a normal exercise PCWP also had a near-
. 
normal (equivocal) LV functional reserve. The elevation of PCWP 
on exercise was however appreciably lower than in the symptomatic 
patients (p <O.Ol). 
The mean LVEF dropped slightly from 62 ± 8% at rest to 57 ± 12% at 
peak. exercise (p = NS), with just over half the patients (53% 
versus 81% in the symptomatic group) having an abnormal LV 
functional reserve. In 9 patients the LVEF remained essentially 
unchanged (equivocal response) and in only 4 patients (14% versus 
80% of normal controls) was there a normal LV functional reserve. 
In contrast to the moderate increase in peak and average diastolic 
filling rates at peak exercise in the symptomatic group, there was 
a marked increase in PFR from 2.22 ± 0.73 to 4.44 + 2.11 EDV/sec 
(p <O.Ol) and ADFR from 1.19 ± 0.~9 to 2.18 + 0.56 EDV/sec (p 
<O.Ol) in this group of patients. However, this still only 
represents 68% of the peak exercise values for the normal controls. 
VII.2.2.1D DIFFERENCES WITHIN THE SYMPTOMATIC GROUP AS DEFINED BY 
EXERCISE LVEF RESPONSE: 
Outlined above, only 6 patients had a normal or equivocal response 
(Group lA), with the majority (25/31) of the symptomatic group 
having a fall in exercise LVEF of> 5% ·(Group lB), It is 
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interesting to note that this equivocal LVEF response to exercise 
occurred over a wide range of resting left ventricular ejection 
fractions and the stratification of the patients into two subgroups 
based on exercise ejection fraction response is graphically 
illustrated in Figure 7.1 overleaf. 
The mean resting haemodynamic and radionuclide measurements for the 
two groups are summarised in the following table:-
























Although resting heart rates were similar, SBP was higher in Group 
1B (P <0.01) resulting in a higher resting internal workload (rate-
pressure product of 12960 versus 12155). Cardiac index was similar 
in the two groups, but PCWP was normal in Group 1A (15 ± 2mmHg) and 
abnormal at rest in Group 1B (18 ±. 9mmHg, p = NS). The resting LVEF 
was also similar. Interestingly, at equal heart rates, both peak 
and · average diastolic filling rates were higher in the Group 1B 
patients (PFR 2.20 + 0.72 versus 1.74 + 0.69 EDV/sec, p <0.05; ADFR 
1.18 + 0.31 versus 0.94 + 0.46 EDV/sec, p <0.05). 
Peak Exercise 
The peak exercise results for the two groups is summarised in table 
7. 8. 
Table 7.8: PEAK EXERCISE HAEMODYNAMIC AND RADIONUCLIDE DATA 
HR 
Group 1A 148+25 

















Figure 7.1: SUPINE REST 
SYMPTOMATIC: 














Rather surprisingly, maximum workload completed was appreciably 
higher in the Group lB patients (442 ~ 168 versus 342 ~ 66k-pm/min, 
p <0.05). Heart rate increased to the same peak value but SBP was 
significantly lower in the Group lA patients (187 ~20 versus 232 + 
38mmHg, P <O.Ol)'. In contrast to the similar resting cardiac 
indexes, peak exercise cardiac index was marginally higher in G~oup 
lB patients (p = NS) but the PCWP at peak exercise were identical. 
It is important to note however, that the peak exercise values for 
the Group lB patients were generally at a significantly higher 
external ~ork1oad. 
As illustrated in Figure 7.1, there was an obvious decrease in LVEF 
from 57 ~12% at rest to 44~ 12% at peak exercise in the Group lB 
patients, p <0.01. Forty percent(40%) of this group had a markedly 
reduced peak exercise LVEF of <40% with a range of 24 to 38%. 
Although PFR was slightly higher at peak exercise in Group lB 
patients, p = NS, ADFR was higher in Group lA, p <0.05 (in 
contrast to the values at rest). There was a highly significant 
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difference in the incremental increase of both PFR (81% versus 48% 
in Group lB) and ADFR (84% versus 31% in Group lB). 
VII.2.2.1E DIFFERENCES WITHIN THE ASYMPTOMATIC GROUP AS DEFINED BY 
LV FUNCTIONAL RESERVE 
In the asymptomatic patients stratified by LV functional reserve 
there was a more even distribution with 13 patients having an 
equivocal or normal response (Group 2A) and 15 patients (54%) 
having a fall in exercise LVEF of >5%(Group 2B). This subgroup 
stratification is illustrated in figure 7.2 overleaf. 
One again it is evident that the equivocal or normal LVEF response 
occurred over a wide range of resting values. 
Rest: 
The mean haemodynamic and radionuclide measurements at rest for the 
2 subgroups are summarised in the next table. 
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1. 20±_0. 52 
1.18±_0. 23 
As in the symptomatic patients, heart rate and cardiac index were 
similar in the two groups, with a slightly higher SBP in the Group 
2B patients and a resultant higher rate-pressure product (12960 
versus 12231). The resting PCWP was normal at 15±_4mmHg in the 
Group 2A patients and elevated but not significantly different at 
18±_4mmHg in Group 2B. These resting PCW pressures are identical to 
the symptomatic group. Resting LVEF was similar in the two groups, 
and only marginally higher ·than the resting values in the 
symptomatic patients (Group A = 63+10 versus 58±_16%; Group B = 61+ 
8 versus 57±_12%). 
Figure 7.2: SUPINE REST 
ASYMPTOMATIC: 
AND EXERCISE EJECTION 
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FRACTION 
E.F. GROUP2A GROUP2B 100 (n 13) (n 15) 
80 
60 e e 
40 ::: ~ 
20 
rest exercise rest exercise 
The PFR was slightly higher in the Group 2A patients (2.41 ±0.98 
versus 2.05 ±1.43 EDV/sec, p = NS), with similar resting average 
diastolic filling rates (1.20 ± 0.52 and 1.18 ± 0.23 EDV/sec). The 
indices of diastolic filling were higher in the asymptomatic subset 
with a normal exercise LVEF, but Group lB and Group 2B values were 
similar. 
Peak Exercise 
The peak exercise results in the two groups are summarised in the 
following table:-
., 
Table 7.10: PEAK EXERCISE HAEMODYNAMIC AND RADIONUCLIDE DATA 
HR SBP CI W EF PFR ADFR WORK 
Gr. 2A 167+22 219±21 9.4±1.5 18±7 65+11 4.63+0.85 2.31+0.45 708+212 
Gr. 2B 179±17 248±30 9.9±2;5 25+8 49± 8 4.27±1.07 2.06±0.63 690±168 
The maximum workload completed was the same in these two subsets of 
patients. Heart rates were similar (p = NS) but SBP was 
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appreciably higher in the Group 2B patients (p <0.01) with a 
resultant higher rate-pressure product (44392 versus 36573). The 
exercise cardiac index was marginally higher in Group 2B, but the 
PCWP was significantly higher (25± 8 versus 18± 7mmHg, p <0.05). 
There was a slight increase in exercise PCWP in the Group 2A 
patients from 15± 4 to 18±7mmHg which is in sharp contrast to the 
symptomatic Group lA subset where a similarly normal resting LV 
filling pressure of 15± 7mmHg increased markedly to 31±12mmHg. 
Figure 7.2 illustrates the obvious decrease in LVEF at peak 
exercise in the Group 2B patients from a mean of 61±8% to 49±8% 
which is of a similar magnitude to that occurring in the 
symptomatic patients. This is significantly lower than the Group 
2A subset (p <0.01). However, in sharp contrast to the symptomatic 
group, only 2 patients (13% versus 40%) had, a significantly reduced 
LVEF < 40%. Both PFR and ADFR were marginally higher in the Group 
2A patients (PFR 4.63±0.85 versus 4.27 +1.07 EDV/sec, ADFR 
2.31+0.45 versus 2.06±0.63 EDV/sec) and significantly higher than 
the corresponding values in the symptomatic patient subsets. 
Although possibly implying better diastolic filling, it should be 
noted that higher exercise heart rates in this group could also 
explain this observation. 
VII.2.2.1F SUMMARY OF SUPINE EXERCISE DATA: 
1. The maximal external workload completed during supine bicycle 
exercise was significantly higher in the asymptomatic patients 
(698 ± 186 versus 423 ± 158k-pm/min, p <9.01) and the limiting 
symptom was leg fatigue rather than shortness of breath. 
2. Exercise haemodynamics were abnormal in both groups with an 
appreciable elevation in PCWP (symptomatic, 30 + 11mmHg; 
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asymptomatic, 22 ± 8mmHg). 
3. Most symptomatic patients had an abnormal LVEF response to 
supine bicycle exercise. In contrast, mean LVEF dropped 
' 
slightly in the asymptomatic group (62 ± 8% to 57 + 12%, p = 
NS), with only half the patients having an abnormal functional 
reserve. A normal LVEF response occurred over a wide range of 
resting values. 
4. Diastolic function was abnormal in both groups of patients. 
) 
5. Thus exercise-induced LV dysfunction is common in asymptomatic 
patients with chronic severe aortic regurgitation. In 
addition, these patients are able to tolerate an elevated PCWP 
on exercise, with leg fatigue being the most common limiting 
symptom. 
VII.2.2.2 ERECT EXERCISE 
Erect exercise will be discussed in the same way under the 
following subheadings:-
VII.2.2.2A Measurements at rest for the two groups. 
VII.2.2.2B Summary of erect rest data. 
VII.2.2.2C Peak exercise results for the two groups. 
VII.2.2.2D Differences within the symptomatic patients defined by 
exercise LVEF response. 
VII.2.2.2E Differences within the asymptomatic group defined by LV 
functional reserve. 
VII.2.2.2F Summary of isometric exercise data. 
In general, the responses to upright exercise were directionally 
similar to those recorded in the supine position. Differences in 
the magnitude of the changes can be readily explained by 
predictable haemodynamic changes related to the postural change. 
It will be noted that not all the patients participated in this 
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part of the evaluation, with 17 symptomatic patients and 23 of the 
asymptomatic subgroup performing upright bicycle exercise. 
VII.2.2.2A MEASUREMENTS AT REST FOR THE TWO GROUPS 
Symptomatic Patients irr ~ 17) 
It should be noted that in only half of this group of patients were 
the haemodynamics measured in both supine and erect postures.. The 
mean heart rate at rest was 93 + 7/min with 5 patients having a 
resting tachycardia (compared to a mean of 82±12 in the supine 
posture). The mean SBP of 147 ± 13mmHg was lOmmHg lower than in 
the supine posture. 
2 
Resting cardiac index was low-normal at 
2.7+0.5 L/min/M and appreciably lower than in the supine position 
2 ' 
(3.2+0.3 L/min/M , P <0.05) due to a significantly lower "stroke 
2 
volume" index of 30 ± 6 versus 40 + 9ml/M , p <0.01 (this 
measurement reflects forward flow and is not the true stroke 
volume). Sev~n patients (41%) had a reduced cardiac index which is 
in contrast to 16% in the supine posture. Only half of this 
subset of patients had a depressed cardiac index in both the erect 
and supine positions. 
The mean PCWP at rest was normal at l0±3mmHg compared to 17±8mmHg 
in the supine position, with only 2 patients (12% versus 65% in the 
supine posture) having elevated resting values. 
The LVEF was normal at 61±17% with a range of· 36 to 87%. The five· 
patients with a reduced resting LVEF in the supine position had a 
similarly reduced LVEF in the upright posture. Three of these 5 
patients had a low resting cardiac index, but in contrast to the 
supine position, only 1 had an elevated PCWP. 
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Both the PFR of 2.32 ± 0.50 EDV/sec (versus 2.13± 0.72EDV/sec) and 
the mean ADFR of 1.31± 0.31 EDV/sec (versus 1.14 + 0.34EDV/sec) are 
slightly but not significantly higher than in the supine posture. 
This is probably a function of a higher erect heart rate. 
Asymptomatic Group in ~ ~ 
Although SBP was the same as in the symptomatic group, heart rate 
(103 ± 10 versus 93 ± 7/min, p <O.Ol) and cardiac.index (3.5 ± 0.5 
2 
versus 2.7 + 0.5 L/min/M , p <O.Ol) were significantly higher with 
no asymptomatic patient having a reduced resting cardiac index 
(same as supine posture). In comparison to the symptomatic group, 
resting PCWP was lower at 7 ±3mmHg (versus 10±3mmHg, p <O.Ol) with 
all patients having a normal resting value (compared to only 43% in 
the supine posture). 
The mean LVEF ranged from 51 to 81% (mean 64 ± 8%) and was similar 
to that of the symptomatic group (61±17%), but in contrast, all 
patients had a normal resting value (compared to only 93% · in the 
supine posture). 
The PFR of 2.66 + 0.69 EDV/sec (versus 2.32 ± 4.50 EDV/sec) and the 
ADFR of 1.52 + 0.44 EDV/sec(versus 1.31±0.31 EDV/sec) are both 
higher than in the symptomatic group and during the supine posture 
(PFR 2.22±0.73EDV/sec; ADFR 1.19±0.39EDV/sec.), once again a 
function of the higher erect heart rate. 
VII.2.2.2B SUMMARY OF ERECT REST DATA: 
1. The differences at rest compared to the supine posture can be 
explained by the predictable haemodynamic changes related to 
posture. 
2. Left ventricular ejection fraction was similar in the two 
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postures and a reduced resting LLVEF was present in both body 
positions in the same patient. 
Table 7.11: ERECT HAEMODYNAMIC AND RADIONUCLIDE DATA AT REST 
SYMPTOMATIC (n = 17) ASYMPTOMATIC (n = 23) 
PT HR SBP CI SVI w EF PFR ADFR PT HR SBP CI SVI w EF PFR ADFR 
*MA 90 150 2.8 30 22 *SA 104 110 3.3 31 5 54 2.50 o. 90 
*FA 82 170 2.1 26 15 56 2.99 1. 62 *LA 120 160 4.6 38 11 
BB 88 150 3 .o 35 4 74 2.22 1.47 *SA 80 150 3.0 38 6 60 2.66 1.41 
RC 7,8 160 2.3 30 5 60 1. 82 1.03 *MB 92 145 3.1 34 6 63 1.26 0. 75 
DD 90 150 2.9 32 9 70 2.49 1.42 *SC 120 145 3.2 26 10 74 2.94 1. 86 
EG 110 150 2.4 22 4 44 2.35 0.87 GD 118 140 3.4 29 11 59 3.09 1.70 
MH 84 160 1.9 23 - 41 1.86 0.87 *DD 102 160 4.6 45 10 63 3.14 1.95 
EJ 105 160 3.5 34 5 84 3.25 1.96 HH 85 150 3.7 43 6 69 1.89 1.19 
JL 90 135 4.0 45 9 43 1.95 1.25 *PJ 112 130 3.3 30 9 51 3.45 1.92 
*NL 120 150 2.8 23 10 40 1.76 0.97 *JJ 110 160 4.1 37 6 72 3.40 1. 76 
RL 75 120 2.9 39 7 85 2.35 1.40 KK 110 160 3.6 33 7 60 2.52 1.56 
ML 98 135 2.0 20 30 36 1.66 o. 99 FN 108 150 3.3 30 5 53 2.25 1.42 
SM 92 150 2.4 26 7 76 *NO 98 150 3.0 31 2 63 2.87 1.40 
HM 110 150 2.9 26 7 59 2.41 1.39 *MP 136 150 3.4 25 5 71 3.20 1.92 
*JN 94 130 2.7 29 5 61 2.49 1. 48 JP 90 150 3.3 36 7 77 2.51 1.53 
*PP 80 130 2.4 31 9 87 3.16 1.62 IR 90 150 3.5 38 8 60 2.41 1.27 
*HW 100 150 3.2 32 6 67 2.51 1.27 SR 90 140 3.5 39 10 67 2.07 1.44 
ws 104 140 2.6 25 10 60 
TS 98 130 3.3 34 8 54 2.10 1.18 
FT 115 150 4.3 38 8 56 2.40 1. 64 
*CV 84 120 5 65 2.25 1.26 
*DV 72 150 3.4 47 3 71 2.41 1.11 
*AW 142 150 2.8 20 4 81 4.61 2.77 
MEAN 93 147 2.7 30 10 61 2.32 1.31MEAN 103 145 3.5 34 7 64 2.66 1. 52 
±.SD 7 13 o. 5 6 3 17 o. 50 0. 3l±.SD 10 13 0. 5 7 3 8 0.69 0. 44 
* GROUP lA * GROUP 2A 
VII.2.2.2C PEAK EXERCISE RESULTS FOR THE TWO GROUPS 
Symptomatic Group ~ ~ l1l 
Because patients were exercised to the maximum work capacity as 
determined during supine exercise, the mean value of 476 ±. 168k-
pm/min was similar to the external workload during that posture. 
Heart rate increased from 93±. 7/min at rest to 159±_23/min at peak 
exercise with a similar peak value to that achieved during supine 
exercise. 
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Systolic blood pressure rose from 147 +13 to 218~36mmHg - a similar 
incremental rise. Cardiac index increased by a mean of 152% 
2 
from 
2.7 ~ 0.5 to 6.8~ 1.8 L/min/M with the peak value similar to that 
2 
in the supine posture (7.0 + 2.0 L/min/ ). Despite a normal 
resting PCWP of 10 ~3mmHg, it rose significantly to 22~7mmHg (p 
<O.Ol) (range 10 to 30mmHg) at peak exercise, being abnormal in all 
but 4 patients (76%). The response was similar to that recorded 
during supine exercise and those with a normal peak exercise PCWP 
all had a low resting value of < 7mmHg. 
Most patients (75%) experienced a significant fall in exercise LVEF 
from 61~17% at rest to 51~19% at peak exercise. The 4 patients 
with a normal exercise PCWP all had a significant fall in exercise 
LVEF. Although PFR and ADFR increased marginally (PFR 2.32~0~50 to 
2.94~1.11 EDV/sec; ADFR 1.31~0.31 to 1.48~0.68 EDV/sec), both the 
peak values and the incremental rise were slightly lower than 
during supine exercise. 
Asymptomatic Group in ~ ~ 
The work capacity achieved was significantly higher than in the 
symptomatic group (713~196 versus 476~168k-pm/min, p <0.01). In 
addition, heart rate (p <0.01), cardiac index (p <0.01) and stroke 
volume index (p <O.Ol) were all significantly higher although 
elevation of PCWP was similar in the two groups. Both heart rate 
(103~10 to 176~16/min) and SBP (145~13 to 216~25mmHg) increased 
appreciably and although heart rate was similar to that achieved 
during supine exercise, SBP was lower with a resultant lower rate-
pressure product (38016 versus 40655). Cardiac index increased 
2 
markedly by 183% from 3.5 ~0.5 to 9.9±3.1 L/min/M , similar to the 
supine posture. PCWP rose from a low-normal mean of 7+3 to 
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18±7mmHg (range 6 to 30mmHgl, and was abnormal in just over half 
the patients (52% versus 64% during peak supine exercise). 
In contrast to the symptomatic group, only 10 patients (43% versus 
75%) had an abnormal LV functional reserve with the mean exercise 
LVEF dropping marginally from 64+8 to 58±11% which is similar to 
that seen during supine ex~rcise, p = NS. The abnormal response 
was less common (43% versus 53%) than during supine exercise but in 
the majority (7/10) the drop in exercise LVEF occurred during both 
postures. Similar to supine exercise, both PFR (2.66±0.69 to 
4.79+2.19 EDV/sec) and ADFR (1.52±0.44 to 2.15±0.82 EDV/sec) 
increased markedly and was significantly higher (p <O.Ol) than in 
the symptomatic group. 



































































































65 10 70 
29 30 26 2.20 
35 26 69 
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SVI W EF PFR 
59 10 64 4.05 
68 15 66 5.92 
81 16 57 6.38 
62 19 67 5.08 
54 10 72 5.15 
47 24 46 3.31 
73 25 60 5.80 
58 15 52 4.14 
65 29 50 4.91 
68 18 72 5.69 
58 15 55 4.70 
65 6 61 2.29 
46 22 
63 13 70 6.44 
54 25 52 4.86 
51 25 56 3.64 
34 12 35 
39 30 48 2.92 
57 25 45 3.81 
15 63 6.03 
76 13 70 4.74 























MEAN159 218 6.8 
±SD 23 36 1.8 
43 22 51 2.94 1.48MEAN176 216 
12 7 19 1.11 0.68±SD 16 25 
9.9 
3.1 
57 18 58 4.79 2.15 
13 7 11 2.19 0.82 
* GROUP 1A * GROUP 2A 
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VII.2.2.2D DIFFERENCES WITHIN THE SYMPTOMATIC GROUP DEFINED BY 
EXERCISE LVEF RESPONSE 
As occurred during supine exercise, the majority (75%) had an 
abnormal peak LVEF response to exercise and constitute Group lB. 
Four patients (Group lA), either increased or did not change their 
LVEF on exercise. Once again it is evident that the Group lA 
response occurred over a wide range of resting LV. ejection 
fractions. The following Figure 7.3 graphically depicts the 
stratification of the symptomatic subsets. 














rest exercise rest exercise 
Rest 
The resting mean haemo~ynamic and radionuclide measurements are 
summarised in the following table:-

























1. 42±.0. 31 
1. 27 ±.0. 32 
haemodynamic 
measurements and radionuclide LVEF and diastolic fill~ng rates were 
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similar in both subsets of patients. Although resting PFR and ADFR 
were both significantly higher in the Group lA patients in the 
erect posture, this difference was not apparent in the Group lB 
patients during the two postures. Similar differences in heart 
rate occurred and thus cannot explain this observation. 
Peak Exercise 
The peak exercise mean haemodynamic and radionuclide data for the 
two subgroups is summarised in Table 7.14. 
Table 7.14: PEAK EXERCISE HAEMODYNAMIC AND RADIONUCLIDE DATA 
HR SBP CI W EF PFR ADFR Ex.Cap 
GR. lA 153±25 193±47 6.5±1.1 24±6 65±21 3.76±1.11 1.81+0.83 413±125 
GR. lB 160±24 228±30 7.0±2.0 21±7 46±16 2.58±0.95 1.34±0.60 500±186 
As occurred during supine exercise, peak work capacity was slightly 
higher in the Group lB patients (500±186 versus 413±125k-pm/min, p 
= NS). Although peak heart rates were similar, SBP was 
significantly higher in the Group lB patients, p <0.05. 
Commensurate with the increased work achieved, cardiac index was 
2 
slightly higher (7.0±2.0 versus 6.5±1.1 L/min/M ) but PCWP (21±7 
and 24±6mmHg) similar in the two subsets. As illustrated in Figure 
7.3 Group lB patients had a marked decrease in exercise LVEF (p 
<0.05), with 42% of this subset having a significantly reduced 
value of <40% (range 25 to 35%). 
As was evident at rest, PFR (3.76±1.11 versus 2.58±0.95 EDV/sec, p 
<0.01) and ADFR (1.81±0.83 versus 1.34±0.60 EDV/sec, p = ·NS) were 
higher in the Group lA patients. 
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VII.2.2.2E DIFFERENCES WITHIN THE ASYMPTOMATIC GROUP DEFINED BY LV 
FUNCTIONAL RESERVE 
As occurred during supine exercise, patient stratification by means 
of LV functional reserve in asymptomatic aortic regurgitation 
resulted in a more even distribution of patients, with 12 patients 
(55%) having a normal or equivocal response (Group 2A) and 10 
patients (45%) having a fall in peak LVEF of >5% (Group 2B). This 
is graphically illustrated in Figure 7.4. 
Figure 7.4: ERECT REST AND 
ASYMPTOMATIC · 













It is again evident that a normal LV functional reserve occurred 
over a wide range of resting LV ejection fractions with a range of 
51 to 81%. 
The mean haemodynamic and ERNA data at rest are summarised in the 
following table:-
Table 7.15: REST HAEMODYNAMIC AND ERNA DATA 
HR 
Gr. 2A 104+21 




















The resting haemodynamic and LVEF measurements were similar in the 
two subsets of patients with resting heart rate higher, SBP lower 
and PCWP approximately half that in the supine posture where Group 
2B patients had an abnormal resting LV filling pressure of 18±4mmHg 
(compared to 8±2mmHg in the erect posture). 
In comparison to the symptomatic subgroup with a normal exercise 
LVEF, resting heart and cardiac index were higher in the erect 
posture. Resting PCWP was identical in the two groups. A resting 
LVEF of 66±9% (versus 61 + 20%) was marginally higher in the Group 
2A asymptomatic subset. As was evident during the supine posture, 
both PFR (2.89 ± 0.89 versus 2.36±0.35 EDV/sec, p = NS), and ADFR 
(1.58 ±0.56 versus 1.44±0.19 EDV/sec, p = NS) were only marginally 
-
higher in the Group 2A patients. The higher absolute values in 
both Groups 2A and 2B in the erect posture are related to a higher 
resting heart rate (see Table 7.9). 
Peak Exercise 
The peak exercise results in the two groups are summarised in the 
following table:-





















In comparison to supine exercise, maximum work achieved was 
slightly higher in Group 2A (775±195 versus 665±180k-pm/min, p = 
NS) with a resultant higher cardiac index (11.1±2.1 versus 8.6±1.5 
2 
L/min/M, p <0.01). However, peak PCWP was lower but nevertheless 
marginally elevated at 16±6mmHg (versus 20±6mmHg in Group 2B, p = 
NS). In addition, SBP (212±26 versus 221±25mmHg, p = NS) and the 
rate-pressure product (37100 versus 38233) were lower. Six 
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patients (46%) in Group 2A had an abnormal exercise PCWP, which is 
similar to the number during supine exercise and appreciably lower 
than the percentage of Group 2B patients with abnormal exercise 
PCWP during both supine (83%) and erect exercise (60%). Figure 7.4 
illustrates the significant decrease in LVEF from 62±7% at rest to 
50±9% at peak exercise in Group 2B. This ejection fraction 
response is significantly different to that of the Group 2A subset 
(p <0.01). The incremental drop is approximately the same as 
occurred 
higher 
during supine 'exercise. The mean value 
than in the symptomatic subset (50±9 versus 
was slightly 
46+16%). In 
contrast however, only 1 patient (10% versus 42% in the symptomatic 
group) had a markedly reduced peak exercise LVEF of < 40%. 
Both PFR and ADFR rose markedly in the Group 2A patients during 
peak exercise in the erect posture (PFR 2.8+0.81 to 5.36±1.43 
EDV/sec or an 85% increase; ADFR 1.58±0.56 to 2.48±0.60 EDV/sec or 
a 57% increase), with less imp~essive incremental rises 
Group 2B patients (PFR 70%; ADFR 22%). Nevertheless, 




were higher than in the supine posture. Once again, both at rest 
and, more particularly at peak exercise, these measures of 
diastolic function appear to correlate best with an abnormal LVEF 
response to exercise. 
Table 7.17 summarises the supine and erect rest and peak exercise 
haemodynamic and radionuclide data for both the symptomatic and 
asymptomatic groups of patients. 
153 
Table 7 .1 7: SUMMARY OF REST AND EXERCISE HAEMODYNAMIC AND 
RADIONUCLIDE DATA 
SUPINE ERECT SUPINE ERECT 
n = 31 n = 17 n = 28 n 23 
REST PEAK REST PEAK REST PEAK REST PEAK 
HR 82+12 152.±_21 93.±_7 159.±_23 80.±_16 17 3.±_20 103+10 1 76.±_16 
SBP 157.±_18 223.±_39 147.±_13 218.±_36 157.±_15 235.±_29 145+13 216.±_25 
CI 3.2+ 7.0.±_ 2. 7 :t 6. 8.±_ 3.4.±_ 9. 7 :t 3. 5.±_ 9.9+ 
0. 7 2 .o o. 5 1.8 0.6 3.1 0. 5 3.1 
FFI 40.±_9 46.±_12 30+6 43+12 44+8 57.±_13 34.±_7 57.±_13 
(SVI) 
w 17.±_8 30+11 10+3 22.±_7 17.±_4 22+8 7+3 18.±_7 
EF 57.±_12 47.±_14 61.±_17 51.±_19 62.±_8 57±12 64.±_8 58.±_11 
PFR 2.13+ 3.25+ 2.32.±_ 2.94± 2.22.±_ 4.44+ 2.66.±_ 4.79± 
0.72 1.43 o. 50 1.11 o. 73 2.11 o. 69 2.19 
ADFR1.14:t 1.58+ 1.31.±_ 1. 48.±_ 1.19.±_ 2 .18.±_ 1.52.±_ 2.15.±_ 
o. 34 0. 75 0.31 0.68 o. 39 0.56 o. 44 0.82 
WORK 423.±_ 476+ 698± 713+ 
158 168 186 196 
VII.2.2.2F SUMMARY OF ERECT EXERCISE DATA: 
1. The haemodynamic response was directionally similar to that 
during supine exercise with the same magnitude of change in 
cardiac index, but a lower SBP and a slightly lower exercise 
PCWP (symptomatic 22 + 7 versus 30 + llmmHg; asymptomatic 18 :t 
7 versus 22 :t 8mmHg). 
2. Similar to the supine posture, most symptomatic patients had an 
abnormal LVEF response to erect bicycle exercise. However, 
only 39% of the asymptomatic group (versus 53% in the supine 
posture) had an abnormal functional reserve. Importantly, in 
the majority of cases the fall in LVEF on exercise occurred 
during both postures. 
3. Diastolic filling rates were reduced in both groups and similar 
to those obtained during supine exercise. 
VII.2.2.3 ISOMETRIC EXERCISE: 
This part of the exercise evaluation will compare the effects of 
isometric handgrip and supine bicycle exercise on LV performance in 
154 
symptomatic and asymptomatic patients with aortic regurgitation, 
firstly for the two big groups as a whole and then stratified 
according to their supine bicycle exercise LV functional reserve. 
Twenty four (24) of the symptomatic group and twenty six (26) 
asymptomatic patients were evaluated using this form of exercise. 
VII.2.2.3A Measurements in symptomatic patients. 
VII.2.2.3B Measurements in asymptomatic patients. 
VII.2.2.3C Differences within the symptomatic group as defined by 
supine bicycle exercise LVEF response. 
VII.2.2.3D Differences within the asymptomatic group as defined by 
isotonic exercise LV functional reserve. 
VII.2.2.3E Summary of isometric exercise data. 
The table overleaf (Table 7.18) outlines the haemodynamic and 
radionuclide data during isometric handgrip exercise for both the 
symptomatic and asymptomatic groups. 
VII.2.2.3A MEASUREMENTS IN SYMPTOMATIC PATIENTS 
The following table summarises the mean resting, isometric and 
isotonic exrcise data in this group of patients (mean ~SD). 
Table 7.19: RESTz ISOMETRIC AND ISOTONIC EXERCISE DATA IN THE 
SYMPTOMATIC PATIENTS 
HR SBP CI w EF PFR ADFR 
REST 82~12 157~18 3. 2~0. 7 17~8 57+12 2 .13~0. 72 1.14~0.34 
ISOMETRIC 86+13 170~21 3. 2~0. 8 20~9 56+13 2 .10~0. 38 1.18~0.38 
ISOTONIC 152~21 223+39 7 .0~2 .o 30+11 47~14 3.25~1.43 1. 58~0. 75 
During both forms of exercise heart rate, SBP and rate-pressure 
product increased (isometric 14620; isotonic 33895), but the 
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increase was much less during handgrip exercise. Although cardiac 
index and PCWP increased significantly with bicycle exercise (p 
<0.01), cardiac index remained unchanged and PCWP increased only 
marginally during isometric exercise (17.±_8 to 20.±_9mmHg, p = NS). 
Similarly, although LVEF fell significantly (57.±_12 to 47.±_14%, p 
<0.01) at peak bicycle exercise, it remained unchanged during 
handgrip; similar observations were made when evaluating diastolic 
filling rates during isometric exercise. 
Table 7.18: ISOMETRIC EXERCISE HAEMODYNAMIC AND RADIONUCLIDE DATA 
SYMPTOMATIC (n = 24) ASYMPTOMATIC (n = 26) 
PT HR SBP CI FFI w EF PFR ADFR PT HR SBP CI FFI w EF PFR ADFR 
MA 80 170 2.6 33 19 54 1.50 0. 79 *SA 80 140 3. 6 . 45 14 66 3.24 1. 62 
FA 80 210 2.9 36 28 60 3.13 1.51 LA 85 180 3.2 37 19 63 1.44 0.75 
BB 84 200 2.7 33 22 64 1.95 1.35 SA 80 180 3.4 42 15 57 1. 67 1.00 
RC 70 180 2.6 37 20 46 1.12 0.45 *MB 80 170 3.8 47 25 61 1.93 1.07 
DD 68 165 3.5 52 20 80 2.75 1.39 *SC 76 150 3.6 47 21 71 2.18 1.17 
MdV 82 190 3.7 45 24 70 2.43 1.52 *AC 90 170 3.6 40 16 52 3.33 1.59 
EG 98 170 2.5 25 15 43 1.99 1.02 GD 96 170 4.1 42 27 50 1.93 1.17 
KG 100 180 1.9 19 25 59 3.36 1.87 DD 78 175 3.8 49 22 59 2.28 1.14 
MH 80 190 2.6 33 - 45 2.38 0. 78 HH 70 180 3.3 47 19 61 1. 52 0.91 
EJ 80 200 3.5 43 28 61 1. 83 1.18 *PJ 92 150 3.7 40 13 45 1.98 1. 29 
JL 85 140 3.8 45 29 40 2.61 1.22 *JJ 75 195 3.8 51 23 73 2.19 1.21 
*NL 120 155 3.8 31 18 34 1.07 0. 57 KK 100 170 4.3 43 20 60 2.60 1.39 
*RL 80 155 3.7 46 13 73 2.11 1.18 *GM 80 155 3.0 37 13 69 2.10 1. 28 
ML 110 160 1.6 15 50 30 2.12 o. 95 *FN 108 180 3. 7 34 18 40 1.46 0.91 
*SM 96 180 3.4 35 21 72 *NO 74 160 3.4 46 11 67 2.17 
NM 110 145 5.5 50 6 72 2.01 MP 102 170 4.9 48 15 71 2.24 1.35 
HM 84 170 3.3 39 13 54 1.03 *JP 72 180 4.3 60 20 68 2.11 1. 25 
MN 80 170 3.4 43 20 - 1.44 0.92 IR 92 190 3.8 41 21 62 2.35 1.50 
EN 80 130 3.7 46 9 60 2.22 1.33 SR 84 165 2.7 32 33 65 2.23 1.25 
*JN 65 130 2.6 40 16 62 1.58 ws 82 180 2.9 36 17 60 1. 80 1.14 
pp 78 160 3.0 39 20 63 2.33 1.22 TS 80 160 2.8 35 25 52 1. 36 0.85 
*MvB 85 165 2.5 30 15 43 1.99 1.01 FT 84 145 3.9 46 22 50 1. 69 1.06 
EvH 85 180 57 1. 69 1.14 VdS 72 180 3.2 44 17 67 2.42 1.12 
HW 94 160 4.4 47 15 57 2.49 1. 42 *CV 66 125 2.9 44 12 62 1.66 0.81 
*DV 62 150 3.2 52 21 56 1. 78 0.68 
*AW 130 150 3.5 27 10 70 4.95 2.58 
MEAN 86 170 3.2 37 20 56 2.10 1.18 MEAN 84 166 3.6 43 19 61 2.18 l. 21 
+SD 13 21 0.8 9 9 13 0.60 0. 38 .±_SD 14 17 0.5 7 5 8 o. 7 4 0. 37 
* GROUP lA * GROUP 2A ' 
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VII.2.2.3B MEASUREMENTS IN ASYMPTOMATIC PATIENTS 
The following table summarises the mean resting, isometric and 
bicycle exercise data in the asymptomatic patients (mean ±SD). 
Table 7.20: REST, ISOMETRIC AND 
ASYMPTOMATIC PATIENTS 
HR. SBP CI w 
ISOTONIC EXERCISE DATA 
EF PFR ADFR 
REST 80~16 157~15 3.4±0.6 17+4 62~8 2.22~0.73 1.19~0.39 
ISOMETRIC 84±14 166+17 3.6~0.5 19~5 61±8 2.18~0.74 1.21~0.37 
ISOTONIC 173~20 235~29 9.7±3.1 22±8 57±12 4.44+2.11 2 .. 18~0.56 
As was seen in symptomatic patients, heart rate, SBP and rate-
pressure product increased but to a lesser degree than during 
supine bicycle exercise. Cardiac index and PCWP were only 
marginally higher than the resting values (p = NS). The 
radionuclide measurements of LVEF, PFR and ADFR were similar to the 
resting values (p = NS), which is in sharp contrast to the results 
during isotonic exercise. 
When compared to the isometric exercise response in the symptomatic 
patients, heart rate, SBP and PCWP were similar~ with caridac 
index, LVEF and diastolic filling rates marginally higher. 
VII.2.2.3C DIFFERENCES WITHIN THE SYMPTOMATIC GROUP AS DEFINED BY 
SUPINE BICYCLE EXERCISE LVEF RESPONSE 
Group lA: (n = 6) 
This is the subset of patients with a normal or equivocal LVEF 
response to supine bicycle exercise. The mean resting, isometric 




Table 7.21: REST, ISOMETRIC AND ISOTONIC EXERCISE DATA IN GROUP IA 
SYMPTOMATIC PATIENTS 
HR SBP CI w EF PFR ADFR 
REST 85± 9 143±12 3.1±0.5 15± 2 58±16 1.74±0.69 0.94±0.46 
ISOMETRIC 89±20 157±18 3.2±0.6 17+ 3 57±18 1.69±0.47 0.92±0.31 
ISOTONIC 148±25 187±20 6.6±1.8 31±12 58±20 3.15±1.38 1.73+0.70 
There is a marginal increase in heart rate during isometric 
exercise with a moderate increase in SBP (p = NS) and thus rate-
pressure product (13973 versus 12155 at rest). Cardiac index was 
similar to the resting value, with a slight elevation of PCWP 
(17±3mmHg, p = NS). LVEF remained unchanged with PFR and ADFR 
similarly altering little from the resting values. However, 1 
patients (MvB) had a significant fall in isometric LVEF from 51 to 
43% which is in sharp contrast to his response during isotonic 
exercise (51 to 49%). 
Group lB: (n = 25). 
In this subgroup with a significant fall in LVEF during supine 
bicycle exercise (57±12 to 44+12%), the isometric heart rate is 
again marginally higher with a moderate increase in SBP and rate-
pressure product (14792 versus 12960 at rest}. As occurred in the 
Group lA patients, cardiac index remained unchanged with a slight 
increase in PCWP from 18±9mmHg at rest to 21±10mmHg during 
handgrip (p = NS). 
Importantly, although somewhat expected, LVEF remained unchanged 
(as did diastolic filling rates) with only 2 patients (12%) having 
a significant fall in LVEF during isometric exercise (F.A. 67 to 
60%; H.W. 64 to 57%). Thus this form of stress did not appear to 
help stratify symptomatic patients with chronic aortic 
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regurgitation into those with and without an abnormal LVEF response 
to exercise. 
The results in this subset are summarised in Table 7.22 (mean ±_SD). 
Table 7.22: REST 1 ISOMETRIC AND ISOTONIC EXERCISE DATA IN GROUP lB 
SYMPTOMATIC PATIENTS: 
HR SBP CI w EF PFR ADFR 
REST 81+10 160±_17 3. 2±_0. 8 18± 9 57±_12 2. 20±_0. 72 1.18±_0. 31 
ISOMETRIC 86±_12 172±_21 3.2±_0.9 21±_10 56±_12 2.20±_0.59 1.22±_0.38 
ISOTONIC 148±_35 232±_38 7.2±_2.1 30+11 44±.12 3.26±_1.44 1.54±_0.78 
VII.2.2.3D DIFFERENCES WITHIN THE ASYMPTOMATIC GROUP AS DEFINED BY 
ISOTONIC EXERCISE LV FUNCTIONAL RESERVE 
Group 2A: (n = 13 ) . 
The mean resting, isometric and isotonic exercise results are 
summarised in the table below (mean ±_SD). 
Table 7.23: REST 1 ISOMETRIC AND ISOTONIC EXERCISE DATA IN GROUP 2A 
ASYMPTOMATIC PATIENTS 
HR SBP CI w EF PFR ADFR 
REST 81±.21 151±_16 3.3±_0.5 15± 4 63±_10 2.41±_0.9·1.20±_0.52 
ISOMETRIC 83±_18 160±_19 3.5+0.4 16± 6 62±_10 2.39±_0.94 1.29±_0.49 
ISOTONIC 167±_17 219±_21 9.4±_1.5 18±. 7 65±_11 4.63±_0.85 2.31±_0.45 
The haemodynamic and radionuclide responses to isometric exercise 
in this subset of patients varied little from those in the same 
symptomatic subgroup, with a marginal increase in heart rate and 
PCWP, a modest rise in SBP and essentially no change in cardiac 
index, LVEF and diastolic filling rates. However, 1 patient in 
this subgroup with normal LV functional reserve during isotonic 
exercise had a significant fall in LVEF during isometric handgrip 
(D.V. 63 to 56%). 
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Group 2B: (n = 15) 
The results in this subset of patients are summarised in the table 
below (mean ±:SD). 
Table 7.24: REST, ISOMETRIC AND ISOTONIC EXERCISE DATA IN THE 
GROUP 2B ASYMPTOMATIC GROUP 
HR SBP CI w EF PFR ADFR 
REST 80±:21 162±13 3.5±0.7 18± 4 61+ 8 2.05±1.43 1.18±0.23 
ISOMETRIC 85+10 173±11 3.6±0.6 21± 5 60+ 6 1 •. 96±0.41 1.13±0.22 
ISOTONIC 179+17 248±:30 9.9±2.5 25± 8 49± 8 4.27±1.07 ~.06±0.63 
Once again the effects of handgrip isometric exercise on the 
haemodynamic and radionuclide variables are ·similar to the 
symptomatic subset with a fall in LVEF at peak bicycle exer-cise. 
LVEF remained unchanged with only 1 patient having an ,abnormal LV 
functional reserve ( S. A. 62 to 57%). Although SBP was 
significantly higher than the resting value (p <0.01), PCWP was 
only marginally higher (p = NS) and thus this form of LV stress was 
not a helpful alternative method in the asymptomatic group of 
patients with chronic severe aortic regurgitation. 
VII.2.2.3E SUMMARY OF ISOMETRIC EXERCISE DATA 
1. Isometric handgrip exercise had only a minimal effect on the 
measured haemodynamic and radionuclide variables in both the 
symptomatic and asymptomatic patients. 
2. This form of exercise was not a good alternative method of left 
ventricular stress in patients with chronic severe aortic 
regurgitation. 
VII.2.2.4 EQUIVALENT WORKLOAD EXERCISE 
In an attempt to evaluate the patterns of change in _ haemodynamic 
and radionuclide variables during supine exercise in more detail, 
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the measurements at each of the first 3 levels of exercise for both 
symptomatic and asymptomatic patients were compared and the mean 
values obtained are summarised in the following two tables (see 
Appendix VII, VIII, IX for individual patient details) and 
discussed under subheadings:-
VII.2.2.4A Level 1 
VII.2.2.4B Level 2 
VII.2.2.4C Level 3 
. 














2 .13±_0. 7 2 
1.14±_0.34 

















1. 58±_0. 66 
n = 30 
Table 7.26: ASYMPTOMATIC HAEMODYNAMIC AND 
REST LEVEL 1 LEVEL 2 
HR 80±_16 111±_23 125±_25 
SBP 157±_15 179±_21 192+20 
CI 3.4±_0.6 5. 7 ±.0. 9 6. 6±_0. 9 
w 17±_4 21±.7 20±_6 
EF 62±_8 58±8 58±_10 
PFR 2.22+0.73 2.91±_0.79 3 .19±_0. 90 
ADFR 1.19±.0. 39 1. 54±.0. 32 1.68±_1.29 
n = 28 n = 28 n = 28 
VII.2.2.4A LEVEL 1 


















1. 9 7 ±.0. 51 


















All the haemodynamic variables increased during the first level of 
supine bicycle exercise, with heart rate rising from 82+12 to 




p <0.01), cardiac index from 3.2+0.7 to 
5.4±1.3L/min/M (69%, p <0.01) and PCWP by 59% from 17 to 27mmHg (p 
<0.01). The exercise LVEF fell slightly from 57 to 51% (p = NS), 
with only 39% of this group having a normal or equivocal response 
at this level of exercise. This subset of 12 patients included the 
6 patients in Group lA who had an equivocal or normal response at 
peak exercise (vida supra). PFR increased appreciably by 25% (p 
<0.05), with only a marginal increase in ADFR (p = NS). 
Asymptomatic Patients (n = 28) 
In the same way, the haemodynamic parameters all increased during 
the first level of exercise in the asymptomatic patients with a 
similar incremental rise in heart rate of 39% (80±16 to 111±23/min, 
p <0.01), SBP of 14% (157±15 to 179±2lmmHg, p <0.01) and a cardiac 
2 
index increase of 68% (3.4±0.6 to 5.7±0.9 L/min/M, p <0.01). In 
contrast, there was only a marginal increase in PCWP (p = NS) from 
17±4 to 21±7mmHg (compared to a 59% increment in the sym~tomatic 
group). 
There was a slight decrease in exercise LVEF from 62±8 to 58±8% (p 
= NS) but 9 patients (32% versus 61% of the symptomatic group) had 
a significant fall in LVEF (62+4 at rest to 50±11%). This subset 
of asymptomatic patients had a similar incremental rise in cardiac 
index (74% versus 68% for the whole group) but a higher mean PCWP 
(25+8 versus 21±7mmHg) and an appreciably greater incremental rise 
in PCWP of 39% (versus 24% for the group). Nevertheless, this rise 
in PCWP remained significantly less than during equivalent exercise 
in the symptomatic patients (59%). Both PFR and ADFR increased 
significantly by 31% (PFR 2.22±0.73 to 2.91±0.79 EDV/sec, p <O.Ol) 
and 29% (ADFR 1.19±0.39 to 1.54+0.32 EDV/sec, p <0.05) 
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respectively, which is marginally higher than in the symptomatic 
group. 
VII.2.2.4B LEVEL ~: 
The following table summarises the incremental change in 
haemodynamic and radionuclide variables during the 2nd level of 
supine bicycle exercise. 



















Symptomatic Group (n = 30) 









All haemodynamic variables increased significantly (p <O.Ol) 
ranging from 31% for SBP (157±18 to 205±3lmmHg), through 62% for 
heart rate (82+12 to · 133±16/min) and 65% for PCWP (17±8 to 
28±12mmHg) to a 91% increase in cardiac index (3.2±0.7 to 6.1±1.6 
2 
L/min/M ). The level 2 exercise LVEF fell appreciably from 57±12% 
at rest to 50±15% (p <0.05), but was little changed from the level 
1 value of 51±19%. The peak an~ average diastolic filling rates 
increased significantly by 46% and 39% respectively (PFR 2.13±0.72 
to 3.11±1.09 EDV/sec, p <O.Ol; ADFR 1.14±0.34 to 1.58±0.66EDV/sec, 
p <0.05). 
Nine patients (31%) had an equivocal or normal LV functional 
reserve at this level of exercise (similar to level 1) and included 
the 6 patients who form the Group lA subset. This subgroup of 
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patients had a similar resting LVEF of 58±15% (versus 56±2%) to the 
subgroup with a fall in exercise LVEF. Resting cardiac index was 
2 
marginally higher (3.4 ±0.7 versus 3.1±0.7 L/min/M ) with a similar 
incremental rise of 88% and 90% respectively. The PCWP both at 
rest and level 2 exercise was lower (rest 14±4 versus 18±9mmHg; 
exercise 23±12 versus 30±llmmHg) but with-similar incremental rises 
of 64% and 66% respectively. 
Asymptomatic Group (n ~ 28) 
The incremental rise in heart rate and SBP was slightly lower 
compared to the symptomatic group with heart rate increasing from 
80+16 to 125±25/min (56%, p <0.01) and SBP rising from 157±15 to 
192+20 (22%, p <0.01) and a lower rate pressure product (24000 
versus 27265). 
2 
The cardiac index rose from 3.4±0.6 to 6.6+0.9 
L/min/M (94%, p <0.01). The marginal increase in PCWP from 
17±4mmHg at rest to 20±6mmHg (18%, p = NS) is in sharp contrast to 
the 65% rise in the symptomatic group. The mean level 2 LVEF 
remained unchanged at 58±8% compared to the first level, with half 
the.patients(l4) having a normal or equivocal response (compared to 
31% of the symptomatic group). 
Neither resting LVEF (61±10 versus 63±6%), nor the haemodynamic 
2 
variables of cardiac index (3.4±0.5 versus 3.4±0.7 L/min/M ) or 
PCWP (16±4 versus l7±5mmHg) distinguished those with a normal or 
equivocal response from the subset with a fall in exercise LVEF. 
The PFR and ADFR increased by 44% and 41% respectively (p <0.01), 
which is a similar incremental rise to that in the symptomatic 
group. 
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VII.2.2.4C LEVEL 3: 
Similar to level 2 exercise, the following table summarises the 
incremental change from rest in the haemodyamic and radionuclide 
measurements during the 3rd level (450k-p.m./min) of supine bicycle 
exercise in both the symptomatic and asymptomatic groups. 
Table 7.28: LEVEL 3 INCREMENTAL CHANGE IN HAEMODYNANIC AND 
RADIONUCLIDE DATA 
'SYMPTOMATIC ASYMPTOMATIC 
HR +84% +78% 
SBP +40% +32% 
CI +131% +126% 
w +59% +24% 
EF -11% -8% 
PFR +53% +70% 
ADFR +48% +66% 
Symptomatic Group (n = 21) 
All haemodynamic measurements increased significantly (p <O.Ol) 
ranging from 40% for SBP (157±18 to 220±36mmHg), through 59% for 
PCWP (17±8 to 27±llmmHg) and 84% for heart rate (82±12 to 
151±18/min) to a marked 131% increase in cardiac index (3.2±0.7 to 
2 
7.4±1.8 L/min/M ). 
The LVEF fell slightly from 57±12 to 51±15% (-11%, p = NS) but it 
should be noted that this drop occurred during the first level of 
exercise, after which it plateaued with a further marginal fall to 
47±14% only being recorded at peak exercise. 
The PFR and ADFR increased further during this level of exercise, 
PFR by 46% (2.13±0.72 to 3.26±1.26 EDV/sec, p <O.Ol) and ADFR ·by 
39% (1.14±0.34 to 1.69±0.68 EDV/sec, p <0.01). 
Five patients (24% versus 31% in level 2) had a normal or equivocal 
LVEF response, and included 4 of the Group lA subset. The other 16 
165 
patients had a significant fall in exercise LVEF from 59±.11 to 
47±.11%, p <0.01. Although resting and level 3 exercise cardiac 
index was similar in Groups lA and lB (resting 3.5±_0.9 versus 
2 2 
3.3+0.7 L/min/M ; exercise 7.3±_1.6 versus 7.5±_2.0 L/min/M ), 
' resting PCWP was somewhat lower and in the normal range in the 
Group lA patients (13±.5 versus l7±.9mmHg, p = NS). In addition, 
resting peak and average diastolic filling rates were marginally 
higher (PFR 2.39±_1.61 versus 2.10±_0.50 EDV/sec; ADFR 1.16±_2.10 
versus 1.11±_0.14 EDV/sec) with a significant increase in ADFR of 
81% at level 3 exercise in the Group lA patients implying better 
overall diastolic function in this subset. 
Asymptomatic Patients (n = 28) 
As occurred during !~vel 2 exercise, the incremental rise in heart 
rate and SBP was slightly lower in the asymptomatic group with 
heart rate increasing by 78% from 80±.16 to 142±.25/min (p <O.Ol) a~d 
SBP rising by 32% from 157±_18mmHg at rest to 208±.25mmHg (p <0.01). 
2 
Cardiac index rose by 126% from 3.4±.0.6 to 7.7±.1.2 L/min/M (p 
<O.Ol) with an insignificant rise in PCWP of 24% from 17±.4 to 
21±.7mmHg (compared to a 59% rise in the symptomatic group). It 
should again be noted that similar to the symptomatic patients, 
after an initial increase in PCWP during the first level of 
exercise, no further increase occurred during successive levels. 
Similarly, after an initial marginal fall in exercise LVEF, no 
further drop occurred with the LVEF at level 3 of supine bicycle 
exercise 57±.11% (versus 62±.8% at rest). 
Twelve patients (43% versus 50% in Level 2) had no significant fall 
in exercise LVEF, and although resting cardiac index was similar to 
2 
the Group 2B subset (3.3±.0.5 and 3.6±.0.6 L/min/M ), resting PCWP 
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was lower and in the normal range at 15±4mmHg (versus 
18±4mmHg). Resting peak and average diastolic filling rates were 
marginally higher (PFR 2.47±1.01 versus 2.03±0.36 EDV/sec, p = NS; 
ADFR 1.27±0.55 versus 1.13±0.20 EDV/sec, p = NS), with a much 
bigger incremental rise in PFR (70%) from 2.22±0.73 EDV/sec at rest 
to 3.78±0.97 EDV/sec (p <0.01) and ADFR (66%) 1.19±0.39 EDV/sec at 
rest to 1.97±0.51 EDV/sec (p <0.01). This superior diastolic 
filling may explain the lower pulmonary capillary wedge pressures, 
better systolic function and exercise capacity in this group of 
patients with chronic severe aortic regurgitation. 
Figure 7.5 overleaf graphically summarises the pattern of change 
in the haemodynamic and ERNA variables at each level of supine 
bicycle exercise in the symptomatic and asymptomatic groups. 
VII 2.2.4D SUMMARY OF EQUIVALENT WORKLOAD EXERCISE 
1. An appropriate incremental increase in heart rate, SBP and 
cardiac index was noted in both groups of patients. 
2. Whereas PCWP increased marginally during graded supine bicycle 
exercise in the asymptomatic group (17 ± 4 to 21 + 7mmHg, p = 
NS), wedge pressure increased significantly (17 ± 8 to 27 + 
11mmHg, p < 0.01) and early (during level 1 exercise) in the 
symptomatic patients and then appeared to plateau. 
3. A similar early but non-significa~t fall in LVEF was noted in 
both groups of patients, 
levels of exercise. 
followed by a plateau over the next 2 
4. At similar exercise heart rates there was better diastolic 
filling in the asymptomatic patients and this may help to 
explain the lower PCWP, better systolic function and exercise 
capacity in this group of patients. 
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Figure 7.5: PATTERNS OF CHANGE IN HAEMODYNAMIC AND ERNA VARIABLES 
DURING GRADED SUPINE EXERCISE: 
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5. Thus the direction and magnitude of change in haemodynamic and 
radionuclide variables appears maximal early during supine 
bicycle exercise. 
VII.2.3 CARDIAC CATHETERISATION 
The cardiac catheterisation data of the two groups of patients is 
outlined in tables 7.29 and 7.30. All patients had normal 
coronary angiograms. 
VII.2.3.1 SYMPTOMATIC GROUP (n' = 32) 
Aortic Pressure: 
The mean systolic aortic pressure was 145 ± 2lmmHg with a range of 
110 - 220mmHg. The mean diastolic aortic pressure was 55 + 12mmHg 
with a range of 30 - 80mmHg. This value was marginally higher than 
reports in the literature (50± 6mmHg, Mann 1975). Fifteen of the 
thirty two patients (47%) had an aortic diastolic pressure > 
60mmHg, but this was not associated with a higher systemic vascular 
resistance (18.2 ± 3.0 versus 16.8 + 3.0 Wood units, p: NS in the 
other 17 patients). It is however consistent with severe aortic 
regurgitation as a major determinant of the amount of regurgitation 
is the pressure difference between the aorta and the left ventricle 
and not the aortic diastolic pressure alone. 
In the subset with an aortic diastolic pressure > 60mmHg, the mean 
aortic pressure was 94 ± 11mmHg (range 83 to 127mmHg). This' was 
appreciably higher than that recorded in the other subset (79 ± 8, 
range 67 to 93mmHg, p < 0.001). The left ventricular end-diastolic 
pressures were the same in the two subsets (19 ± 5 versus 19 + 
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llmmHg p = NS) and thus the aorta to left ventricular pressure 
difference in the subset with the higher aortic diastolic pressure 
was significantly higher (75 ± 15 versus 59+ 9mmHg, p < 0.01). 
Pulmonary Capillary Wedge Pressure: (PCWP) 
The mean resting supine PCWP was elevated at 16 ± 7mmHg with a 
range of 9 to 44mmHg. Thirteen of the 32 patients (41%) had 
abnormal resting values. A reasonably good correlation existed 
between the PCWP measured at cardiac catheterisation and that 
measured during the exercise evaluation (r = +0.72 vide infra). 
Left Ventricular End-diastolic Pressure: (LVEDP) 
The mean LVEDP was elevated at 19 ± 8mmHg and ranged from 8 to 
40mmHg. It was elevated in twenty one of the 32 patients(66%). 
There was a good correlation between the PCWP and LVEDP at cardiac 
catheterisation (r = +0.76). Similarly there was a good 
correlation between the LVEDP at cardiac catheterisation and the 
resting PCWP at exercise evaluation (r = +0.74, vide infra). 
Cardiac Index: 
The group mean cardiac index was normal (3.21 ± 0.92L/min) with a 
range of 1.90 to 6.43L/min. 
2 
Five patients had. a reduced cardiac 
index of < 2.5L/min/m and all these patients had an elevated LVEDP 
(mean 3lmmHg, range 20 to 40mmHg). The correlation between the 
resting cardiac index obtained by the dye dilution technique at 
cardiac catheterisation and that obtained by the thermodilution 
technique during the exercise evaluation was poor (r = +0.37). 
Left Ventricular End-diastolic Volume Index: (LVEDVI). 
2 
The mean EDVI was markedly elevated at 193 + 63ml/M with all but 2 
2 
patients having an EDVI > llOml/M . 
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Table 7.29: CARDIAC CATHETERISATION DATA (SYMPTOMATIC) n = 32: -
PT. AoP AoP PCWP LVEDP CI EDVI ESVI EF RF RF A.R. 
s D A F 
M.A. 140 50 14 20 2.78 200 96 52 67 4+ 
F.A. 140 50 12 16 3.56 202 95 51 48 32 4+ 
R.A. 150 65 10 8 3.63 188 165 '64 65 4+ 
M.B. 160 50 24 28 3.35 269 152 43 59 4+ 
B.B. 140 30 12 14 3.25 236 93 59 66 75 4+ 
R.C. 150 50 18 20 2.42 187 112 40 51 4+ 
D.D. 170 60 16 26 3.80 229 67 70 70 4+ 
MdeV 140 30 12 18 2.54 300 146 50 78 3-4+ 
E.G. 150 50 14 20 3.61 245 109 55 72 4+ 
K.G. 130 50 20 25 2.27 152 58 61 73 4+ 
M.H. 140 60 20 36 2.30 189 109 41 60 4+ 
B.H. 135 55 44 32 1.90 205 113 44 71 3+ 
E.J. 180 50 9 12 3.01 129 49 61 54 52 4+ 
J.L. 110 45 20 24 4.42 282 214 23 23 3-4+ 
N.L. 160 80 22 16 3.73 170 99 41 56 3+ 
R.L. 133 60 7 8 2.50 92 27 69 35 3+ 
M.L. 140 65 34 40 1.90 194 133 31 65 4+ 
S.M. 130 50 11 20 3.02 157 57 63 '63 4+ 
H.M. 180 50 13 16 2.50 3+ 
N.M. 120 70 4 3 2.70 115 33 69 64 3+ 
H.M. 140 60 16 12 3.03 196 126 35 53 3-4+ 
M.N. 130 40 14 16 2.85 237 69 70 77 4+ 
E.N. 140 60 12 26 3.92 166 69 57 44 3-4+ 
J.N. 160 90 14 20 4.36 172 70 59 45 37 3-4+ 
P.N. 140 45 16 20 2.83 212 78 63 76 4+ 
G.N. 155 60 10 12 3.64 371 121 67 82 3+ 
N.P. 130 50 15 14 2.52 234 80 65 80 4+ 
P.P. 150 60 16 28 2.96 99 30 69 39 44 4+ 
MvB 130 60 13 18 2.91 134 68 48 38 3+ 
EvH 140 70 12 12 3.25 142 64 54 47 4+ 
MvW 220 80 14 22 3.61 110 51 54 28 3+ 
H.W. 135 45. 12 15 5.11 222 89 59. 59 4+ 
MEAN 145 55 16 19 3.21 193 88 54 58 4+ 
±_S.D. 21 12 7 8 0.92 63 9 12 16 
AoP = systolic aortic EF = ejection fraction 
s 
pressure 
AoP = diastolic aortic RF = angiographic regurgitant 
d A 
pressure fraction 
PCWP = Pulmonary capillary RFF = electromagnetic flowmeter 
pressure 
regurgitant fraction 
LVEDP = left ventricular AR = angiographic grade of aortic 
end-diastolic pressure regurgitation 
CI = cardiac index EDVI = left ventricular end-
diastolic volume index 
ESVI = left ventricular end-systolic 
volume index 
Left Ventricular End-systolic Volume Index: (LVESVI) _ 
2 
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Twenty eight of the group had an ESVI > 50ml/M . The mean ESVI of 
2 
the group was 88 + 9ml/M . 
• 
Left Ventricular Ejection Fraction: (LVEF) 
The mean value for the group was within the normal range at 54 + 
12%. Only 28% of cases (9 patients) had an abnormal resting LVEF 
of <50%. 
Regurgitant Fraction: 
The mean angiographic regurgitant fraction was 58 + 16% with a 
range of 23 to 82%. Sixteen patients had a regurgitant fraction of 
> 60%. In 4 patients the regurgitant fraction was also measured 
by an electromagnetic flowmeter with a good correlation (r = 
+0.82). 
Degree of Aortic Regurgitation: 
All patients had angiographically severe aortic regurgitation with 
22 patients having 4+ aortic regurgitation and 8 having 3+ 
regurgitation. 
VII.2.3.2 ASYMPTOMATIC GROUP:· (n = 28) 
Aortic Pressure: 
The group mean systolic aortic pressur~ was similar to that of the 
symptomatic group (146 ± 18mmHg) but the mean diastolic aortic 
pressure was significantly higher (62 + l~mmHg, p <0.05). In 
addition the systemic vascular resistance was appreciably lower 
(14.8 ± 3.2 Wood units, range 8.0 to 23.1, p < 0.01). As occurred 
in the symptomatic group, there was no difference in the systemic 
vascular resistance when the group was st~atified according to an 
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aortic diastolic pressure > 60mmHg (15 ± 2.3 v~rsus 14.6 ± 4.5, p = 
NS). Eighteen patients (64%) had an aortic diastolic pressure > 
60mmHg in contrast to 47% of the symptomatic group. 
Nevertheless, this is similarly compatible with haemodynamically 
severe AR with the same explanation as described in the symptomatic 
group (vide supra). The subset with an aortic diastolic pressure> 
60mmHg had a significantly higher aorta to left ventricular 
pressure gradient (80 ± 10mmHg, range 63 to 96mmHg, p < 0.01) than 
that recorded in the subset with tfie lower diastolic pressure (66 ± 
11, range 47 to 81mmHg). As occurred in the symptomatic group LV 
end-diastolic pressures were the same in both subsets (15 + 5 
versus 15 ± 5, p = NS). 
Pulmonary Capillary Wedge Pressure: 
In contrast to the elevated resting PCWP in the symptomatic group 
(16 + 7mmHg), the asymptomatic patients had a normal mean value of 
13 + 3mmHg (p <0.05) and only 4 patients had values above 15mmHg. 
A reasonably good correlation existed between the PCWP and LVEDP 
obtained at catheterisation (r = +0.60). Although in individual 
patients there was a poor correlation between the PCWP measured at 
catheterisation and that obtained at the time of the exercise 
evaluation (r = +0.23), the group ranges were similar. 
Left Ventricular End-diastolic Pressure: 
The range of LVEDP in this group was 6 to 28mmHg with an upper 




number of patients with abnormal PCW pressures (4 
13 patients (46%) had abnormal supine LVEDPs with a 
16 to 28mmHg. Importantly, a reasonable correlation 
existed between the PCWP at exercise evaluation and the LVEDP 
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measured at cardiac catheterisation (r = +0.52). 
Cardiac Index: 
The mean cardiac index was appreciably higher than in the 
2 
symptomatic group (3.86 ± 0.54 versus 3.20 + 0.92L/min/m , p 
2 
<O.Ol). No patients had a reduced cardiac index(< 2.5L/min/m ). 
As in the symptomatic group, there was a poor correlation between 
·resting cardiac index obtained by the dye dilution and 
thermodilution techniques (r = +0.15). 
Left Ventricular End-diastolic Volume Index: 
2 
The mean LVEDVI was 194±lllml/M which is similar to that in the 
2 
sypmtomatic group (193±63ml/M ), with all patients having an LVEDVI 
2 
> llOml/M . 
Left Ventricular End-systolic Volume Index: 
2 
The LVESVI ranged from 43 to 164ml/M with a mean of 
This value was significantly higher than that in the 
2 
group (88±9ml/M, p <0.01). 




The mean LVEF in this group was normal at 56 ± 9% with a range of 
32 to 71%. Only 5 patients (18%) had a reduced LVEF < 50% in 
contrast to 9 patients in the symptomatic group. 
Regurgitant Fraction: 
The angiographic ·regurgitant fraction was lower than in the 
symptomatic group (p <0.05), ranging from 23 to 81% with a mean 
value of 49 ± 13%. In contrast to half the patients in the 
symptomatic group, only 5 patients (18%) had a regurgitant fraction 
of > 60%. In 8 patients the regurgitant fraction was also measured 
using the electromagnetic flowmeter technique with 5 out of 8 
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having a good correlation (mean angiographic 49% VS mean 
electromagnetic flowmeter 47% r = +0.85). 
Degree of Aortic Regurgitation: 
Similarly all patients had angiocardiographically defined severe 
aortic regurgitation with all but 5 patients having 4+ aortic 
regurgitation. These patients had 3+ regurgitation. 
Table 7.30: CARDIAC CATHETERISATION DATA (ASYMPTOMATIC) n. =- 28 
PT. AoPS AoPD PCWPLVEDP CI EDVI ESVI EF RFA RFF A.R~ 
S.A. 155 70 10 14 4.17 162 73 54 30 20 3+ 
L.A. 140 60 10 10 3.54 244 96 50 50 4+ 
S.A. 115 35 14 15 3.21 225 119 47 50 4+ 
M.B. 160 70 14 10 4.70 3-4+ 
S.C. 115 65 10 10 3.96 137 60 55 44 25 3+ 
A.C. 150 55 15 14 3.09 304 96 68 81 4+ 
G.D. 170 80 15 22 3.76 142 62 55 37 4+ 
D.D. 135 65 14 20 3.97 196 76 60 54 4+ 
H.H. 140 45 11 16 3.36 166 68 59 47 3-4+ 
p. J. 140 60 11 14 3.36 136 60 55 52 4+ 
J.J. 170 80 14 18 4.31 220 70 67 61 3-4+ 
K.K. 130 40 15 14 5.41 200 63 69 58 4+ 
G.M. 125 55 9 8 4.44 140 61 56 23 3+ 
P.M. 160 50 8 6 3.06 189 80 56 65 3-4+ 
F.N. 180 60 16 16 4.20 237 133 44 60 60 4+ 
N.O. 145 70 12 10 3.88 155 66 57 48 4+ 
M.P. 160 75 13 12 4.13 175 82 52 53 61 4+ 
J.P. 160 65 12 22 3.79 152 58 61 28 25 3-4+ 
I.R. 160 60 20 28 3.40 233 156 32 48 3i 4+ 
S. R. 140 50 16 22 3.44 161 45 71 58 50 4+ 
w.s. 160 70 9 12 4.51 183 72 60 46 4+ 
T.S. 125 55 10 16 3.92 258 135 46 54 4+ 
A.T. 140 55 13 14 3.67 252 99 61 74 4+ 
Sv/dS 150 60 9 20 3.70 233 108 53 52 3+ 
L.V. 150 50 13 20 3.55 267 164 38 46 4+ 
c.v. 105 60 10 12 3.25 135 43 68 36 3+ 
D.V. 155 90 19 16 3.99 165 73 55 28 3-4+ 
A.W. 130 70 11 12 6.42 119 54 53 28 4+ 
MEAN 146 62 13 15 3.86 194 111 56 49 4+ 
±.SD 18 13 3 5 o. 54 47 12 9 13 
VII 2. 3. 3 SUMMARY 
1. The mean aortic diastolic pressure was higher than the reported 
literature with 47% of the symptomatic patients and 64% of the 
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asymptomatic group having an aortic diastolic · pressure > 
60mmHg. However, as explained, this finding is nevertheless 
compatible with haemodynamically severe chronic aortic 
regurgitation. 
2. A moderately good correlation was found between the LVEDP at 
cardiac catheterisation and the resting PCWP measured with a 
Swan-Ganz catheter at the exercise evaluation (symptomatic 
group r = 0.74, asymptomatic group r = 0.52). 
3. A poor correlation excisted between the cardiac index meas~red 
by the dye dilution technique at cardiac catheterisation and by 
thermodilution at the exercise study. 
4 .. The EDVI was significantly increased in both 
2 
(symptomatic 193 + 63, asymptomatic 194 ± lllml/m • 
groups 
5. The LVEF determined by angiography and by ERNA were similar in 
the two groups. 
6. Angiographic severe aortic regurgitation and normal coronary 
angiography was present in all patients. 
VII.3.0 EARLY POSTOPERATIVE EVALUATION: 
Twenty-two(22) symptomatic patients underwent aortic valve 
replacement. The choice of prosthetic heart valve was influenced 
by the ability of the patient to take anticoagulant therapy and not 
by the ~ge of the patient, as the majority of our patients 
undergoing aortic valve replacement for chronic severe aortic 
regurgitation are in the younger age group < 40 years (mean 33 + 14 
years), where bioprostheses are contraindicated because of 
premature degeneration. The final decision on prosthesis choice 
was at the discretion of the surgeon. 
In only twelve patients were mechanical devices inserted, using the 
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St Jude Medical tilting disc pyrolite prosthesis. Three patients 
had size 23mm, 7 patients size 25mm and 2 patients size 27mm aortic 
valve replacements. 
Eleven patients had bioprosthetic devices inserted:· 8 Hancock (3 
size 23mm, 2 size 25mm, 3 size 27mm) and 3 Mitroflo bovine 
pericardia! valve (size 25mm) replacements. 
There were no operative deaths. One patient died suddenly on the 
17th postoperative day secondary to poor intra-operative 
myocardial protection and subsequent severe postoperative left 
ventricular dysfunction. A second patient died suddenly 2 months 
after operation and a third died at 6 months of the complications 
of infective endocarditis. The two late deaths occurred in 
patients with significant pre-operative cardiomegaly and a DED of 
9.7cm and 6.8cm and a DES of 7.7cm and 5.8cm re~pectively. In 
addition they had evidence of reduced left ventricular systolic 
function with a fractional shortening of 21% and 15% and respective 
resting LVEFs of 42% and 34%. Interestingly, and rather sadly, the 
second patient (DED 6.8cm, DES 5.8cm, FS 16%, LVEF 34%) had near 
normalised his echocardiographic dimensions at 6 months 
postoperatively (DED 6.2cm, DES 4.0cm) and had normal resting 
systolic function (FS 35%, LVEF 55%). 
Sixteen of this group of patients had adequate early 
echocardiograms and resting ERNAs performed 
postoperative day. Table 7.31 details these 
postoperative 
on the lOth 
results. The 
individual pre-operative values are in subscript brackets. 
VII.3.l LV DIMENSIONS 
Pre-operatively, all 16 patients had echocardiographic evidence of 
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LV enlargement; the average LV DED was 7.4 ± l.lcm. Five patients 
had marked LV dilatation with an LV DED > 8.0cm (range 8.3 to 
9.7cm). The mean LV DES was 5.1 + l.lcm with 6 patients having a 
LV DES> 5.5cm (range 5.5 to 7.7cm). 
Aortic valve replacement resulted in a significant early reduction 
in mean LV DED to 5.8 ± 1.3cm (p <0.01) with a variable response in 
the 5 patients with marked dilatation - in this subgroup the 
percentage decrease in DED varied from 6 to 35%. When indexed for 
body surface area, this value of 5.8 + 1.3cm falls at the upper 
limit of normal at 3.4 ± 0.7cm and in the compensated range for 
chronic aortic regurgitation. 
The group mean LV DES similarly decreased but less markedly from 
5.1 + l.lcm to 4.7 + 1.4cm, p = NS. However, in 4 of the 6 
patients with an LV DES > 5.5cm this dimension increased in the 
early postoperative period. The value of 4.7 ± 1.4cm, when indexed 
2 
for body surface area, is 2.8 ± 0.7cm/M which falls into the 
2 
decompensated range for chronic aortic regurgitation (> 2.6cm/M ). 
VII.3.2 LV MASS AND R/TH RATIO 
All but one of this group of patients had significant pre-operative 
left ventricular hypertrophy as determined by the echocardiographic 
measurement of cross sectional area (CSA). The mean value was 33 + 
2 2 
8cm with a range of 19 to 48cm . 
The mean R/Th ratio of 3.3 ± 0.8, used as an index of the volume to 
mass ratio, was in the normal range in the majority, with only 3 
patients having values of > 4.0 (i.e in the decompensated range 
implying inadequate LV hypertrophy). Two of these 3 patients had 
considerable LV dilatation with a DED of 9.7cm and 8.4cm 
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respectively. 
Early postoperatively there was no significant change in CSA (33 + 
2 
8 to 29 + 7cm ). 
VII.3.3 LV SYSTOLIC PERFORMANCE: 
The mean pre-operative fractional shortening (FS) for the group was 
31 + 8% which is in the normal range, signifying compensated 
chronic aortic regurgitation. However, 5 patients had an 
abnormally low FS < 25%. Paradoxical septal motion precluded 
calculation of FS in the early postoperative period. 
Pre-operative group mean resting left ventricular ejection fraction 
(LVEF) as measured by equilibrium radionuclide angiocardiography 
was at the lowe~limit of normal (51± 13%) and in 6 patients the 
LVEF was between 40 and 50% and in 2 patients it was considerably 
reduced to < 40%. There was a uniform but insignificant drop in 
early postoperative LVEF in all but 5 patients, to a mean value of 
44 + 18%. This phenomenon does not represent a true decrease in 
contractility, but merely reflects altered loading conditions on 
the left ventricle. 
VII 3.4 SUMMARY OF EARLY POSTOP DATA 
1. There was a significant decrease in DED early postop except in 
the 5 patients with marked LV dilatation where the response was 
variable. 
2. The end-systolic dimension similarly decreased but not in the 
subset of patients with a DES > 5.5cm. 
3. Regression of LV hypertrophy was not seen early following 
aortic valve replacement. 
4. Most patients had a marginal drop in LVEF early' postop, 
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probably reflecting altered loading conditions on the LV rather 
than reduced contractility. 
Table 7.31: EARLY POSTOPERATIVE 1lQ DAYS) ECHOCARDIOGRAMLERNA DATA 
(n = 16) 
ECHOCARDIOGRAM ERNA 
PT DED DEDI DES DES! FS R/Th ws CSA LVEF 
MB 7.8 3.9 6.5 3.3 3.9 700 28 26 
( 9 • 7 ) ( 4. 9) ( 7 . 7 ) ( 3. 9) ( 21) ( 4 • 4 ) (1004) ( 3 7) (42) 
BB 5.4 3.4 4.2 2.6 1.3 189 46 50 
( 8. 3) ( 5 . 3 ) ( 5. 0) ( 3 • 2 ) (40) ( 3. 5) (588) ( 36) ( 6 5) 
RC 7 .o 3.5 6.1 3.1 2.9 350 31 31 
( 8. 4) ( 4 . 2 ) ( 5 . 5 ) ( 2. 8) ( 34) ( 4. 2) (651) (29) (44) 
MdV 4.2 2.8 3.4 2.3 1.2 149 31 45 
( 7. 0) ( 4 . 7 ) ( 4 . 4 ) ( 3. 0) ( 3 7) ( 2 • 2 ) (306) (43) ( 7 4) 
EG 4.8 3.2 3.6 2.4 1.3 180 37 44 
( 7 • 7 ) ( 5 . 1 ) ( 5. 0) ( 3. 3) ( 35) ( 3 . 5 ) (560) (30) (41) 
KG 5. 0 2.5 3.8 1.9 2.1 271 23 70 
( 6. 0) ( 3 . 1 ) ( 4. 0) ( 2. 0) ( 33) ( 1. 9) (300) (38) (59) 
MH 7.5 3.5 6.5 3.0 3.1 438 33 20 
( 8. 6) ( 4. 0) ( 6. 0) ( 2. 8) (30) (2.9). (401) (48) (43) 
· BH 5.8 3.4 4.6 2.7 2.6 343 24 33 
( 6. 7) ( 3 . 9 ) ( 5. 0) ( 2 . 9 ) (25) ( 3 .1) (475) ( 33) (50) 
JL 8.1 5. 0 7.2 4.4 4.5 518 25 31 
( 8. 6) ( 5 . 3 ) ( 6 . 7 ) ( 4 • 1 ) (22) ( 3 • 3 ) . ( 430) (40) (42) 
NL 6 .o 3.8 5.0 3.2 2.5 325 27 24 
( 7 . 4 ) ( 4. 7) ( 5. 6) ( 3. 5) ( 24) ( 3. 7) (592) ( 26) ( 33) 
ML 7.3 4.2 5.9 3.4 3.6 511 26 31 
( 6 . 8 ) ( 4. 0) ( 5. 8) ( 3 • 4 ) (15) ( 4. 2) (595) (19) (34) 
SM 3.8 2.5 3.0 2.0 1.6 190 19 82 
( 6. 2) ( 4 .1) ('3.7) ( 2 . 4 ) (40) ( 3 .1) (465) ( 23) (74) 
HM 5.8 3.7 4.8 3.1 2.7 375 24 43 
( 7. 2) ( 4 . 6 ) ( 5. 2) ( 3 . 3 ) (28) ( 3. 0) (450) (32) (57) 
NP 5.7 3.8 4.0 2.6 1.9 343 33 63 
( 6 . 6 ) ( 4 . 4 ) ( 4. 7) ( 3 .1) (29) ( 2. 2) (330) ( 38) (49) 
EvH 4.9 3 .o 2.5 1 .. 5 1.5 184 33 68 
( 6 . 7 ) ( 4. 0) ( 4. 4) ( 2 • 7 ) (34) ( 3. 9) (663) (28) (52) 
MvW 4.3 2.8 3.8 2.5 40 
( 5 . 9 ) ( 3 . 8 ) ( 3 • 5 ) ( 2 • 3 ) (41) ( 2 • 5 ) (435) ( 27) (62) 
MEAN5.8 3.4 4.7 2.8 21 2.5 331 29 44 
±S.Dl.3 0.7 1.4 o. 7 9 1.0 157 7 18 
( 7 . 4 ) ( 4 . 4 ) ( 5 . 1 ) ( 3. 0) ( 31) ( 3. 3) (521) ( 33) (51) 
( 1.1) ( 0. 6) ( 1.1) ( 0. 6) ( 8) ( 0. 8) (180) ( 8) ( 13) 
) = Pre-operative values. 
VII.4.0 SIX MONTH POSTOPERATIVE EVALUATION: 
Of the 22 symptomatic patients who underwent technically successful 
aortic valve replacement, 19 patients were re-evaluated at 6 months 
180 
postoperatively. This assessment included an evaluation of their 
clinical status, echocardiographic dimensions and systolic function 
and exercise testing including haemodynamic monitoring and 
simultaneous equilibrium radionuclide angiocardiography. 
catheterisation was not performed. 
VII.4.l CLINICAL STATUS: 
VII.4.l.l Functional Class: 
Cardiac 
All but 3 patients were asymptomatic and in NYHA functional Class I 
at re-assessment. Two of these patients had mild Class IIA 
symptoms and one patient had a one month history of symptoms of 
congestive heart failure (Class IV), clinical features of infective 
endocarditis together with a leaking Hancock aortic valve 
prosthesis. Thus 84% of the survivors of aortic valve replacement 
had a normal effort tolerance and 2 of the 3 mildly symptomatic 
patients had improved by one functional class. One death occurred 
in each of the groups of patients in pre-operative functional class 
II, III and IV. 
VII.4.1.2 Left Ventricular Hypertrophy on Electrocardiogram: 
All patients had significant left ventricular hypertrophy with 
repolarisation change as assessed by the Sokolow Lyon index with a 
mean value of 70 + 22mm. Following successful aortic valve 
replacement (AVR) there was a significant decrease in the ECG 
indices of left ventricular hypertrophy to 52 ± 15mm and 3 patients 
had no electrocardiographic evidence of hypertrophy at this 
assessment. The degree of pre-operative LV hypertrophy was not 
predictive of normalisation. 
181 













Seventeen of the 19 patients demonstrated a reduction in cardio-
thoracic ratio with the mean value falling from 0.60 ± 0.05 to 0.53 
+ 0. 05. In 9 patients (47%) there was a normalisation of the 
cardio-thoracic ratio, and a further 5 patients had a ratio of 
between 0.50 and 0.55. 
In the two patients with no change in cardio-thoracic ratio, one 
had a normal LV DED on the echocardiogram, but the second had 
persistent LV dilatation with a DED of 6.9cm. Normalisation of 
cardio-thoracic ratio was usually (8 out of 9) associated with a 
182 
normal LV DED. 
VII.4.2 ECHOCARDIOGRAPHY: 
The table (7.32) on the following page summarises the effect of 
aortic valve replacement on LV volume, mass and systolic function 
at the 6 month postoperative evaluation. 
VII.4.2.1 LV Dimensions 
The mean pre-operative LV DED was 7.1 ± 0.9cm with a range of 6.0 
to 8.6cm. Four patients (22%) had marked LV dilatation with an LV 
DED > 8.0cm. The mean LV DED fell early postoperatively to 5.8 ± 
1.3cm and showed a continued reduction to a value of 5.0 ± l.Ocm at 
6 months, p <O.Ol, i.e. to within the normal range of < 5.3cm for 
our laboratory. Three out of the 4 patients with severe pre-
operative LV dilatation (LVDED > 8.0), had persistent LV dilatation 
postoperatively (8.3 + 0.3 to 6.8 + 0.4cm), confirming that this 
measure is an indicator of a poor prognosis. However, as 
previously described, it usually only occurs in a small number of 
patients (4 in my series). 
The mean LV DES decreased marginally from 4.9 + 0.8 to 4.7 ± 1.4cm 
early postoperatively, but there was a significant reduction to 3.5 
+ l.lcm at 6 months (p <0.01). 
Of the 7 patients with a pre-operative DES > 5.5cm, 2 patients were 
not evaluated at 6 months following valve replacement surgery. One 
patient (R.A.) was lost to follow-up and a second patient with 
marked pre-operative LV dilatation (M.B. - DED 9.7cm, DES 7.7cm) 
died suddenly 2 months after technically successful aortic valve 
replacement. Four of the remaining 5 patients (80%) in this subset 
showed a significant reduction in DES (6.0 ± 0.5 to 4.0 ± 0.6cm, p 
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<0.01). In this sub-group of patients, 60% (3 of 5) also had 
marked pre-operative LV enlargement with a LV DED of > 8.0cm, but 
2 out of the 3 showed a marked reduction in LV DED (8.6cm to 5.4cm; 
8.6cm to 6.4cm) with a significant improvement in LV DES (6.0cm to 
3.5cm; 6.7cm to 4.9cm). Appreciating the small sample size, these 
results are nevertheless at variance with the presently held 
opinion· that a pre-operative LV DES > 5.5cm predicts a poor 
postoperative outcome. 
Table 7.32: SIX MONTH POSTOPERATIVE ECHOCARDIOGRAM: (n = 18) 
DED DES FS R/Th ws CSA 
Pre- Post Pre- Post Pre- Post Pre- Post Pre- Post Pre- Post 
FA 7.6 5.0 4.9 4.3 35 14 2.5 2.1 456 292 43 23 
RC 8.4 7.2 5.5 6.8 34 5 4.2 3 .o 651 390 29 32 
MdeV7.0 3.8 4.4 1.9 37 50 2.2 1.3 306 152 43 25 
EG 7.7 4.8 5 .o 3.2 35 33 3.5 1.6 560 224 30 30 
KG 6.0 4.7 4.0 2.7 33 42 1.9 1.6 300 204 38 29 
MH 8.6 5.4 6.0 3.5 30 35 2.9 1.9 401 270 48 17 
JL 8.6 6.4 6.7 4.9 22 23 3.3 2.9 430 347 40 29 
NL 7.4 5.1 5.6 3.6 24 29 3.7 2.6 592 332 26 19 
ML 6.8 6.2 5.8 4.0 15 35 4.3 2.8 595 395 19 18 
SM 6.2 4.2 3.7 2.5 40 40 3.1 2.3 465 280 23 14 
HM 6.0 3.3 3.7 2.3 38 30 3 .o 1.7 570 248 22 13 
HM 7.2 4.5 5.2 3.2 28 28 3 .o 2.1 450 286 32 19 
JN 6.2 4.5 4.2 3.5 32 22 3.4 2.2 482 263 20 17 
PN 8.0 6.9 5.3 4.3 33 38 3.3 2.9 467 546 35 30 
GN 7. 0 4.5 5 .o 3 .o 29 33 2.9 1.9 525 206 31 21 
NP 6.6 4.8 4.7 3.2 29 33 2.2 2.4 330 264 38 12 
MvB 6.2 4.9 4.6 3.5 25 25 3.1 2.2 465 301 23 21 
EvH 6.7 4.4 4.4 3 .o 34 32 4.0 1.8 663 220 28 21 
MEAN7.1 5 .o 4.9 3.5 31 30 3.1 2.2 484 290 32 22 
±SD 0.9 1.0 0.8 1.1 6 5 0. 7 1.5 109 90 9 6 
VII.4.2.2 LV Mass and R/Th Ratio 
As mentioned previously, all but one patient had significant left 
ventricular hypertrophy as measured by echocardiographic cross 
2 
sectional area (CSA), with a mean value of 32 ± 9cm and a range of 
. 2 
19 to 48cm . There was a significant decrease in cross sectional 
area at the 6 month postoperative assessment, with a mean value for 
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2 
the group of 22 + 6cm , p <O.Ol. ' Eight patients(44%) normalised 
their LV mass, and the pre-operative degree of left ventricular 
hypertrophy measured echocardiographically was not predictive: 50% 
of the sub-group with severe left ventricular hypertrophy p~e-
operatively normalised their LV mass postoperatively (mean 36 + 9 
2 
to 17 ± 3cm ), 
The mean pre-operative R/Th ratio was in the normal range at 3.1 ± 
0.7 with only 3 patients having inadequate hypertrophy for the 
degree of LV dilatation and falling in the decompensated range for 
chronic aortic regurgitation (> 4.0). However, at 6 months 
postoperatively, all patients had a normal volume to mass ratio as 
reflected by a mean R/Th of 2.2 ± 1.5, p <0.05. 
VII.4.2.3 LV Systolic Performance: 
Appreciating that paradoxical septal motion significantly 
interferes with and invalidates the calculation of fractional 
shortening (%FS) postoperatively, there was nevertheless no change 
in FS from a pre-operative value of 31 ± 6% to 30 ± 5% at 6 months 
postoperatively. In only 4 patients was there an obvious decrease 
in fractional shortening, with significant paradoxical septal 
motion seen in 3 of this group. However, fractional shortening 
appeared to be a poor indicator of postoperative systolic function 
when compared to equilibrium radionuclide angiocardiography. 
VII.4.3 EXERCISE EVALUATION: 
The pre- and postoperative exercise evaluation included resting and 
peak exercise haemodynamic and equilibrium radionuclide 
angiocardiogra~hic (ERNA) data in path the supine and semi-erect 
postures, during both isotonic (bicycle) and isometric (handgrip) 
/ 
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exercise. It will be discussed and tabulated in the following 
way:-
VII.4.3.1 Pre-operative supine rest and peak exercise haemodynamic 
and ERNA data (PRE-OP SUPINE) 
VII.4.3.2 Postoperative supine rest and peak exercise haemodynamic 
and ERNA data (POSTOP SUPINE) 
VII.4.3.3 Pre-operative and postoperative supine 
haemodynamic and ERNA data at equivalent 
(POSTOP SUPINE EWL). 
exercise 
workload 
VII.4.3.4 Pre-operative erect rest and peak exercise haemodynamic 
and ERNA data (PRE-OP ERECT) 
VII.4.3.5 Postoperative erect rest and peak exercise haemodynamic 
and ERNA data (POSTOP ERECT) 
VII.4.3.6 Pre- and postoperative isometric exercise haemodynamic 
and ERNA data (SUPINE ISOMETRIC) 
VII.4.3.1 PRE-OP SUPINE 
The results in Table 7.33 have been reported in the symptomatic 
group as a whole (see sections VII.2.2.1A and VII.2.2.2A) and are 
summarised as follows:-
1. Resting haemodynamics were similar to the asymptomatic group 
but in the symptomatic patients:-
SBP was higher (157 + 18 versus 137 ± 15mmHg, p < 0.01). 
16% of this group had a reduced resting cardiac index versus 
no asymptomatic patients. 
67% had an elevated PCWP versus 57% of the asymptomatic 
group. 
2. The mean resting LVEF was 57 + 11% but 29% had a reduced LVEF < 
50%. 
3. Resting peak and average diastolic filling rates were abnormal 
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with a significantly reduced PFR (p <0.01) but an only 
marginally reduced ADFR (p = NS). 
4. The maximal external workload completed during supine bicycle 
exercise was 423 ± 158k-pm/min and the limiting symptom was 
shortness of breath. 
5. Exercise haemodynamics were abnormal with a marked elevation in 
PCWP to 30 ± 11mmHg. 
6. Most symptomatic patients had an abnormal LVEF response to 
supine bicycle exercise. However, in the small subset with a 
normal LVEF response, this occurred over a wide range of 
resting values. 
7. Diastolic function was abnormal in all patients on exercise. 
Table 7.33: PRE-OPERATIVE RESTING AND PEAK EXERCISE HAEMODYNAMIC 
AND ERNA DATA: (SUPINE ISOTONIC)(n = 19) *Group 1A -------\-
HR 
R Ex 
FA 68 165 
*RC 75 110 
*MdV 80 140 
*EG 100 142 
*KG 100 130 
MH 84 160 
(150) 
BH 86 122 
*JL 80 140 
NL 120 170 
ML 100 160 
SM 88 150 
HM 70 148 
NM 100 170 
HM 78 175 
(160) 
JN 65 180 
*PN 78 144 
GN 65 170 
NP 80 150 
MvB 80 120 
Mean 84 150 




R Ex R Ex 
170 300 2.3 
170 180 2.3 
170 220 3.7 
170 220 3.4 
170 220 2.8 
190 280 3.1 
(270) 
160 2,20 
130 175 3.4 
150 180 3.4 
150 240 1.9 
150 200 3.5 
160 190 1.8 
130 190 4.9 
150 260 3.0 
(250) 
130 170 2.4 
150 210 3.5 
140 210 3.2 
130 160 3.1 
160 210 2.5 
154 212 3.0 






























































































































VII.4.3.2 POSTOP SUPINE: 
These results, including the equivalent workload data, are 
summarised in table 7.34 overleaf. 
Heart Rate 
The group mean heart rate at rest and on peak exercise was 
unchanged. Fewer patients (2 as opposed to 5) had a resting 
tachycardia at the time of the postoperative study. 
Systolic Blood Pressure 
The mean resting systolic blood pressure was slightly lower at 138 
± 23mmHg, p = NS. Three patients ·showed an increase in systolic 
blood pressure (157 + 12 to 180 + 13mmHg), At peak exercise 
systolic blood pressure rose appropriately (mean 189 + 27mmHg), but 
was significantly lower than pre-operatively (p <0.05). 
Cardiac Index 
The group mean resting cardiac index was similar to the pre-
2 
operative value (3.1 ± 0.5 versus 3.0 + 0.7L/min/M ), and only 1 
patient (compared to 6 patients pre-operatively) had a reduced 
cardiac index. This patient had a markedly reduced pre-operative 
2 
value of 1.8L/min/M . At peak exercise, there was a significant 
2 
increase in cardiac index to 7.0 ± 1.5L/min/M (p <0.01), which was 
2 
similar to the pre-operative value of 6.7 ± 2.3L/min/~. 
Pulmonary Capillary Wedge Pressure(PCWP) 
The mean postoperative resting PCWP was normal at 14 + 4mmHg. 
However, 6 patients(32%) had an elevated PCWP at rest, 3 of whom 
had normal ·pre-operative values. Only one of this subset of 
patients had a reduced resting cardiac index. 
188 
Table 7.34: POSTOPERATIVE RESTING AND PEAK EXERCISE HAEMODYNAMIC AND 
ERNA DATA: (SUPINE ISOTONIC) (n = 19) 
HR SBP CI PFR ADFR 











































































































































Mean 82 157 138 189 3.1 
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7.0 14 26 63 66 2.61 4.55 1.15 2.21 











At peak exercise, the PCWP rose signifcant1y to 26 + lOmmHg (range 
10 to 43mmHg, p <0.01), which was similar to the pre-operative 
value of 30 ± llmmHg. Although only 4 patients(20%) had a normal 
postoperative peak supine exercise PCWP, this is twice the pre-
operative number. 
Left Ventricular Ejection Fraction(LVEF) 
There was a ~light improvement in mean resting supine LVEF to 63 + 
189 
14% compared with 54 ± 13% pre-operatively, p = NS. However, only 
2 patients(lO%) had an abnormal resting value of < 50% which is 
markedly improved from th~ pre-operative number of 8 patients, or 
42% of cases. 
Seven patients (37%) had a pre-operative resting LVEF < 45% with 3 
patients having values of < 40% (N.L. 33%, M.L. 34%, H.M. 40%). 
Two of the three patients in this subset and 3 out of 4 in the 
range 40 to 45% normalised their postoperative resting LVEF. Thus 
it would appear that an abnormal resting LVEF is reversible in the 
majority of patients undergoing successful aortic valve replacement 
despite the degree of pre-operative depression. However, very few 
patients had a markedly reduced resting LVEF < 35% (n = 2) and the 
surgical outcome in this subset remains to be answered. 
At peak exercise there was a marginal increase in LVEF to 66 + 18%. 
However, this value was significantly higher than the pre-operative 
value of 45 ± 15%, p < 0.01. Nine patients (47%) had a. pre-
operative peak exercise LVEF < 40% and included all the patients·(n 
= 7) with a resting LVEF < 45%. In this subset 7 of 9 patients 
(78%) normalised their postoperative resting LVEF and 5 of 8 (63%) 
\ 
had an exercise LVEF > 50%. Thus, although a significantly 
depressed pre-operative exercise LVEF is usually associated with an 
appreciable reduction in resting ejection fraction, it does not 
appear to be a poor. prognostic marker in the assessment of patients 
with chronic severe AR. 
Peak Filling Rate(PFR) 
The resting value increased, albeit non-significantly, to 2.61 ± 
1.05 EDV/sec from the pre-operative value of 2.17 + 0.85 EDV/sec. 
There was a significant increase at peak exercise to 4.55 + 1.66 
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EDV/sec (p <0.01), which is a marked improvement from the pre-
operative value of 3.31 ± 1.41 EDV/sec. This implies a substantial 
improvement in diastolic function postoperatively, as exercise 
heart rates were similar. 
Average Diastolic Filling Rate(ADFR) 
Although the resting postoperative and pre-operative mean values 
were similar (1.15 ± 0.54, EDV/sec versus 1.12 ± 0.42 EDV/sec), the 
peak exercise value of 2.21 ± 0.96 EDV/sec was significantly 
improved from ·the pre-operative value of 1.59 ± 0.81 EDV/sec (p 
<0.01), confirming the improvement in LV relaxation. 
Exercise Capacity 
-
The external workload achieved postoperatively for the group 
improved appreciably from 400 ± 185 to 514 + 155k-pm/min (p 
<0.05)with a range of 250 to 900k-pm/min. This represents 
approximately 3.5 levels or 10.5 minutes of exercise and a 40% 
improvement on pre-operative exercise duration. 
VII.4.3.3 PRE- AND POSTOPERATIVE SUPINE EWL: 
Most of the reported studies in patients with chronic aortic 
regurgitation compare peak exercise variables pre- and 
postoperatively, often at different external workloads. This 
results from a generally improved exercise capacity in the 
postoperative period. As my data was acquired for each level of 
graded supine, symptom-limited bicycle exercise, I am able to 
compare both haemodynamic and ERNA data at equivalent 
workloads(EWL), with the bracketed numbers in the tables 
representing those values. In general, this was one or two levels 
below postoperative peak supine exercise, although in two cases 
191 
pre-operative exercise capacity was better than that achieved 
postoperatively. 
Heart Rate/Systolic Blood Pressure 
In the postoperative period at equivalent external workloads, the 
mean heart rate was lower (134 + 23.vs 149 + 20/min, p <0.05) as 
was systolic blood pressure (179 ± 28 vs 211 + 35mmHg, p <0.01). 
Thus at the same external workload, the rate-pressure product or 
internal workload was also lower (23986 vs 31439). 
Cardiac Index 
2 
Cardiac index, however, was similar at 6.3 ~ 1.6L/min/m and did 
not differ appreciably from the peak supine exercise values noted 
above. 
Pulmonary Capillary Wedge Pressure(PCWP) 
When corrected for equivalent external workload, there was a slight 
decrease in PCWP to 23 ± 9mmHg compared to 26 ~ lOmmHg 





workload was appreciably lower than 





Nevertheless, this resulted in only one further patient (i.e. a 
total of 5 patients) having a normal exercise PCWP. 
Left Ventricular Ejection Fraction(LVEF) 
The pre- and postoperative supine exercise LVEF values at 
equivalent workloads were identical to that at peak exercise (45 + 
15 and 45 + 15 and 65 ± 15 and 66 + 18%). 
Peak Filling Rate/Average Diastolic Filling Rate 
Once again, the values at peak exercise and those at equivalent 
external workloads did not differ significantly:-
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PFR (3.31 + 1.41 to 4.55 + 1.66 versus 3.27 + 1.44 to 4.47 + 1.88 
EDV/sec.) 
ADFR (1.59 + 0.81 to 2.21 + 0.96 versus 1.60 + 0.81 to 1.99 + 0.81 
EDV/sec.) 
In summary, a comparison of pre- and postoperative supine exercise 
haemodynamic and ERNA data at equivalent external workloads, show 
litte change from values at peak supine exercise but confirms that 
at equivalent external workloads, the rate-pressure product is 
considerably reduced postoperatively. 
VII.4.3.4 PRE-OP ERECT: 
The pre-operative erect resting and peak exercise haemodynamic and 
radionuclide data is summarised in Table 7.35 overleaf. The 
resting and peak exercise naemodynamics are similar to those for 
the symptomatic group as a whole although peak exercise cardiac 
2 
index was lower(5.7 ± 2.7 versus 6.8 ± 1.8L/min/M ). In contrast 
both resting and peak exercise radionuclide determined LVEF, PFR 
and ADFR were lower in the subgroup undergoing aortic valve 
replacement when compared to the overall group (see sections 
VII.2.2.2A and VII.2.2.2B). The pre-operative data is summarised 
as follows:-
1. The difference at rest compared to the supine posture can be 
explained by the predictable haemodynamic changes related to 
posture. 
2. Left ventricular ejection fraction was similar in the two 
postures and a reduced resting LVEF was present in both body 
positions in the same patient. 
3. The haemodyanmic response was directionally similar to that 
during supine exercise with the same magnitude of change in 
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cardiac index, but a lower SBP and a slightly lower exercise 
PCWP (22 + 7 versus 30 ± 11mmHg). 
4. Similar. to the supine posture, most symptomatic patients had an 
abnormal LVEF response to erect bicycle exercise. Importantly, 
in the majority of cases the fall in LVEF on exercise occurred 
during both postures. 
5 • Diastolic filling rates were reduced nd similar to those 
' 
obtained during supine exercise. 
Table 7.35: PRE-OPERATIVE RESTING AND PEAK EXERCISE HAEMODYNAMIC 
AND ERNA DATA: (Erect Isotonic) (n = 10) 
HR SBP CI PCWP LVEF PFR ADFR 
R Ex R Ex R Ex R Ex R Ex R Ex R Ex 
FA 82 160 170 260 2. 1 8.0 15 30 56 61 2.99 5.09 1.62 1.58 
RC 78 115 160 190 2.3 3.8 5 13 60 45 1.82 1.46 1.03 0.92 
EG 110 142 150 200 2.4 5.4 4 12 44 32 2.35 2.12 0.87 0.93 
MH 84 160 160 260 1.9 7 .o 41 25 1.86 1.39 0.87 0.67 
JL 90 140 135 190 4.0 8.7 9 20 43 30 l. 95 2.62 l. 25 1.14 
NL 120 165 150 180 2.8 5.5 10 18 40 39 1.76 2.69 0.97 0.89 
ML 98 160 135 220 2 .o 4.6 30 30 36 26 1.66 2.20 0.99 1.07 
SM 92 175 150 220 2.4 6.1 7 26 76 69 
HM 110 190 150 270 2.9 5.8 7 21 59 35 2.41 l. 39 
JN 94 170 130 150 2.7 6.2 5 28 61 68 2.49 4.25 l. 48 2.70 
Mean96 158 147 214 2.6 5.7 10 22 52 43 2.14 2.73 1.16 1.26 
±SD 14 21 11 39 0.6 2.7 8 7 13 17 0.44 1.31 0. 28 o. 71 
VII.4.3.5 POSTOP ERECT: 
The postoperative erect resting and peak exercise haemodynamic and 
radionuclide data is summarised in Table 7.36 overleaf. 
Heart Rate 
The group had a resting tachycardia of 101 ± 16/min with a range of 
72 to 120/min. This was slightly higher than the pre-operative 
rate of 96 ± 14/min. At_ peak exercise the heart rate increased to 
161 + 18/min which was similar to that achieved in the pre-
operative study (158 ± 18/min). In comparison to the postoperative 
supine study, the resting heart rate was significantly higher (101 
194 
versus 82/min), but the heart rate achieved at peak exercise 
(equivalent external workloads) was similar (161/min versus 
157/min). 
Table 7.36 POSTOPERATIVE RESTING AND PEAK EXERCISE HAEMODYNAMIC 
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MeanlOl 161 134 178 2.9 7.4 8 20 71 71 3.22 4.65 1.46 2.16 
±SD 16 18 11 23 0.6 2.0 3 9 17 19 0.94 1.83 0.41 0.75 
, Systolic Blood Pressure 
The mean resting SBP fell marginally by 13mmHg from 147 + llmmHg 
pre-operatively to 134 ± 19mmHg at 6 months postoperatively (p = 
NS). This value was similar to the resting supine postoperative 
value of 138 ± 23mmHg. There was a significant increase in SBP at 
peak exercise to 178 + 23mmHg (p <0.01) which was appreciably lower 
than the pre-operation mean of 214 + 39mmHg (p <0.01). Because of 
the higher resting heart rate, the rate-pressure product (RPP) at 
rest in the erect posture was higher than in the supine posture 
(13534 vs 11316), but at peak exercise the values were similar 




Cardiac index rose from a resting level of 2.9 ± 0.6L/min/M 
2 




had a reduced postoperative resting cardiac index of < 2.5L/min/M 
compared to 60% of the patients pre-operatively. However, the mean 
2 
values at rest were similar at 2.9 ± 0.6 vs 2.6 + 0.6L/min/M • In 
contrast, the cardiac index at peak exercise was appreciably higher 
' 2 
(7.4 + 2.0 versus 5.7 ± 2.7L/min/M , p <O.Ol) but at a higher 
external workload (514 + 155 vs 400 ± 185k-pm/min). These results 
are similar to those recorded during supine exercise. 
Pulmonary Capillary Wedge Pressure(PCWP) 
All patients had a normal postoperative erect resting PCWP with a 
mean of 8 ± 3mmHg. At peak exercise, this increased to 201 ± 9mmHg 
but 44% of patients had a normal exercise PCWP, which is twice the 
pre-operative number. Nevertheless, the pre- and postoperative 
mean values at rest (10 ± 8 and 8 ± 3mmHg) and peak exercise (22 + 
7 and 20 ± 9mmHg) were similar. This is in contradistinction to 
the postoperative supine PCWP where despite the mean resting value 
decreasing from 17 ± 9 to 14 + 4mmHg, one third of patients had an 
abnormal PCWP at rest. In addition, the peak exercise PCWP was 
higher at 26 ± lOmmHg(compared to 20 ± 9mmHg), with only 22% (i.e. 
half the erect number) having a normal peak exercise PCWP. Thus, 
although in the erect posture the mean pre- and postoperative PCWP 
remained essentially unchanged, all patients normalised their 
resting PCWP postoperatively and twice the pre-operative number 
normalised their peak exercise PCWP. In contrast, during supine 
exercise, one third (33%) still had an abnormal postoperative 
resting PCWP, with only 22% having a normal peak exercise value 
(half the number during the erect posture). 
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Left Ventricular Ejection Fraction(LVEF) 
The resting postoperative LVEF in the erect posture improved 
markedly from 52 ± 13 to 71 ±17% (p <O.Ol) with a range of 22 to 
91%. Only 2 patients(ll%) had an LVEF < 50% compared to half the 
patients pre-operatively. This value is also higher than the 
postoperative mean of 63 ± 14% during supine exercise. 
The LVEF remained unchanged at peak exercise (71 + 19%, range 14 to 
94%) which is slightly higher than during supine exercise (66 + 
18%). Only 2 patients had an abnormally low exercise LVEF, both 
these patients having an abnormal resting value. This is in marked 
contrast to the pre-operative period where the majority (70%) had a 
significantly reduced peak exercise LVEF (mean 33 ± 7%, range 25 to 
45%). One third of this group (6 patients) had a normal functional 
reserve, with -7 patients having an equivocal response (LVEF 
remained unchanged) and only 5 patients having an abnormal 
response. Interestingly, 4 of the 5 patients with an abnormal 
response and 5 of the 7 patients with an equivocal response had a 
resting postoperative LVEF of> 70% (74 ± 5% and 81 + 8%). It has 
been suggested that in patients with a resting LVEF > 70% there may 
be no further increase in LVEF on exercise. 
Peak Filling Rate(PFR) 
In the postoperative evaluation, the erect rest PFR increased 
significantly from 2.14 ± 0.44 to 3.22 ± 0.94 EDV/sec (p <0.05)i 
representing a 50% improvement. At peak exercise there was an 
even greater 70% improvement from the pre-operative value of 2.73 ± 
1.31 to 4.65 ± 1.83 EDV/sec (p <0.01), implyihg a substantial 
improvement in both resting, and exercise diastolic function. 
Although the supine resting value postoperatively was appreciably 
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lower, the peak exercise value is similar (4.55 + 1.66 vs 4.65 + 
1.83 EDV/sec). 
Average Diastolic Filling Rate(ADFR) 
Similarly, there was an improvement in both the resting and peak 
exercise average diastolic filling rates from a pre-operative 
resting mean of 1.16 + 0.28 to 1.45 + 0.41 EDV/sec (26% 
improvement, p = NS) and a more marked 71% peak exercise 
improvement from 1.26 + 0,71 to 2.16 ±·0.75 EDV/sec (p <O.Ol). 
Although the resting supine postoperative mean of 1.15 + 0.54 
EDV/sec was substantially lower than the rest erect value (vide 
supra), the peak exercise results were also similar (2.21 ± 0.96 vs 
2.16 + 0.75 EDV/sec.). 
Exercise Capacity 
The improvement in external workload achieved postoperatively is 
the same as during supine exercise (vide supra). 
VII.4.3.6 SUPINE ISOMETRIC 
The isometric handgrip exercise data will compare the haemodynamic, 
ejection fraction and diastolic filling rate responses pre- and 
postoperatively and is summarised in Table 7.37. The workload 
achieved during each evaluation was essentially unchanged (28 ± 5 
and 2 9 + 5 l b ) . 
Heart Rate 
There was a slight diminution in exercise heart rate between the 
pre- and postoperative studies (90 ± 16 to 81 ± 12/min, p = NS). 
Although there was a slight increase in exercise heart rate from 




LVEF response to isometric exercise from a mean pre-operative value 
of 52 + 14% to 63 + 15% postoperatively, this occurred parri passu 
with the improved resting LVEF (54 ± 13 to 63 + 14%). In the 
overwhelming majority(93%) of pre-operative studies, the LVEF 
remained unchanged from the resting value. In the postoperative 
period the majority 72% also remained unchanged with 2 
patients(ll%) having a normal functional reserve and 3 patients 
(17%) a fall in exercise LVEF. 
Table 7.37: PRE- AND POSTOPERATIVE HAEMODYNAMIC AND ERNA DATA: 
(Supine Isometric) (n = 14; n = 18) 
HR SBP CI PCWP LVEF PFR ADFR. 





































































































Mean90 81 169 149 3.1 3.2 













































































































52 63 2.16 2.51 1.16 1.11 
14 15 0.73 l.58 0.48 0.46 
Peak Filling Rate/Average Diastolic Filling Rate 
Although a small (16%) but insignificant increase occurred in PFR 
during handgrip exercise from 2.16 ± 0.73 pre-operatively to 2.51 ± 
1.58EDV/sec postoperatively, the ADFR remained essentially 
unchanged (1.16 + 0.48 and 1.11 ± 0.46 EDV/sec). 
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VII 4.4 SUMMARY OF SIX MONTH POSTOP DATA 
1. Excellent symptomatic relief was noted following aortic valve 
2. 
replacement, with most patients in NYHA class I • 
2 
Regression of LVH was complete (CSA < 20cm ) or near-complete 
2 
(CSA < 24cm ) in the majority of patients (12/18). By 
discriminant analysis, regression of LVH could be accurately 
predicted by the following non-invasive variables:-
( i ) 




DED < 7.0cm 
2 
CSA < 30cm 
Resting LVEF > 50% 
Maximum exercise HR > 148/min. 
Exercise SBP > 220mmHg 
3. There was a progressive reduction in DED over the 6 month 
period, although a pre-operative value of > 8.0cm was 
associated with persistent LV dilatation. By contrast, albeit 
a small sample size (n = 5), a pre-operative DES> 5.5cm was 
not associated with a poor postoperative result. 
4. Resting haemodynamics remained unchanged. During supine 
bicycle exercise, SBP was significantly lower but exercise PCWP 
remained markedly elevated (26 + 10mmHg versus 30 ± 11mmHg pre-
op) - only 1/5 of patients had a normal postoperative exercise 
PCWP. 
5. An abnormal resting LVEF pre-operatively was reversible i? the 
majority of patients undergoing successful AVR - however, very 
few patients had a marked reduction in LVEF <35% and the 
surgical outcome in this subset remains unanswered. Similarly, 
a significantly reduced pre-operative exercise LVEF (<40%) was 
not a poor prognostic marker. This improvement in systolic 
function was parallelled by improved LV relaxation both at rest 
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' 
and on exercise. 
6. Similar changes in haemodynamics and radionuclide variables 
were noted during erect bicycle exercise. 
VII.5.0 SEQUENTIAL STUDIES 
Sequential studies at 6 monthly intervals were performed in a total 
of 26 patients, 23 asymptomatic subjects and 3 patients with early 
symptoms who refused valve replacement surgery. Nine of these 
patients (including one of the symptomatic group) were subsequently 
re-evaluated at 12 months after their initial assessment. Although 
this latter cohort of patients is significantly smaller than the 
one assessed at 6 months, the results from this part of the study 
will be included as they provide both completeness and some 
important and interesting observations, particularly with regard to 
the progression of the baemodynamic burden and its effects on LV 
function. 
Two asymptomatic patients developed symptoms at 12 to 18 months 
after their initial assessment and underwent successful aortic 
valve replacement. The one patient (A.C.) developed dyspnoea on 
effort associated with progressive LV dilatation, a rise in both 
resting and peak exercise pulmonary capillary wedge pressure but an 
unchanged resting LVEF. At 6 months postoperatively he was 
asymptomatic, had near-normalised his LV size (DED 5.5cm, DES 
4.6cm) but had marginally abnormal resting LVEF of 45% (pre-
operative LVEF 55%). The second patient (J.J.) underwent aortic 
valve replacement for recurrent severe chest pain requiring 
hospitalisation. At cardiac catheterisation 12 months earlier he 
had normal coronary arteries. Although he had a slight increase in 
LV size at sequential evaluation, both resting and exercise 
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haemodynamics and radionuclide measures remained unchanged and six 
months postoperatively he was asymptomatic with normal 
echocardiographic dimensions and resting LV contractile function. 
Each study included an assessment of clinical status, 
echocardiographic LV dimensions and systolic function and an 
exercise evaluation including haemodynamic monitoring and 
simultaneous equilibrium radionuclide angiocardiography as outlined 
previously. Repeat cardiac catheterisation was not performed. 
VII.5.1 CLINICAL STATUS 
VII.5.l.l Functional Class 
None of the 23 asymptomatic patients developed any symptoms over 
the 6 to 12 month follow up period and all 3 symptomatic patients 
remained in functional class II(NYHA). 
VII.5.1.2 Left Ventricular Hypertrophy on Electrocardiogram 
All patients had severe left ventricular hypertrophy with 
repolarisation change as assessed by the Sokolow Lyon index, with 6 
patients having a pseudo-anterior myocardial infarct pattern. Over 
the 6 to 12 months follow up period no significant change occurredr 
VII.5.1.3 Cardia-Thoracic Ratio(CTR) 
The mean CTR at initial assessment was 0.56 ~ 0.06 (range 0.48 to 
0.69) and remained essentially unchanged at 6 and 12 month 
assessments. Five patients had an increase of > 0.04 in CTR (range 
0.04 to 0.09), but in only one of these(PJ> was there a 




Table 7.38 summarises the serial echocardiographic LV dimensions 
and systolic function for the 26 patients over the 6'to 12 month 
follow up period. 
Table 7.38: SERIAL EVALUATION OF ECHOCARDIOGRAPHIC DATA: 
DED DES %FS WS 
0 6 12 0 6 12 0 6 12 0 6 12 
*SA 6.3 6.1 4.2 4.2 33 31 473 441 
LA 7.1 7.1 4.8 4.4 32 38 473 524 
SA 7.6 6.5 7.4 5.2 4.5 5.5 32 31 26 950 406 592 
*MB 6.7 6.3 4.2 4.3 36 31 670 339 
*AC 7.6 8.5 8.0 5 .o 5.8 5.8 34 32 26 409 580 680 
DD 7.3 7.3 4.8 5 .o 34 32 477 564 
HH 7.5 7.2 7.3 5.5 5.2 5.8 27 31 21 433 425 378 
PJ 6.6 7 .o 4.4 4.8 33 31 420 544 
*JJ 6 .. 6 7.2 4.8 4.8 27 33 396 540 
KK 7.2 7 .o 8.5 5 .o 4.4 4.9 30 37 42 491 400 638 
*GM 5.9 6.2 3.9 4 .o 34 35 369 496 
PM 7.6 7.3 4.7 5 .o 38 32 760 840 
*NO 6.8 7.1 6.8 4.1 4.1 4.7 40 42 31 418 410 482 
MP 6.0 6.3 4.4 4.7 26 25 369 441 
SR 6.0 6.0 3.8 3.4 37 40 375 280 
ws 5 .o 6.3 3. 0 4.0 40 36 341 490 
TS 7.9 7.3 4.8 5.0 39 31 490 449 
FT 7.2 6.3 5 .o 5.1 30 19 420 341 
VdS 8.2 7.0 6.8 5.4 4.6 4.5 34 34 34 547 630 419 
LV 7.9 8.2 78 5.3 5.5 5.2 34 33 33 600 581 390 
*CV 5.5 5.9 3.5 3.7 36 37 330 285 
*DV 6.1 5.9 4.1 4.1 33 30 305 375 
*AW 5.2 5.4 3.6 3.3 31 39 416 315 
MA 7.2 6.3 7.2 4.8 3.9 4.2 33 38 42 589 334 524 
DD 5. 3 5.1 3.4 3.2 36 37 331 325 -
MN 7.1 7.3 4.6 4.5 35 38 443 477 
MEAN 6.7 6.7 7.5 4.5 4.4 5~1 33 34 32 461 452 549 
+SD 0.9 0.8 0. 6 o. 7 0.6 0.6 4 5 7 135 117 153 
* GROUP 2A 
0 = Initial assessment 
6 = Six month assessment 
12 = Twelve month assessment 
VII.5.2.1 LV Dimensions 
The . mean LV DED remained unchanged at the 6 month follow up 
assessment (6.7 ± 0.8 vs 6.7 ±0.9cm). Three patients (12%) had a 
significant increase in LV DED at 6 month evaluation (mean 6.4 + 
. ' 
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1.3 to 7.3 ± l.lcm). Importantly, in 4 patients a decrease in 
dimension from 7.7 + 0.4 to 6.8 ± 0.5cm was recorded. Only one 
patient CKK) increased his LV DED at the 12 month assessment from 
7.2 to 8.5cm and it remained at 8.0cm at the 18 month assessment. 
The LV DES also remained unchanged (4.4 + 0.6 vs 4.5 + 0.7cm at 
initial assessment) with a range of 3.0 to 5.5cm. Only 1 patient 
(AC) had a significant increase in LV DES from 5~0 to 5.8cm at 6 
months, remaining at this value at the 12 month assessment. Six 
months later (i.e. 18 months after the initial assessment), this 
patient developed symptoms and underwent successful aortic valve 
replacement. One patient (HH) had an initial LV DES of 5.5cm, with. 
a measurement of 5.2cm at 6 months and 5.8cm at 12 months, but to 
date remains asymptomatic and well. 
VII.5.2.2 LV Systolic Function 
As occurred with the LV dimensions, fractional s~ortening(%FS) 
4 remained unchanged over the 6 to 12 month reassessment period. 
mean %FS at initial assessment was 33 ± 4% with a range of 26 to 
40%. Three patients had a moderate increase in %FS over the first 
6 month period (29 ± 2 to 36 ± 3%) with one of these (KK) having a 
further increase in %FS from 37 to 42% at the 12 month assessment. 
This same patient increased his LV DED from 7.2 to 8.5cm over this 
period. 
Two patients significantly decreased their %FS (TS 39 to 31%; FT 30 
to 19%) over the 6 month period but with no change in resting LVEF 
assessed by equilibrium radionuclide angiocardiography (vide 
infra) . 
VII.5.2.3 LV Systolic Wall Stress(WS) 
In all but 2 patients the WS was normal at initial assessment with 
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a mean of 461 ± 135mmHg and a range of 305 to 950mmHg. It remained 
essentially unchanged at the 6 month evaluation with a mean.of 452 
± 117mmHg. However, in 10 patients (38%) there was an appreciable 
increase in WS of > 50mm from a mean of 411 ± 72 to 518 ± 73mmHg. 
In only 3 of these patients was there a significant increase in LV 
DED to explain this increased stress. In both patients with 
abnormal initial values (SA; LV) there was a decrease in WS, in one 
primarily due to reduction in LV dimension and the second due to an 
increase in LV posterior wall thickness (increased LV hypertrophy). 
At the 12 month assessment, there was a slight increase in WS in 6 
of the 9 patients studied with the mean value increasing from 503 + 
140 to 549 + 153mmHg. 
VII.5.3 EXERCISE EVALUATION 
The serial exercise evaluation included resting and peak exercise 
haemodynamic and equilibrium radionuclide angiocardiographic(ERNA) 
data in both the supine and semi-erect postures. Patients were 
once again stratified according to their exercise LV functio~al 
reserve at initial assessment. Those with an equivocal or normal 
response constituted group 2A(n:9) and those with a > 5% drop in 
exercise LVEF group 2B(n=l7). 
VII.5.3.1 Serial Supine Resting Haemodynamics 
In the group as a whole, there was no appreciable change in heart 
rate and SBP but a significant decrease in resting cardiac index at 
12 months in the 9 patients studied at that time (p <O.Ol). There 
was a progressive increase in PCWP from 16 + 4 to 18 + 4 and 20 + 




Table 7. 39: SERIAL EVALUATION OF SUPINE RESTING HAEMODYNAMICS: 
HR SBP CI w 
0 6 12 0 6 12 0 6 12 0 6 12 
*SA 78 70 150 135 3.5 2.8 13 17 
LA 70 70 165 160 2.9 2.9 16 19 
SA 70 72 66 170 160 160 3. 0 3.3 2.9 12 18 18 
*MB 72 68 150 120 2.8 3.4 21 21 
*AC 90 90 88 160 150 140 3.1 3.2 2.8 16 20 22 
DD 76 78 170 170 2.9 4.2 20 23 
HH 70 66 70 160 140 140 3.4 2.8 2.1 18 23· 18 
PJ 90 88 140 130 4.4 3.9 14 13 
*JJ 74 72 180 170 3.8 3.5 21 17 
KK 100 78 80 160 140 150 4.9 3.8 3.8 17 26 25 
*GM 70 85 150 160 2.7 3.8 13 15 
PM 64 64 68 180 200 200 3.5 2.7 2.2 15 18 23 
*NO 72 66 68 150 170 180 3.5 3.3 2.9 11 18 15 
MP 100 104 160 150 3.9 3.2 15 15 
SR 78 74 160 150 2.6 2.3 30 26 
ws 82 76 150 160 2.8 4.0 15 17 
TS 68 60 140 130 3 .o 2.2 20 20 
FT 84 80 140 130 4 .o 5.2 18 15 
VdS 80 75 70 160 160 160 4.6 4.5 3.1 14 11 15 
LV 70 75 70 180 190 160 3.7 4.1 3.6 16 15 18 
*CV 66 60 120 110 3 .o 2.5 11 15 
*DV 62 60 140 140 2.8 3.3 16 20 
*AW 135 120 140 140 3.4 4.0 11 12 
MA 75 76 64 165 180 160 2.5 2.0 2.1 16 27 23 
DD 68 64 160 150 3.5 3.1 20 16 
MN 70 76 155 170 3.5 3.4 16 20 
MEAN 78 76 72 156 153 161 3.4 3.4 2.8 16 18 20 
+SD 15 14 8 14 12 19 0.6 0. 7 0.6 4 4 4 
* Group 2A 
Table 7.40 SUBSET SERIAL SUPINE RESTING HAEMODYNAMIC DATA: (mean 
±.S.D. ) 
HR SBP CI PCWP 
0 6 12 0 6 12 0 6 12 0 6 12 
2A 80 77 78 149 144 160 3.2 3.3 2.9 15 17 19 
22 19 14 16 21 28 0.4 o. 5 0.1 4 3 5 
2B 77 75 70 160 157 161 3.5 3.4 2.8 17 19 20 
11 10 5 12 21 19 0.7 0.9 0.7 4 5 4 
Similar to the initial assessment in both the symptomatic and 
asymptomatic groups, heart rate and cardiac index were similar in 
the two subsets with a higher SBP in group 2B (p <0.05) and thus a 
higher resting rate-pressure product (12320 VS 11920). Resting 
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PCWP was similarly normal in group 2A patients (15 + 4mmHg) and 
slightly elevated in group 2B. 
Heart rate and SBP remained essentially unchanged in both subgroups 
over the 12 month period the apparent elevation in SBP at 12 
months in group 2A is due to the small sample size of 2 patients 
with the mean for these two patients at 6 months being 160 + 
14mmHg. Both subsets showed an unchanged resting cardiac index at 6 
month assessment but a significant drop occurred at 12 months in 
group 2B (p <0.01). 
2 
All Group 2A patients had a normal index of > 
2.5L/min/m , with 3 of the Group 2B patients(43%) having a 
progressive fall to an abnormal resting cardiac index at 12 months. 
Although resting PCWP was normal in group 2A patients (15 ± 4mmHg), 
44% had an abnormal value at initial assessment. Six patients had 
a progressive increase in PCWP at 6 months with 66% now having an 
abnormal resting PCWP. In contrast, 65% of the group 2B patients 
had an initial elevation of PCWP with 9 patients having a 
progressive increase at 6 months and 71% of patients having a PCWP 
> 15mmHg at this assessment. 
Only 2 patients had a further increase in resting PCWP at the 12 
month assessment~ Thus in both groups there is a progressive 
increase in PCWP (Group 2A p <0.01, Group 2B p <0.05), with a 
greater percentage of group 2A patients developing an abnormal PCWP 
with time. 
VII.5.3.2 Serial Supine Resting Radionuclide Data 
In the overall group (data outlined in Table 7.41 overleaf) the 
resting LVEF remained unchanged, but there was a progressive fall 
in both PFR (2.28 ± 0.75 to 2.12 + 0.49 at 6 months and 1.93 ± 0.57 
EDV/sec at 12 months) and ADFR (1.20 + 0.39 to 1.09 + 0.26 and 1.06 
208 
~ 0.25 EDV/sec at 12 months). 
Table 7. 41: SERIAL EVALUATION OF SUPINE RESTING RADIONUCLIDE DATA: 
EF PFR ADFR 
0 6 12 0 6 12 0 6 12 
*SA 65 59 2.46 1.98 1.11 o. 96 
LA 63 65 1.82 1.96 1.17 0.99 
SA 62 61 62 1.89 1.55 1.62 0. 91 0.93 0.91 
*MB 64 68 1. 91 1.91 1.03 1.03 
*AC 55 52 54 3.35 2.67 2.69 1.60 1.37 1.35 
DD 61 60 2.29 2.20 1.03 1.20 
HH 62 64 56 1. 72 1.87 1.69 1.01 1.07 0.82 
PJ 59 46 2.19 2.25 1.35 1.02 
*JJ 71 71 2.12 2.30 1.16 1.16 
KK 62 66 72 2.71 2.86 2.59 1.59 1.25 1.47 
*GM 72 73 2.23 2.50 1. 27 1.28 
PM 58 62 54 1.47 1.18 1.13 0.83 0.85 0. 76 
*NO 65 70 71 2.19 2.59 2.24 1.02 1.01 1. 21 
MP 69 63 2.41 1.98 1.67 1.29 
SR 66 65 2.42 2.45 1.21 1.15 
ws 61 65 2.26 2.17 1.25 1.24 
TS 53 53 1.37 1.26 0.83 0. 7 4 
FT 50 50 1.97 1.76 1.21 1.04 
VdS 66 61 70 2.37 2.18 2.29 1.25 0.97 1.02 
LV 65 74 68 1.96 2.39 1.89 1.13 1.41 1.18 
*CV 63 63 1.79 1.75 0.86 o. 77 
*DV 63 62 2.19 1.94 0. 77 o. 70 
*AW 73 70 5.35 3.36 2.73 1.97 
MA 57 60 53 1.82 1.46 1.20 0.93 0.96 0.83 
DD 78 76 2.69 2.56 1.34 1.05 
MN 57 58 1.97 1.92 1.04 1.05 
MEAN 63 63 62 2.28 2.12 1.93 1.20 1.09 1.06 
~SD 6 7 8 o. 75 o. 49 0. 57 o. 39 o. 26 0.25 
* GROUP 2A 
Table 7. 42: SUBSET SERIAL SUPINE RESTING RADIONUCLIDE DATA (Nean 
±S.D. > 
EF PFR ADFR 
0 6 12 0 6 12 0 6 12 
2A 66 65 63 2.62 2.33 2. 47 . 1.28 1.14 1. 28 
6 7 12 1.12 0. 51 0.32 0. 59 0. 38 0.10 
2B 62 62 62 2.08 2.0 1. 77 1.16 1.07 0.99 
6 7 8 o. 39 0.46 0. 54 o. 24 0.17 0.24 
In both subgroups resting LVEF remained essentially unchanged over 
the 12 month period, with only 2 of the group 2B patients,having a 
significant fall in resting LVEF at 6 months (LVEF 59 to 46%) 
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unassociated with. any change in resting haemodynamics, but 
associated with an appreciable fall in ADFR from 1.35 to 1.02 
EDV/sec. One other patient in this subset(HH) had a significant 
drop in LVEF at the 12 month assessment (LVEF 64 to 56%) associated 
with an appreciable reduction in cardiac index and ADFR and a 
slight fall in PFR. 
Although the measures of diastolic function remained essentially 
unchanged in the group 2A patients, there was a small but 
progressive fall in both PFR (2.08 ± 0.39 to 2.00 + b.46 at 6 
months and 1.77 + 54 EDV/sec at 12 months) and ADFR (1.16 ± 0.24 to 
0.99 + 0.24 EDV/sec at 12 months) in the Group 2B patients. 
VII.5.3.3 Serial Supine Exercise Haemodynamics 
In the group as a whole (see table 7.43) heart rate and cardiac 
index remained unchanged but there was a progressive increase in 
SBP (p <O.Ol) and peak exercise PCWP (PCWP 23 ± 5 to 25 + 9 ·at 6 
months, p = NS and 30 + 11 at 12 months, p <0.01). 
Once stratified into subgroups(table 7.44), the pattern remained 
unchanged in both subsets, with similar heart rates and cardiac 
indexes but a higher SBP in the group 2B patients at initial and 6 
month assessments (p <0.01) and thus a higher rate -pressure 
product. There was also a significant increase in SBP in the group 
2B subset at 12 months (p <0.05). In addition, group 2B patients 
had a significantly higher PCW pressure at peak exercise (p <0.01). 
Although 78% of group 2A patients had a normal peak exercise PCWP 
(< 15mmHg) at initial assessment, only 33% were normal at 6 months. 
In contrast, only 12% of group 2B patients had an initial normal 
exercise PCWP, with no patients having a normal value at 6 months. 
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*SA 200 190 
LA 190 180 
SA 190 196 
*MB 165 145 
*AC 130 165 
DD 180 180 
HH 165 160 
PJ 172 186 
*JJ 190 172 
KK 170 178 
*GM 160 174 
PM 150 150 
*NO 140 148 
MP 200 200 
SR 140 150 
ws 190 178 
TS 185 165 
FT 190 205 
VdS 165 164 
LV 180 180 
*CV 168 170 
*DV 140 132 
*AW 198 170 
MA 170 165 
DD 164 148 
MN 180 135 
MEAN 172 169 
+SD 20 19 
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9.7 10.1 10.2 23 25 30 
2.2 2.2 2.5 5 9 11 





2A 166 163 161 
26 18 1 
2B 175 172 172 





















0 . 6 12 
9.5 9.9 10.0 17 19 25 
1.6 1.1 3.5 6 4 14 
9.9 10.2 10.2 26 29 32 
3.1 2.6 2.5 8 5 11 
In both subsets, although exercise LVEF remained unchanged at 6 
months, a significant drop occurred at the 12 month assessment 
with the group 2A LVEF falling from 66 + 9 to 54 ± 14% (p <0.01) 
and the group 2B LVEF from 51+ 10 to 45 + 7% (p <0.05). Although 
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this was associated with a progressive but non-significant decrease 
in PFR (4.2 + 1.17 to 3.57 + 0.67 EDV/sec) and ADFR (1.91 ± 0.61 to 
1.74 ± 0.29 EDV/sec) in the group 2B patients, these measures of 
diastolic filling remained unchanged in the group 2A subset. 
VII.5.3.4 Serial Supine Exercise Radionuclide Data 
The serial data for the group is summarised in Table 7.45. A 
slight but progressive increase in exercise capacity is noted over 
the 12 month period. This may relate to a "training effect", 
although it is more likely due to familiarisation with the exercise 
apparatus and protocol. Although there is virtually no change in 
Table 7.45: SERIAL EVALUATION OF SUPINE EXERCISE RADIONUCLIDE 
DATA: 
EF 















































































MEAN 56 56 
±_SD 8 12 
































































































































































































4.34 4.49 3.97 2.08 2.14 1.91 675 738 817 
1.09 1.17 0.95 0.59 0.60 0.49 178 209 170 
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peak exercise LVEF or diastolic filling rates at the 6 month 
assessment, a progressive fall in all 3 radionuclide variables is 
noted at'l2 months (LVEF 56+ 12 to 47 ± 9%, p <0.01; PFR 4.49 + 
1.17 to 3.97 ± 0.95 EFV/sec, p = NS; ADFR 2.14 + 0.59 to 1.91 + 
0.49EDV/sec, p = NS). 
Three of the nine(33%) group 2A patients and 9/17(53%) of the group 
2B patients improved their exercise capacity by 1 level (150k-
pm/min) with two of the group 2B patients improving by 2 levels. 
From table 7.46 it is evident that group 2A patients had a 
significantly higher exercise LVEF, PF~ and ADFR than the Group 2B 
subset (p <0.01), with no patient having a reduced peak exercise 
LVEF of < 50%(compared to 4 patients or 24% of group 2B) . 
Table 7. 46: SUBSET SERIAL SUPINE EXERCISE RADIONUCLIDE DATA: (Mean 
±S.D.) 
EF PFR ADFR Ex. Cap. 
0 6 12 0 6 12 0 6 12 0 6 12 
2A 67 66 54 4.59 5.30 5.17 2.39 2.50 2.44 717 750 825 
7 9 14 0.94 0. 71 0.42 0.45 0. 36 0. 7 3 215 218 318 
2B 51 51 45 4.21 4.10 3.57 1.91 l. 97 1.74 653 732 814 
9 10 7 1.17 1 .. 16 0.67 o. 61 0.62 o. 29 159 211 146 
VII.5.3.5 Serial Erect Resting Haemodynamic Data 
In the group as a whole (table 7.47), there was no change in 
resting heart rate, SBP and cardiac index over the 12 month study 
period. However, there was a small but progressive increase in 
PCWP (p <0.01). This is similar to the supine posture although 
cardiac index fell significantly at the 12 month assessment. 
When stratified according to initial exercise LVEF response (table 
7.48), the two subgroups of patients had similar serial 
haemodynamics in the erect posture with a higher resting heart 
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rate, significantly lower PCWP (p <O.Ol) and similar SBP and 
cardiac index values to the supine posture. There was no reduction 
in resting cardiac index at 12 months, and all patients in both 
subgroups had a normal serial erect resting PCWP (compared to the 
supine posture with 44% abnormal in group 2A increasing to 66% 
abnormal at 6 months; 65% abnormal in group 2B, increasing to 71% 
abnormal at 6 months). As is evident rn the above table, there was 
a progressive increase in resting PCWP in group 2A patients from 5 
+ 2mmHg at initial assessment to 8 + 3mmHg at 6 months (p <0.05) 
and 10 ~ 2mmHg at the 12 month assessment (p = NS). The PCWP in 
contrast remained unchanged in the group 2B patients. 
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Table 7. 48: SUBSET SERIAL ERECT RESTING HAEMODYNAMICS (Mean + 
S.D. ) 
HR SBP CI PCWP 
0 6 12 0 6 12 0 6 12 0 6 12 
2A 101 98 100 144 147 153 3.6 3.4 3.4 5 8 10 
20 19 9 18 12 6 1.9 0.6 0.4 2 3 2 
2B 103 97 92 146 147 151 3.5 3.4 3.3 8 9 7 
17 16 10 9 13 10 0.6 1.0 0.8 2 3 2 
VII.5.3.6 Serial Erect Resting Radionuclide Data 
Similar to the supine posture, in the group as a whole (Table 
7.49), resting LVEF remained essentially unchanged although there 
was a small but progressive fall in PFR (2.66 ± 0.76 to 2.53 ± 0.62 
at 6 months and 2.46 + 0.89 EDV/sec at 12 months, p = NS) and ADFR 
(1.50 + 0.48 to 1.47 + 0.34 at 6 months and 1.45 + 0.49 EDV/sec at 
12 months, p = NS). Although the resting LVEF was similar in both 
postures, both PFR (2.66 + 0.76 versus 2.28 ± 0.75 EDV/sec) and 
ADFR (1.50 ± 0.48 vs 1.20 + 0.39 EDV/sec) were higher in the erect 
posture, almost certainly related to the higher erect resting heart 
rate. 
Although resting LVEF remained unchanged at 6 months in both 
subsets, 3 group 2A patients (PJ; ·-DV; AW) and 1 group 2B patient 
(FT) had progressive reductions in resting LVEF, with all 4 however 
remaining within the normal range. This reduction in LVEF was 
associated with an appreciable fall in PFR, a lesser fall in ADFR 
and in 2 patients it was associated with a reduction in cardiac 
index. In 3 other patients (SA; PM; MA), the fall in resting LVEF 
only became apparent at the 12 month assessment, and in all it was 
associated with an appreciable reduction in diastolic filling 
rates. 
In group 2A, PFR fell at 6 months (2.82 + 0.85 to 2.61 + 0.66 
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EDV/sec) and then plateaued, with ADFR remaining essentially 
unchanged. In group 2B, PFR and ADFR remained essentially unchanged 
over the 12 month follow up period. 
Table 7.49: SERIAL EVALUATION OF ERECT RESTING RADIONUCLIDE DATA: 
EF PFR ADFR 
0 6 12 0 6 12 0 6 12 
*SA 54 63 2.50 2.22 o. 90 1.39 
LA 68 2.68 1.38 
*SA 60 59 55 2.66 3.08 2.45 1.41 1. 72 1.54 
*MB 63 65 1.25 1.69 0.75 1.05 
AC 63 65 4.09 4.12 2.20 2.32 
*DD 63 64 3.14 3.24 1.95 1. 94. 
HH 69 67 68 1.89 2 .. 13 2.09 1.19 1.39 1.21 
*PJ 61 51 3.45 1.96 1.92 1.17 
*JJ 72 71 3.40 2.80 1.76 1.63 
*KK 60 63 60 2.52 2.62 2.75 lo 56 I 1.77 1.70 
GM 68 2.95 
. 
1.90 
PM 66 49 1.50 1.00 0.87 0.66 
*NO 63 75 2.87 2.75 1.40 1. 41 
MP 71 60 3.20 3.01 1.92 1.45 
SR 67 63 2.07 2.71 1.44 1.46 
ws 60 70 2.43 1.50 
TS 54 49 2.10 1.79 1.18 0.95 
FT 56 48 2.40 2.25 1. 64 1.34 
VdS 61 67 2.50 2.75 1.52 1.64 
LV 62 64 2.11 2.58 1. 33 1. 42 
*CV 65 70 2.25 2.28 1·. 26 1.31 
*DW 71 64 2.41 2.10 1.11 1.04 
*AW 81 I 68 4.61 3.97 2.77 2.27 
MA 69 63 2.37 1.93 1.28 1.07 
DD 70 79 2.49 2.49 1.42 1.45 
MN 67 2.16 1.43 
MEAN 64 64 61 2.66 2.53 2.46 1. 50 l. 47 1. 45 
+SD 7 7 6 0. 76 0.62 0.89 0.48 o. 34 0.49 
* Group 2A 
Table 7.50: SUBSET SERIAL ERECT RESTING RADIONUCLIDE DATA: (Mean + 
S.D.) 
EF PFR ADFR 
0 6 12 0 6 12 0 6 12 
2A 65 65 58 2.82 2.61 2.60 1.53 1.52 1.62 
7 6 4 o. 85 0 .'66 0.21 0.57 o. 39 0.11 
2B 64 64 63 2.36 2.48 2.41 1.47 1.43 1.39 
7 8 7 0.47 0.60 1.04 o. 28 0. 32 0.56 
2W 
VII.5.3.7 Serial Erect Exercise Haemodynamics 
Table 7.51 summarises the serial erect exerci~e haemodynamic data 
in the 26 patients studied. Similar to the supine posture, heart 
rate and cardiac index remained unchanged with similar mean 
values. In addition there was a progressive increase in peak 
exercise PCWP (p <0.01), but lower values were recorded in the 
erect posture. Although SBP was higher during the supine posture, 
there was nevertheless a progressive increase in SBP over the 
twelve month period (p <0.01). 
When stratified into subsets (table 7.52) serial heart rates were 
similar in the two groups with a small but progressive rise in SBP 
which was consistently higher in the group 2B patients (219 ± 15 
versus 209 ± 28mmHg). 
As was also evident during supine exercise, exercise PCWP rose 
progressively with time, particularly in group 2A (p <0.05), and 
was consistently higher in the group 2B patients (p <0.05). 
Although 60% of group 2A patients (versus 78% during supine 
exercise) had a normal exercise PCWP at initial assessment, only 
40% (versus 33% during supine exercise) had a normal value at 6 
months, and no patient had a normal exercise PCWP at 12 month 
assessment. In contrast, approximately 1/3 of group 2B 
patients(versus 12% during supine exercise) had a normal exercise 
PCWP at initial and 6 month assessments, but similarly no patient 
had a normal PCWP at 12 months. Despite similar subset serial 
heart rate, SBP and exercise PCWP responses during the two exercise 
postures, cardiac index was consistently higher in the erect 
2 
posture in the group 2A patients (11.0 versus 9.1L/min/M at rest, 
p <0.05), but with the mean values remaining essentially unchanged 
217 
over the assessment period. 
Table 7.51: SERIAL EVALUATION OF ERECT EXERCISE HAEMODYNAMIC DATA: 
HR SBP CI PCWP 
0 6 12 0 6 12 0 6 12 0 6 12 
*SA 170 182 170 190 10.1 8.7 10 12 
LA 185 180 230 220 12.6 12.7 15 18 
*SA 180 194 172 220 240 220 14.6 12.6 12.2 16 20 27 
MB 170 155 230 210 10.6 10.6 19 25 
AC 160 165 190 220 9.7 8.4 15 20 
*DD 180 170 270 250 13.2 13.7 25 20 
HH 170 174 180 250 250 270 9.8 10.2 10.6 15 25 20 
*PJ 170 185 180 180 11.1 11.0 20 29 
*JJ 180 170 210 195 12.3 8.5 18 21 
*KK 170 172 180 220 250 220 9.9 12.8 11.4 15 28 22 
GM 176 240 9.4 12 
PM 150 168 200 200 10.7 9.3 22 25 
*NO 160' 140 150 210 250 230 10.4 11.6 11.0 6 15 18 
MP 200 204 210 200 9.3 7.9 22 20 
SR 145 158 220 230 7.3 8.8 25 33 
ws 194 186 200 240 6.6 9.5 12 23 
TS 182 175 200 210 7.2 8.7 30 30 
FT 188 190 190 190 10.8 12.7 25 22 
VdS 165 160 300 300 9.5 13.6 14 17 
LV 170 170 270 280 15.7 12.3 21 25 
*CV 180 174 220 200 11.5 15 12 
*DV 140 130 190 210. 10.6 14.0 13 10 
*AW 200 180 200 190 6.4 7.5 12 17 
MA 172 160 230 190 7.5 6.2 42 38 
DD 180 150 240 210 8.1 9.9 26 15 
MN 150 200 5.9 13 
MEAN 176 170 167 214 221 237 10.1 10.4 10.6 18 21 24 
±.SD 16 17 10 24 29 38 2.3 2.3 2.3 6 8 6 
* Group 2A 
Table 7.52: SUBSET SERIAL ERECT EXERCISE HAEMODYNAMICS: (Mean + 
S.D. ) 
HR SBP CI PCWP 
0 6 12 0 6 12 0 6 12 0 6 12 
2A 173 170 161 209 216 223 11.0 11.2 11.5 15 18 22 
16 20 16 28 24 6 2.3 2.3 0.6 5 7 5 
2B 179 170 167 219 224 243· 9.1 10.0 10.1 21 22 24 
16 16 8 15 30 46 2 .o 2.3 2.7 5 8 7 
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VII.5.3.8 Serial Erect Exercise Radionuclide Data 
The group data is summarised in table 7.53. As occurred during 
supine exercise, there was a slight but progressive increase in 
exercise capacity over the 12 month period. In contrast, at 6 
month assessment, despite no change in exercise LVEF, there was a 
marginal fall in PFR (4.84 ± 1.43 to 4.39 + 1.23 EDV/sec) and ADFR 
(2.41 + 0.59 to 2.18 ± 0.72 EDV/sec) with a further significant 
fall in these measures at 12 months (PFR, p <0.05; ADFR, p <0.01). 
At that time exercise LVEF had dropped appreciably from 59 + 13 to 
52± 5% (p <0.05). 
A progressive improvement in exercise capacity 





months. As occurred during supine exercise, group 2A patients had 
a significantly higher exercise LVEF (p <0.01) and PFR (p <0.05) 
with no patient at initial or 6 month assessment having an exercise 
LVEF < 50% (versus 4 of the group 2B patients). Peak exercise LVEF 
remained unchanged at 6 months in both subsets, with a significant 
drop in group 2A (66 ± 8 to 53 ± 6%, p <O.Ol) at the 12 month 
assessment. This fall in exercise LVEF was associated with a 
progressive reduction in diastolic filling rates (PFR, p <0.05; 
ADFR, p = NS). 
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4.84 4.39 4.01 2.41 2.18 1.84 708 756 817 
1.43 1.23 1.01 0.59 0.72 0.59 187 197 170 
Table 7.54: SUBSET SERIAL ERECT EXERCISE RADIONUCLIDE DATA: (Mean 
+S.D.) 
EF 
0 6 12 
2A 64 66 53 
7 8 6 
2B 51 55 52 




5.27 4.61 4.10 
1.50 1.28 0.53 
4.06 4.22 3.99 




2.48 2.40 2.12 
0.63 0.76 0.33 
2.20 2.01 1.73 
0.40 0.67 0.67 
VII 5.4 SUMMARY OF SEQUENTIAL DATA 
Ex. Cap 
0 6 12 
791 805 900 
207 220 150 
690 718 775 
96 168 175 
1. The clinical status of all patients evaluated remained 
unchanged over the 6 to 12 month study period. 
2. Echocardiographica1ly determined LV dimensions and systolic 
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function remained stable. However, 10 patients had a 
progressive rise in systolic wall stress. 
3. There was a gradation in haemodynamic abnormalities with a 
progressive rise in both resting and exercise PCWP, an increase 
in exercise SBP and a reduction in resting cardiac index over 
time. 
4. Although resting LVEF remained unchanged, there was a 
progressive increase in the number of patients with an abnormal 
LV functional reserve - this appeared to be associated with 
both a higher afterload (increased SBP) and increased diastolic 
stiffness (reduced peak and average diastolic filling rates). 
5. Some patients (18%) showed a variable LVEF response to exercise 






Each subsection of results will be discussed and this will be 
followed by an overall discussion and a reflection of the results. 
VIII.1.0 CLINICAL CHARACTERISTICS 
VIII.l.l Demographic Data 
It will be noted that the mean age of the two groups at the time of 
initial assessment was 32 years in the symptomatic group (range 14 
to 66 years) and 24 years in the asymptomatic group (range 16 to 44 
years). Although the symptomatic patients were slightly older, 
consistent with the natural history of the disease (Segat 1956, 
Rapaport 1975, Bonow 1983), the two groups are both young ( < 35 
years) and thus comparable, particularly in view of the clinical 
problem of the development of LV dysfunction before the onset of 
symptoms. In addition, being a disease of the young in our 
country, this highlights the problems of valve replacement surgery, 
particularly premature xenograft failure (Rose 1978, Thandroyen 
1980, Curcio 1981), the ability to use anticoagulant therapy 
(geographical locality) and the devastating sequelae of central 
nervous system emboli (Stinson 1977, Cohn 1979). Although earlier 
valve replacement surgery may be recommended in an ideal- society, 
imperfect valve design precludes this recommendation in our patient 




The male preponderance was confirmed in the asymptomatic group 
(ratio 6:1), but the sex ratio was similar in the symptomatic 
patients. This is almost certainly a reflection of the fact that 
asymptomatic males are identified and referred at the time of pre-
employment medical examinations. Furthermore, local demographic 
factors are of great importance. Males come to major cities for 
employment at a young age; females come when they become 
symptomatic. 
VIII.l.2 Aetiology 
Although acute rheumatic fever remains a major health problem in 
this country, only about half the patients evaluated had a history 
consistent with a previous acute attack, and in approximately 40% 
of the cases in both groups, the aetiology was unknown. 
VIII.l.3 Symptomatology 
The natural history of chronic aortic regurgitation is marked by a 
stable prolonged initial plateau phase and subsequent progressive 
deterioration (Goldschlager 1973, Rapaport 1975). Once signs and 
symptoms of congestive heart failure supervene, irreversible LV 
dysfunction may have occurred with a subsequent suboptimal surgical 
result (Clark 1980), There is, of course, a natural reluctance for 
clinicians to recommend open heart surgery in asymptomatic or 
minimally symptomatic patients; thus, in the practical management 
of patients with chronic severe aortic regurgitation, the clinicia·n 
relies heavily on the detection of significant early symptom~. The 
evaluation and interpretation of · these symptoms is highly 
subjective. Moreover, experience with patients has shown that 
symptoms do not always reflect 
(Patterson 1-972, Franciosa 1979), 
underlying cardiac function 
other reports have shown a poor 
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correlation between LV size and symptomatic status 
Henry 1980) and more recently it has been established 
(Borow, 1980, 
that long-
term survival after aortic valve replacement is best predicted by 
the state of the LV systolic pump function (Greves 1981). 
As it is our policy to advise aortic valve replacement at the 
earliest onset of symptoms, it will be noted that 87% of the 
symptomatic group were in NYHA functional class IIA and IIB (NYHA 
1979). No patients were Class IV limited and only 3 patients (13%) 
were Class III. This is in accordance with the reported impression 
that surgery is being recommended earlier in the natural history of 
symptomatic chronic severe aortic regurgitation and appears to be 
associated with an improved late survival (Henry 1980, Turina 
1984). However, two other studies showed that functional capacity 
alone did not correlate with the probability of survival (Samuels 
1979, Cunha 1980), but when combined with LV ejection fraction 
Greves et al(l981) showed that 5 year survival of patients in 
functional Class III and IV improved from 63% to 90% if the LVEF 
was >0.50. Ten patients had a previous episode of congestive heart 
failure which responded well to therapy, with the majority in 
functional Class II at the time of assessment. The mean duration 
of symptoms was 16±4 months with a wide range from 1 to 130 months. 
Although classical angina pectoris is a well known symptom in 
chronic aortic regurgitation, 
effort-induced oppressive chest 










29% of the asymptomatic patients had 
atypical left praecordial chest pain. 
Subsequent to completion of this study, one of the asymptomatic 
patients(J.J.) underwent succesful aortic valve replacement with 
I 
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cessation of chest pain following two hospital admissions with 
severe chest pain unassociated with ECG change or a rise in cardiac 
enzymes. Coronary angiography had revealed normal coronary 
arteries. Nearly half the symptomatic group gave a history of 
short-lived, rapid, regular palpitations almost exclusively effort-
related and unassociated with any other symptoms.· Holter 
monitoring was not performed in any patients, but it is now 
appreciated that both pre-operative and particularly postoperative 
ventricular ectopy may be an important factor in the long-term 
outcome of these patients(Olshausen 1983, Olshausen 1984). 
VIII.l.4 Clinical Assessment 
All patients had the classical peripheral and auscultatory features 
of severe aortic regurgitation with a similarly wide pulse pressure 
' 
in both symptomatic and asymptomatic groups. No patients were in 
congestive heart failure at the time of assessment and thus 
clinical features were not helpful in the stratification of 
patients in this study. 
VIII.l.5 Electrocardiogram 
Patients with chronic severe aortic regurgitation generally have 
hearts of greater weight than that observed in other conditions 
(Roberts 1985) and consequently have larger QRS voltages. Although 
QRS voltage criteria for LV hypertrophy are not always reliable 
(Scott 1960, Baxley 1968, Reichek 1981, Devereaux 1983), it remains 
an important and integral part of the clinical assessment. The 
Sokolow-Lyon index (1949), using the sum of the s wave in v plus 
1 
the larger of the R wave in either V or V of > 35mm, is the most 
5 6 
widely used QRS criteria for LY hypertrophy. More recently, 
Roberts et al (1985) in a necropsy correlated study, reported the 
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usefulness of the total 12-lead QRS amplitude (normal< l75mm). 
Voltage criteria for LV hypertrophy was fulfilled in 73% of 
necropsy patients using the Sokolow-Lyon index, compared to 90% 
using the total 12-lead QRS amplitude. 
In my study, sinus rhythm was present in all patients, with all but 
2 patients in each group (94% of the symptomatic and 93% of the 
asymptomatic patients) having LV hypertrophy with repolarisation 
change as assessed by the Sokolow-Lyon index. More specifically, 
22/28 asymptomatic and 19/32 symptomatic patients had severe LV 
hypert.rophy with LV voltage >60mm. All 4 patients with no 
electrocardiographic evidence of LV hyper~rophy had an increased 
CSA on their echocardiogram. 
VIII.l.6 Chest Radiograph 
Cardiomegaly, as assessed by a cardio-thoracic ratio(CTR) >0.50 was 
present in all but l patient in the symptomatic , group (mean 
0.55+0.06) and in all but 4 patients in the asymptomatic group 
(mean 0.59+0.05). However, all 4 asymptomatic patients had mild to 
moderate LV dilatation on M-mode echocardiography (DED 5.9 to 
6.7cm). 
Although previous studies have reported the prognostic importance 
of the CTR in the late survival of patients with aortic valve 
disease (Chikos 1977, Hammermeister 1979), this variable did not 
appear to have important predictive value in my series. In 
addition, although a sudden, significant increase in CTR at follow-
up assessment is used as an indication for aortic valve 
replacement, this phenomenon was not encountered in the 12 to 18 
month follow up period of this study. However, it should be 
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appreciated that this was a relatively short-term evaluation. 
VIII.2.0 INITIAL ASSESSMENT 
VIII.2.1 M-MODE ECHOCARDIOGRAPHY 
Chronic AR results in LV chamber dilatation and an increase in LV 
muscle mass. If the haemodynamic volume overload is gradual, 
compensatory myocardial hypertrophy develops and, even though LV 
diastolic volume and muscle mass may be increased, the ratio of EDV 
to muscle mass (V/M ratio) and peak systolic wall stress(PSWS) 
remain normal. Early in the evolution of these above changes, the 
contractile state of the myocardium remains normal with a preserved 
LVEF. Thus, compensated chronic AR typically produces LV chambe~ 
enlargement, a large LV stroke volume and normal systolic EF. It 
appears that the large stroke volume is maintained by virtue of a 
large end-diastolic volume with an increased number of sarcomeres 
around the circumference of the ventricle and normal shortening of 
each sarcomere (Ross 1974). 
Eventually, compensatory hypertrophy may fail to keep pace with-the 
volume overload (increased V/M ratio) with the resultant increase 
in systolic wall stress/afterload causing a decrease in fibre 
shortening by virtue of the inverse force/velocity relation. In 
contrast, if the quality of the hypertrophied muscle is abnormal, 
muscle shortening may decline in the presence of a normal 
after load. 
Thus, in the later stages of chronic AR, the systolic EF falls and 
the ESV increases; the LV diastolic pressure rises and the patient 
develops pulmonary venous hypertension and congestion. Unless 
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interrupted by aortic valve replacement, a vicious cycle follows, 
progressing to irreversible myocardial damage. Unfortunately, 
this unwanted end result may occur before the onset of significant 
symptoms, making optimal timing of aortic valve replacement 
difficult. 
A major purpose of this study was to examine the predictive value 
of several pre-operative echocardiographic variables and these will 
be highlighted in the discussion of the sequential and 
postoperative results. 
Agai~st a background of the above knowledge, the results of this 
prospective study show that all but one asymptomatic and two 
symptomatic patients had LV dilatation manifested by increases in 
both end-diastolic and end-systolic dimensions determined 
echocardiographically. Left ventricular fractional shortening was 
normal in the majority of patients, being significantly reduced in 
only 1 symptomatic patient and borderline in 2 patients in each of 
the symptomatic and asymptomatic groups. Importantly, all the 
symptomatic patients in this subset had symptoms for less than 6 
months. These findings are consistent with previous 
echocardiographic studies (Johnson 1976, Venco 1976, Gaasch 1978, 
Henry 1980, McDonald 1980, Stone 1984, Fioretti 1985). 
The degree of LV dilatation was similar in the two groups of 
patients (DED 
asymptomatic), 
6.9±l.lcm symptomatic versus DED 6.8±0.9cm 
although 5 patients (16%) in the symptomatic group 
in contrast to only 2 (7%) asymptomatic patients had marked LV 
dilatation (DED > 8.0cm). Although previously thought to be less 
predictive than the DES, it has recently been reported to be the 
best pre-operative predictor of persistent postoperative LV 
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enlargement (Fioretti 1985) - its importance in my study will be 
discussed in the postoperative and sequential assessments. 
With regard to the DES, once believed to be predictive of a poor 
postoperative result (Borow 1980, Henry 1980), 25% of the 
symptomatic group had dimensions in this range (including 4 of the 
5 patients with a DED > 8.0cm). Only 7% of the asymptomatic 
patients had a DES > 5.5cm. Two other studies (Turina 1979, Cunha 
1980) failed to find any significant relationship between both late 
survival and late clinical results on the basis of LV dimensions 
obtained from pre-operative M-mode echocardiograms. 
Numerous studies have highlighted the significant limitations of 
assessing LV size and function in patients .with severe aortic 
regurgitation. with the use of M-mode echocardiography (Johnson 
1976, Abdulla 1980, O'Rourke 1980). 
Normalisation of echocardiographic dimensions occurred in two-
thirds of the subset of symptomatic patients who underwent aortic 
valve replacement and remained unchanged in the one symptomatic 
patient followed over a twelve month period. 
A radius to wall thickness ratio of > 4.0, which reflects whether 
the degree of LV hypertrophy is appropriate for a given chamber 
volume, has been reported to identify patients with chronic aortic 
regurgitation who are at risk of persistent postoperative LV 
enlargement (Gaasch 1978, Gaasch 1983). This index is 
related to the end-diastolic volume to mass ratio within 
linearly 
a broad 
range of dimensions and mass and has been proposed to be 
independant of fractional shortening. Importantly however, the 
R/Th must be "normalised" for LV systolic pressure. The rationale 
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for pressure normalisation of R/Th rests in the relationship 
between wall stress and pressure, radius and wall thickness. Since 
the R/Th ratio at end-diastole is nearly ~qual to this ratio at the 
time of peak systolic stress (Grant 1965), the product of peak 
systolic pressure and the R/Th ratio provides an index of peak 
systolic stress. Peak systolic stress is known to be near normal 
in patients with chronic compensated heart disease (<550mmHg) and 
increased (>600mmHg) in those with decompensated hearts (Grossman 
1975, Gaasch 1979, Gaasch 1983). At initial assessment in my 
study, 3 symptomatic and 2 asymptomatic patients had a R/Th ratio > 
4.0 and a systolic wall stress of >SOOmmHg. All the symptomatic 
patients had an associated DES > 5.5 whereas neither of the 
asymptomatic group patients had an increased DES. 
Following surgical correction of chronic aortic regurgitation some 
postoperative regression of left ventricular hypertrophy is common, 
although previous studies have reported a persistently increased LV 
mass in most patients (Kennedy 1977, Gaasch 1978, Pantely 1978, 
Schuler 1979, Clark 1980, Henry 1980). The causes of incomplete 
regression are not known, but include paraprosthetic regurgitation, 
systemic hypertension, patient-prosthesis mismatch and the amount 
of LV hypertrophy present pre-operatively may influence the extent 
of postoperative regression(Gaasch 1982). In a subset of 9 cases 
with incomplete regression in their series, the mean cross-
2 
sectional area (CSA) was 28±2cm • In my study a virtually 
identical number of patients in each group (ll/28 symptomatic, 
10/28 asymptomatic) had a significant degree of left ventricular 
2 
hypertrophy as- assessed by an echocardiographic CSA > 30.0cm • In 
only one patient (M.B.) was it associated with an increased R/Th 
ratio and systolic wall stress, implying inadequate hypertrophy for 
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the massive LV dilatation in this man (DED 9.7cm, DES 7.7cm). 
Although Starling's cardiac output curve (Guyton 1973) and the 
shortening velocity of the cardiac wall fibre (Braunwald 1976) are 
the two common techniques for assessing the contractile state of 
the heart, Sagawa et al (1977) proposed a third technique based on 
the time-varying systolic pressure/volume relation. They claimed 
that the ventricular pressure/volume ratio at end-systole was 
relatively insensitive to cardiac loading (a major limitation in 
the use of LVEF) and varied greatly in response to changes in 
ventricular contractility. Subsequent clinical reports (Nivatpunin 
1979, Branzi 1984) showed that the peak LV systolic 
pressure/systolic volume ratio was more sensitive than ejection 
fraction in detecting subtle changes in myocardial function in 
humans. 
A previous invasive study (Nivatpumin 1979) showed a curvilinear 
relationship between the plot of peak systolic pressure/volume 
ratio versus ejection fraction with a ratio of < 1 in patients with 
an LVEF < 40% and ranging between 1 and 5 in patients with an LVEF 
> 60%. Substituting fractional shortening for LVEF, my study 
confirms this curvilinear relationship with a lower ratio generallY, 
associated with a lower percentage fractional shortening. No case 
was associated with a ratio of < 1, although only one patient (M.L) 
had a fractional shortening of < 20%. 
M-mode echocardiographic measurements of LV volume have been 
criticised because of poor correlation with arigiographic values 
(Johnson 1976, Teichholz 1976, Abdulla 1980). This is born out in 
this study, particularly in the asymptomatic group where the 
echocardiogram consistently underestimated angiographic end-
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systolic volume and thus further evaluation of this measure of 
contractility was not undertaken (symptomatic r = 0.87, asympto-
matic r = 0.51). 
VIII.2.2 EXERCISE EVALUATION 
The data on LV performance during exercise in man are inconclusive 
and physical fitness, methodologic problems and body position 
during exercise account partialy for the inconsistency of these 
results. 
VIII.2.2.1 Normal Values 
In general, normal subjects have a significant increase in stroke 
volume on exercise (Wang 1960, Bevegard 1963, Epstein 1967) with 
variable changes in end-diastolic and end-systolic volume 
(Braunwald 1963, Weiss 1979, Poliner 1980). LV ejection fraction 
usually increases by at least 5% due to an increase in stroke 
volume that may be mediated by several mechanisms including a 
decrease in end-systolic volume, an increase in end-diastolic 
volume, an increase in end-diastolic volume greater than the 
increase in. end-systolic volume and lastly an increase in end-
diastolic volume with a decrease in end-systolic volume. From 
previous work it appears that both the Frank-Starling mechanism and 
an increase in LV contractility are important in augmenting the 
stroke volume in normal subjects (Poliner 1980, Iskandrian 1981). 
This change in LV ejection fraction has been widely used to 
characterise a normal versus abnormal response to exercise (Port 
1980, Rerych 1980, Bar-Shlomo 1982). Importantly, it has recently 
been shown that patients with a high resting ejection fraction 
(> 70%) may not increase their ejection fraction on exercise 
(Poliner 1981, Wasserman 1984). 
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A previous non-invasive study evaluating patterns of LV diastolic 
filling in chronic aortic regurgitation (Lavine 1985), compared 
their results to a group of .normal controls. The group comprised 
24 subjects, with a mean resting peak filling rate of 3.09±0.71 
EDV/sec and an ADFR (mean filling rate) of 1.63±0.29 EDV/sec. 
In my group of normal controls the mean resting LV ejection 
fraction was 63+3% with a significant rise on exercise to a mean of 
79±7%. In only one patient was there no significant increase in LV 
ejection fraction, and it will be noted that he had the highest 
resting value of 67% and probably represents a normal response in 
this subset(Poliner· 1981, Wasserman 1984). Peak filling rate was 
2.96+0.46 EDV/sec which is similar to the above study and ADFR was 
also in a similar range. 
VIII.2.2 .. 2A The Effects of Posture on Resting _ Haemodynamics and 
Radionuclide Data . in Symptomatic and Asymptomatic 
Chronic Severe Aortic Regurgitation 
The influence of posture on the haemodynamic and functional 
responses to exercise in normal persons (Poliner 1980, Manyari 
1983) and in patients with coronary artery disease (Thadani 1977, 
Freeman 1981) are well described. In patients with chronic severe 
. . 
aortic regurgitation these effects should be particularly relevant 
because of the alterations in load and fluctuations in the degree 
of regurgitation. In a recent study of patients with moderate to 
severe aortic regurgitation (Shen 1985), posture was demonstrated 
to be important in determining the LV response to exercise, with 
exercise-induced LV dysfunction occurring significantly more often 
during supine than erect exercise. These workers recommended that 
comparisons not be made between different postures in individual 
I 
patients and that because exercise-induced LV dysfunction occured 
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significantly more often during supine exercise, this position be 
used for assessing LV functional capacity in asymptomatic patients_ 
with aortic regurgitation. 
This study of patients with chronic severe aortic regurgitation 
confirms that upright and supine body positions alter LV function 
at rest, with higher erect heart rate, lower erect systolic blood 
pressure and stroke volume index (forward flow) and significantly 
lower pulmonary capillary wedge pressure (PCWP). The increased 
heart rate is thought to be the result of increased sympathetic and 
reduced vagal tone (Gauer 1965) with the lower stroke volume 
occurring because of decreased LV preload. However, although 
cardiac index was significantly lower in the semi-erect posture in 
the symptomatic patients, with 41% having a reduced resting cardiac 
2 
index(CI) <2.5 L/min/M (compared to 16% in the supine posture), 
the CI remained unchanged during both postures in the asymptomatic 
group, with no patients having a reduced cardiac output. These 
results in the asymptomatic group are at variance with previous 
reports (Poliner 1980, Manyari 1983, Thadani 1977, Freeman 1981, 
Sheu 1985), and despite similar erect LV filling pressures to 
symptomatic patients, this group of patients was able to maintain a 
similar cardiac output. 
Although PCWP was abnormal at rest in the supine posture in both 
symptomatic and asymptomatic patients, with·only approximately 40% 
in each having a normal resting value of < 15mmHg, it was markedly 
lower in the semi-erect posture with all the asymptomatic patients 
and 88% of the symptomatic group having normal resting semi-erect 
LV filling pressures. 
The technique used for measuring pressure in the supine position in 
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our laboratory is from a zero reference level in the fourth right 
intercostal space and mid-axillary line. This zero reference level 
was not altered for measurements during semi-erect exercise. The 
mid-portion of the LV in the sitting posture often lies in the 
fifth or sixth intercostal space and it is possible that the 
pressures recorded from this chamber in the sitting position were 
minimally underestimated. 
Left ventricular ejection fraction was similar at rest in both 
postures which is consistent with previous findings in normal 
subjects (Poliner 1980, Manyari 1983), but in contrast to the 
results reported in patients with AR (Shen 1985). Although almost 
one third of symptomatic patients had a reduced resting LVEF in 
both postures, only 7% of asymptomatic patients in the supine 
posture and none in the erect posture had an abnormal LVEF at rest. 
Thus, despite a decrease in preload, ejection fraction is 
maintained and may be due to a compensatory increase in 
contractility. 
Although it would appear that both peak and average diastolic 
filling rates are higher in the erect posture in both groups, this 
may be a function of an increased heart rate rather than any other 
factor. In the su~ine posture however, both filling rates are 
significantly lower than controls which is in agreement with a 
previous study using gated blood pool scintigraphy to evaluate the 
pattern of diastolic filling in patients with moderate to severe 
a6rtic regurgitation (Lavine 1985). With virtually identical 
resting haemodynamics in the two groups in the supine posture, 
diastolic filling rates are similar, albeit marginally higher in 
' 
the asymptomatic group. 
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VIII.2.2.2B Effects of Posture on the Exercise Haemodynamics and 
Radionuclide Data in Symptomatic and Asymptomatic 
Severe Chronic Aortic Regurgitation. 
At peak exercise, corresponding to the same external workload 
during both postures, the heart rate, systolic blood pressure, 
stroke volume index and cardiac index achieved in each group was 
similar. However, to maintain the same cardiac index at peak 
exercise, the percentage increase in stroke volume index was much 
more marked in the erect posture, w{th a 43% increase in the 
symptomatic group and a huge 68% rise in asymptomatic patients. 
This is in agreement with the work of Thadani(l978) in normal 
subjects. 
Peak exercise pulmonary capillary wedge pressure was lower in the 
erect posture, with a significantly smaller number of patients 
having an abnormal value (75% versus 90% in the symptomatic group 
and 52% versus 64% in the asymptomatic group). However, despite a 
normal or elevated PCWP during exercise, all the symptomatic and 
the majority of asymptomatic patients in this subset nevertheless 
had an abnormal LV functional reserve during both postures. 
During exercise, mean LVEF decreased significantly in the supine 
posture with 81% of the symptomatic group having an abnormal LV 
functional reserve (Group lB). In contrast, the fall in LVEF in 
the asymptomatic group was less, remaining normal at 57±12%, and 
with only 53% of patients having an abnormal LVEF response (Group 
2B). These findings during supine exercise are in agreement with 
previous studies (Borer 1978, Dehmer 1981, Shen 1985). Contrary to 
the study by Shen(l985), LVEF also fell, although less 
significantly, during semi-erect exercise, with 75% of the 
symptomatic and 43% of the asymptomatic patients having an abnormal 
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LV functional reserve. These figures are only marginally lower 
than during supine exercise and refute the suggestion that changes 
in loading conditions and contractility during upright exercise may 
mask LV dysfunction in patients with chronic severe aortic 
regurgitation (Braunwald 1976, Lewis 1982, Shen 1985). 
Although diastolic filling patterns in chronic aortic regurgitation 
have been reported at rest using ERNA, there are no reports to my 
knowledge of diastolic filling rates during exercise. The peak 
exercise heart rates were similar in the two groups during both 
exercise postures and therefore these values can be compared. The 
absolute values and incremental rise in both PFR and ADFR were 
higher during peak supine exercise in both groups, reflectirig 
better peak and overall filling. Nevertheless, these supine values 
were significantly lower than in normal controls, with the 
asymptomatic group being two-thirds of normal and the symptomatic 
patients having values of approximately 50% of normal controls. 
Several explanations are possible for the abnormal pattern of 
diastolic filling in these patients and include abnorm~l 
incremental elastance (a change in pressure divided by the change 
2 
in volume at a common wall stress of 40Kdyne/cm and ending when a 
2 
20ml/M volume increase in the LV occurs, Rousseau 1982), 
simultaneous filling from the antegrade mitral and retrograde 
aortic flow (Lavine 1985) and abnormal stiffness (McCullagh 1972, 
Grossman 1974). Because volumes were not measured due to technical 
considerations and wall stress cannot be determined from 
radionuclide data, the role of incremental elastance could not be 
assessed. Similarly, radionuclide techniques cannot quantitate the 
extent and timing of antegrade or retrograde flow and thus the role 
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of diastolic regurgitant flow in altering diastolic filling 
patterns could not be evaluated. Finally, the role that abnormal 
LV chamber stiffness plays in chronic aortic regurgitation is not 
clear and does not correlate with peak filling rates (Magorien 
1984). 
Exercise capacity is used as a measure of cardiac reserve and also 
as a quantitative measure of functional class. Bonow and his group 
from the NIH(l980) showed that treadmill time did not correlate 
with echocardiographic dimensions and systolic function measured 
noninvasively. Many patients had a good effort tolerance despite a 
significant decrease in LV function, confirming the observation 
r 
that patients with severe aortic regurgitation and left ventricular 
dysfunction may be asymptomatic. They showed that exercise 
capacity was an independent measure of cardiac reserve and a good 
predictor of normalisation of posioperative LV systolic function.· 
In my study, the normal controls averaged 6 levels or 18 minutes of 
supine and semi-erect, graded, symptom-limited, bicycle exercise' 
with leg fatigue being the m~jor limiting factor. This protocol 
conforms with the general principles of graded exercise testing 
which are well summarised by Bruce (1971). On an average, the 
exercise capacity in the symptomatic group was approximately 50% of 
normal controls, with dyspnoea the major limiting factor in the 
vast majority of cases. It is quite remarkable that almost half 
this group were able to tolerate an exercise PCWP ranging between 
30 and 55mmHg. In sharp contrast, the exercise capacity in the 
asymptomatic group was almost 80% of normal controls, with leg 
fatigue the major limiting symptom. Only one-quarter of this group 
had a PCWP >30mmHg with a range of 30 to 38mmHg. Thus the ability 
238 
to tolerate an extremely high wedge pressure on exercise appears to 
be a major compensatory mechanism in chronic aortic regurgitation. 
Two mechanisms could have permitted this ability to tolerate the 
abnormally high pulmonary capillary wedge pressures: increased 
pulmonary lymphatic flow, allowing accelerated fluid removal (Uhley 
1967) and chronic changes in capillary walls inhibiting 
transudation of fluid into the interstitium· (Litchfield 1982). In 
addition, chronotropic competence (Eckberg 1971) contributed to our 
patients exercise tolerance. 
VIII.2.2.2C Ejection Fraction Response to Supine Exercise in 
Symptomatic Aortic Regurgitation: Relation to 
Simultaneous Haemodynamics and Radionuclide Diastolic 
Filling 
Since the demonstration by Borer et al (1978) that the left 
ventricular EF measured by ERNA may respond abnormally to stress in 
asymptomatic subjects with normal function at rest, this technique 
has received a great deal of attention. It has been heralded as a 
technique to identify a subset of patients with chronic aortic 
regurgitation (AR) who, despite normal resting LV function, have 
impaired LV functional reserve and are at risk for developing 
progressive LV dysfunction (Dehmer 1981, Bonow 1982, Lewis 1982, 
Huxley 1983, Iskandrian 1983, Johnson 1983). However, the 
determinants of the exercise EF response in chronic aortic 
regurgitation are complex and include changes in heart rate, 
regurgitant flow, preload, afterload and myocardial contractility. 
It would therefore appear to be overly sensitive, occurring very 
early in the natural history of chronic aortic regurgitation and 
there is growing evidence that exercise induced LV dysfunction is 
reversible (Bonow 1984, Gee 1985) and cannot be used to optimise 
the timing of aortic valve·replacement •. 
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Only limited data is available with regard to the haemodynamic 
correlates, particularly in symptomatic patients, and in some 
reports these were not simultaneously recorded (Boucher 1983, 
Massie 1985). In normal subjects, the haemodynamic response of the 
left ventricle to supine exercise is a small increase in stroke 
volume with either a drop, or at most, a 3mm increase ,in end-
diastolic pressure. 
In chronic volume overload as occurs in aortic regurgitation, the 
haemodynamic burden is complex, with both volume overload and a 
dynamic change in regurgitant volume. In addition, impaired 
cardiac function often does not result in distinct haemodynamic 
abnormalities at rest. In an attempt to better understand the LV 
ejection fraction response to exercise, Boucher et al (1982) 
correlated it with pulmonary capillary wedge pressure(PCWP) and 





They were able to show that this group 
resting and exercise LVEF with no 
significant change in ejection fraction on exercise. The majority 
(81%) of the symptomatic patients in my study had an abnormal LV 
functional reserve during maximal supine symptom-limited exercise 
(Group lB). The small remaining subset (Group lA) had an equivocal 
response with no patient displaying an EF increase of >5%. 
Importantly this equivocal or near/normal response occurred over a 
wide range of LV ejection fractions (LVEF 33 -76%), but those 
patients with a low resting LVEF < 50% had a slight drop in 
exercise LVEF, whereas those with an obviously normal value of >60% 
had a slight rise in EF. Two of this subset had resting ejection 
fractions of >70% and might thus not be expected to increase their 
LVEF further on exercise (Poliner 1981, Wasserman 1984). 
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The only differences at rest in these subsets was a higher and 
abnormal PCWP of 18±9mmHg in the Group lB patients associated with 
significantly higher peak and average_ftiastolic filling rates. In 
conjunction with the elevated PCWP, bigger end-diastolic volumes 
are postulated, which is confirmed by the echocardiographic 
measurement of a DEDI of 4.3±0.6 versus 3.9±0.8cm in the Group lA 
patients. The improved diastolic filling in the Group lB patients 
is unexplained and may merely reflect the small sample size (n = 6) 
with a near-normal functional reserve. 
Although echocardiographic DESI, fractional shortening and R/Th 
ratio are similar in the two subsets, the end-systolic wall stress 
is slightly higher in the Group lB patients (510±156 versus 434±21 
in Group lA, p = NS). Its significance is difficult to explain in 
the light of its role in limiting exercise in asymptomatic patients 
(vide infra) as Group lB symptomatic patients had a better exercise 




a slightly lower resting LVEF in the Group lA symptomatic. 
(58±16 versus 63+10% in the asymptomatic Group 2A 
resting haemodynamics and echocardiographic dimensions, 
resting %FS and wall stress are virtually identical. The only 
obvious difference is the peak and average diastolic filling rates, 
which are markedly lower and may reflect increased diastolic 
stiffness. However, these results should be interpreted with 
caution in view of the othe~wise paradoxical finding of better 
diastolic filling in Group lB patients and as mentioned, may just 
reflect the small number of patients in this subset. 
The haemodynamic correlates at peak exercise are not comparable due 
to the rather surprising finding that the Group lB patients had a 
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greater supine bicycle exercise tolerance. Thus, despite the 
normal LV functional reserve in a small number of symptomatic 
patients, their exercise capacity was only about 1/3 ·normal and 
about 50% of that achieved by asymptomatic patients with the same 
LVEF response. In addition, it was associated with a marked 
increase in PCWP and slower diastolic filling, albeit at a higher 
heart rate. Despite this, it is interesting to postulate that 
although the LV size, the degree of LV hypertrophy, the R/Th ratio 
and systolic wall stress at rest measured echocardiographically was 
the same in the symptomatic and asymptomatic patients, increased 
diastolic stiffness with a resultant significant increase in 
exercise PCWP and shortness of breath was the limiting factor in 
the exercise capacity of these patients. 
VIII.2.2.2D Ejection Fraction Response to Supine Exercise 
Asymptomatic Aortic Regurgitation: Relation 
Echocardiography and Simultaneous Haemodynamic 
Radionuclide Diastolic Filling Data. 
In the asymptomatic patients in this study, the radionuclide 
findings are generally comparable with those previously reported 
(Dehmer 1981, Bonow 1982, Lewis 1982, Boucher 1983, Huxley 1983, 
Iskandrian 1983, Johnson 1983, Massie 1985). Approximately half 
the patients had a decrease in LVEF at peak supine exercise (Group 
2B), with 13 patients having an equivocal or normal response (Group 
2A). Once again, this latter response occurred over a wide range· 
of resting ejection fractions and interestingly, two patients with 
a resting LVEF >70% had a significant rise on exercise (Poliner 
1981, Wasserman 1984). In addition, contrary to a recent report by 
Massie et al (1985) in asymptomatic patients and my own symptomatic 
group, nearly one third of this subset had a normal LV functional 
reserve. This response has previously been noted but in a small 
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minority of patients and usually in those with only modest aortic 
regurgitation (AR). Although previous reports (Levinson 1970, 
Lewis 1970, Boucher 1983, Massie 1985) show that patients with 
asymptomatic AR have essentially normal haemodynamics at rest, 
approximately half this group in my series had elevated resting LV 
filling pressures with only about 60% of these falling into the 
subgroup with an abnormal LV functional reserve, i.e. 40% of 
patients with an abnormal PCWP at rest had a normal exercise LVEF 
response. No other haemodynamic differences were noted in the 
subgroups at rest. 
Radionuclide determined PFR was marginally higher in the Group 2A 
' 
patients and possibly reflects improved relaxation, associated with 
a normal resting PCWP and LV functional reserve. 
Although radionuclide volumes were not determined, supine resting 
echocardiographic data and cardiac catheter volumes are available. 
When stratified on LV functional reserve, the echo DEDI was 
significantly higher in the Group 2B patients (4.5+0.4 versus 
3.9±0.6cm in Group 2A, p <0.01), with similar %FS (33±4 versus 
34±4%) and R/Th ratio (3.1±0.6 versus 2.9±0.6). Although the 
volume to mass ratios were similar and within the normal range, 
resting systolic wall stress (SWS) was slightly higher in the group 
with an abnormal LV functional reserve (513+158 versus 417±90mmHg). 
A similar pattern is also evident in the symptomatic group, with 
virtually identical values to the two asymptomatic subgroups (see 
Appendix IV and V). 
The difference in resting end-diastolic volume index at cardiac 
catherisation confirms the findings at echocardiography of 





exercise in both the symptomatic (203±_63 versus 
2 
and asymptomatic groups (208±_39 versus 172±_13ml/M ). 
As wall thickness could not be accurately measured in many 
patients, wall stress was not calculated. 
The exercise capacity was similar in these two subsets of patients, 
but significantly higher than in the symptomatic group. This is in 
contrast to the study of Boucher et al (1983) who reported a 
correlation between the exercise LVEF response and exercise 
capacity. Cardiac index increased appropriately during exercise (3 
fold increase) but in sharp contrast to normal subjects, exercise 
PCWP was abnormal in both subgroups, but significantly higher in 
those patients with a fall in exercise LVEF. Apart from being 
associated with an appreciable fall in LVEF, it was also associated 
with lower peak and average diastolic filling rates. The slightly 
higher peak exercise heart rate may be partially responsible for 
this observation, but increased diastolic stiffness is an 
alternative explanation. It will nevertheless be remembered that 
leg fatigue rather than breathlessness was the major limiting 
symptoms in the asymptomatic patients with chronic severe AR.· 
Although a recent study by Massie (1985) found that the EF response 
to supine exercise correlated closely with the exercise-induced 
increase in cardiac index (r = 0.81, P < 0.001) and significantly, 
though less closely and in an inverse manner with the increase in 
PCWP (r = -0.69, p <0.01), this was not the experience in an 
earlier study by Boucher et al (1983). However, in this latter 
study, exercise radionuclide and haemodynamic measurements were not 
simultaneously obtained. Nevertheless, my study similarly found no 
significant correlation between the change in exercise EF and 
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changes in cardiac index, pulmonary capillary wedge pressure or 
peak diastolic filling rate, and thus its usefulness in the 
management of these patients is questionable. The mechanism 
responsible 
with chronic 
for the variable exercise LVEF response in 
severe AR is uncertain. These findings 
patients 
are not 
surprising in view of the known limitations of this dimensionless 
measure of LV function. The LVEF is altered in a complex fashion 
by changes in heart rate, loading conditions and contractility and 
is only a net measure of a number of factors, some of which serve 
to increase and others to decrease LV function. When LV preload 
is reduced or afterload is increased, EF may fall. Although earlier 
reports suggested that the abnormal EF response was the result of a 
decrease in LV preload (EDV) caused by a shortened diastolic 
filling period and .a decrease in regurgitant volume secondary to an 
increase in heart rate (Judge 1971, Steingart 1983), more recent 
work has shown a variable change in EDV during exercise in these 
patients (Dehmer 1981, 
preload, as reflected 
(Group 2B > Group 2A) on 
Peter 1982, Johnson 1983). In my study, 
by the PCWP,increased in both subgroups 
exercise, with resting values also higher 
in the Group 2B subset. However, the PCWP may not be a true 
measure of preload(EDV) when the diastolic compliance of the LV is 
abnormal. 
However, at rest, end-systolic wall stress, which is a measure of 
LV afterload, was higher in the group 2B patients (513~158 versus 
417~90mmHg). Although stress was not measured during exercise, one 
of its direct variables, namely systolic blood pressure, rose 
considerably higher in the Group 2B patients (248 ~30 versus 219~ 
2lminHg). The other two variables, namely end-systolic volume and 
wall thickness, were not measured during exercise, but resting 
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values were similar in the two subgroups. Thus, the higher levels 
of resting wall stress suggest an important role of afterload 
excess in the LV functional reserve of patients with asymptomatic 
severe AR. This observation is in agreement with other reports 
(Osbakken 1981, Lewis 1982, Reichek 1982, Iskandrian 1983, 
Greenberg 1985, Kawanishi 1986). The fact that resting LVEF was 
normal despite higher SWS implies adequate basal reserve mechanisms 
which are exhausted when demands on the ventricle increase during 
exercise. Recent reports (Kumpuris 1982, Gaasch 1983) have also 
highlighted the prognostic significance of an abnormally high pre-
operative SWS - this issue will be addressed in the discussion of 
my postoperative results. 
It has been suggested that SWS is the stimulus for compensatory 
hypertrophy of the LV (Grossman 1975). To maintain SWS in the same 
range as those patients with a normal LV functional reserve, cross-
sectional area(CSA) as a measure of LV hypertrophy, should have 
been and was significantly higher as these patients had more LV 
2 
dilatation (CSA 31±6 versus 26±6cm, p <0.01). Whether this 
imbalance between load and hypertrophy was secondary to a gradual 
failure to develop adequate hypertrophy is therefore unlikely and 
the role of a change in the severity of regurgitation or a 
reduction in myocardial contractility cannot be answered from the 
available data. 
Other factors known to influence the ejection fraction response to 
exercise, namely age (Port 1980, Rodeheffer 1984) and the presence 
of associated coronary artery disease were not issues in this study 
as the majority were young patients with a mean age of 24 years 
(range 16 to 44years) and all patients had normal coronary 
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angiograms. Although cuff systolic pressure rather than end-
systolic pressure was used to calculate SWS, it has been found to 
closely correlate with end-systolic pressure in normal patients and 
in patients with heart disease, including aortic regurgitation 
(Grossman 1977, Bonow 1982, Reichek 1982). 
Thus these findings confirm other published results (Hochreiter 
1982, Lewis 1982, Iskandrian 1983, Goldman 1984, Greenberg 1985) 
that in the group of asymptomatic patients with preserved resting 
LV function there exists a subset with an elevated resting SWS. In 
my study, these patients had a resting SWS > 450mmHg, which appears 
to rise substantially on exercise and is associated with a drop in 
exercise LVEF. It would thus appear that afterload in excess of 
available myocardial reserve is an important determinant of this 
response. 
In addition, lack of adequate hypertrophy to normalise wall stress 
and increased diastolic stiffness both at rest and on exercise 
(vide supra) suggest the failure of compensatory mechanisms. This 
impaired haemodynamic response to supine exercise may thus 
represent an intermediate stage between well compensated AR and the 
onset of overt LV dysfunction. Two recent studies (Bonow 1983, 
Huxley 1983) have shown that these patients do not have improved 
exercise responses over time and that they are at increased risk of 
becoming symptomatic and developing progressive deterioration of 
rest LV function. This issue will be addressed in my discussion on 
sequential evaluation. 
Nevertheless, there is no evidence to suggest that this abnormal LV 
functional reserve is an indication for aortic valve replacement 
since patients under close follow up who exhibit functional· 
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deterioration or develop symptoms have excellent surgical results 
(Henry 1980, Bonow 1984). The important implication is that 
patients with exercise induced LV dysfunction deserve careful and 
close follow up. 
In the light of the fact that afterload excess may be an important 
factor in the apparent deterioration of LV performance, an 
important and as yet unanswered question is whether the early use 
of vasodilators would significantly alter the natural history of 
severe AR, thus delaying the need and hazards of valve replacement 
surgery. At present there is evidence in the short term that 
arterial dilating agents will reduce both LV volume and systolic 
pressure (Greenberg 1981), two of the important determinants of 
systolic wall stress. 
VIII.2.2.2E Ejection Fraction Response to Erect Bicycle Exercise in 
Symptomatic Aortic Regurgitation: Relation to 
Simultaneous Haemodynamics and Radionuclide Diastolic 
Filling Rates. 
Several studies utilising upright bicycle exercise have found that 
resting LVEF was similar and the EF response to upright exercise 
was generally a >5% increase in both asymptomatic and symptomatic 
patients. Because of this discrepancy in LV functional reserve 
between the two postures, it has been recommended that the EF 
response in one posture during exercise should not be applied to 
another (Iskandrian 1981, Lewis 1982, Marx 1982). 
In addition, changes in posture significantly alter the 
haemodynamic profile, with resting values for end-diastolic 
pressure, PCWP, cardiac index and stroke volume index being 
significantly lower and heart rate higher in the erect position 
(Wang 1960, Bevegard 1963, Tuckman 1966). During upright exercise, 
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changes in EDV may be variable with either a decrease due to a 
reduction in regurgitant volume secondary to a shorter diastolic 
filling time (Iskandrian 1981), or an increase in EDV. During leg 
exercise, the blood pooled in the dependant region is shifted 
centrally by sympathetically mediated vasoconstriction and the 
action of the muscle pump(Clement 1976). However, because this 
marked enhancement of venous return is independant of posture, 
similar levels of EDV are expected during both body positions on 
exercise (Marx 1982, Shen 1985). Pulmonary capillary wedge 
pressure also increases but should normally not exceed 15rnmHg(Ross 
1966, Braunwald 1969, Rahimtoola 1975). Although it has recently 
become appreciated that only about 40% of asymptomatic or minimally 
symptomatic patients have a normal exercise PCWP in the supine 
posture (Boucher 1983), the response to upright exercise is not 
well reported. Similarly, diastolic filling patterns have, to my 
knowledge, not previously been described in patients with chronic 
severe aortic regurgitaion during upright exercise with the 
increased EDV and reduced diastolic filling period, the expected 
response would be more rapid filling to accommodate this increased 
volume. 
Contrary to the earlier reports (Iskandrian 1981, 
1982), my study shows that a similar proportion 




demonstrated an abnormal LV functional reserve to upright 
exercise (75% versus 81%), Despite a poor correlation 
between a normal erect and supine LV functional reserve, 10 of 12 
or 83% of patients had an abnormal LV functional reverse in both 
erect and supine postures. Once again it is evident that a normal 
LVEF response to exercise occurred over a wide range of resting 
ejection fractions. 
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The resting haemodynamic profiles were identical in the two subsets 
and in agreement with previous reports on the changes in the 
upright posture (Wang 1960, Bevegard 1963, Tuckman 1966). In sharp 
contrast however, peak and average diastolic filling rates during 
the resting phase of upright bicycle exercise are significantly 
higher in the group lA patients at similar heart rates and PCWP and 
although this may thus reflect improved relaxation in this subset, 
I caution this conclusion because of the small sample size (n = 4). 
At peak exercise, the external workloads are dissimilar making 
direct comparisons difficult. In individual patients, the maximum 
workload achieved was the same as during supine exercise, wi~h the 
order of body position during bicycle exercise not randomly 
allocated. Nevertheless, the haemodynamic profile in both 
subgroups was similar apart from a significantly higher systolic BP 
in the group lB patients which is similar to the findings during 
supine exercise. As was evident at rest, at similar peak exercise 
heart rates and PCW pressures both peak and average diastolic 
filling rates were again significantly higher in the group lA 
patients. Although one could postulate that systolic w~ll stress 
~afterload) was lower in this group and important in modulating the 
ejection fraction response to exercise, it would appear that 
improved diastolic filling during the upright posture may also play 
a role. Further studies will need to be done to evaluate this 
observation. 
VIII.2.2.2F Ejection Fraction Response to Erect Exercise in 
Asymptomatic Aortic Regurgitation: Relation to 
Simultaneous Haemodynamics and Radionuclide Diastolic 
Filling Rates: 
Although it is interesting to evaluate the exercise response in 
symptomatic chronic aortic regurgitation, the management of these 
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patients is generally straightforward. A far more problematic 
group are asymptomatic patients with chronic severe aortic 
regurgitation and significant LV dilatation. It is in this group 
that non-invasively determined prognostic markers are of crucial 
importance in the optimal timing of valve replacement surgery. 
As occurred in the supine posture,_ a far more even spread of 
patients occurred in this group when divided according to their LV 
functional reserve. Thirteen patients formed group 2A and 10 
patients group 2B. Nine of the thirteen Group 2A patients (69%) in 
the asymptomatic group had the same erect and supine exercise LVEF 
responses. Eighty percent (80%) of the group 2B asymptomatic 
patients had the same response, which is similar to the proportio~ 
of symptomatic group lB patients. As occurred in the symptomatic 
group, the resting haemodynamic profiles in the two subsets of 
asymptomatic patients were virtually identical, but heart rate was 
higher and PCWP significantly lower than in the supine posture. A 
similar pattern of improved diastolic filling is noted in the group 
2A patients in the erect posture at rest. Although the maximum 
external workload achieved was once again dissimilar, a number of 
important differences were noted. 
Although systolic BP and PCWP were significantly higher in the 
group 2B patients during supine exercise, there is only a marginal 
difference in both these haemodynamic parameters at peak exercise 
in the erect posture. Cardiac index was significantly higher at an 
equivalent heart rate in the group 2A patients, implying improved 
forward flow. Since two of the variables of the systolic wall 
stress equation, namely systolic pressure (cuff BP) and end-
diastolic volume (in this study PCWP was used as a measure of EDV) 
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are not grossly dissimilar in the two subgroups, by inference, a 
marked rise in SWS is probably not the operative mechanism in 
determining the EF response to erect bicycle exercise in 
asymptomatic patients with chronic severe AR. However, there is a 
marked difference in diastolic filling rates with much more 
adequate relaxation in the subgroup with a normal LV functional 
reserve. This differenc~ cannot be ascribed to alterations in 
heart rates. Whether the improved forward flow and normal LV 
functional reserve in this subset of patients is due to systolic-
diastolic interdependance (Bonow 1981, Polak 1982, Bahler 1983) or 
volumetric change secondary to improved relaxation is uncertain. 
Thus it would appear from this study, in contrast to the report by 
Shen et al (1985), that exercise posture is not important in the 
stratification of asymptomatic patients on the basis of LV 
functional reserve. Upright exercise, being more physiological and 
more closely mimicking normal daily activity, should be the posture 
of choice in the evaluation of these patients. In addition, 
although afterload excess is the predominant mechanism responsible 
for the abnormal functional reserve during supine exercise, 
diastolic relaxation appears to be an important mechanism in the 
upright posture. 
VIII.2.2.2G The Role of Isometric Exercise in the Evaluation of LV 
Performance in Chronic Severe Aortic Regurgitation: 
In contrast to the sympathetically mediated increase in heart rate 
and contractility during dynamic exercise (Crawford 1979, Stratton 
1983), a significant increase in systemic pressure is the most 
marked haemodynamic change during isometric handgrip exercise. 
However, there appears to be a great individual variation in the 
blood pressure response to isometric stress (Alain 1937, Chaney 
252 
1983). Many variables affect the increase in BP and include the 
intensity of the stress (Mitchell 1974), age (Kino 1975), sex 
(Petrofsky 1976), systemic hypertension (Lamid 1973) and heart 
disease (Fisher 1973). Although no increase in LVEDP is noted in 
normals (Helfant 1971, Kivomitz 1971), LV filling pressure commonly 
rises during isometric exercise in patients with chronic AR 
(Osbakken 1981). It has been postulated that the preservation of 
exercise capacity in chronic AR during isometric exercise is 
related to this elevation in LVEDP with a resultant d~crease in 
regurgitant volume (Gerson 1984). 
Nevertheless, despite certain theoretical advantages including its 
ability to provoke afterload mismatch (Ricci 1982) and evoke a 
greater elevation of LVEDP, numerous disadvantages (Gorlin 1957, 
Ellestad 1969, Atkins 1971) preclude its use in the routine non-
invasive evaluation of LV functional reserve. However, recent 
studies (Gordon De Puey 1984, Shen 1985) have found that it may be 
a useful method for detecting LV dysfunction in patients with AR 
when adequate bicycle exercise cannot be accomplished. 
In contrast, in my study using a standard protocol, there was 
minimal change in the haemodynamic and radionuclide systolic and 
diastolic profiles from the resting values in both symptomatic :and 
asymptomatic patients with chronic severe AR. When patients were 
stratified according to their LVEF response to supine dynamic 
exercise, despite a modest increase in systolic BP (mean r~nge 9 to 
14mmHg), minimal change in the other variables was again noted. 
It would thus appear from my study that, contrary to earlier 
reports (Paulsen 1981, Gumbiner 1983, Gordon De Puey 1984, Shen 
1985), some of which were inhomogeneous with regard to the severity 
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of the AR and in general were conducted on small numbers of 
patients, isometric handgrip is a poor form of exercise in patients 
with chronic severe AR and measurements obtained in this way did 
not differ appreciably from resting haemodynamics or radionuclide 
ejection fraction or diastolic filling rates. It can thus not be 
recommended for use as an alternative to dynamic bicycle exercise. 






Although it is well known that exercise type and body position may 
significantly influence the circulatory responses to exercise, the 
intensity of exercise has also been cjted as important in 
uncovering mild to moderate degrees of functienal impairment 
(Epstein 1969, Brady 1980, Jones 1981). 
In an attempt to better evaluate the patterns of change in 
haemodynamic and radionuclide measurements and to possibly better 
explain the limiting factors to exercise in both symptomatic and 
asymptomatic severe AR, numerous variables were examined at 
equivalent workloads for the first three levels of supine bicycle 
exercise. This graded exercise protocol conforms with the general 
principles of· effort stress testing in several ways, including: (i) 
exertion was initially submaximal, (ii) increments of work output 
were small, (iii) each stage was of sufficient duration to allow 
physiologic adaptation, (iv) the work was familiar to most 
patients, and (v) exercise was terminated for patient specific 
factors (Bruce 1971). 
As has been previously noted, resting values in the two groups were 
similar although the LVEF at rest was slightly lower in the 
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symptomatic group (57+ 12 versus 62 + 8%). 
During the first level of exercise, an abnormal LV functional 
reserve was present in 61% of the symptomatic group and only 32% of 
asymptomatic patients. The other significant difference was a 59% 
incremental rise in PCWP in symptomatic compared to 24% in 
asymptomatic subjects. However, although the incremental changes 
in diastolic filling were similar, both peak and average diastolic 
filling rates were appreciably higher in the asymptomatic patients 
at a similar heart rate and lower PCW pressure (EDV). Thus, 
although it would appear that at a low workload, significant 
volumetric changes, 
associated with 
particularly in end-diastolic volume (preload) 
an elevated PCWP and systolic wall stress 
(afterload), are responsible for the abnormal LV functional reserve 
seen in many of the symptomatic and some of the asymptomatic 
patients, the role of impaired relaxation cannot be discounted. 
At an external workload of 300 kilo-pond meters/minute ("level 2), a 
slightly bigger percentage of symptomatic patients (69%) but an 
appreciably higher percentage of asymptomatic patients (50% versus 
32% at level 1) had an abnormal LV ejection fraction response to 
supine bicycle exercise. This was associated with a similar 
incremental rise in heart rate and cardiac index, a higher SBP and 
a significantly higher PCWP in the symptomatic group. Thus a 
s~gnificant increase in PCWP (and presumably EDV) and systolic wall 
stress (afterload) may once again exp~ain the fall in EF in the 
symptomatic group but not in the asymptomatic group. Here the drop 
in exercise ejection fraction in nearly half this group was 
associated with a much lower PCWP and SBP. Diastolic filling rates 
were similar in the two groups. Thus a reduced preload and/or a 
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decrease .in contractility at this modest workload may explain the 
drop in EF. 
Although a slightly bigger percentage of symptomatic patients (76% 
versus 69% in level 2) demonstrated an abnormal LV functional 
reserve during the third level of supine bicycle exercise, the 
number of asymptomatic patients remained constant. Incremental 
changes in heart rate, SBP and cardiac index were again similar, 
but the symptomatic group once again had appreciably higher PCW 
pressures, although unchanged from level 2. When the symptomatic 
group were stratified according to LV functional reserve, PCWP was 
lower and filling rates higher in the group lA patients. Thus, 
although increases in end-diastolic volume and systolic wall stress 
once again appear to be the operative mechanism in the symptomatic 
subset with an abnormal LV functional reserve, abnormal diastolic 
stiffness may be a contributing factor. 
In the asymptomatic group as a whole, it will be noted that at the 
same external workload (450k-p.m./min), heart rate, PCW pressure 
and SBP are lower with a higher overall LVEF and significantly 
better diastolic filling. On stratification, group 2A asymptomatic 
patients had an appreciably lower PCWP and better diastolic filling 
rates. This superior 
afterload, may explain 
diastolic filling, 
the better LV 




improved exercise capacity in asymptomatic patients with chronic 
severe aortic regurgitation. Why its influence only becomes 
apparent at this level of exercise in unexplained. 
Thus, in summary, there appears to be a progressive increase in the 
number of patients with an abnormal LV functional reserve with 
increasing levels of exercise. However, in the symptomatic group, 
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the greatest increment ,(61%) occurs during the first level of 
exercise with only a small further ,increase to 76% during level 3. 
In contrast, in the asymptomatic patients, although only 
approximately l/3 had a fall in LVEF during the first level of 
exercise, there was a progressive increase in this proportion 
during level 2 to 50% and then a plateau. 
PCWP(and presumably volumetric) changes 
Secondly, significant 
occurred early during 
supine bicycle exercise, particularly in the symptomatic group, and 
then appeared to plateau. Thirdly, although increases in EDV and 
systolic wall stress (afterload) appear to be the overriding 
mechanism for an abnormal LV functional reserve in symptomatic 
patients, diastolic stiffness may play an important role in the 
functional response of asymptomatic patients. Finally, from this 
data it would appear that low level exercise (1 to 2 levels) is 
adequate to stratify patients on the basis of LV functional 
reserve, accepting the fact that exercise capacity has been 
proposed as an important and independant marker for success 
following aortic valve replacement~ 
VIII.2.3. CARDIAC CATHETERISATION: 
It will be noted that in the majority of reports concerning aortic 
regurgitation, cardiac catheterisation was not performed in many 
and in only some of the patients in other studies. In my series of 
60 cases, all patients underwent complete right and left heart 
catheterisation and left ventriculography, aortography and coronary 
angiography so as to verify the severity of the aortic 
regurgitation and exclude associated valvular or coronary artery 
disease. Thus abnormal haemodynamics and contractile function were 
due solely to chronic severe aortic regurgitation and its effects 
on LV function. 
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The vast majority of symptomatic patients (87%) in my study were in 
NYHA functional class II. Only 3 patients were class III limited 
and thus this group (n = 32) has been considered as a whole and 
compared to the asymptomatic group (n = 28). 
In aortic regurgitation, the need for an acceptable forward cardiac 
output requires an abnormally large stroke volume to compensate for 
the regurgitant volume which may be as high as 75% of the total LV 
stroke volume (Morrow 1965). The large stroke volume results in an 
increase in systolic blood pressure while regurgitation through the 
incompetent aortic valve produces a lowered aortic diastolic 
pressure. The amount of regurgitation is dependent on the orifice 
size of the aortic valve, the length of diastole and the pressure 
difference between the aorta and the left ventricle. 
Although an appreciable number of both symptomatic and asymptomatic 
patients in my study had an aortic diastolic pressure higher than 
the reported literature, it should be noted that this finding is 
nevertheless consistent with severe AR. It did not relate to a 
change in systemic vascular resistance, but was rather associated 
with a significantly higher aorta to left ventricular pressure 
difference (p < 0.01), 
regurgitation. 
a major determinant of the severity of the 
Chronic LV dilatation is essential and may be associated with 
different diastolic patterns of accommodation to the increased 
diastolic volume. In some patients, an increased LV end-diastolic 
pressure develops as if a normal diastolic pressure - volume curve 
was operative. In contrast, a second group displays apparent stress 
relaxation in diastole and appears to have better mechanical LV 
performance after surgery (Gault 1970). 
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Previous data evaluating the influence of LV end-diastolic pressure 
on late results after aortic valve replacement in severe aortic 
regurgitation are inconsistent (Hirshfeld 1974, Samuels ~979) and 
its influence on outcome in patients undergoing aortic valve 
replacement in this study will be discussed in the postoperative 
assessment. With regard to LV filling pressure measured indirectly 
by pulmonary capillary wedge pressure and directly by LV end-
diastolic pressure in my study, the correlation was reasonably good 
in the symptomatic group (r = 0.76) but only moderate in the 
asymptomatic patients (r = 0.60). The explanation may lie in the 
variable left atrial booster pump function in patients with altered 
LV diastolic properties (Braunwald 1961, Rahimtoola 1975). The 
symptomatic group had both an abnormal pulmonary capillary wedge 
pressure of 16 ± 7mmHg, with 41% of patients having a value of > 
l5mmHg, and an elevated LV end-diastolic pressure of 19 + 8mmHg 
with 66% having an abnormal value of > 15mmHg. In contrast, the 
asymptomatic group had a normal pulmonary capillary wedge pressure 
(13 ± 3mmHg) and LV end-diastolic pressure (15 ± 5mmHg) with only 
14% having an abnormal wedge pressure. However, only 3 patients 
had a left ventricular end-diastolic pressure greater than 20mmHg 
compared to 10 of the symptomatic group. Thus the correlation in 
the symptomatic group may be due to higher and less variable PCW 
pressures. 
In addition to higher filling pressures, the symptomatic group also 
2 
had a lower mean cardiac index (3.2 ± 0.9 versus 3.9 ± 0.9L/min/M ) 
measured by the indicator dye dilution technique (Hamilton 1948), 
2 
with 16% (5 patients) having values of < 2.5L/min/M . All these 
' had evidence of significant resting LV dysfunction with associated 
elevation of LV end-diastolic pressure (range 20-40mmHg, mean 
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3lmmHg). In contrast, no asymptomatic patient had a reduced 
resting cardiac index. 
The thermodilution technique first introduced by Fegler in 1954 has 
been widely used for the measurement of cardiac output and previous 
reports have demonstrated a close agreement between thermodilution 
and dye dilution techniques in haemodynamically stable 
patients(Ganz 1971, Weisel 1975). However, there has been 
disagreement as to whether left-sided regurgitation renders the dye 
. 
dilution technique inaccurate(Rahimtoola 1965, Samet 1966). It has 
been suggested that the distortion of the dye curve, with a 
resultant miscalculation of cardiac output (an approximately 20% 
underestimation), is caused by recirculation of indicator in the 
coronary arterial system. Samet(l966), and more recently Hillis et 
al(l985), have shown that right-sided injection and samy~ing of 
"cold" yields a curve less subject to recirculation-induced 
distortion in patients with AR and is preferable to dye and left-
sided sampling. In comparing the cardiac output at catheterisation 
with that obtained during the resting phase of the exercise 
evaluation using the thermodilution technique, our series showed 
poor correlation coefficients of 0.37 in the symptomatic group and 
0.15 in the asymtomatic group. An underestimation of cardiac 
output by the dye dilution technique occurred in 32% of the 
symptomatic group and only 14% of the asymptomatic subjects. 
Similar cardiac outputs by the two dilution techniques were 
recorded in approximately 40% in each group with an overestimation 
by the dye technique in half the asymptomatic patients but in only 
one quarter of the symptomatic group. This discrepancy between 
these two tech~iques should not detract from the results as only 
the thermodilution method was used in the exercise evaluation. The 
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protocol followed was that previously reported by Elkayam et al 
0 
(1983), .namely a 5ml injectate at 0 C, taking the mean value of the 
second, third and fourth consecutive cardiac output measurements. 
We consistently found that the first reading was not accurate and 
may be related to the temperature of the catheter's contents after 
a long pause and on-going graded exercise; this was particularly 
found during the staged exercise measurements. No obvious 
explanation for this observation has been found and none of the 
. 
factors. operating in critically ill patients ~ere identified (Ganz 
1971, Wessel 1971, Weisel 1975, Snyder 1976). 
The LV end-diastolic volume index (LVEDVI) was markedly elevated 
2 
(normal LVEDVI 70-± 20ml/m , 
2 
Dodge 1983) in both groups with mean 
2 
values of 193 ± 63ml/m in the symptomatic group and 194 ± 47ml/M 
in the asymptomatic patients. In this latter group,· this large 
end-diastolic volume was associated with a normal or near normal LV 
end-diastolic pressure in the majority of cases, whereas in nearly 
half the symptomatic group the LV end-diastolic pressure was 
significantly elevated > 20mmHg. The considerable · increase in 
LVEDVI in both groups serves to confirm that all the patients 
evaluated had significant longstanding aortic regurgitation. 
Gault et al(l970) described a rightward shift of the left 
ventricular pressure volume curve in patients with chronic volume 
' 
overl'oad and it is possible that this phenome~on was responsible 
for·the large volume - low pressure status of the left ventricle in 
the majority of asymptomatic and some of the symptomatic patients 
and is the reason why you cannot equate PCWP and LV end-diastolic 
volume in these patients. 
Similarly, end-systolic volume index was markedly elevated (normal 
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2 
LVESVI 24 ± lOml/M , Dodge 1983) in both groups but surprisingly it 
was higher 
versus 88 
in the asymptomatic group (mean LVESVI 111 
2 




explanation is the fact that 3 of the symptomatic group had near-
normal LV volumes despite symptoms but, with only one patient(P.P) 
having an elevated LV end-diastolic pressure. A previously poor 
predictive value has been reported for angiographically derived LV 
volumes (Greves 1981). Both groups had similar resting LV ejection 
fractions (LVEF) measured angiographically using the area-length 
method (LVEF 0.54 + 0.12 symptomatic versus LVEF 0.56 + 0.09 
asymptomatic, Dodge 1960). Although 28% of the symptomatic group 
had abnormal resting values of < 0.50, only 18% of the asymptomatic 
patients had reduced systolic pump function. In the symptomatic 
group, half the patients (n = 9) had severe LV dysfunction with 
associated elevation of LV end-diastolic pressure > 20mmHg and 
2 
reduced resting cardiac index < 2.5L/min/M . In contrast, the 
subset of asymptomatic patients with abnormal LV contractile 
function (n = 5), all had a normal resting cardiac index with only 
2 of the group having an obviously elevated LV filling pressure. 
Both these subset were associated with marked LV dilatation. It 
would thus appear that in symptomatic patients with reduced resting 
LV systolic pump function, approximately half the patients will 
have added haemodynamic evidence of significant LV dysfunction with 
a reduction in cardiac index and an elevation of LV filling 
pressure. 
As will be noted from the angiographic data, all patients had 
qualitatively graded severe (3 to 4+) aortic regurgitation (Sandler 
1963, Hunt 1973). More recently Croft et al (1984) have reported 
that the angiographic grading of regurgitation was often at 
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variance with the measured regurgitant volume index, particularly 
in patients with LV cardiomegaly. 
2 
In patients with an LVEDVI > 
l20ml/M , angiographic grading of regurgitation was particularly 
likely to underestimate the regurgitant volume index, calculated by 
subtracting forward cardiac index from angiographic cardiac index. 
This was particularly true in patients with 3+ and 4+ regurgitation 
who, on the basis of qualitative assessment, might be recommended 
for aortic valve replacem~nt. They suggested that a quantitative 
assessment be performed before surgical therapy is recommended. 
In this regard, several methods of varying sophistication and 
reliability have been described (Sandler 1963, Hunt 1973, Lam 1981, 
Frank 1966, Clobanu 1982), including methods using electromagnetic 
flowmeters · (Mennel 1972) and catheter-tip velocity 
transducers(Nichols 1981). However, many of these techniques 
require specialised equipment, are tedious and time-consuming, thus 
precluding their widespread use. Only one previous study (Hunt 
1973) had compared the angiographic grading of aortic regurgitation 
with the regurgitant volume index, an accurate and widely used 
measure of valvular regurgitation (Hunt 1973, Sorensen 1980, 
1982). In addition, relatively little attention has been given to 
the magnitude of the regurgitant volume itself, which is indeed the 
basis for both the haemodynamic abnormality and the clinical 
syndrome, with elimination of the re~urgitant volume being the 
primary effect of successful valve replacement. Levine and Gaasch 
(1983) have proposed that there are convincing conceptual reasons 
and some experimental data to indicate that the. ratio of 
regurgitant volume to end-diastolic volume is the major determinant 
of the ventricular response to surgical correction of chronic 
aortic regurgitation. Although in isolation it may not optimise 
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the timing of valve replacement, its sequential non-invasive 
evaluation (Sorensen 1980, Konstam 1981, Urquhart 1981) and the 
determination of when the product of systolic EF and regurgitant 
fraction (by substitution equal to the ratio of regurgitant volume 
to end-diastolic volume) begins to fall, may help time aortic valve 
replacement. 
Using the angiographically derived regurgitant fraction (ratio of 
regurgitant volume to total stroke volume) rather than the 
regurgitant volume index, the mean value in the symptomatic group 
was 58 ± 16% with half the patients having a regurgitant fraction 
of > 60%. Although the mean value in the asymptomatic group did 
not differ appreciably (49 ± 13%), less than one fifth had a 
regurgitant fraction of > 60%. 
In 8 asymptomatic and 4 symptomatic patients, the angiographic 
regurgitant fraction was compared to that measured using the 
electromagnetic flowmeter technique, with a good correlation (r = 
0.85 in the asymptomatic and r = 0.82 in the symptomatic patients 
evaluated). These results again confirm that the patients evaluated 
in this study had a significant degree of aortic regurgitation. 
VIII.3.0 EARLY POSTOPERATIVE EVALUATION: 
The prognostic value of the pre-operative non-invasive evaluation 
of LV size, wall stress, systolic function and preserved exercise 
capacity is well accepted. Num-erous echocardiographic variables 
have been cited as important prognostic indicators, with a pre-
operative LV DES > 55mm (Grossman 1977, 
Henry 1980), LV DED > 80mm (Gaasch 1978, 
Stone 1984), fractional shortening< 29%, 
Bonow 1980, Cunha 1980, 
Clark 1980, Henry 1980, 
R/Th ratio > 4 (Gaasch 
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1978, Osbakken 1981, Kumpuris 1982) all being associated with an 
adverse prognosis. In addition, p~rsistent postoperative LV 
dilatation with a DED > 70mm is a poor prognostic indicator (Gaasch 
1978, Clark 1980, Henry 1980). It has been shown that the 
reduction in end-diastolic dimension (DED) occurs early, i.e. 
between 2 weeks and 2 months postoperatively (Venco 1976, Gaasch 
1978, Schuler 1979, Henry 1980), with little further change at 
later evaluation. This decrease in end-diastolic dimension may be 
predicted by 
(Clarke 1980, 
the pre-operative LV DES and fractional 
Henry 1980, Kumpuris 1982, Stone 1984). 
shortening 
However, a 
recent long-term study (Fioretti 1985) has shown that a decrease in 
LV size continues beyond the first postoperative year and that the 
persistence of moderate LV dilatation after surgery does not 
indicate a poor clinical prognosis. This observation confirms the 
earlier'work of Toussaint (1981). Importantly they also found that 
pre-operative M-mode echocardiographic variables were poor 
predictors of the clinical outcome and the regression of LV size. 
Fractional shortening (%FS) is generally not calculated 
postoperatively because'of the invariable occurrence of paradoxical 
septal motion. This is thought to be a motion artefact caused by 
exaggerated systolic anteromedial translation of the entire frame 
of reference (Kerber 1982, Waggoner 1982, Force 1983). 
Although systolic dysfunction (%FS or LVEF) at rest is widely 
reported as a sensitive predictor of ultimate outcome (Cunha 1980, 
Henry 1980, Forman 1981, Greves 1981), it is not specific, with 
improvement and even normalisation of LV systolic function 
frequently occurring despite severe pre-operative depression 
(Kennedy 1977, Gaasch 1978, Borer 1979, Schuler 1979, Schwarz 1979, 
Bonow 1980, Clark 1980, Ross 1981). In addition, the abrupt and 
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profound changes in loading conditions caused by ,aortic valve 
replacment, make the evaluation of LV systolic function 
particularly difficult in the early postoperative period. 
Following surgical correction of chronic AR substantial changes in 
LV volume, mass and systolic performance are well described and are 
a function of the pre-operative severity and time (Gaasch 1978, 
• 
Schuler 1979, Henry 1980, Carroll 1982, Kumpuris 1982, Carroll 
1983, Fioretti 1985). Despite the controversy regarding the time 
course of postoperative changes in LV dimensions (Tousaint 1981, 
Kumpuris 1982, Gaasch 1983), both angiographic EDV (Kennedy 1977, 
Panteley 1978, Schwarz 1979, Clark 1980) and echocardiographic DED 
(Gaasch 1978, Schuler 1979, Henry 1980) have been used to show that 
most patients achieve a normal or near-normal end-diastolic volume 
following aortic valve replacement. In general it would appear 
those patients who normalise their EDV do so within the first 7 to 
10 days after surgery. In patients with persistent LV dilatation, 
some show progressive chamber enlargement while others show no 
change or a modest decrease in heart size. The identification of 
this subset in the early postoperative period is thought to be 
important because aggressive medical therapy should be implemented 
in an attempt to reduce the high risk of congestive heart failure 
and early mortality. 
In contrast to the postoperative changes in LV volume, the 
regression of left ventricular hypertrophy (LVH) is variable and 
may never be complete (Kennedy 1977, Gaasch 1978, Panteley 1978, 
Schuler 1979, Schwarz 1979, Clark 1980, Henry 1980). The factors 
responsible for incomplete regression of LVH following technically 
successful aortic valve replacement are not well defined. The 
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extent of myocardial fibrosis (Schwarz 1978), associated systemic 
hypertension, patient-prosthesis mismatch (Rahimtoola 1978), and 
perhaps genetic or other undefined factors may all be important. 
Regression of LVH is likely to be associated with a decrease in LV 
diastolic chamber ~tif~ness, a major determinant of LV end-
diastolic pressure. This could account for a gradual late 
improvement in congestive symptoms over and above that related to 
the early reduction in LV volume. 
A normalisation or near-normalisation of LV end-diastolic pressure 
(LVEDP) commonly occurs following aortic valve replacement, even in 
patients with preoper~tiv~ LV failure (Gault 1970, Kennedy 1977, 
Panteley 1978, Borer 1979, Schwarz 1979, Clark 1980, Henry 1980). 
The mechanisms are incompletely understood but a decrease in 
regurgitant volume is almost certainly the major factor and a 
change in LV diastolic compliance has been suggested by Gault 
(1970). A later ·study by Schwarz (1978) concluded that the LV 
''stiffness constant" did not change after aortic valve replacement 
but this study had several methodologic flaws, the most important 
of which was the timing of the assessment. Because LV mass is not 
stable in the early postoperative period, studies which aim to 
evaluate the physical properties of the LV in diastole should not 
be performed before 6 month~. Although the above studies report a 
normalisation of LVEDP at rest, Lee et al (1971) have reported an 
abnormal elevation in LVEDP during exercise in several patients 
following aortic replacement (AVR). They postulated that this was 
due to persistent postoperative LV hypertrophy associated with a 
resultant decrease in diastolic compliance. 
There are in general only modest changes in resting LVEF at 6 
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months after surgical correction of severe aortic regurgitation, 
with pre-operative values ranging from normal to severely depressed 
(Kennedy 1977, Panteley 1978, Borer 1979, Schuler 1979, Schwarz 
1979, Clark 1980, Henry 1980). Although the time course of change 
in postoperative resting LVEF has not been defined, there is reason 
to believe that early postoperative studies might not reflect the 
eventual improvement. In a study by Boucher (1982), it was found 
that LVEF dropped significantly from 55 ± 12 to 40 + 14% early 
postoperatively, associated with a marked decrease in EDV. They 
concluded that this early reduction was predominantly the result of 
altered loading conditions rather than improved contractile 
function. Most patients with normal pre-operative values remain 
unchanged, in contrast to patients with LV dysfunction in whom 25-
50% can 
1980). 
expect an increase in resting LVEF (Clark 1980, Henry 
Borer et al (1979) showed that despite a slight increase in 
resting LVEF following AVR, the response to exercise remained 
abnormal in most patients. As previously discussed, the LVEF is 
determined by a complex interplay between preload, afterload and 
the contractile state of the LV. In those patients with a 
postoperative decrease in EDV and some regression of LVH, it is 
likely that an increase in LVEF is due to a combination of a 
reduction in systolic wall stress (afterload) and/or an increased 
contractile state. Thus at optimal preload, a postoperative 
decrease in LVEF is likely to be related to excessive afterload 
and/or depressed LV contraction. 
The early postoperative evaluation of my group of patients was thus 
designed to help examine the time course of change in both the 
anatomical and functional status of the left ventricle following 
successful AVR for chronic severe aortic regurgitation. 
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Although there was· a significant reduction in LV end-diastolic 
dimension from 74 ± 11 to 58± 13mm (p <0.05), only 38% (6 of 16 
patients) normalised their DED early postoperatively. This is 
sharp contrast to the early reports quoted above where early 
normalisation was the rule. In addition, it should be appreciated 
that 4 of the 5 patients with marked LV dilatation pre-operatively, 
had significant residual LV dilatation postoperatively, with a 
LVDED > 70mm. 
Although changes in end-systolic dimension (DES) are variable in 
the early postoperative period, there was a slight overall decrease 
in my study. More importantly however, is the observation that 
two-thirds (66%) of the patients with a pre-operative LVDES > 
55mm, increased this dimension in the early postoperative period. 
Only minor changes in cross-sectional area (CSA) were noted at 10 
days postoperatively, which is in agreement with previous reports. 
One of the proposed mechanisms includes postoperative oedema of the 
posterior LV wall, and although apparent in some individual 
patients in my study, as a group posterior wall thickness remained 
unchanged. This probably reflects the fact that the regression of 
LV hypertrophy is a slow, time-dependent process. 
Although paradoxical septal motion precluded the calculation of 
echocardiographic 
appreciating the 
fractional shortening postoperatively, and 
significant effect of changes in loading 
conditions on radionuclide determined LVEF, early postoperative 
LVEF was nevertheless measured. There was a uniform drop in early 
postoperative LVEF, confirming the results of Boucher et al (1981), 
with follow up data at 6 months (vide infra) showing that this 
merely reflected altered loading conditions rather than reduced LV 
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contractility. 
Thus, in summary, my data confirms that in patients with moderate 
LV dilatation there is a uniform decrease in echocardiographic DED, 
although early normalisation only occurred in about one-third of my 
patients, possibly related to the degree of pre-operative LV 
dilatation. In addition it would appear that patients with marked 
pre-operative LV dilatation run a major risk of significant, 
peTsistent postoperative dilatation and a poor surgical result. 
The slow regression of LV hypertrophy is also confirmed and finally 
it would appear that the early assessment of LV systolic function 
can be obtained using the radionuclide LVEF, but has little 
relevance to the ultimate 6 month outcome. 
VIII.4.0 SIX MONTH POSTOPERATIVE ASSESSMENT: 
As previously discussed, the postoperative changes in LV volume, 
mass and contractile fupction are generally stabilised by 6 months 
(Gaasch 1978, Schuler 1979, Henry 1980, Carroll 1982, Kumpuris 
1982), but further improvement has recently been reported up to 27 
months postoperatively (Toussaint 1981, Fioretti 1985). 
In general, it is reported that end-diastolic dimension normalises, 
and does so early. This is however contrary to my experience. 
Although regression of LV hypertrophy is usually incomplete, it is 
nevertheless associated with normalisation or near normalisation of 
resting LVEDP, sometimes despite pre-operative LV failure. 
Resting LVEF as a rule remains unchanged. However it has been 
reported that on exercise, LVEDP may rise, and the LV functional 
response remains abnormal in most patients. Nevertheless, the 
resting changes in mass and volume result in an overall improvement 
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in congestive symptoms following successful AVR for chronic severe 
AR. 
VIII.4.1 Improved Functional Status: 
My results are in agreement with previous reports (Kennedy 1977, 
Panteley 1978, Schwarz 1978) of an improvement in functional 
status, with 84% of my patients becoming asymptomatic and the 
majority of the rest improving by at least 1 functional class. It 
is thus encouraging to report that there appears to be littl~ doubt 
that the quality of life can be appreciably improved by AVR in 
severe symptomatic AR. 
VIII.4.2 Reduction in LV Voltage on Electrocardiogram: 
Several previous studies have shown that the electrocardiographic 
. 
(ECG) evidence for LVH is significantly decreased in approximately 
75% of patients following successful AVR, with normalisation of 
voltage in about half of these (Schwarz 1978, Carroll 1980, Henry 
1980). Despite only providing a semiquantitative measure of LV 
mass, it is a simple and inexpensive method of evaluating 
regression of myocardial hypertrophy, with most of the ECG voltage 
' 
changes also occurring within 6 months of valve replacement 
surgery. ' In agreement with the above experience, a significant 
decrease in LV voltage occurred in 87% of my patients, but with 
normalisation in only one quarter. In this subset, the degree of 
pre-operative LV hypertrophy did not appear predictive, except to 
say that none had a modest degree (< 60mm) of LV hypertrophy on 
their electrocardiogram. 
VIII.4.3 Decrease in Radiographic Cardia-Thoracic Ratio(CTR): 
The importance of a postoperative decrease in heart size was 
emphasised in a report on the long-term results of AVR by Hirshfeld 
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with a postoperative reduction in heart size surv~ved 
years compared to a 43% survival rate in those with an 
or increase in heart size. In my study, 89% of the 
had a reduction in CTR with approximately half this group 
having a normal heart size at the 6 month assessment. Thus my work 
confirms a reduction in CTR in the vast majority of patients 
following AVR for chronic severe aortic regurgitation, and it would 
appear that radiographic normalisation of heart size is common. 
VIII.4.4 Postoperative Changes in LV Dimensions: 
Although it appears to be generally accepted that changes in LV DED 
occur within 7 to 10 days following successful AVR (Hirschfeld 
1974, Gaasch 1978, Henry 1980), more recent studies with bigger 
patient groups, have shown continued reduction in LV size after the 
first 8 months following valve replacement (Toussaint 1981, 
Fioretti 1985). 
My series is in agreement with the more recent work, showing an 
overall reduction in LV DED by 42% at 6 months, but importantly, 
40% of this overall decrease occurred relatively late, i.e. between 
the 10 day and 6 month assessment. Thus, although 38% of the group 
had normalised their DED early postoperatively, 72% had a normal LV 
DED at 6 months, confirming the overall impression that most 
patients achieve a normal or near-normal end-diastolic volume 
following AVR. 
Although marked LV dilatation is uncommon in most reported series, 
including my own (22% had a DED > 80mm), three quarters (75%) had 
persistent postoperative dilatation with a mean LV DED o£ 68 ± 4mm. 
Although the prognostic significance cannot be assessed from my 
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the reported literature (Gaasch 1978, Schuler 1979, Carroll 1981, 
Carroll 1982). Forty four percent (44%) of my patients normalised 
2 
their LV mass, 23% near-normalised (CSA < 24.0cm ) and only one 
third of the group had significant persistent LVH. The mean pre-
operative CSA for this subset was significantly higher (36.1 ~ 5.5 
2 
versus 28.5 ~ 10.1cm , p <0.01), refuting an earlier claim in a 
study on hypertension-induced LVH (Rowland 1982) that the greater 
the LV mass before treatment, the more marked the regression of the 
hypertrophy. However, this difference may be due to the different 
inciting stimuli and type of LV hypertrophy (Grossman 1980). Half 
the patients who normalised their LV mass postoperatively had 
severe pre-operative hypertrophy. Nevertheless, the numbers are 
small and one would be reluctant to postulate that the degree of 
pre-operative LVH may be predictive of postoperative regression. 
When stratified into normal postoperative CSA (subset 1, n = 8) and 
persistent postoperative LVH (subset 2, n = 6), certain important 
differences were apparent (see Appendix VI). The degree of pre-
operative LV dilatation was slightly higher in subset 2 (OED 76 + 
10 versus 69 ~ 9mm, p = NS) and includes 3 of the 4 patients with 
marked LV dilatation. Although normalisation of pre-operative EDV 
was the rule in subset 1 patients (75%), persistent LV dilatation 
occurred in half the subset 2 patients. However, the degree of 
pre- and postoperative afterload stress was similar in the two 
groups, suggesting that the degree of LVH was appropriate for the 
chamber size and the maintenance of a normal systolic wall stress 
(Gaasch 1979, Panidis 1984). 
Although pre-operative resting PCWP was significantly lower in the 
subset 1 patients (12 ± 4 versus 18 ~ 4mmHg, p <0.01), the degree 
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of LV hypertrophy did not appear to significantly influence the 
postoperative, supine resting or peak exercise PCWP. 
Postoperatively there were similar incremental improvements in both 
resting and exercise radionuclide determined ejection fraction in 
both subsets. However, there was a slight (p = NS) but definite 
reduction in peak exercise PCWP in the subset with a normal 
postoperative LV mass which was significantly lower than the 
exercise value in the subset with persistent LV hypertrophy. 
The most striking differences were in the resting and exercise peak 
and average diatolic filling rates. In the subset who normalised 
their LV mass postoperatively, incremental improvements ranged from 
48% for resting average diastolic filling rate (p = NS) to 103% for 
exercise ADFR (p <O.Ol) and from 61% for resting peak filling rate 
(p <0.05) to 85% for exercise PFR (p <0.01). Importantly, these 
values were at similar heart rates (Bianco 1985) and thus appear to 
reflect a marked improvement and normalisation of diastolic 
function both at rest and on exercise in this subset of patients. 
This was also associated with an appreciably lower exercise PCWP 
and a higher LVEF in this group, highlighting the importance of 
diastolic relaxation and filling to adequate systolic function 
(Bonow 1981, Polak 1982, Bahler 1983, Bianco 1985). The exact 
implictions of this marked impr~vement in diastolic function on the 
long-term results of patients undergoing AVR for symptomatic severe 
AR remain to be determined. 
VIII.4.6 LV Function at Rest and during Supine Bicycle Exercise 
after AVR in Patients with Chronic AR: 
A major concern in chronic AR has been the development of 
irreversible myocardial dysfunction with late death from congestive 
heart failure despite technically successful AVR. For example, 78% 
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of late postoperative deaths from 1972 to 1978 in the National 
Institutes of Health study (Bonow 1982) were related to chronic 
congestive heart failure. As a result, several prognostic 
indicators relating to LV dimensions and systolic function have 
been proposed to aid in the appropriate timing of surgery and the 
identification of high-risk patients with a poor prognosis 
(Copeland 1977, Fischl 1977, Cunha 1980, Forman 1980, Henry 1980, 
Greves 1981, Gaasch 1983). 
Using the rationale that a decrease in LVEF on exercise may 
represent an intermediate point between normal function and LV 
dysfunction at rest (Borer 1978), a pre-operative fall in LVEF on 
exercise has been suggested as a predictor of a high-risk group of 
patients who may have subsequent deterioration in myocardial 
function after AVR (Borer 1978, Borer 1979, Bonow 1982). However, 
during exercise there is a complex interplay of changes in preload, 
afterload and contractility, all of which may singly or in 
combination, influence the ejection fraction response to exercise, 
particularly in patients with chronic AR. Thus it is difficult, if 
not impossible-, to differentiate changes in loading conditions from 
myocardial degenerative changes. There is increasing evidence.that 
exercise-induced LV dysfunction in symptomatic patients is often 
reversible after surgery (Bonow 1983, Bonow 1984), and a recent 
study by Gee et al (1985) with a 30 month follow up period found no 
prognostic significance of exercise-induced LV dysfunction in 
chronic AR. 
Most studies addressing changes in resting and exercise 
haemodynamics following AVR for chronic 
' . 
severe AR report an 
approximately 20% incidence of abnormal findings at re-evaluation 
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{Bristow 1964, Beck 1966, Lewis 1966, Ross 1966, Bjork 1967, 
Hultgren 1969). Despite intense interest in diastolic function 
particularly in patients with ischaemic heart disease, (Bonow 1981, 
Mancini 1983, Poliner 1984), hypertension (Inouye 1984, Fouad 1984, 
Smith 1985) and congestive heart failure (Monrad 1984), few reports 
address the problem in chronic volume overload (Eichhorn 1982) and 
to my knowledge there are no reports in patients following 
successful AVR. 
Apart from the fact that LV dysfunction appears to be reversible, 
it has become appreciated that preserved exercise capacity (Bonow 
1980) and the duration of pre-operative LV dysfunction (Bonow 1984) 
are important determinants of reversibility. However, a few recent 
reports suggest that improved operative techniques in the current 
surgical era rather than pre-operative LV function determines the 
postoperat~ve result (Fioretti 1983, Daniel 1985, Fioretti 1985). 
The good degree of haemodynamic improvement observed in the present 
study is in accord with the observations of other workers (Bristow 
1964, Beck 1966, Ross 1966, Bjork 1967, Hultgren 1969). Exercise 
capacity improved by at least one exercise level in the majority of 
patients (2/3) and represents a 40% overall improvement in exercise 
duration. Normalisation of resting cardiac index occurred, in 4 out 
of 5 patients with a depressed pre-operative value, and although 
resting PCWP remained abnormal in nearly one third of cases (32%), 
this represents a significant drop from the pre-operative 
assessment where 53% of patients had an abnormal resting LV filling 
pressure. However, in contrast to some previous reports, exercise 
PCWP remained markedly abnormal, with normalisation occurring in 
only 2 patients (12.5%). Obvious causes of residual cardiac 
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dysfunction after valve replacement surgery, including-prosthesis 
insufficiency (Petersen 1967), pre-existing coronary arte~y disease 
(Linhart 1968) and persistent postoperative LV dila~ation (Braun 
1973) were not operative in this study. Although an increase in 
LVEDP on exercise in general reflects an increase in LV end-
diastolic volume (Ross 1966), it has been postulated that this may 
be magnified by an increase in LV stiffness (Braunwald 1963). From 
my study it will be noted that at similar resting and peak exercise 
heart rates, both peak and average diastolic filling rates improved 
significantly with near-normalisation in the subset with regression 
of LV hypertrophy. Associated improvements included peak exercise 
PCWP, which was appreciably lower than in the group with residual 
LVH (25 + 10 versus 35 ± 8mmHg, p = NS), and also peak exercise 
LVEF. Thus, although regression of LV hypertrophy is associated 
with improved diastolic filling and an appreciable reduction in 
exercise PCWP, normalisation is uncommon and this may reflect the 
preload dependance of this chronic severely volume overloaded LV 
following AVR. 
Another important finding is that resting LVEF increased 
significantly with normalisation in 78% of those patients with 
abnormal pre-operative values. This finding is contrary to earlier 
reports from our own (Forman 1980) and other institutions (Cohn 
1974, Fischl 1977, Greves 1981) citing a depressed pre-operative 
resing LVEF a's a poor prognostic indicator. In agreement with the 
recent literature (Bonow 1982, Bonow 1983, Bonow 1984, Gee 1985), 
exercise LVEF increased appreciably from 45 ± 15 to 66 ± 19%, with 
\ 
normalisation in three-quarters of cases. In addition, the level 
of pre-operative exercise LVEF does not appear to be predictive, as 
3 out of 5 patients in the subgroup with an exercise value of < 35% 
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normalised postoperatively. 
Coincident with an improvement in clinical status and echocardio-
\ 
graphic measures of LV mass and size, there is an improvement in 
exercise capacity, resting haemodynamics and radionuclide 
determined systolic and diastolic function. Significant improve-
ments occurred in exercise systolic and diastolic function, but in 
contrast, persistent and marked elevation in exercise PCWP was 
noted. Markedly improved relaxation precludes the incrimination of 
abnormal diastolic stiffness as the operative mechanism and this 
must reflect significant LV dilatation on exercise. Thus it would 
appear that the previously chronic volume-overloaded LV of aortic 
regurgitation is critically preload dependent (Rankin 1975) in 
maintaining a normal resting and peak exercise (supine) LVEF 
following AVR. 
Postoperatively the majority of these patients were limited by leg 
fatigue and not by shortness of breath as they were pre-
operatively, and improved diastolic relaxation may thus play a 
pivotal role in this late improvement in congestive symptoms on 
exercise. 
VIII.4.7 LV Function at Equivalent Workloads During Supine Bicycle 
Exercise after AVR for Chronic .Aortic Regurgitation: 
Despite many reports on the postoperative evaluation of patients 
following aortic valve replacement for chronic AR, numerous factors 
make this comparison extremely difficult. Aortic valve replacement 
results in an abrupt change in preload due to the cessation of 
regurgitation, and is reflected by an appreciable decrease in early 
postoperative DED (Gaasch 1978, Schuler 1979, Henry 1980, Carroll 
1982, Kumpuris 1982). Apart from the change in loading conditions, 
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prosthetic aortic valves are mildly stenotic, thus substituting 
mild pressure overload for severe volume overload. In addition, 
the exercise capacity is generally improved, thus a comparison of 
results at peak exercise in fact reflects changes at different 
external workloads. 
In an attempt to minimise this latter variable, we evaluated· LV 
function at equivalent workloads during supine bicycle exercise 
after AVR. Both haemodynamic and radionuclide variables showed 
little change between equivalent workload and peak supine exercise 
and thus this form of analysis appears to add little to the overall/ 
assessment of these patients. The importance of this, however, is 
that it is not necessary to exercise these patients to exhaustion. 
VIII.4.8 LV Function at Rest and during Erect Bicycle Exercise 
after AVR in Patients with Chronic AR: 
Contrary to earlier reports (Crawford 1979, Poliner 1980, Thadani 
1981, Shen 1985}, I have shown that there appears to be very little 
influence of posture on the exercise response of the left ventricle 
in patients with chronic severe aortic regurgitation. As a result, 
erect exercise, which more closely simulates normal daily activity, 
is recommended as the posture of choice for exercise evaluation. 
In an attempt to justify its use in the postoperative assessment of 
thes~ patients, this posture was also used at the 6 month 
evaluation in my study. However, it should be noted that the 
sample size is much smaller (n = 9), because the tilting facility 
was not available pre-operatively in the other cases. 
The pleasing haemodynamic improvement noted during supine bicycle 
exercise was mirrored in the erect posture. Resting cardiac index 
likewise normalised in 5 out of 6 patients with PCWP remaining 
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unchanged. Exercise heart rate was similar in the two postures but 
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normalisation in 80% of those patients with reduced pre-operative 
values. Overall resting LVEF was higher in the erect posture (71 ± 
17 versus 63 ± 14%) which is contrary to the effect of posture on 
LVEF in normal subjects where resting values are similar in both 
postures (Poliner 1980). 
During erect exercise, LVEF increased significantly with 
normalisation of abnormal pre-operative values in a slightly higher 
percentage during this posture (83% versus 75%). Again, the level 
of pre-operative exercise LVEF did not appear predictive, with two-
thirds of patients with marked reduction in pre-operative exercise 
LVEF ( <35%) normalising postoperatively. 
As occurred during the supine posture, a striking improvement in 
diastolic function occurred with normalisation of resting and 
near-normalisation of peak exercise PFR and ADFR. 
Thus the overall improvements in haemodynamics and radionuclide-
derived measures of systolic and diastolic function were similar 
during the two postures and amplifies our recommendation that the 
erect posture be the body position of choice in the exercise 
evaluation of these patients. 
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VIII.4.9 The Use of Isometric Handgrip in the Postoperative 
Evaluation of Chronic AR: 
Despite some of the previously mentioned theoretical advantages of 
using isometric handgrip exercise as a means of LV stress, it has 
again been shown to be of no benefit in the postoperative 
evaluation of patients with chronic AR. This part of the study 
therefore reinforces our recommendation that this form of exercise 
has no role in the pre- or postoperative assessment of the effects 
of chronic volume overload due to aortic regurgitation on the 
structure and function of the left ventricle. 
VIII.S.O SEQUENTIAL ASSESSMENT: 
Against the background of the common indications for valve 
replacement surgery (Rahimtoola 1977), increasing attention is 
being given to the role of early valve replacement in asymptomatic 
or minimally symptomatic patients with chronic severe aortic 
regurgitation (Kirklin 1973, Isom 1974, Smith 1976), particularly 
when associated with LV dysfunction (Henry 1980, Turina 1984). The 
rationale for early operation is the prevention of deteriorating 
myocardial-function (Kouchoukos 1976). 
However, more recently the excellent prognosis with conservative 
therapy in the subset of asymptomatic patients with chronic severe 
aortic regurgitation and normal LV function has been reported 
(Bonow 1983). The issue has been further complicated by the fact 
that most of the well known non-invasively determined prognostic 
indicators have at one time or another been shown to be of limited 
value (Linhart 1975), including an echocardiographic LV .DES > 55mm 
and more recently the LV ejection fraction response to exercise 
(Gee 1985). 
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Nevertheless, there remains the worrying clinical problem of a 
group of patients who develop LV dysfunction prior to the onset of 
symptoms. The natural history study of Bonow et al (1983) showed 
that once LV dysfunction develop~d, symptoms were likely to develop 
within a shor~ time (months). My own experience forms the subject 
of this last part of the discussion. 
VIII.5.1 Clinical Status: 
Functional status, the degree of LV hypertrophy on 
electrocardiogram and the cardio-thcracic ratio remained 
essentially unchanged over the 6 to 12 month follow-up period 
despite nearly half (12/26) of the patients having an LV DED of > 
70mm and 4 out of 26 having a LV DES > 50mm. It would thus appear 
that on clinical grounds an annual assessment in asymptomatic 
patients with chronic severe aortic regurgitation seems adequate. 
VIII.5.2 Serial Echocardiographic Dimensions: 
Appreciating the limitations of the M-mode echocardiogram (Linhart 
1975, Johnson 1976, Bhatt 1978, Abdulla 1980), the mean LV DED 
remained unchanged at 6 months, .with only a small number (12%) 
showing progressive dilatation during this period. Two of the 
three cases had progressed into the range ( > 70mm) predictive of 
the development of symptoms or LV dysfunction. 
In the one patient where 12 month follow up was available, no 
further increase in DED occurred. None of the other 
echocardiographic measurements, namely, DES or fractional 
shortening or systolic wall stress were predictive of this change 
in diastolic dimension. In only one patient did progressive 
dilatation first occur at the 12 month assessment. Thus, in 
\ 
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summary, in an asymptomatic group of patients with chronic severe 
AR, LV diastolic size appeared to be relatively stable over a short 
term (12 month) assessment period, with progressive LV dilatation 
only occurring in a small minority of cases. 
Similarly, end-systolic dimension (DES) remained stable over the 
first 6 month assessment period, but there was a progressive 
increase in DES in nearly half (4/9) the patients at the 12 month 
evaluation. The LV DES was > 50mm in 75% of these cases, and thus 
predictive of those patients who may increase their end-systolic 
dimension at serial assessment. The increase in DES was often 
associated with a fall in fractional shortening. Two of the three 
patients with a LV DES > 55mm at the 12 month assessmeqt remained 
asymptomatic, although one (A.C) became symptomatic at 18 months 
and subsequently underwent successful aortic valve replacement. 
VIII.5.3 Serial Echocardiographic Systolic Function and 
Stress: 
Fractional shortening (%FS) as a measure of systolic function 
remained stable over the 12 month sequential assessment period, 
although in 3 patients (12%) there was a progressive fall in FS to 
within the abnormal range at 12 months. All three were associated 
with a LV DES > 5.5cm. 
Importantly, two of the patients who demonstrated an obvious fall 
in %FS at 6 months had no change in resting LVEF assessed by 
equilibrium radionuclide angiocardiography. It would thus be 
reasonable to recommend that a deterioration in echocardiographic 
systolic function be substantiated by another non-invasive measure 
in the serial assessment of asymptomatic severe AR. 
Despite an overall unchanged systolic wall stress at 6 months, an 
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appreciable number of patients (38%) had a moderate increase in 
wall stress (411 ± 72 to 518 ± 73mmHg) due to progressive LV 
dilatation in some patients. Thus it would appear that inadequate 
hypertrophy is the operative mechanism in most cases where·there is 
a progressive increase in systolic wall stress. When stratified on 
LV functional reserve (vide infra), the afterload in the subgroup 
with a normal functional reserve was significantly lower than in 
the group with a fall in exercise LVEF. 
VIII.5.4 Serial Changes in Supine Resting Haemodynamics and 
Radionuclide Data: 
In agreement with previous haemodynamic studies and the known 
pathophysiologic changes in chronic volume overload (Braunwald 
1969, Lewis 1970, Judge 1971, Vatner 1976, Boucher 1983), resting 
heart rate and systolic BP remained essentially unchanged but there 
was a slight and progressive increase in LV end-diastolic pressure 
(PCWP) and an increase in echocardiographic LV end-diastolic 
dimension. In addition, a small progressive reduction in resting 
cardiac index was noted. 
When stratified according to LV functional reserve, only minor 
changes were apparent, with a progressive increase in PCWP ·and 
. 
decrease in cardiac index in both subsets. However, cardiac index 
remained within the normal range in the subgroup lA patients 
despite a significant number of them developing an abnormal resting 
PCWP, signifying less severe LV dysfunction (Braunwald 1969). 
Although systolic function as determined by radionuclide LVEF 
remained unchanged, with time there was a progressive fall in both 
peak and average diastolic filling rates in the subgroup lB 
patients, and· this impairment of diastolic function (increased 
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diastolic stiffness) may thus be a marker for an abnormal 
functional reserve in asymptomatic patients with chronic severe 
aortic regurgitation. 
VIII.5.5 Serial Changes in Supine Exercise Haemodynamics and 
Radionuclide Data: 
Exercise capacity was variable, although one-third of the group 
with a normal LVEF response and half the patients with an abnormal 
LV functional reserve increased their capacity by 1 exercise level 
(150k-p.m./min). This may be due to a training effect (Froelicher 
1983), but more likely reflects familiarisation with the exercise 
protocol. 
As occurred at rest, with time there was a progressive rise in PCW 
pressure on exercise, with a bigger percentage of patients 
developing abnormal exercise wedge pressures but maintaining the 
same cardiac output. This pattern of a progressive increase in 
PCWP only to be followed at a later stage by a fall in cardiac 
output has been well described (Braunwald 1969) and in haemodynamic 
terms represents an intermediate phase between normality and 
overt, se~ere LV dysfunction. 
When divided according to LV functional reserve, patients with a , 
fall in exercise LVEF demonstrated a higher systolic BP and PCWP 
i.e. afterload and in addition had significantly lower peak and 
average diastolic filling rates. Thus although the degree of 
afterload stress appears to significantly infl~ence the LVEF 
response to exercise, abnormalities of diastolic filling appear to 
play a contributory role, with abnormal diastolic stiffness at rest 
being an early marker as suggested in the above discussion. 
With time, one-third of patients with a normal functional reserve 
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developed a fall in LVEF on exercise. In one patient this was 
associated with an appreciable change in diastolic filling. A 
small minority (18%) of the subgroup lB patients normalised their 
functional reserve without an apparent reason, doing so at 6 months 
in all cases. Thus, in some asymptomatic patients there appears to 
be a variable LVEF response to exercise. 
Thus it would appear .that in the sequential assessment of patients 
with asymptomatic severe AR there is a gradation of haemodynamic 
changes, starting with a progressive rise in both exercise and 
resting PCWP, and in patients with an abnormal LV functional 
reserve, associated with a reduction in resting cardiac index. In 
addition, a progressive increase in the number of patients with an 
abnormal LV functional reserve, was also noted. 
This study thus confirms the observation by Borer et al (1979) that 
an abnormal LV functional reserve is common in asymptomatic 
patients with chronic severe AR and in addition shows that there is 
a progressive increase in the number of patients with this 
.abnormality. Apart from excessive afterload being an important 
pathogenetic mechanism, confirming the work of Lewis (1982) and 
Greenberg (1985), it would appear that increased diastolic 
stiffness plays a contributory role in this response to exercise. 
VIII.5.6 Serial Changes in Erect Resting Haemodynamics and 
Radionuclide Data 
In contrast to the progressive abnormalities in PCWP in both 
subsets and the reduction in resting cardiac index in subset lB 
patients in the supine posture, no such changes were evident in the 
erect posture. Although this is in agreement with the recent 
observation by Shen et al (1985), I don't agree with their 
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recommendation that the supine position thus be the posture of 
choice for evaluation of these patients, as most of the other 
haemodynamic and radionuclide changes are similar (vide infra) and 
more importantly the majority of these abnormalities are fully 
reversible after aortic valve replacement. 
In the erect posture, resting LVEF remained essentially unchanged 
over the 12 month follow up period, although one-third of patients 
(similar to the supine evaluation) with a normal functional reserve 
had a progressive fall in resting LVEF, however remaining within 
the normal limits. This drop in LVEF was associated with a 
significant decrease in diastolic filling rates and once again 
serves to highlight the importance of systolic-diastolic 
interaction (Bonow 1981, Polak 1982, Bahler 1983). 
VIII.5.7 Serial Changes in Erect Exercise Haemodynamics and 
Radionuclide Data: 
The serial exercise haemodynamic changes were similar during this 
posture, with a progressive rise and ·a greater percentage of 
patients (particularly subset 1) developing an abnormal PCWP on 
exercise but maintaining the same cardiac output. 
As seen during supine bicycle exercise, exercise capacity improved 
in a similar number of subgroup lA patients but in a much lower 
percentage (21%.versus 50%) of subset lB patients. Exercise LVEF 
remained unchanged although significantly lower in group lB 
patients at 6 months. It is again evident that intersubgroup and 
intrasubgroup variation (6 months and 12 month assessments) in LV 
functional reserve correlates significantly with changes in 
diastolic filling. Changes in subset status were less frequent 
during this posture. 
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VIII.6.0 CONCLUSIONS: 
In the overall analysis of this study I believ~ that a number of 
important conclusions can be drawn, some of which differ from 
previously published work. The explanation probably lies in the 
fact that this thesis must be seen in the South African context 
where severe valvular heart disease is a disease of the young. 
These conclusions will be numerically listed and include:-
1. The clinical features, including the electrocardiogram and 
chest X-ray, and degree of LV dilatation measured 
echocardiographically were similar in the two groups of 
patients studied. However, twice the number of symptomatic 
patients had marked LV dilatation (DED > 80mm). Thus clinical 
evaluation and echocardiography did not help differentiate the 
symptomatic from asymptomatic groups. 
2. In both groups exercise posture was not important in the 
stratification of patients on the basis of the LV ejection 
fraction response to exercise. A similar percentage of 
patients had an abnormal LV functional reserve in both the 
supine and erect postures. Upright exercise is more 
physiological and therefore the posture of choice in the 
exercise evaluation of patients with chronic severe aortic 
regurgitation. 
3. The haemodynamic profiles at rest and during peak exercise 
during both body positions are in agreement with previous 
reports. In the supine posture it is important to note that 
resting PCWP was abnormal in 50% of the asymptomatic group and 
abnormal in all of this group on exercise. Although resting 
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values were lower in the erect posture, similar peak exercise 
values were recorded. The ability to tolerate an extremely 
high exercise PCWP (range 30 - 50mmHg in the symptomatic group) 
appears to be a major compensatory mechanism in patients with 
chronic severe AR. 
4. This study confirms that a drop in LVEF on exercise is common, 
in patients with chronic severe AR, occurring in 81% of the 
symptomatic group and in approximately 50% of the asymptomatic 
patients. The resting value did not appear to be predictive, 
with a normal or equivocal exercise response occurring over a 
wide range of resting ejection fractions. 
The exercise LVEF correlated poorly with other measured 
variables (haemodynamic and radionuclide) and thus its 
usefulness in the management of these patients is questionable. 
This is not surprising given the known limitations of this 
dimensionless measure of LV function. 
5. Although resting and exercise diastolic filling patterns (both 
peak and average diastolic filling rates) measured non-
invasively were significantly abnormal in both groups of 
patients, marked improvement with near-normalisation occurred 
postoperatively. This was associated with a lower PCWP and 
higher LVEF both at rest and on exercise, highlighting the 
important contribution of diastolic relaxation and filling to 
adequate systolic function. 
6. An abnormal functional reserve and elevation of PCWP occurred 
early during graded, supine, syptom-limited bicycle exercise 
and was generally maximal at level 2 or 3 of exercise. This 
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was followed by a plateau phase. Low level exercise is thus 
adequate to stratify patients, accepting the fact that 
exercise capacity has been demonstrated to be an independent 
prognostic factor. 
7. Isometric exercise appears to be a poor form of stress in 
patients with chronic severe aortic regurgitation and is not 
recommended as an alternative to dynamic bicycle exercise. 
8. The early postoperative assessment confirmed a uniform decrease 
in LVDED in the patients with moderate LV dilatation, but 
contrary to most reports, 
one third of the patients. 
pre-operative dilatation 
early normalisation occurred in only 
In addition, patients with marked 
run a major risk of persistent 
postoperative LV enlargement; my study confirms that regression 
of LVH is a slow process following aortic valve replacement. 
9. The sequential evaluation of the asymptomatic patients showed a 
gradation in haemodynamic changes which was similar during both 
supine and upright exercise. There was also a progressive 
increase in the number of patients with an abnormal LV 
functional reserve and, although an increase in afterload 
appears to be the dominant mechanism, increased diastolic 
stiffness may play a contributory role. It is also important 
to note that some patients showed a variable LVEF response to 
exercise. 
10. Findings at the six month postoperative assessment form the 
last conclusion and in summary serves to re-affirm our present 
practice at this institution of only recommending aortic valve 
replacement in symptomatic patients with AR. 
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(a) Postoperatively there was a marked improvement in 
symptomatic status and thus quality of life with 84% of the 
group becoming asymptomatic. 
(b) Contrary to previous reports, normalisation of EDV 
following AVR can be·a late phenomenon, occurring between two 
weeks and six months in about half the patients following valve 
replacement. 
(c) A pre-operative DES > 55mm was found not to be a , poor 
predictor of postoperative outcome with resting haemodynamics 
and LV functional reserve normalising in most cases. 
(d) LV mass normalised or near normalised in the majority of 
cases undergoing AVR (77%). 
the reported literature. 
This observation is different to 
(e) Exercise capacity improved by at least one exercise level 
in most cases. 
(f) Despite normalisation of echocardiographic dimensions and 
resting LVEF, PCWP remained abnormal (> l5mmHg) at rest in one 
third of the patients. On exercise PCWP was markedly abnormal. 
in 87.5% of the stu.dy group. This finding has not been 
appreciated in the past and although LVH regressed and 
diastolic filling improved in some cases, this finding may 
reflect the preload dependence of the chronically volume 
overloaded left ventricle. 
(g) Both resting and peak exercise LVEF normalised in ± 75% of 
cases. This could not be predicted by the level of pre-
operative exercise LVEF and thus serves to confirm a recent 
report that a drop in LVEF on exercise does not appear to be of 
prognostic significance. 




The patient's blood was labelled using the Brookhaven National 
Laboratory (BNL) Red Cell Kit for preparing Technetium-99m labelled 
red blood cells. 
Four millilitres(4ml) of the patients blood was withdrawn into a 
heparinised 5ml syringe and this sample was then transfered to the 
lOml capacity BNL vacutainer reagent tube containing 2.0 micrograms 
of tin, 3.67 milligrams of sodium citrate and 5.50 milligrams of 
dextrose. The blood containing BNL tube was then gently mixed for 5 
minutes at room temperature to dissolve the freeze-dried solids in 
the blood. 
Six millilitres(6ml)' of sterile normal saline was then added to the 
tube to dilute any plasma trapped in the cell sediment, thus 
minimising the depression of red blood cell labelling yield. The 
tube was gently inverted 6-8 times to ensure adequate mixing. It 
was then centrifuged upside down for 5 minutes at 2900 revolutions 
per minute to separate the red blood cells: the tube was 
maintained in the inverted position to-avoid disturbin~ the packed 
red cells. Using a sterile 20 gauge needle, approximately 1.2ml of 
packed red cells were removed and added to 30mCi(lllO 
megaBequerels) of Technetium-99m, in a volume of 1 to 3ml in a 
sterile pharmaceutical vile. The Technetium-red blood cell mixture 
was then incubated for 10 minutes at room temperature with gentle 
mixing. Labelling now being complete, the mixture was drawn into a 
sterile syringe and injected into the patient. 
APPENDIX II: 
LEFT VENTRICULAR EJECTION FRACTION NORMAL VALUES 
VARIATION, VALIDATION, REPRODUCIBILITY. 
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The following are the resting normal values for the Groote Schuur 
Hospital Cardiac Clinic/Department of Nuclear Medicine 
Laboratories. 
A. NORMAL VALUES. 
Forty four(44) subjects without clinical, che~t X-ray or 
electrocardiographic evidence of cardiac disease were studied. 
Subjects included normal volunteers and patients with malignant 
disease being screened prior to therapy with the cardio-toxic agent 
Adriamycin. The .mean left ventricular ejection fraction was 65% 
(S.D.±8%). We have accepted 65 + 2 S.D. as normal i.e. 49-81%. 
B. CORRELATION WITH CONTRAST ANGIOGRAPHY. 
In 36 patients who had contrast right anterior oblique left 
ventriculography in the course of routine investigation and during 
the same admission had Multigated Equilibrium Blood Pool Scanning 
performed, the results of l~ft ventricular ejection fraction by the 
two techniques were compared. Contrast left ventricular ejection 
fraction was calculated from the end-diastolic and end-systolic 
frames of the contrast left ventricular angiogram using the area-
length method. Patients were unselected and included patients with 
regional left ventricular wall motion abnormalities and valvular 
heart disease. The correiation was good (R = 0.891). 
C. INTER-OBSERVER VARIATION. 
Eighty seven(87) studies performed on 39 patients were analysed by 
two different operators. The operators were unaware of results 
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obtained previously. There was a good correlation between the 
results obtained by the two operators (R = 0.978). 
D. INTRA-OBSERVER VARIATION. 
One hundred(lOO) studies performed on 42 patients were analysed on 
two separate occasions, more than 10 days apart by the same 
operator. The operator was unaware, at the time of the second 
analysis, of the initial results. There was a good correlation 
between the results obtained on the two analyses (R = 0.995). 
E. REPRODUCIBILITY. 
Fifty five(55) patients were studied with Multigated Equilibrium 
Blood Pool Scanning on two occasions. No interventions had been 
performed and there was no clinical, electrocardiographic or chest 
X-ray evidence of any change in their cardiac condition. The left 
ventricular ejection fractions were calculated without knowledge of 
the previous results. A good correlation was obtained (R = .975). 
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APPENDIX III: 


















CHRONIC AORTIC REGURGITATION 
Compensated Borderline Decompensated 
< 3. 7 3.7 - 4.0 >4.0 
<2.5 2.5 - 2.6 >2.6 
>29 25 - 29 <25 
<3.8 3.8 - 4.0 >4.0 
<550 550 - 600 >600 
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APPENDIX IV: 
ECHOCARDIOGRAPHIC RESULTS STRATIFIED ON LV FUNCTIONAL 
RESERVE: (Symptomatic Group) 
GROUP 1A(n = 6) 
DEDI DES! FS R/Th sws CSA 
*N.L. 4.7 3.5 24 3.7 592 26 
*R.L. 2.7 1.4 48 2.9 269 26 
*S.M. 4.1 2.4 40 3.1 465 23 
*J.N. 4.3 2.9 32 3.4 482 20 
*N.P. 4.4 3.1 29 2.2 330 38 
*MvB. 3.2 2.4 25 3.1 465 23 
MEAN 3.9 2.6 33 3.1 434 26 
±_SD 0.8 0. 7 9 0. 5 21 6 
GROUP 1B(n = 21) 
M.A. 3.8 2.5 33 2.5 589 29 
F.A. 5.1 3.3 35 2.5 456 43 
R.A. 4.5 3.3 28 3.8 608 27 
M.B. 4.9 3.9 21 4.4 1004 37 
B.B. 5.3 3.2 40 3.5 588 36 
R.C. 4.2 2.8 34 4.2 651 30 
D.D. 4.0 2.6 36 2.2 331 25 
MdV. 4.7 3 .o 37 2.2 306 43 
E.G. 5'.1 3.3 35 3.5 560 30 
K.G. 3.1 2 .o 33 1.9 300 38 
M.H. 4.0 2.8 30 2.9 401 48 
B.H. 3.9 2.9 25 3.2 475 33 
E.J. 3.9 2.6 34 2.7 542 29 
J.L. 5.3 4.1 22 3.3 430 41 
M.L. 4 .o 3.4 15 4.3 595 19 
H.M. 3.8 2.3 38 2.3 439 30 
H.M. 4.6 3.3 28 3 .o 450 32 
M.N. 4.3 2.8 35 2.8 443 35 
E.N. 3.9 2.7 32 2.7 382 26 
P.P. 3.4 1.9 44 3.6 499 16 
EvH 4 .o 2.7 34 3.9 663 28 
MEAN 4.3 2.9 32 3.1 510 32 
±_SD 0.6 0. 5 6 0. 7 156 6 
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APPENDIX y: 
ECHOCARDIOGRAPHIC RESULTS STRATIFIED ON LV FUNCTIONAL 
RESERVE (Asymptomatic Group) 
GROUP 2A(n=13) 
DEDI DES! FS R/Th SWS CSA 
*S .A. 4.2 2.8 33 3.2 473 23 
*M.B. 4.2 2.7 36 4.8 670 16 
*S .. C. 3.5 2.3 36 3 .o 354 22 
*A. C. 5.5 3.6 34 2.9 409 36 
*P.J. 4.5 3 .o 33 3 .o 420 26 
*J.J. 4.2 3 .o 27 2.2 396 38 
*S.M. 3.3 2.2 34 2.5 369 27 
*F.N. 4.3 3.2 25 2.9 401 26 
*N.O. 3.5 2.1 40 2.6 418 33 
*J.P. 3.6 2.2 40 2.7 460 29 
*C.V. 3.5 2.2 36 2.8 330 20 
*D.V. 3.3 2.2 33 2.5 305 28 
*A.W. 3.5 2.4 31 2.6 416 20 
' 
MEAN 3.9 2.6 34 2.9 417 26 
±SD 0.6 0. 5 4 0.6 90 6 
GROUP 2B(n=15) 
L.A. 4.6 3.1 32 3 .o 473 31 
S .A. 4.5 3.1 32 4.8 950 21 
G.D. 4.3 2.9 33 3.0 480 32 
D.D. 3.9 2.6 34 2~8 477 35 
H.H. 4.7 3.4 27 2.9 433 36 
K.K. 4.5 3.1 30 3.3 491 29 
P.M. 5.5 3.4 38 3.8 760 27 
M.P. 4.1 3 .o 26 2.3 369 30 
I.R. 4.8 3.2 33 2.8 482 47 
S.R. 4.0 2.5 37 2.5 375 27 
w.s. 3.7 2.2 40 2.3 341 21 
T.S. 4.3 2.6 39 3.5 490 30 
A.T. 4.7 3.3 30 3.0 420 32 
VdS. 4.5 2.9 34 3.4 547 36 
L.V. 4.9 3.3 34 3.3 600 35 
MEAN 4.5 3.0 33 3.1 513 31 
±_SD 0.4 0.4 4 0.6 158 6 
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APPENDIX VI: 
PRE- AND POSTOPERATIVE ECHOCARDIOGRAPHIC, HAEMODYNAMIC 
AND RADIONUCLIDE VARIABLES IN PATIENTS WITH NORMAL AND 
ABNORMAL LV MASS FOLLOWING AVR: (Mean + S.D. ) 
NORMAL CSA (n = 8) ABNORMAL CSA (n = 6) 
PRE-OP PO STOP PRE-OP PO STOP 
CSA 28.5 + 10.1 16.4 + 2.7 36.1 + 5.5 29.1 + 2.3 
EDV 6.9 + 0.9 4.8 + 2.2 7.6 + 1.0 5.6 + 1.4 
sws 486 + 95 292 + 48 452 + 139 310 + 146 
FS 28 + 11 32 + 6 33 + 6 32 + 16 
HR 90 + 16 80 + 29 86 + 11 75 + 12 
R 
PCWP 12 + 4 13 + 4 18 + 4 16 + 5 
R 
EFR 50 + 16 63 + 12 54 + 13 64 + 22 
PFR 1.97+ 1.11 3.17±,1.36 2.27± 0.88 2.33± 0.83 
R 
ADFR 0.99+ 0.53 1.47± 0.69 1.15± o. 49 1.05± o. 37 
R 
HR 162 + 12 162 + 19 134 + 13 156 + 16 
EX 
PCWP 31 + 11 25 + 10 31 + 13 35 + 8 
EX 
EF 44 +·. 20 67 + 16 41 + 11 59 + 25 
EX 
PFR 3.04+ 1. 30 5.62± 1. 22 2.92± 1.03 3.13± 1. 56 
EX 
ADFR 1. 51± 0.96 3.06 + 0.09 1. 18± 0.51 1.21± o. 59 
EX 
R = Rest 
Ex = Peak Exercise 
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APPENDIX VII: 
SUPINE EXERCISE AT EQUIVALENT EXTERNAL WORKLOADS: 
(LEVEL 1 : 150k-p.m./min) 
SYMPTOMATIC GROUP (n = 31) ASYMPTOMATIC GROUP (n = 28) 
PT HR SBP CI FFI w EF PFR ADFR PT HR SBP CI FFI W EF PFR ADFR 
MA 130 200 4.4 34 34 54 2.48 SA 132 160 6.7 51 13 63 4.00 2.05 
FA 110 230 4.8 44 40 60 LA 120 210 6.3 53 24 54 2.67 1.34 
RA 107 200 6.2 58 15 57 2.86 1.58 SA 100 200 5.7 57 18 56 1.98 1.13 
MB 100 230 4.3 43 45 39 1.55 0. 75 MB_llO 180 5.6 51 25 66 2.63 1. 82 
BB 116 210 5.9 51 32 54 2.72 1.17 sc 100 160 4.8 48 17 66 2.78 1.50 
RC 95 170 3.3 35 23 38 1.31 0.62 AC 100 170 5.4 38 15 55 3.99 2.00 
DD 115 200 6.7 58 29 69 4.43 2.16 GD 120 190 6.0 50 27 53 2.07 1.26 
MdV 120 200 5.1 43 52 56 3.81 1.77 DD 90 190 4.7 52 25 57 2.97 1.46 
EG 125 190. 4. 6 36 25 32 HH 110 180 7.4 68 21 51 2.00 1.07 
KG 130 220 4.8 36 33 49 3.56 1.77 PJ 110 150 5.0 45 15 51 3.52 1.74 
MH 102 220 4.2 41 - 38 JJ 104 180 5.8 56 20 68 2.43 1.52 
BH 116 200 - 38 2.67 0.89 KK 120 190 5.5 46 21 56 3.45 1.71 
EJ 138 240 5.8 42 35 61 3.16 1.65 GM 100 170 5.5 55 15 61 2.61 1.43 
JL 100 145 5.8 58 17 35 2.38 1. 33 PM 85 200 5.5 65 17 58 
NL 145 165 4.8 33 25 31 1.48 0.86 . FN 160 200 6.2 38 30 40 3.23 1.64 
RL 95 150 6.Q 63 15 77 2.77 1.41 NO 90 180 5.1 57 11 65 2.47 1.53 
ML 130 190 2.7 21 50 28 1.59 0.96 MP 168 190 6.4 38 30 67 4.98 2.13 
SM 120 190 5.4 45 18 71 JP 80 190 5.4 68 18 66 1.89 1.18 
HM 132 190 4.2 32 31 33 JR 112 215 ·4.3 39 24 53 3.15 1.56 
NM 130 160 7.3 56 7 78 2.94 SR 110 180 4.9 44 43 57 3.55 1.48 
HM 120 210 4.4 36 23 44 1.78 1.07 ws 108 170 4.0 37 15 59 3.21 1.85 
MN 130 200 7.4 57 25 44 1.75 1.14 TS 110 170 5.4 49 32 39 2.13 o. 91 
EN 140 150 7.5 54 20 56 4.02 1.61 FT 114 150 6.1 53 27 51 2.17 1.36 
JN 120 160 5.5 46 38 66 2.74 1. 74 SvS 95 190 7.9 83 16 60 2.61 1. 64 
PN 96 170 6.1 63 14 56 3.09 1.77 LV 110 210 7.6 69 25 53 2.58 1.33 
GN 110 160 7.9 72 14 60 3.11 1.60 cv 88 130 5.6 64 12 62 2.22 1.41 
NP 120 140 6.1 51 23 46 1.47 o. 57 DV 85 140 5.6 66 25 64 2.86 1. 46 
pp 100 160 5.2 52 29 60 3.07 1.81 AW 170 180 5.4 32 15 68 4.46 2 .. ·17 
MvB 110 180 4 .o 36 33 49 2.83 1.37 
EvH 100 180 49 2.26 1.28 
HW 110 190 5. 7 52 21 56 3.23 1.74 
MEAN117 187 5.4 46 27 51 2.64 1.42 MEANlll 179 5.7 53 21 58 2.91 1. 54 
+SD 14 27 1.3 12 11 14 0.85 o. 53 +SD 23 21 0.9 12 7 8 o. 79 0.32 
PT = patient initials 
HR = heart rate 
SBP = systolic blood pressure 
CI = cardiac index 
FFI = forward flow index 
w = pulmonary capillary wedge pressure 
EF = ejection fraction 
PFR = peak filling rate 
ADFR = average diastolic filling rate 
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APPENDIX VIII: 
SUPINE EXERCISE AT EQUIVALENT EXTERNAL WORKLOADS: 
(LEVEL 2: 300k-p.m./min) 
SYMPTOMATIC GROUP Cn=30) ASYMPTOMATIC GROUP (n=28) 
PT HR SBP CI FFI W EF PFR ADFR PT HR SBP CI FFI W EF PFR ADFR 
MA 160 210 5.8 36 38 52 SA 154 180 7.2 47 11 60 2.46 1.14 
FA 125 250 5.3 43 35 60 4.87 2.35 LA 135 210 8.4 62 22 54 4.02 1.82 
RA 142 230 7.4 52 14 51 3.47 1. 65 SA 110 210 7. 0 63 16 56 2.76 1.60 
MB 130 270 5.7 44 50 36 MB 118 185 6.7 56 22 65 2.89 1. 82 
BB 142 260 6.0 42 31 51 2.34 1.30 s·c 122 170 5.6 46 15 75 3.68 1.92 
RC 110 180 3.6 33 23 31 1.11 0. 47 AC 130 190 7 .o 39 15 58 5.24 2.77 
DD 125 210 8.0 64 26 72 3.93 1.59 GD 128 190 6.2 48 20 51 2.67 1.65 
MdV 140 220 6.6 47 55 52 3.82 1.91 DD 98 210 6.1 62 25 52 3.37 1.78 
EG 142 220 4.8 34 28 28 2.35 0.89 HH 110 180 7.4 68 21 51 2.00 1.07 
MH 110 220 4.3 39 - 35 2.49 1.02 PJ 128 165 6.6 52 18 45 4.62 1.72 
BH 122 220 - 38 2.07 0.96 JJ 115 190 6.9 60 18 73 2.82 1.81 
BJ 130 240 6.1 47 25 57 2.78 1.78 KK 140 220 6.7 48 25 53 3.72 1.82 
JL 115 150 5.5 47 13 38 2.53 1.43 GM 110 180 6.0 54 16 64 2.96 1.90 
NL 150 160 5.0 34 16 31 1.56 0.86 PM 100 200 7 .o 70 18 57 1.89 1.07 
RL 108 175 6.7 62 20 78 3.82 1. 78 FN 168 210 7.2 43 30 40 3.62 1.59 
ML 150 220 3.4 23 45 26 2.01 1.04 NO 100 190 5.8 58 9 65 2.66 1.76 
SM 140 190 5.7 40 24 75 MP 188 210 8.5 45 30 68 4.21 2.02 
HM 148 190 4.1 28 30 28 J.P 90 190 5.9 65 19 69 2.18 1. 49 
NM 150 180 8.3 55 8 77 3.50 IR 126 220 5.1 41 25 50 3.01 1.45 
HM 145 240 5.4 38 26 48 3.61 1. 32 SR 124 190 6.3 51 33 58 3.87 1. 72 
MN 155 220 7.4 48 28 35 2.15 1.00 ws 126 180 5.2 41 16 60 
EN 150 170 7.4 49 20 50 4.12 1. 84 TS 120 190 5.9 49 25 37 2.16 0.91 
JN 140 170 5.7 41 40 71 4.86 2.55 FT 130 170 6.8 52 28 44 1.90 1. 24 
PN 114 200 8.7 76 14 59 3.22 1.59 SvS110 210 7.6 69 18 58 3.45 1. 74 
GN 130 180 9.0 70 15 58 4.88 2.33 LV 130 230 8.3 64 30 50 3.14 1.48 
NP 150 160 8.4 56 37 46 4.07 1. 62 cv 102 140 6.4 63 12 69 2.73 1.48 
PP 110 180 5.8 53 28 61 4.02 2.21 DV 90 160 6.1 68 21 62 3.03 
AW 185 200 5.4 29 14 68 5.01 2.79 
MvB 120 210 4.0 33 35 49 2.88 1.63 
EvH 120 210 - 48 1.44 0.74 
HW 125 210 6.8 55 20 56 3.33 1.61 
MEAN133 205 6.1 46 28 50 3.11 1. 58 MEAN125 192 6.6 54 20 58 3.19 1. 68 
+SD 16 31 1.6 12 12 15 1.09 o. 66 ±_SD 25 20 0.9 11 6 10 0.90 1.29 
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APPENDIX IX: 
SUPINE· EXERCISE AT EQUIVALENT EXTERNAL WORKLOADS: 
(LEVEL 3: 450k-p.m./min) 
SYMPTOMATIC GROUP(n=22) ASYMPTOMATIC GROUP(n:28) 
PT HR SBP CI FFI W EF PFR ADFR PT HR SBP CI FFI W EF PFR ADFR 
MA 170 230 6.2 36 38 52 3.06 1.54 SA 190 210 8.3 44 15 54 3.25 2.02 
FA 150 300 6.6 44 40 54 4.91 2.04 LA 170 230 8.6 50 20 54 4.48 2.88 
RA 167 240 9.7 58 16 50 3.14 1. 41 SA 140 230 8.4 60 15 56 4.67 2.66 
BB 158 270 6.9 44 32 49 2.42 1.42 MB 130 200 7.3 56 25 61 3.07 1. 85 
DD 145 220 9.1 63 26 66 sc 140 180 6.3 45 15 78 3.98 2.70 
MH 124 250 4.9 39 - 32 2.14 0.89 AC 130 210 8.3 64 14 60 5.19 2.51 
EJ 150 260 6.7 45 32 50 3.15 GD 155 200 6.8 44 34 43 
JL 125 160 6.5 52 35 35 3.26 1.18 DD 98 230 8.2 84 25 58 3.77 2.14 
NL 170 180 5.3 31 18 29 1.32 o. 71 HH 140 230 8.6 61 17 55 3.08 1.84 
RL 120 200 8.4 70 16 78 4.34 2.13 PJ 145 170 6.9 48 24 47 3.96 1.84 
ML 160 240 4.5 28 38 24 2.58 1.12 JJ 130 195 8.5 65 18 66 2.84 1.42 
SM 150 200 6.3 42 30 77 KK 160 250 7.5 47 23 55 4.75 2.11 
NM 155 175 9.4 61 8 78 2.80 GM 125 200 7.7 61 15 69 4.77 1.82 
HM 160 250 5.9 37 25 36'1.98 PM 130 220 8.8 49 20 50 3.07 1.29 
MN 180 250 8.1 45 33 36 1. 99 1.04 FN 170 210 7.3 43 25 46 4.05 1.48 
EN 150 170 7.9 53 15 53 5.56 2.56 NO 112 190 6.6 59 8 62 2.91 1.85 
JN 180 170 7.3 40 48 67 4.49 2.58 MP 180 210 8.3 46 25 65 3.54 1.49 
PN 144 210 10.2 71 17 51 3.02 1.33 JP 104 210 7.5 72 15 66 2.54 1.63 
GN 170 210 11.6 68 15 58 6.01 2.94 IR 148 240 5.9 40 31 46 3.97 1.95 
pp 130 210 6.2 48 33 52 2.79 1.41 SR 140 220 7 .o 50 30 50 3.68 1.62 
EvH 130 210 - 43 2.45 1.37 ws 162 200 5.5 34 20 54 
HW 140 240 8.5 61 20 55 3.35 2.00 TS 140 190 6.1 44 28 38 
FT 140 180 8.0 57 26 44 2.05 1.24 
SVS130 230 10.4 80 19 58 4.97 2.12 
LV 160 260 10.5 66 37 44 3.52 1. 92 
cv 115 160 7.9 69 13 68 3.18 1. 84 
DV 100 160 6.5 65 18 64 2.84 1.69 
AW 198 210 6.9 35 15 83 6.33 3.36 
MEAN151 220 7.4 49 27 51 3.26 1. 69 MEAN142 208 7.7 55 21 57 3.78 1.97 













































Average diastolic filling rate 
Systolic aortic pressure 




Aortic valve replacement 
Brookhaven National Laboratories 
Blood pressure 
Body surface area 








Dimension at end-diastole 
Dimension at end-diastole 
Dimension at end-systole 







End-diastolic volume indexed 
End-diastolic volume per second 
Ejection fraction 
Example 
Effective orifice area 
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Equilibrium radionuclide angiocardi~graphj 
End-systolic volume 






















































= Forward flow index 
= Percentage fractional shortening 
= Gram 
= Gram per centimeter cubed 
= Group 
= Symptomatic patients with normal exercise LVEF 
= Symptomatic patients with abnormal exercise 
LVEF 
= Asymptomatic patients with normal exercise 
LVEF 
= Asymptomatic patients 
LVEF 
= Wall thickness 
= Heart rate 
= Infective 
with 
= kilo-pond meters per minute 
= Left anterior oblique 
= Low energy mobile 
= Litres per minute 
abnormal 
= Litres per minute per meter squared 
= Left ventricular 
exercise 
= Left ventricular dimension at end-diastole 
= Left ventricular end-diastolic pressure 
= Left ventricular end-diastolic volume indexed 
= Left ventricular ejection fraction 




= Milliter per beat per minute 
= Millimeter 
= Millimeters of mercury 
= Millimeters per second 
= Miles per hour 
= Medical Data System 
= number of patients 
= National Institutes of Health 
= Not significant 
= New York Heart Association 
= Systolic blood pressure (cuff) 
= Partial pressure of carbon dioxide 
= Pulmonary capillary wedge 




























































Peak filling rate (diastolic) 
Postoperative 
Pre-operative 
Peak systolic gradient 
Peak systolic pressure 
Patient initials 




Angiographic ~egurgitant fraction 
Electromagnetic flowmeter regurgitant 
fraction 
Ribonucleic acid 
Rate pressure product 
Radius to wall thickness ratio 
Systolic blood pressure 
Standard deviation 
Second 
Stroke volume index 
Systolic wall stress 
Posterior wall thickness 
Time to peak filling rate 
Micrometers 
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United States Catheter and Instrument Company 
Namely 
Versus 
Pulmonary capillary wedge pressure 
Systolic wall stress 
Please note that the Echocardiographic dimensions are expressed in 
either centimeters or millimeters. 
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